{"doc_id": 0, "doc": {"person_id": 115969791, "visit_occurrence_id": 99557233, "visit_start_datetime": "2017-04-06 09:51:26", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 109.0, "current_label": 0, "next_value": 137.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2012-05-06 15:04:05, ended at 2012-05-06 15:25:16\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute sinusitis\n- Vitamin D deficiency\n- Primary diagnosis: Acute bronchitis\n- Impaired glucose tolerance test\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-05-06, presumably until 2012-06-20, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- 24 HR testosterone 0.104 MG/HR Transdermal System, through Transdermal route, presumably until 2012-11-25. Instructions: apply 1 Patch to skin daily.  \n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-06-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- 12 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-06-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-20 15:17:45, ended at 2012-06-20 16:06:54\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Testicular hypofunction\n- Impaired glucose tolerance test\n- Vitamin D deficiency\n- Hyperlipidemia\n- Tension-type headache\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-25 15:00:34, ended at 2012-07-25 15:35:53\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance test\n- Neck sprain\n- Testicular hypofunction\n- Injury due to motor vehicle accident\n- Sprain of sacroiliac region\n\n### Drug\n- metaxalone 800 MG Oral Tablet, through Oral route, started on 2012-07-25, presumably until 2013-01-16, with intended 0 refill(s). Instructions: take 800 mg by mouth every bedtime.\n- diclofenac sodium 75 MG Delayed Release Oral Tablet, through Oral route, started on 2012-07-25, presumably until 2013-01-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-22 14:17:05, ended at 2012-08-22 14:56:00\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Injury due to motor vehicle accident\n- Neck sprain\n- Sprain of sacroiliac region\n- Vitamin D deficiency\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-24 15:07:58, ended at 2012-09-24 15:29:49\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchitis\n- Thoracic back sprain\n- Neck sprain\n- Sprain of ligament of lumbosacral joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-25 00:00:00, ended at 2012-11-25 00:00:00\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Testicular hypofunction\n\n### Drug\n- 24 HR testosterone 0.104 MG/HR Transdermal System, through Transdermal route, started on 2012-11-25, presumably until 2013-09-22, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-13 00:00:00, ended at 2013-01-13 00:00:00\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 138 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 13.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Testosterone Free [Mass/volume] in Serum or Plasma: 6.6 (picogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 203 (nanogram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.160 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-16 10:46:15, ended at 2013-01-16 11:17:40\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 7.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n- Hyperlipidemia\n\n### Drug\n- vitamin E, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2013-01-16, presumably until 2013-07-15, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed.\n- wheat germ oil, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- alpha tocopherol, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- omega-3 acid ethyl esters (USP), through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- omega-3 fatty acids, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-09-22. Instructions: take 81 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-08 12:19:16, ended at 2013-04-08 13:01:16\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 7.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- ciclesonide 0.037 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2014-09-22. Instructions: 1 Spray by Nasal route Every Day. One sample\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-18 00:00:00, ended at 2013-09-18 00:00:00\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Testicular hypofunction\n\n### Drug\n- 24 HR testosterone 0.167 MG/HR Transdermal System, started on 2013-09-18, presumably until 2013-12-05, with intended 3 refill(s). Instructions: APPLY ONE PATCH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-05 00:00:00, ended at 2013-12-05 00:00:00\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Testicular hypofunction\n\n### Drug\n- 24 HR testosterone 0.167 MG/HR Transdermal System, through Topical route, started on 2013-12-05, presumably until 2014-09-22, with intended 3 refill(s). Instructions: 4 mg by Topical route Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2014-01-20, presumably until 2014-09-22, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-22 09:15:08, ended at 2014-01-22 10:04:24\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance test\n- Testicular hypofunction\n- Vitamin D deficiency\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, presumably until 2014-09-22. Instructions: take 250 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-22 15:03:11, ended at 2014-09-22 16:04:31\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Acute upper respiratory infection\n- Acute pharyngitis\n- Testicular hypofunction\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- 24 HR testosterone 0.167 MG/HR Transdermal System, through Topical route, started on 2014-09-22, presumably until 2018-11-29, with intended 3 refill(s). Instructions: 4 mg by Topical route Every Day.\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2014-09-22, presumably until 2014-12-28, with intended 0 refill(s). Instructions: take 1 tablet by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-04 00:00:00, ended at 2014-12-04 00:00:00\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2014-12-04, presumably until 2015-01-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-10 15:42:01, ended at 2014-12-10 16:58:58\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tinea of perianal region\n\n### Drug\n- nystatin 100 UNT/MG / triamcinolone acetonide 0.001 MG/MG Topical Ointment, started on 2014-12-10, presumably until 2015-09-28, with intended 0 refill(s). Instructions: Apply twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-28 00:00:00, ended at 2014-12-28 00:00:00\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pharyngitis\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2014-12-28, presumably until 2015-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2015-01-16, presumably until 2017-06-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-24 11:13:09, ended at 2015-02-24 11:43:32\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Upper respiratory tract infection due to Influenza\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2015-02-24, presumably until 2015-08-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed.\n- oseltamivir 75 MG Oral Capsule, through Oral route, started on 2015-02-24, presumably until 2015-09-28, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-01 00:00:00, ended at 2015-03-01 00:00:00\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2015-03-01, presumably until 2015-09-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-28 11:48:24, ended at 2015-09-28 12:25:00\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Disorder of kidney and/or ureter\n- Vitamin D deficiency\n- Testicular hypofunction\n- Hyperlipidemia\n- Impaired glucose tolerance test\n- Primary diagnosis: Pilonidal cyst\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2015-09-28, presumably until 2015-10-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-03 15:22:08, ended at 2016-02-03 15:39:21\nThe patient in this visit was 55 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute sinusitis\n\n### Drug\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2016-02-03, presumably until 2016-02-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-14 14:22:32, ended at 2016-11-14 15:29:30\nThe patient in this visit was 55 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.1 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 141 (milligram per deciliter calculated)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.0 (calculated)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.5 (calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 311 (milligram per deciliter calculated)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.9 (percent hemoglobin)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 239 (nanogram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.13 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Testosterone Free [Mass/volume] in Serum or Plasma: 52.1 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.32 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 265 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Pure hypercholesterolemia\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Constipation\n\n### Drug\n- dicyclomine hydrochloride 10 MG Oral Capsule, through Oral route, started on 2016-11-14, presumably until 2017-06-01, with intended 3 refill(s). Instructions: take 1 Cap by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-28 16:23:25, ended at 2016-12-28 16:56:26\nThe patient in this visit was 55 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Impaired glucose tolerance\n- Steatosis of liver\n- Testicular hypofunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-25 10:37:47, ended at 2017-01-25 11:31:17\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Headache\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Pure hypercholesterolemia\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, presumably until 2018-11-15, with intended 0 refill(s). Instructions: take 500 mg by mouth 3 times a day Pt takes prior to dental cleanings due to mitral prolapse\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2017-08-02, with intended 4 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2018-01-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2001-08-30, presumably until 2017-11-09, with intended 0 refill(s). Instructions: Shake well and inhale 2 puffs every 4 to 6 hours as needed for wheezing or shortness of breath.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-02 10:51:03, ended at 2017-02-02 11:49:33\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- latanoprost 0.05 MG/ML Ophthalmic Solution, started on 2017-01-26, presumably until 2017-01-26, with intended 6 refill(s). Instructions: INSTILL 1 DROP INTO BOTH EYES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-06 15:52:06, ended at 2017-02-06 16:58:20\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.17 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.5 (percent hemoglobin)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 261 (milligram per deciliter calculated)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus without complication\n- Vitamin D deficiency\n- Primary diagnosis: Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 11:12:28, ended at 2017-02-09 11:58:49\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Pure hypercholesterolemia\n- Vitamin D deficiency\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-07 16:28:15, ended at 2017-03-07 17:07:31\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Removal impacted cerumen requiring instrumentation, unilateral\n\n### Condition\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Impacted cerumen\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-02 00:00:00, ended at 2017-04-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-04 13:45:00, ended at 2017-04-04 23:59:00\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-04 14:11:23, ended at 2017-04-04 15:17:59\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9.5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-06 09:51:26, ended at 2017-04-06 10:09:29\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent hemoglobin)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.4 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 42 (milligram per deciliter calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.29 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 175 (milligram per deciliter calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Acute bronchitis\n- Vitamin D deficiency\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2017-04-06, presumably until 2017-06-01, with intended 0 refill(s). Instructions: take 5-10 mL by mouth 3 times a day as needed for Cough\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, started on 2017-03-17, presumably until 2018-11-15, with intended 0 refill(s). Instructions: RINSE TWICE A DAY\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2017-04-06, presumably until 2017-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day for 3 days\n\n", "cumulated_visit_num": 33, "cumulated_approximate_token_count": 7694}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-06 15:04:05, ended at 2012-05-06 15:25:16\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute sinusitis\n- Vitamin D deficiency\n- Primary diagnosis: Acute bronchitis\n- Impaired glucose tolerance test\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-05-06, presumably until 2012-06-20, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed for Cough.\n- 24 HR testosterone 0.104 MG/HR Transdermal System, through Transdermal route, presumably until 2012-11-25. Instructions: apply 1 Patch to skin daily.  \n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-06-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- 12 HR guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet, through Oral route, started on 2012-05-06, presumably until 2012-06-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-20 15:17:45, ended at 2012-06-20 16:06:54\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Testicular hypofunction\n- Impaired glucose tolerance test\n- Vitamin D deficiency\n- Hyperlipidemia\n- Tension-type headache\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-25 15:00:34, ended at 2012-07-25 15:35:53\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance test\n- Neck sprain\n- Testicular hypofunction\n- Injury due to motor vehicle accident\n- Sprain of sacroiliac region\n\n### Drug\n- metaxalone 800 MG Oral Tablet, through Oral route, started on 2012-07-25, presumably until 2013-01-16, with intended 0 refill(s). Instructions: take 800 mg by mouth every bedtime.\n- diclofenac sodium 75 MG Delayed Release Oral Tablet, through Oral route, started on 2012-07-25, presumably until 2013-01-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-08-22 14:17:05, ended at 2012-08-22 14:56:00\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Injury due to motor vehicle accident\n- Neck sprain\n- Sprain of sacroiliac region\n- Vitamin D deficiency\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-09-24 15:07:58, ended at 2012-09-24 15:29:49\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute bronchitis\n- Thoracic back sprain\n- Neck sprain\n- Sprain of ligament of lumbosacral joint\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-25 00:00:00, ended at 2012-11-25 00:00:00\nThe patient in this visit was 51 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Testicular hypofunction\n\n### Drug\n- 24 HR testosterone 0.104 MG/HR Transdermal System, through Transdermal route, started on 2012-11-25, presumably until 2013-09-22, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-13 00:00:00, ended at 2013-01-13 00:00:00\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 78 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 232 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 138 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 13.5 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Testosterone Free [Mass/volume] in Serum or Plasma: 6.6 (picogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 203 (nanogram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.160 (micro-international unit per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.99 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-16 10:46:15, ended at 2013-01-16 11:17:40\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 7.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n- Hyperlipidemia\n\n### Drug\n- vitamin E, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2013-01-16, presumably until 2013-07-15, with intended 1 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed.\n- wheat germ oil, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- alpha tocopherol, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- omega-3 acid ethyl esters (USP), through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- omega-3 fatty acids, through Oral route, presumably until 2014-09-22. Instructions: take 2,000 mg by mouth Every Day.  \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2014-09-22. Instructions: take 81 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-08 12:19:16, ended at 2013-04-08 13:01:16\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 7.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis due to pollen\n\n### Drug\n- ciclesonide 0.037 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2014-09-22. Instructions: 1 Spray by Nasal route Every Day. One sample\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-18 00:00:00, ended at 2013-09-18 00:00:00\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Testicular hypofunction\n\n### Drug\n- 24 HR testosterone 0.167 MG/HR Transdermal System, started on 2013-09-18, presumably until 2013-12-05, with intended 3 refill(s). Instructions: APPLY ONE PATCH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-12-05 00:00:00, ended at 2013-12-05 00:00:00\nThe patient in this visit was 52 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Testicular hypofunction\n\n### Drug\n- 24 HR testosterone 0.167 MG/HR Transdermal System, through Topical route, started on 2013-12-05, presumably until 2014-09-22, with intended 3 refill(s). Instructions: 4 mg by Topical route Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-20 00:00:00, ended at 2014-01-20 00:00:00\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Anxiety state\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2014-01-20, presumably until 2014-09-22, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-22 09:15:08, ended at 2014-01-22 10:04:24\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance test\n- Testicular hypofunction\n- Vitamin D deficiency\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, presumably until 2014-09-22. Instructions: take 250 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-22 15:03:11, ended at 2014-09-22 16:04:31\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Acute upper respiratory infection\n- Acute pharyngitis\n- Testicular hypofunction\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- 24 HR testosterone 0.167 MG/HR Transdermal System, through Topical route, started on 2014-09-22, presumably until 2018-11-29, with intended 3 refill(s). Instructions: 4 mg by Topical route Every Day.\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2014-09-22, presumably until 2014-12-28, with intended 0 refill(s). Instructions: take 1 tablet by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-04 00:00:00, ended at 2014-12-04 00:00:00\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2014-12-04, presumably until 2015-01-16, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-12-10 15:42:01, ended at 2014-12-10 16:58:58\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Tinea of perianal region\n\n### Drug\n- nystatin 100 UNT/MG / triamcinolone acetonide 0.001 MG/MG Topical Ointment, started on 2014-12-10, presumably until 2015-09-28, with intended 0 refill(s). Instructions: Apply twice a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-28 00:00:00, ended at 2014-12-28 00:00:00\nThe patient in this visit was 53 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pharyngitis\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2014-12-28, presumably until 2015-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-01-16 00:00:00, ended at 2015-01-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2015-01-16, presumably until 2017-06-01, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH AT BEDTIME AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-02-24 11:13:09, ended at 2015-02-24 11:43:32\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Upper respiratory tract infection due to Influenza\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2015-02-24, presumably until 2015-08-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 6 hours as needed.\n- oseltamivir 75 MG Oral Capsule, through Oral route, started on 2015-02-24, presumably until 2015-09-28, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-01 00:00:00, ended at 2015-03-01 00:00:00\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute bronchitis\n\n### Drug\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2015-03-01, presumably until 2015-09-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-09-28 11:48:24, ended at 2015-09-28 12:25:00\nThe patient in this visit was 54 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Disorder of kidney and/or ureter\n- Vitamin D deficiency\n- Testicular hypofunction\n- Hyperlipidemia\n- Impaired glucose tolerance test\n- Primary diagnosis: Pilonidal cyst\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2015-09-28, presumably until 2015-10-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 10 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-03 15:22:08, ended at 2016-02-03 15:39:21\nThe patient in this visit was 55 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute sinusitis\n\n### Drug\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2016-02-03, presumably until 2016-02-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily for 3 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-14 14:22:32, ended at 2016-11-14 15:29:30\nThe patient in this visit was 55 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.11 (million per liter)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 210 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 9.1 (femtoliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.3 (nanogram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 141 (milligram per deciliter calculated)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.0 (calculated)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.5 (calculated)\n- Hemoglobin [Mass/volume] in Blood: 14.9 (gram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.3 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 311 (milligram per deciliter calculated)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.9 (percent hemoglobin)\n- Platelets [#/volume] in Blood by Automated count: 208 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 239 (nanogram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.13 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Testosterone Free [Mass/volume] in Serum or Plasma: 52.1 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.32 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 8 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 265 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Pure hypercholesterolemia\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Constipation\n\n### Drug\n- dicyclomine hydrochloride 10 MG Oral Capsule, through Oral route, started on 2016-11-14, presumably until 2017-06-01, with intended 3 refill(s). Instructions: take 1 Cap by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-12-28 16:23:25, ended at 2016-12-28 16:56:26\nThe patient in this visit was 55 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Impaired glucose tolerance\n- Steatosis of liver\n- Testicular hypofunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-25 10:37:47, ended at 2017-01-25 11:31:17\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Headache\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n- Pure hypercholesterolemia\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, presumably until 2018-11-15, with intended 0 refill(s). Instructions: take 500 mg by mouth 3 times a day Pt takes prior to dental cleanings due to mitral prolapse\n- metformin hydrochloride 1000 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2017-08-02, with intended 4 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2017-01-25, presumably until 2018-01-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, started on 2001-08-30, presumably until 2017-11-09, with intended 0 refill(s). Instructions: Shake well and inhale 2 puffs every 4 to 6 hours as needed for wheezing or shortness of breath.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-02 10:51:03, ended at 2017-02-02 11:49:33\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Vitamin D deficiency\n- Pure hypercholesterolemia\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- latanoprost 0.05 MG/ML Ophthalmic Solution, started on 2017-01-26, presumably until 2017-01-26, with intended 6 refill(s). Instructions: INSTILL 1 DROP INTO BOTH EYES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-06 15:52:06, ended at 2017-02-06 16:58:20\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.17 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.5 (percent hemoglobin)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 261 (milligram per deciliter calculated)\n- Hyaline casts [#/area] in Urine sediment by Microscopy low power field: NONE SEEN (per low powered field)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Bacteria [#/area] in Urine sediment by Microscopy high power field: NONE SEEN (per high power field)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Type 2 diabetes mellitus without complication\n- Vitamin D deficiency\n- Primary diagnosis: Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-09 11:12:28, ended at 2017-02-09 11:58:49\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of kidney and/or ureter\n- Pure hypercholesterolemia\n- Vitamin D deficiency\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-07 16:28:15, ended at 2017-03-07 17:07:31\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Removal impacted cerumen requiring instrumentation, unilateral\n\n### Condition\n- Disorder of kidney and/or ureter\n- Primary diagnosis: Impacted cerumen\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-02 00:00:00, ended at 2017-04-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-04 13:45:00, ended at 2017-04-04 23:59:00\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-04 14:11:23, ended at 2017-04-04 15:17:59\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9.5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Dizziness and giddiness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-06 09:51:26, ended at 2017-04-06 10:09:29\nThe patient in this visit was 56 years old, unknown race, unknown ethnicity, MALE.\n\n### Measurement\n- Body height: 5' 9.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.1 (percent hemoglobin)\n- Triglyceride [Moles/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.4 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.4 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 42 (milligram per deciliter calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.29 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 175 (milligram per deciliter calculated)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Acute bronchitis\n- Vitamin D deficiency\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2017-04-06, presumably until 2017-06-01, with intended 0 refill(s). Instructions: take 5-10 mL by mouth 3 times a day as needed for Cough\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, started on 2017-03-17, presumably until 2018-11-15, with intended 0 refill(s). Instructions: RINSE TWICE A DAY\n- azithromycin 500 MG Oral Tablet, through Oral route, started on 2017-04-06, presumably until 2017-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day for 3 days\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 109.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d4b146d9af6ab0ddd2d539ac3f568ce067de6f26a19173e9bfec2261b41bf74b", "prompt_hash": "37d334985b35df6b891e33c5fe7941c91ff07e8d6a5ce65961eda3ce34db07eb", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115969842, "visit_occurrence_id": 46071774, "visit_start_datetime": "2011-11-21 10:44:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 200.0, "current_label": 0, "next_value": 160.5, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2009-01-08 00:00:00, ended at 2009-01-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-22 12:55:31, ended at 2009-11-22 17:40:53\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-29 09:44:00, ended at 2009-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 119 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 09:30:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study\n\n### Condition\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-03 00:00:00, ended at 2010-01-03 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-01-04 00:00:00, ended at 2010-01-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-26 11:20:22, ended at 2010-01-26 15:28:03\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-01-26 13:39:00, ended at 2010-01-26 20:14:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Disorder of cardiovascular system\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-28 00:00:00, ended at 2010-01-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyanosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-28 08:19:58, ended at 2010-01-28 09:43:49\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-28 09:51:00, ended at 2010-01-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 14:17:57, ended at 2010-02-11 14:42:27\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-23 08:56:07, ended at 2010-11-23 11:57:55\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Visual disturbance\n- Hyperlipidemia\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2010-11-23, presumably until 2010-11-24, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:21:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-28 13:16:40, ended at 2010-12-28 13:55:25\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 09:54:08, ended at 2011-01-02 10:38:28\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-28 10:53:15, ended at 2011-02-28 13:13:17\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-28 00:00:00, ended at 2011-07-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-04 22:20:00, ended at 2011-08-05 03:26:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 36.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Hyperlipidemia\n- Dizziness and giddiness\n- Nuclear senile cataract\n- Essential hypertension\n- Gastroesophageal reflux disease\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-05 10:45:10, ended at 2011-09-05 11:33:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Right lower quadrant pain\n- Diarrhea\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-09-05, presumably until 2011-10-30, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Deficiency anemias\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:40:00, ended at 2011-09-20 12:30:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.04 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 455 (picogram per milliliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n\n### Condition\n- Right lower quadrant pain\n- Deficiency anemias\n- Diarrhea\n- Disorder of intestine\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n- midazolam 1 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-10-21 21:47:00, ended at 2011-10-22 00:08:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Essential hypertension\n- Nausea and vomiting\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n- Chest pain\n- Dizziness and giddiness\n- Disorder of function of stomach\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-10-21, presumably until 2011-10-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-30 11:03:49, ended at 2011-10-30 11:52:44\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-21 08:54:05, ended at 2011-11-21 10:26:50\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2012-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2013-02-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-21 10:44:00, ended at 2011-11-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 343 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Disorder of hematopoietic structure\n- Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 27, "cumulated_approximate_token_count": 7080}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-01-08 00:00:00, ended at 2009-01-08 00:00:00\nThe patient in this visit was 64 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2010-01-03, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-22 12:55:31, ended at 2009-11-22 17:40:53\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-29 09:44:00, ended at 2009-11-29 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 119 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.5 (ratio)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.4 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-30 09:30:00, ended at 2009-12-30 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; complete study\n\n### Condition\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-03 00:00:00, ended at 2010-01-03 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-03, presumably until 2010-01-04, with quantity of 30.0, with intended 0 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-01-04 00:00:00, ended at 2010-01-04 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-12-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-26 11:20:22, ended at 2010-01-26 15:28:03\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-01-26 13:39:00, ended at 2010-01-26 20:14:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.47 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 122 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 216 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- MCH [Entitic mass] by Automated count: 35.5 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Erythrocyte sedimentation rate: 6 (millimeter per hour)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Eruption\n- Disorder of cardiovascular system\n- Pain in limb\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-01-28 00:00:00, ended at 2010-01-28 00:00:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cyanosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-28 08:19:58, ended at 2010-01-28 09:43:49\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-28 09:51:00, ended at 2010-01-28 23:59:00\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 14:17:57, ended at 2010-02-11 14:42:27\nThe patient in this visit was 65 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory dermatosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-23 08:56:07, ended at 2010-11-23 11:57:55\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Visual disturbance\n- Hyperlipidemia\n\n### Drug\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., through Subcutaneous route, started on 2010-11-23, presumably until 2010-11-24, with quantity of 1.0, with intended 0 refill(s). Instructions: 0.5 mL by SUBCUTANEOUS route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-23 10:21:00, ended at 2010-11-23 23:59:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.0 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.0 (ratio)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- General examination of patient\n\n### Condition\n- Essential hypertension\n- Hyperlipidemia\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-12-28 13:16:40, ended at 2010-12-28 13:55:25\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. ID#wrxa12241055 \n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2010-12-28, presumably until 2011-11-07, with quantity of 90.0, with intended 3 refill(s). Instructions: take 20 mg by mouth daily. ID#wrxa12241055 \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-01-02 09:54:08, ended at 2011-01-02 10:38:28\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of left eye: 15 (millimeter mercury column)\n- Intraocular pressure of right eye: 16 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-02-28 10:53:15, ended at 2011-02-28 13:13:17\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Determination of refractive state\n\n### Condition\n- Primary diagnosis: Nuclear senile cataract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2011-07-28 00:00:00, ended at 2011-07-28 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-04 22:20:00, ended at 2011-08-05 03:26:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.79 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.78 (million per microliter)\n- MCH [Entitic mass] by Automated count: 36.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n\n### Condition\n- Hyperlipidemia\n- Dizziness and giddiness\n- Nuclear senile cataract\n- Essential hypertension\n- Gastroesophageal reflux disease\n\n### Drug\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed.\n- meclizine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2011-08-05, presumably until 2011-09-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-05 10:45:10, ended at 2011-09-05 11:33:54\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Right lower quadrant pain\n- Diarrhea\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2011-09-05, presumably until 2011-10-30, with intended 0 refill(s). Instructions: take 420 g by mouth as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-09-20 00:00:00, ended at 2011-09-20 00:00:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Deficiency anemias\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-20 08:40:00, ended at 2011-09-20 12:30:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.04 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.9 (nanogram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 455 (picogram per milliliter)\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Colonoscopy, flexible; with biopsy, single or multiple\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Endoscopic biopsy of large intestine\n\n### Condition\n- Right lower quadrant pain\n- Deficiency anemias\n- Diarrhea\n- Disorder of intestine\n\n### Drug\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n- midazolam 1 MG/ML Injectable Solution, started on 2011-09-20, presumably until 2011-09-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-10-21 21:47:00, ended at 2011-10-22 00:08:00\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 36.8 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.8 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.96 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Essential hypertension\n- Nausea and vomiting\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n- Chest pain\n- Dizziness and giddiness\n- Disorder of function of stomach\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-10-21, presumably until 2011-10-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-10-30 11:03:49, ended at 2011-10-30 11:52:44\nThe patient in this visit was 66 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Irritable bowel syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2011-11-07 00:00:00, ended at 2011-11-07 00:00:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n\n### Drug\n- simvastatin 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n- olmesartan medoxomil 20 MG Oral Tablet, started on 2011-11-07, presumably until 2011-11-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-21 08:54:05, ended at 2011-11-21 10:26:50\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Hyperlipidemia\n- Benign paroxysmal positional vertigo\n\n### Drug\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2012-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- olmesartan medoxomil 20 MG Oral Tablet, through Oral route, started on 2011-11-21, presumably until 2013-02-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-21 10:44:00, ended at 2011-11-21 23:59:00\nThe patient in this visit was 67 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 18 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 44 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 123 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.3 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 343 (picogram per milliliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Disorder of hematopoietic structure\n- Benign paroxysmal positional vertigo\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 200.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "40bb1a874db3a28692399754696afa7690c10048f04509d714183df6aa00a946", "prompt_hash": "df225912f5314a1a57bd2e80a8b117b6276ca481feccafc043f40a47459a0d52", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115970189, "visit_occurrence_id": 61556773, "visit_start_datetime": "2014-05-09 12:59:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 148.0, "current_label": 0, "next_value": 177.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Hospital, started at 2008-02-01 13:51:00, ended at 2008-02-01 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-15 13:45:00, ended at 2010-08-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-31 13:45:00, ended at 2010-08-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-15 11:30:00, ended at 2010-10-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-31 11:30:00, ended at 2010-10-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-12 11:30:00, ended at 2010-11-12 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-30 14:10:00, ended at 2010-11-30 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-17 08:15:00, ended at 2010-12-17 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-28 08:15:00, ended at 2010-12-28 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 08:50:00, ended at 2011-01-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-31 08:50:00, ended at 2011-01-31 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 09:00:00, ended at 2011-04-16 10:06:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 10:07:00, ended at 2011-04-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 20 ML adenosine 3 MG/ML Injection, through Intravenous route, started on 2011-04-16, presumably until 2011-04-16\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-02-27. Instructions: take 3 Tabs by mouth 3 times a day with meals. \n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth every bedtime.\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take 10 mg by mouth daily. \n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-06. Instructions: inject  subcutaneous (under the skin). 3 units before bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-26 00:00:00, ended at 2011-04-26 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-04 00:00:00, ended at 2011-07-04 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-04 15:55:44, ended at 2011-07-04 17:55:02\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-04 17:06:00, ended at 2011-07-04 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Prothrombin time (PT): 14.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 132 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-26 16:11:00, ended at 2011-11-27 13:30:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Body height: 5' 4\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.7 (percent)\n- Prothrombin time (PT): 13.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extracranial arteries; complete bilateral study\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of carotid artery\n- End-stage renal disease\n- Lung field abnormal\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- Cardiovascular symptoms\n- Transplanted kidney present\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-05 11:08:11, ended at 2011-12-05 12:13:27\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-09 08:51:00, ended at 2011-12-10 15:10:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.91 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 55 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 74 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n\n### Procedure\n- Procedure on single vessel\n- Pre-surgery evaluation\n- Endarterectomy, other vessels of head and neck\n- Hemodialysis\n\n### Condition\n- End-stage renal disease\n- Disorder of kidney due to diabetes mellitus\n- Chronic kidney disease stage 5 due to hypertension\n- Primary diagnosis: Postprocedural state finding\n- Disorder of carotid artery\n\n### Drug\n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-09. Instructions: take 20 mg by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. Patient use colace while using narcotic pain medication such as (vicodin, norco, percocet, etc) for pain control.  they may stop taking colace after no longer using that for pain control.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10. Instructions: take 10 mg by mouth daily.\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-12-10, presumably until 2011-12-10\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-09, presumably until 2011-12-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2011-12-10\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-07 00:00:00, ended at 2012-01-07 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-29 00:40:00, ended at 2012-01-29 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-30 19:27:00, ended at 2012-02-06 16:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.68 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 88 (millimeter mercury column)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 28.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Body height: 5' 3\" (inch (US))\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.5 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 420 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 47.8 (millimeter mercury column)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 99.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Other kidney transplantation\n- Delayed allogeneic transplantation, cadaver donor\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Hemodialysis\n\n### Condition\n- Acute pulmonary edema\n- Hyperkalemia\n- Late effect of medical and surgical care complication\n- Chronic kidney disease stage 5 due to hypertension\n- Ischemic heart disease\n- Retention of urine\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Disorder of kidney due to diabetes mellitus\n- Imaging of thorax abnormal\n- Lung field abnormal\n- Acute tubular necrosis\n- Disorder of carotid artery\n- Urinary tract infectious disease\n- Disorder of transplanted kidney\n- End-stage renal disease\n- Hypoxemia\n- Disorder affecting transplanted structure\n- Iatrogenic hypotension\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-02-05\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-04, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2012-02-01, presumably until 2012-02-02\n- ferrous bisglycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-04, presumably until 2012-02-06\n- ferrous aspartate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- ferrous carbonate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-02\n- ferrous glycine sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-06\n- folic acid, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-01-31, presumably until 2012-01-31\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- teferrol, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth One Time.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-05\n- ferrous asparto glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- ferrous cacodylate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-01-31, presumably until 2012-07-16, with intended 3 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-03\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2012-02-04, presumably until 2012-02-06\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-02, presumably until 2012-02-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-01, presumably until 2012-02-06\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-01-31, presumably until 2012-02-06\n- 100 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-02-01, presumably until 2012-02-04\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-06\n- iron, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. Take as directed for 1 week.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-01\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-05, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-02, presumably until 2012-02-13, with intended 0 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-07-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-04\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take as directed for 1 week.\n- methylprednisolone 125 MG Injection, started on 2012-02-01, presumably until 2012-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-31 00:00:00, ended at 2012-01-31 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-31 14:24:05, ended at 2012-01-31 14:52:56\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-08 09:41:00, ended at 2012-02-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 361 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.94 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-10 09:11:27, ended at 2012-02-10 11:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Transplanted kidney present\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-13. Instructions: take 1 Tab by mouth Every Day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-13. Instructions: inject 1-18 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 10:13:00, ended at 2012-02-10 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 17 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 361 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 360 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 08:54:12, ended at 2012-02-13 11:08:46\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 08:58:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 174 (unit per liter)\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 389 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-17 08:58:55, ended at 2012-02-17 11:07:55\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-07-16. Instructions: take 15 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-02-19. Instructions: take 5 mg by mouth 2 times a day before meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:07:00, ended at 2012-02-17 09:07:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:08:00, ended at 2012-02-17 11:12:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 11:13:00, ended at 2012-02-19 15:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: <1.5 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Body height: 5' 2.992\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 19 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n- Packed blood cell transfusion\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Splitting of blood or blood products, each unit\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; without contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Hydronephrosis\n- Pleural effusion\n- Transplanted kidney present\n- Essential hypertension\n- Imaging of abdomen abnormal\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n- Dyspnea\n- Malaise\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 3 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous bisglycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- ferrous aspartate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous carbonate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous glycine sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- folic acid, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 15 mg by mouth Every Day.\n- teferrol, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-02-18, presumably until 2012-02-19\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous asparto glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cacodylate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day before meals.\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Tabs by mouth 3 times a day with meals.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 2 times a day.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-17, presumably until 2012-02-19\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19\n- iron, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- metoprolol tartrate 100 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth 2 times a day.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2012-02-18, presumably until 2012-02-19\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-20 07:40:00, ended at 2012-02-20 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 216 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 418 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 271 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-20 08:53:50, ended at 2012-02-20 11:00:25\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-24 08:03:00, ended at 2012-02-24 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 224 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 304 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 14 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 383 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 245 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCV [Entitic volume] by Automated count: 92.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Anemia\n- Essential hypertension\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 07:35:00, ended at 2012-02-27 08:26:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 261 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 329 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 220 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 08:27:00, ended at 2012-02-27 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- Essential hypertension\n- Foreign body in genitourinary tract\n- Transplanted kidney present\n- End-stage renal disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-02-27, presumably until 2012-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-27 10:45:02, ended at 2012-02-27 14:30:30\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-02 07:44:00, ended at 2012-03-02 11:56:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.32 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 351 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 236 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-02 09:05:00, ended at 2012-03-02 10:02:24\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-03 09:20:03, ended at 2012-03-03 11:25:29\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Disease of liver\n- Infective pneumonia\n- Transplanted kidney present\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-03 11:36:00, ended at 2012-03-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Infective pneumonia\n- Lung field abnormal\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-05 09:16:00, ended at 2012-03-05 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 225 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 194 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 338 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-05 09:43:43, ended at 2012-03-05 11:00:16\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.843\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 08:33:00, ended at 2012-03-12 14:27:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 251 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 429 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-12 08:58:39, ended at 2012-03-12 10:17:33\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 14:28:00, ended at 2012-03-12 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Pulmonary emphysema\n- Lung field abnormal\n- Transplanted kidney present\n- Infective pneumonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-18 08:54:00, ended at 2012-03-18 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Hydronephrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-19 08:39:00, ended at 2012-03-19 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 211 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 396 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 206 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 236 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-19 09:02:42, ended at 2012-03-19 09:30:53\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-26 09:21:00, ended at 2012-03-26 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 12 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 248 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 79 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-26 09:50:05, ended at 2012-03-26 10:46:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.134\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 20:58:00, ended at 2012-04-05 14:33:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 165 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 17.8 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Kidney disease\n- Retention of urine\n- Anemia\n- Fever\n- Essential hypertension\n\n### Drug\n- epoetin alfa 20000 UNT/ML Injectable Solution, started on 2012-04-02, presumably until 2012-04-02\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-04-04, presumably until 2012-05-28, with intended 2 refill(s). Instructions: take 6 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-02\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-07-16. Instructions: take 5 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-05\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-04-03, presumably until 2012-04-04\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2012-04-01, presumably until 2012-04-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-03-31, presumably until 2012-04-05\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- acetylcysteine 200 MG/ML Inhalation Solution, started on 2012-04-03, presumably until 2012-04-04\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-07-02, with intended 2 refill(s). Instructions: take 2 Caps by mouth daily.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-02\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-09 09:34:50, ended at 2012-04-09 10:19:44\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-09 10:24:00, ended at 2012-04-09 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 336 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 481 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-10 00:00:00, ended at 2012-04-10 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-23 08:09:11, ended at 2012-04-23 08:19:43\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-23 09:27:00, ended at 2012-04-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 171 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 07:33:00, ended at 2012-04-30 09:42:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.9 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.89 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 175 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-30 08:10:00, ended at 2012-04-30 09:14:18\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 11:34:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-14 08:33:10, ended at 2012-05-14 09:44:32\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-14 09:50:00, ended at 2012-05-14 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 341 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 262 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-28 08:48:03, ended at 2012-05-28 09:31:57\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 09:39:00, ended at 2012-05-28 12:02:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.99 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 242 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Lung field abnormal\n- Transplanted kidney present\n- Lymphadenopathy\n- Echinococcosis of liver\n- Late effect of medical and surgical care complication\n- Disorder affecting transplanted structure\n- Imaging of abdomen abnormal\n- Essential hypertension\n- Disorder of lung\n- Hydronephrosis\n- Type 2 diabetes mellitus without complication\n- Disease of liver\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:03:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Infective pneumonia\n- Intra-abdominal and pelvic swelling, mass and lump\n- Disease of liver\n- Transplanted kidney present\n- Hydronephrosis\n- Pulmonary emphysema\n- Lung field abnormal\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-06-04 00:00:00, ended at 2012-06-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 08:27:00, ended at 2012-06-08 08:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.55 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 313 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 09:00:00, ended at 2012-06-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Lymphadenopathy\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-08 10:50:30, ended at 2012-06-08 11:23:47\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-02 08:27:52, ended at 2012-07-02 09:28:07\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, presumably until 2015-12-13. Instructions: take 0.4 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-02 09:27:00, ended at 2012-07-02 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 291 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 203 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-07-14 19:40:00, ended at 2012-07-16 13:15:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n\n### Condition\n- Hypervolemia\n- Postprocedural state finding\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Renal failure syndrome\n- Transplanted kidney present\n- Acute renal failure syndrome\n- Benign prostatic hyperplasia without outflow obstruction\n- Dyspnea\n- Pleural effusion\n- Congestive heart failure\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 10 ML furosemide 10 MG/ML Prefilled Syringe, started on 2012-07-15, presumably until 2012-07-16\n- cyclosporine, presumably until 2012-07-16. Instructions: by Misc.(Non-Drug; Combo Route) route 2 times a day.  \n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2013-01-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-07-15, presumably until 2012-07-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-07-14, presumably until 2012-07-15\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-10-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-07-15, presumably until 2012-07-16\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-07-14, presumably until 2012-07-15\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2012-07-23, with intended 1 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-07-15, presumably until 2012-07-15\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-23 09:31:00, ended at 2012-07-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 293 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.68 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-23 10:10:28, ended at 2012-07-23 11:29:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, presumably until 2012-12-04. Instructions: take 5 mg by mouth 2 times a day before meals. 10mg QAM and 5mg QPM\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2021-06-24. Instructions: take 81 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-31 07:33:00, ended at 2012-08-31 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 278 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-01 08:49:47, ended at 2012-10-01 10:18:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-01 10:22:00, ended at 2012-10-01 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 151 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 304 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-03 09:08:35, ended at 2012-12-03 10:39:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-03 10:36:00, ended at 2012-12-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 261 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-04 00:00:00, ended at 2012-12-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2014-03-11. Instructions: take 2 Tabs by mouth 2 times a day before meals.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2013-02-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-31 08:56:33, ended at 2012-12-31 10:30:02\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-31 10:33:00, ended at 2012-12-31 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 215 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.90 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 447 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 219 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 142 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-01 00:00:00, ended at 2013-01-01 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-04 09:10:56, ended at 2013-01-04 09:44:12\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-04 09:59:00, ended at 2013-01-04 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 156 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 221 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 337 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 173 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-21 08:11:00, ended at 2013-01-21 10:07:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 283 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 272 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-21 08:54:08, ended at 2013-01-21 10:02:05\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2014-03-11. Instructions: take 75 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-22 00:00:00, ended at 2013-02-22 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-22 08:44:41, ended at 2013-02-22 09:43:17\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-22 09:57:00, ended at 2013-02-22 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.67 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 125 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 10:13:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 230 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 276 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiovascular symptoms\n- Transplanted kidney present\n- Disorder of kidney due to diabetes mellitus\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 09:11:21, ended at 2013-07-26 09:45:26\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperplasia of prostate\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Cardiovascular symptoms\n- Essential hypertension\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 09:52:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 207 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.20 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-27 00:00:00, ended at 2013-07-27 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Cardiovascular symptoms\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-03 12:29:00, ended at 2013-08-03 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Cardiovascular symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-25 11:30:00, ended at 2013-08-25 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Cardiovascular symptoms\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-07 12:10:53, ended at 2013-09-07 13:38:58\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; less than 3 cm\n\n### Condition\n- Primary diagnosis: Lipoma of skin and subcutaneous tissue (excluding face)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-14 14:43:33, ended at 2013-09-14 15:15:34\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lipoma of skin and subcutaneous tissue (excluding face)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-27 09:13:46, ended at 2013-09-27 10:21:26\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Postprocedural state finding\n- Peripheral vascular disease\n- Essential hypertension\n- Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2013-09-16, presumably until 2014-03-11. Instructions: 10 mg BID.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-27 10:30:00, ended at 2013-09-27 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 334 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.85 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-28 00:00:00, ended at 2013-09-28 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-05 00:00:00, ended at 2013-10-05 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-05 09:30:00, ended at 2013-10-05 13:11:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Lung field abnormal\n- Cardiovascular symptoms\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-05 13:12:00, ended at 2013-10-05 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 278 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-28 00:00:00, ended at 2013-10-28 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-01 10:30:00, ended at 2013-11-01 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-01 10:36:16, ended at 2013-11-01 12:05:45\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-24 00:00:00, ended at 2014-01-24 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe, through Intramuscular route, started on 2014-01-24, presumably until 2014-01-25, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-24 00:00:00, ended at 2014-01-24 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-24 09:04:00, ended at 2014-01-24 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 332 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 230 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 170 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.92 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.90 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Peripheral vascular disease\n- Hyperlipidemia\n- End-stage renal disease\n- Essential hypertension\n- Transplanted kidney present\n- Disorder of kidney due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 09:51:00, ended at 2014-01-24 10:23:34\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-11 00:00:00, ended at 2014-02-11 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2014-02-11, presumably until 2015-02-11, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-02-21 13:53:00, ended at 2014-03-11 18:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium.ionized [Moles/volume] in Blood: 1.29 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Prothrombin time (PT): 18.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.3 (second)\n- Base deficit in Blood: 8.0 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 55.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.69 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 2.008\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 693 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 446 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 27.7 (microgram per milliliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 284 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 9.2 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 327 (unit per liter)\n- Sodium [Moles/volume] in Blood: 148 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 21.3 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Blood: 37.3 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 97.2 (percent)\n- Oxygen [Partial pressure] in Blood: 72 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 153 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Lactate [Moles/volume] in Blood: 1.4 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 95 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: 6.2 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Thrombin time: 15.4 (second)\n\n### Procedure\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, abdomen; single anteroposterior view\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Noninvasive ventilation\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Controlled ventilation procedure and therapy, initiation and management\n- Evaluation of oral and pharyngeal swallowing function\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n- Insertion of endotracheal tube\n- Hemodialysis\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Insertion of catheter into artery\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Infusion of vasopressor agent\n- Occupational therapy evaluation\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of blood specimen from a completely implantable venous access device\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Central venous catheter placement with guidance\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Computed tomography, thorax, diagnostic; without contrast material\n- Enteral infusion of concentrated nutritional substances\n- Long-term drug therapy\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Hospital discharge day management; 30 minutes or less\n- Physical therapy evaluation\n- Collection of capillary blood specimen (eg, finger, heel, ear stick)\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Arterial puncture, withdrawal of blood for diagnosis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Bronchoscopy and biopsy of bronchus\n\n### Condition\n- Bacterial pneumonia\n- Diarrhea\n- Disorder affecting transplanted structure\n- Disorder of lung\n- Dyspnea\n- Immune defect\n- Kidney disease\n- Pulmonary congestion and hypostasis\n- Altered mental status\n- Cardiomegaly\n- Chronic kidney disease\n- Drug abuse in remission\n- Dysuria\n- Electrocardiogram abnormal\n- Fever\n- Lung field abnormal\n- Pleural effusion\n- Pneumocystosis\n- Respiratory insufficiency\n- Schmorl's nodes\n- Shock\n- Thoracic spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Alcohol abuse\n- Disorder of kidney due to diabetes mellitus\n- Infective pneumonia\n- Severe sepsis\n- Transplanted kidney present\n- Acute tubular necrosis\n- Primary diagnosis: Congestive heart failure\n- Disorder of transplanted kidney\n- Hearing loss\n- Postprocedural state finding\n- Sepsis\n- Type 2 diabetes mellitus\n- Acute renal failure syndrome\n- Acute respiratory failure\n- Anoxic encephalopathy\n- Coronary arteriosclerosis\n- Essential hypertension\n- Pulmonary embolism with pulmonary infarction\n- Acidosis\n- Acute diastolic heart failure\n- Benign hypertensive renal disease with renal failure\n- Benign prostatic hyperplasia with outflow obstruction\n- Candidiasis of mouth\n- Dysphagia\n- Hyperkalemia\n- Left heart failure\n- Atherosclerosis of aorta\n- Delay when starting to pass urine\n- Disorder due to type 2 diabetes mellitus\n- Hyperosmolality and or hypernatremia\n- Metabolic encephalopathy\n- Peripheral vascular disease\n- Septic shock\n- Late effect of medical and surgical care complication\n- Trauma and postoperative pulmonary insufficiency\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2014-02-22, presumably until 2014-03-11\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2014-03-10, presumably until 2015-11-28, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-02-23\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-02-25, presumably until 2014-02-25\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-02-23, presumably until 2014-02-27\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2014-03-05, presumably until 2014-03-05\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2014-03-03, presumably until 2014-03-03\n- haloperidol 5 MG/ML Injectable Solution, started on 2014-03-03, presumably until 2014-03-04\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- voriconazole 200 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-03-05\n- meropenem 500 MG Injection, through Intravenous route, started on 2014-02-25, presumably until 2014-03-07\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2014-02-25, presumably until 2014-03-09\n- cetirizine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-02-24, presumably until 2014-02-24\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2014-02-22, presumably until 2014-02-22\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-22\n- 100 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2014-02-25, presumably until 2014-03-09\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-02-24, presumably until 2014-03-07\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2014-02-22, presumably until 2014-02-22\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2014-02-21, presumably until 2014-02-21\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension, through Oral route, started on 2014-02-23, presumably until 2014-02-25\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2014-03-05, presumably until 2014-03-10\n- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray, through Nasal route, started on 2014-02-24, presumably until 2014-02-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-02-22, presumably until 2014-02-22\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2014-02-21, presumably until 2014-02-24\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2014-02-24, presumably until 2014-03-10\n- oseltamivir 75 MG Oral Capsule, through Oral route, started on 2014-02-22, presumably until 2014-02-23\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-03, presumably until 2014-05-09, with intended 0 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 2 times a day with meals.\n- cyclosporine, modified 100 MG/ML Oral Solution, through Oral route, started on 2014-02-25, presumably until 2014-03-10\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-02-23, presumably until 2014-03-02\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2014-02-28, presumably until 2014-03-11\n- lansoprazole 30 MG Disintegrating Oral Tablet, through Oral route, started on 2014-03-08, presumably until 2014-03-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-02-21, presumably until 2014-03-06\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-24, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily.\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-03-09\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2014-03-05, presumably until 2014-03-09\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-03-09, presumably until 2014-03-09\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-02-21, presumably until 2014-03-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2014-03-12, presumably until 2014-03-24, with intended 0 refill(s). Instructions: take 5 Tabs by mouth daily. Please taper dose down 5mg every two days (25mg->25mg->20mg->20mg->15mg->15mg->10mg->10mg->5mg ->5mg->off)\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2014-02-24, presumably until 2014-02-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-02-21, presumably until 2015-01-30, with intended 0 refill(s). Instructions: inject 4 Units subcutaneous (under the skin) 3 times a day before meals.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-02-26, presumably until 2014-03-09\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-03-05, presumably until 2014-03-05\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-24\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2014-02-22, presumably until 2014-02-22\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-03-02, presumably until 2014-03-08\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2014-02-23, presumably until 2014-02-23\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q48H.\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-03-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2014-02-25, presumably until 2014-02-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-02-23, presumably until 2014-03-10\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2014-02-22, presumably until 2014-02-22\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-22\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2014-03-08, presumably until 2014-03-10\n- oseltamivir 6 MG/ML Oral Suspension, through Oral route, started on 2014-02-24, presumably until 2014-03-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-02-23, presumably until 2014-02-23\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2014-03-02, presumably until 2014-03-02\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-27\n- cefepime 1000 MG Injection, through Intravenous route, started on 2014-02-24, presumably until 2014-02-25\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-24\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2014-02-22, presumably until 2014-03-11\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-02-21\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-02-24, presumably until 2014-02-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-02-24, presumably until 2014-03-02\n- sitagliptin 100 MG Oral Tablet, through Oral route, presumably until 2014-03-11. Instructions: take 100 mg by mouth.\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2014-02-26, presumably until 2014-03-04\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2014-02-28, presumably until 2014-02-28\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2014-03-08, presumably until 2014-03-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-18 07:37:00, ended at 2014-03-18 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Pleural effusion\n- Post-inflammatory pulmonary fibrosis\n- Infective pneumonia\n- Trauma and postoperative pulmonary insufficiency\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-24 07:55:33, ended at 2014-03-24 10:08:41\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2015-11-28. Instructions: take 75 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-26 00:00:00, ended at 2014-04-26 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-02 13:12:00, ended at 2014-05-02 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-02 13:13:27, ended at 2014-05-02 15:08:25\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- sitagliptin 50 MG Oral Tablet, through Oral route, started on 2014-04-20, presumably until 2016-08-29. Instructions: take 100 mg by mouth Every Day \n- glipizide 10 MG Oral Tablet, through Oral route, started on 2014-04-20, presumably until 2016-02-29. Instructions: take 10 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 11:26:59, ended at 2014-05-09 12:54:35\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Retention of urine\n- Essential hypertension\n- Hearing loss\n- Hyperlipidemia\n- Urinary symptoms\n- Peripheral vascular disease\n- Primary diagnosis: Transplanted kidney present\n- Benign prostatic hyperplasia with outflow obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-09 12:59:00, ended at 2014-05-09 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocyte sedimentation rate: 44 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 307 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 125, "cumulated_approximate_token_count": 57021}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-01 13:51:00, ended at 2008-02-01 23:59:00\nThe patient in this visit was 66 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-15 13:45:00, ended at 2010-08-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-31 13:45:00, ended at 2010-08-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-15 11:30:00, ended at 2010-10-15 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-31 11:30:00, ended at 2010-10-31 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-12 11:30:00, ended at 2010-11-12 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-30 14:10:00, ended at 2010-11-30 23:59:00\nThe patient in this visit was 68 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-17 08:15:00, ended at 2010-12-17 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-12-28 08:15:00, ended at 2010-12-28 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-16 08:50:00, ended at 2011-01-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-01-31 08:50:00, ended at 2011-01-31 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 09:00:00, ended at 2011-04-16 10:06:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-04-16 10:07:00, ended at 2011-04-16 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or \n\n### Condition\n- End-stage renal disease\n\n### Drug\n- 20 ML adenosine 3 MG/ML Injection, through Intravenous route, started on 2011-04-16, presumably until 2011-04-16\n- sevelamer hydrochloride 800 MG Oral Tablet, through Oral route, presumably until 2012-02-27. Instructions: take 3 Tabs by mouth 3 times a day with meals. \n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth every bedtime.\n- amlodipine 10 MG Oral Tablet, through Oral route, presumably until 2012-02-13. Instructions: take 10 mg by mouth daily. \n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-06. Instructions: inject  subcutaneous (under the skin). 3 units before bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-04-26 00:00:00, ended at 2011-04-26 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-07-04 00:00:00, ended at 2011-07-04 00:00:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-07-04 15:55:44, ended at 2011-07-04 17:55:02\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-07-04 17:06:00, ended at 2011-07-04 23:59:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Prothrombin time (PT): 14.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.72 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 352 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 132 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.6 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-26 16:11:00, ended at 2011-11-27 13:30:00\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Body height: 5' 4\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 96.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.7 (percent)\n- Prothrombin time (PT): 13.7 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.3 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extracranial arteries; complete bilateral study\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Disorder of carotid artery\n- End-stage renal disease\n- Lung field abnormal\n- Chronic kidney disease stage 5 due to hypertension\n- Disorder of kidney due to diabetes mellitus\n- Cardiovascular symptoms\n- Transplanted kidney present\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-26\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2011-11-27, presumably until 2011-11-27\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-11-26, presumably until 2011-11-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-12-05 11:08:11, ended at 2011-12-05 12:13:27\nThe patient in this visit was 69 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Pre-surgery evaluation\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, presumably until 2012-02-06. Instructions: take 20 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-12-09 08:51:00, ended at 2011-12-10 15:10:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 10.6 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Body height: 5' 2\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.91 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 55 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 74 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n\n### Procedure\n- Procedure on single vessel\n- Pre-surgery evaluation\n- Endarterectomy, other vessels of head and neck\n- Hemodialysis\n\n### Condition\n- End-stage renal disease\n- Disorder of kidney due to diabetes mellitus\n- Chronic kidney disease stage 5 due to hypertension\n- Primary diagnosis: Postprocedural state finding\n- Disorder of carotid artery\n\n### Drug\n- benazepril hydrochloride 20 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-09. Instructions: take 20 mg by mouth every bedtime.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. Patient use colace while using narcotic pain medication such as (vicodin, norco, percocet, etc) for pain control.  they may stop taking colace after no longer using that for pain control.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10. Instructions: take 10 mg by mouth daily.\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-12-10, presumably until 2011-12-10\n- calcium acetate 667 MG Oral Capsule, through Oral route, started on 2011-12-09, presumably until 2011-12-10\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-12-09, presumably until 2011-12-09\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2011-12-10\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-12-10, presumably until 2012-02-06, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-07 00:00:00, ended at 2012-01-07 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-29 00:40:00, ended at 2012-01-29 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- End-stage renal disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-30 19:27:00, ended at 2012-02-06 16:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 98 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.68 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 88 (millimeter mercury column)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 28.9 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.81 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Body height: 5' 3\" (inch (US))\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.5 (millimole per liter)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 47 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 420 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.19 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Base deficit in Blood: 5.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 47.8 (millimeter mercury column)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 99.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Other kidney transplantation\n- Delayed allogeneic transplantation, cadaver donor\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Hemodialysis\n\n### Condition\n- Acute pulmonary edema\n- Hyperkalemia\n- Late effect of medical and surgical care complication\n- Chronic kidney disease stage 5 due to hypertension\n- Ischemic heart disease\n- Retention of urine\n- Acute renal failure syndrome\n- Postprocedural state finding\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Disorder of kidney due to diabetes mellitus\n- Imaging of thorax abnormal\n- Lung field abnormal\n- Acute tubular necrosis\n- Disorder of carotid artery\n- Urinary tract infectious disease\n- Disorder of transplanted kidney\n- End-stage renal disease\n- Hypoxemia\n- Disorder affecting transplanted structure\n- Iatrogenic hypotension\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-02-05\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-04, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2012-02-01, presumably until 2012-02-02\n- ferrous bisglycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-04, presumably until 2012-02-06\n- ferrous aspartate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain.\n- ferrous carbonate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-02-01, presumably until 2012-02-02\n- ferrous glycine sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-06\n- folic acid, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML esmolol hydrochloride 10 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2012-01-31, presumably until 2012-01-31\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- teferrol, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-02\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth One Time.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-05\n- ferrous asparto glycinate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- ferrous cacodylate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-02-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-01-31, presumably until 2012-07-16, with intended 3 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-03\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- sevelamer hydrochloride 400 MG Oral Tablet, through Oral route, started on 2012-02-04, presumably until 2012-02-06\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-02, presumably until 2012-02-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-01, presumably until 2012-02-06\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-01-31, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-01-31, presumably until 2012-02-06\n- 100 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-02-01, presumably until 2012-02-04\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-02-04\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-06\n- iron, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. Take as directed for 1 week.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2012-01-31, presumably until 2012-02-01\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-05, presumably until 2012-04-05, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2013-02-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-02, presumably until 2012-02-13, with intended 0 refill(s). Instructions: inject 5 Units subcutaneous (under the skin) daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2012-01-31, presumably until 2012-01-31\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-03, presumably until 2012-07-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-01, presumably until 2012-07-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-04\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-01-31, presumably until 2012-02-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-05, presumably until 2012-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Take as directed for 1 week.\n- methylprednisolone 125 MG Injection, started on 2012-02-01, presumably until 2012-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-01-31 00:00:00, ended at 2012-01-31 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2012-01-31 14:24:05, ended at 2012-01-31 14:52:56\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-08 09:41:00, ended at 2012-02-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 361 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 294 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 7.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.94 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-10 09:11:27, ended at 2012-02-10 11:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Transplanted kidney present\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2012-02-06, presumably until 2012-02-13. Instructions: take 1 Tab by mouth Every Day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2012-02-13. Instructions: inject 1-18 Units subcutaneous (under the skin) 4 times a day before meals and bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-10 10:13:00, ended at 2012-02-10 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.29 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 17 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Platelets [#/volume] in Blood by Automated count: 361 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.90 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 360 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 6.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pre-surgery evaluation\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-13 08:54:12, ended at 2012-02-13 11:08:46\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-13 08:58:00, ended at 2012-02-13 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 174 (unit per liter)\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.80 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 389 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 131 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.3 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.16 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 402 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-17 08:58:55, ended at 2012-02-17 11:07:55\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-07-16. Instructions: take 15 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-10, presumably until 2012-02-19. Instructions: take 5 mg by mouth 2 times a day before meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:07:00, ended at 2012-02-17 09:07:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 09:08:00, ended at 2012-02-17 11:12:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-17 11:13:00, ended at 2012-02-19 15:05:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 16 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: <1.5 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 92.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Body height: 5' 2.992\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 26.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 19 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n- Packed blood cell transfusion\n- Radiologic examination, chest; single view, frontal\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Splitting of blood or blood products, each unit\n- Collection of venous blood by venipuncture\n- Computed tomography, thorax, diagnostic; without contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Hydronephrosis\n- Pleural effusion\n- Transplanted kidney present\n- Essential hypertension\n- Imaging of abdomen abnormal\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n- Dyspnea\n- Malaise\n\n### Drug\n- polysaccharide iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous gluconate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous fumarate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 3 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 4 Caps by mouth 2 times a day. Take as directed.\n- ferrous ascorbate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n- iron,peptonized, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous succinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous bisglycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cysteine glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- ferrous aspartate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ammonium ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- soy protein-iron complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous carbonate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous glycine sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- folic acid, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron succinyl milk protein complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron-dextran complex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 15 mg by mouth Every Day.\n- teferrol, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2012-02-17, presumably until 2012-02-19\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2012-02-18, presumably until 2012-02-19\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day. Hold for loose stools or diarrhea.\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous asparto glycinate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous cacodylate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day before meals.\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: 5 mL by Swish & Swallow route 3 times a day.\n- sevelamer carbonate 800 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Tabs by mouth 3 times a day with meals.\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 2 times a day.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-02-17, presumably until 2012-02-19\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 3 Caps by mouth 2 times a day.\n- insulin aspart, human 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2012-02-17, presumably until 2012-02-19\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19\n- iron, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- ferrous oxalate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-02-17, presumably until 2012-02-19. Instructions: take 1 Cap by mouth 2 times a day.\n- iron sucrose, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous sulfate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- iron carbonyl, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- ferrous lactate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous chloride, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- metoprolol tartrate 100 MG Oral Tablet, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth 2 times a day.\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2012-02-18, presumably until 2012-02-19\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-02-19, presumably until 2012-02-19. Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- iron sorbitex, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ferrous phosphate, through Oral route, started on 2012-02-18, presumably until 2012-02-19. Instructions: take 1 Tab by mouth daily.\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2012-02-17, presumably until 2012-02-18. Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-20 07:40:00, ended at 2012-02-20 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 182 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 216 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.3 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.8 (percent)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 418 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 15 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 271 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-20 08:53:50, ended at 2012-02-20 11:00:25\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Retention of urine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-24 08:03:00, ended at 2012-02-24 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 224 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 304 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 14 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Globulin [Mass/volume] in Serum: 5.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.81 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 383 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 245 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCV [Entitic volume] by Automated count: 92.6 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Anemia\n- Essential hypertension\n- Retention of urine\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 07:35:00, ended at 2012-02-27 08:26:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 261 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.2 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.74 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 329 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 220 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-02-27 08:27:00, ended at 2012-02-27 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder (separate procedure); simple\n\n### Condition\n- Essential hypertension\n- Foreign body in genitourinary tract\n- Transplanted kidney present\n- End-stage renal disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2012-02-27, presumably until 2012-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-02-27 10:45:02, ended at 2012-02-27 14:30:30\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-02 07:44:00, ended at 2012-03-02 11:56:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 217 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.32 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.1 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Platelets [#/volume] in Blood by Automated count: 351 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.44 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 236 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-02 09:05:00, ended at 2012-03-02 10:02:24\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-03 09:20:03, ended at 2012-03-03 11:25:29\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Acute myeloid leukemia, disease\n- Disease of liver\n- Infective pneumonia\n- Transplanted kidney present\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-03 11:36:00, ended at 2012-03-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Infective pneumonia\n- Lung field abnormal\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-05 09:16:00, ended at 2012-03-05 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 225 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 194 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 35.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.7 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 40 (milliliter per minute per square meter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 338 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.68 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-05 09:43:43, ended at 2012-03-05 11:00:16\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.843\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 08:33:00, ended at 2012-03-12 14:27:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 251 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.3 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 154 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 46 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.02 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 429 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.6 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 213 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-12 08:58:39, ended at 2012-03-12 10:17:33\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-12 14:28:00, ended at 2012-03-12 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Pulmonary emphysema\n- Lung field abnormal\n- Transplanted kidney present\n- Infective pneumonia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-18 08:54:00, ended at 2012-03-18 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Hydronephrosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-19 08:39:00, ended at 2012-03-19 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 211 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 149 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 183 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 396 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 206 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.56 (million per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 236 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 19 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 11.5 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-19 09:02:42, ended at 2012-03-19 09:30:53\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-03-26 09:21:00, ended at 2012-03-26 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 12 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 200 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 248 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 2 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 79 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-03-26 09:50:05, ended at 2012-03-26 10:46:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4.134\" (inch (US))\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-03-30 20:58:00, ended at 2012-04-05 14:33:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 165 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 215 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 17.8 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.79 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.1 (percent)\n- MCHC [Mass/volume] by Automated count: 35.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Radiologic examination, chest; single view, frontal\n- Packed blood cell transfusion\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of kidney due to diabetes mellitus\n- Transplanted kidney present\n- Kidney disease\n- Retention of urine\n- Anemia\n- Fever\n- Essential hypertension\n\n### Drug\n- epoetin alfa 20000 UNT/ML Injectable Solution, started on 2012-04-02, presumably until 2012-04-02\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2012-04-04, presumably until 2012-05-28, with intended 2 refill(s). Instructions: take 6 Caps by mouth 2 times a day.\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2012-03-30, presumably until 2012-04-02\n- pioglitazone 15 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-07-16. Instructions: take 5 mg by mouth Every Day.\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-05\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2012-04-03, presumably until 2012-04-04\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2012-04-01, presumably until 2012-04-05\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2012-03-31, presumably until 2012-04-05\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-03-31, presumably until 2012-04-05\n- acetylcysteine 200 MG/ML Inhalation Solution, started on 2012-04-03, presumably until 2012-04-04\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-03-31, presumably until 2012-03-31\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-03-31, presumably until 2012-07-02, with intended 2 refill(s). Instructions: take 2 Caps by mouth daily.\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-04-01, presumably until 2012-04-05\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2012-03-30, presumably until 2012-04-02\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-04-01, presumably until 2012-04-03\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2012-04-05, presumably until 2012-04-30, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-09 09:34:50, ended at 2012-04-09 10:19:44\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-09 10:24:00, ended at 2012-04-09 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 299 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 336 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.50 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.8 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.30 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 166 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.3 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 215 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 481 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-04-10 00:00:00, ended at 2012-04-10 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-23 08:09:11, ended at 2012-04-23 08:19:43\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-23 09:27:00, ended at 2012-04-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 171 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.17 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 311 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.17 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 07:33:00, ended at 2012-04-30 09:42:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.9 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 213 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.89 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 250 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 175 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-30 08:10:00, ended at 2012-04-30 09:14:18\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-04-30 11:34:00, ended at 2012-04-30 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-14 08:33:10, ended at 2012-05-14 09:44:32\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-14 09:50:00, ended at 2012-05-14 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 341 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.22 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 153 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 32.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 262 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-05-28 08:48:03, ended at 2012-05-28 09:31:57\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 09:39:00, ended at 2012-05-28 12:02:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.99 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 242 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.25 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.1 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Lung field abnormal\n- Transplanted kidney present\n- Lymphadenopathy\n- Echinococcosis of liver\n- Late effect of medical and surgical care complication\n- Disorder affecting transplanted structure\n- Imaging of abdomen abnormal\n- Essential hypertension\n- Disorder of lung\n- Hydronephrosis\n- Type 2 diabetes mellitus without complication\n- Disease of liver\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-05-28 12:03:00, ended at 2012-05-28 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Infective pneumonia\n- Intra-abdominal and pelvic swelling, mass and lump\n- Disease of liver\n- Transplanted kidney present\n- Hydronephrosis\n- Pulmonary emphysema\n- Lung field abnormal\n- Pleural effusion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-06-04 00:00:00, ended at 2012-06-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted kidney\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 08:27:00, ended at 2012-06-08 08:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.55 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 118 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95.9 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 313 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.5 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Disorder of transplanted kidney\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-06-08 09:00:00, ended at 2012-06-08 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Lymphadenopathy\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-06-08 10:50:30, ended at 2012-06-08 11:23:47\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-02 08:27:52, ended at 2012-07-02 09:28:07\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, presumably until 2015-12-13. Instructions: take 0.4 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-02 09:27:00, ended at 2012-07-02 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 46 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.3 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 129 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 291 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 203 (unit per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-07-14 19:40:00, ended at 2012-07-16 13:15:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Body height: 5' 7\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.6 (percent)\n- MCHC [Mass/volume] by Automated count: 34.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 131 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- MCV [Entitic volume] by Automated count: 95.7 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Long-term drug therapy\n\n### Condition\n- Hypervolemia\n- Postprocedural state finding\n- Lung field abnormal\n- Type 2 diabetes mellitus without complication\n- Chronic kidney disease\n- Disorder of transplanted kidney\n- Essential hypertension\n- Renal failure syndrome\n- Transplanted kidney present\n- Acute renal failure syndrome\n- Benign prostatic hyperplasia without outflow obstruction\n- Dyspnea\n- Pleural effusion\n- Congestive heart failure\n- Disorder affecting transplanted structure\n- Late effect of medical and surgical care complication\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 10 ML furosemide 10 MG/ML Prefilled Syringe, started on 2012-07-15, presumably until 2012-07-16\n- cyclosporine, presumably until 2012-07-16. Instructions: by Misc.(Non-Drug; Combo Route) route 2 times a day.  \n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2013-01-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2012-07-15, presumably until 2012-07-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- 10 ML furosemide 10 MG/ML Injection, started on 2012-07-14, presumably until 2012-07-15\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-10-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2012-07-15, presumably until 2012-07-16\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2012-07-14, presumably until 2012-07-15\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- glipizide 10 MG Oral Tablet, through Oral route, started on 2012-07-16, presumably until 2012-07-23, with intended 1 refill(s). Instructions: take 1 Tab by mouth Every Day.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2012-07-15, presumably until 2012-07-16\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2012-07-15, presumably until 2012-07-15\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2012-07-15, presumably until 2012-07-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-07-23 09:31:00, ended at 2012-07-23 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 293 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.68 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 306 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-07-23 10:10:28, ended at 2012-07-23 11:29:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, presumably until 2012-12-04. Instructions: take 5 mg by mouth 2 times a day before meals. 10mg QAM and 5mg QPM\n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2021-06-24. Instructions: take 81 mg by mouth daily.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-08-31 07:33:00, ended at 2012-08-31 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 233 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 295 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.3 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.4 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.16 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 278 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.8 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-01 08:49:47, ended at 2012-10-01 10:18:14\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-10-01 10:22:00, ended at 2012-10-01 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 151 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 201 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 304 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.73 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 254 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 224 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.53 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-03 09:08:35, ended at 2012-12-03 10:39:01\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-03 10:36:00, ended at 2012-12-03 23:59:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 150 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 261 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 204 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-12-04 00:00:00, ended at 2012-12-04 00:00:00\nThe patient in this visit was 70 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- glipizide 5 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2014-03-11. Instructions: take 2 Tabs by mouth 2 times a day before meals.\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2012-12-04, presumably until 2013-02-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-31 08:56:33, ended at 2012-12-31 10:30:02\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Essential hypertension\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-12-31 10:33:00, ended at 2012-12-31 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 20 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 215 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.90 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 447 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 180 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.83 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 219 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 142 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Transplanted kidney present\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-01 00:00:00, ended at 2013-01-01 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-04 09:10:56, ended at 2013-01-04 09:44:12\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-04 09:59:00, ended at 2013-01-04 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 156 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 221 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 337 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 173 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.12 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Transplanted kidney present\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-01-21 08:11:00, ended at 2013-01-21 10:07:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 170 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.27 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 283 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 283 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 272 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-21 08:54:08, ended at 2013-01-21 10:02:05\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2014-03-11. Instructions: take 75 mg by mouth 2 times a day.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-02-22 00:00:00, ended at 2013-02-22 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-22 08:44:41, ended at 2013-02-22 09:43:17\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Postprocedural state finding\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-02-22 09:57:00, ended at 2013-02-22 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.67 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 125 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 298 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.4 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.51 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-05-24 10:13:00, ended at 2013-05-24 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.47 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 195 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 230 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 276 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiovascular symptoms\n- Transplanted kidney present\n- Disorder of kidney due to diabetes mellitus\n- Essential hypertension\n- Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-26 00:00:00, ended at 2013-07-26 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-26 09:11:21, ended at 2013-07-26 09:45:26\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperplasia of prostate\n- Postprocedural state finding\n- Type 2 diabetes mellitus without complication\n- Cardiovascular symptoms\n- Essential hypertension\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-26 09:52:00, ended at 2013-07-26 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 207 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 228 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.20 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.5 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-07-27 00:00:00, ended at 2013-07-27 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Cardiovascular symptoms\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-03 12:29:00, ended at 2013-08-03 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transplanted kidney, real time and duplex Doppler with image documentation\n\n### Condition\n- Transplanted kidney present\n- Cardiovascular symptoms\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-08-25 11:30:00, ended at 2013-08-25 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Cardiovascular symptoms\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-07 12:10:53, ended at 2013-09-07 13:38:58\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision, tumor, soft tissue of neck or anterior thorax, subcutaneous; less than 3 cm\n\n### Condition\n- Primary diagnosis: Lipoma of skin and subcutaneous tissue (excluding face)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-14 14:43:33, ended at 2013-09-14 15:15:34\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Lipoma of skin and subcutaneous tissue (excluding face)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-27 09:13:46, ended at 2013-09-27 10:21:26\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n- Postprocedural state finding\n- Peripheral vascular disease\n- Essential hypertension\n- Disorder of kidney due to diabetes mellitus\n\n### Drug\n- furosemide 20 MG Oral Tablet, started on 2013-09-16, presumably until 2014-03-11. Instructions: 10 mg BID.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-27 10:30:00, ended at 2013-09-27 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 109 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 334 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.85 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 7.2 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-28 00:00:00, ended at 2013-09-28 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-05 00:00:00, ended at 2013-10-05 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-05 09:30:00, ended at 2013-10-05 13:11:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Lung field abnormal\n- Cardiovascular symptoms\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-05 13:12:00, ended at 2013-10-05 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.98 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 6.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 278 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-28 00:00:00, ended at 2013-10-28 00:00:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-01 10:30:00, ended at 2013-11-01 23:59:00\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-01 10:36:16, ended at 2013-11-01 12:05:45\nThe patient in this visit was 71 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Postprocedural state finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-24 00:00:00, ended at 2014-01-24 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- 0.5 ML influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Prefilled Syringe, through Intramuscular route, started on 2014-01-24, presumably until 2014-01-25, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-24 00:00:00, ended at 2014-01-24 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-24 09:04:00, ended at 2014-01-24 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 332 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.99 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 230 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 170 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.92 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.5 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 33 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 53 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 7.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.90 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Peripheral vascular disease\n- Hyperlipidemia\n- End-stage renal disease\n- Essential hypertension\n- Transplanted kidney present\n- Disorder of kidney due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-24 09:51:00, ended at 2014-01-24 10:23:34\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peripheral vascular disease\n- Essential hypertension\n- Hyperlipidemia\n- Primary diagnosis: Disorder of kidney due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-11 00:00:00, ended at 2014-02-11 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2014-02-11, presumably until 2015-02-11, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-02-21 13:53:00, ended at 2014-03-11 18:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium.ionized [Moles/volume] in Blood: 1.29 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Prothrombin time (PT): 18.5 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.3 (second)\n- Base deficit in Blood: 8.0 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 55.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.69 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Body height: 5' 2.008\" (inch (US))\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.11 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 693 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 446 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 6.8 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma: 27.7 (microgram per milliliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 284 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.0 (percent)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 9.2 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.1 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 327 (unit per liter)\n- Sodium [Moles/volume] in Blood: 148 (millimole per liter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 21.3 (microgram per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 1.0 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Blood: 37.3 (millimeter mercury column)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 97.2 (percent)\n- Oxygen [Partial pressure] in Blood: 72 (millimeter mercury column)\n- Phosphate [Mass/volume] in Serum or Plasma: 5.3 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 153 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 96 (unit per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 114 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Lactate [Moles/volume] in Blood: 1.4 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 95 (millimeter mercury column)\n- Potassium [Moles/volume] in Blood: 6.2 (millimole per liter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 78 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.7 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Thrombin time: 15.4 (second)\n\n### Procedure\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, abdomen; single anteroposterior view\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Noninvasive ventilation\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Controlled ventilation procedure and therapy, initiation and management\n- Evaluation of oral and pharyngeal swallowing function\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n- Insertion of endotracheal tube\n- Hemodialysis\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Insertion of catheter into artery\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Infusion of vasopressor agent\n- Occupational therapy evaluation\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of blood specimen from a completely implantable venous access device\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Central venous catheter placement with guidance\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Computed tomography, thorax, diagnostic; without contrast material\n- Enteral infusion of concentrated nutritional substances\n- Long-term drug therapy\n- Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial alveolar lavage\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Hospital discharge day management; 30 minutes or less\n- Physical therapy evaluation\n- Collection of capillary blood specimen (eg, finger, heel, ear stick)\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Arterial puncture, withdrawal of blood for diagnosis\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Bronchoscopy and biopsy of bronchus\n\n### Condition\n- Bacterial pneumonia\n- Diarrhea\n- Disorder affecting transplanted structure\n- Disorder of lung\n- Dyspnea\n- Immune defect\n- Kidney disease\n- Pulmonary congestion and hypostasis\n- Altered mental status\n- Cardiomegaly\n- Chronic kidney disease\n- Drug abuse in remission\n- Dysuria\n- Electrocardiogram abnormal\n- Fever\n- Lung field abnormal\n- Pleural effusion\n- Pneumocystosis\n- Respiratory insufficiency\n- Schmorl's nodes\n- Shock\n- Thoracic spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Alcohol abuse\n- Disorder of kidney due to diabetes mellitus\n- Infective pneumonia\n- Severe sepsis\n- Transplanted kidney present\n- Acute tubular necrosis\n- Primary diagnosis: Congestive heart failure\n- Disorder of transplanted kidney\n- Hearing loss\n- Postprocedural state finding\n- Sepsis\n- Type 2 diabetes mellitus\n- Acute renal failure syndrome\n- Acute respiratory failure\n- Anoxic encephalopathy\n- Coronary arteriosclerosis\n- Essential hypertension\n- Pulmonary embolism with pulmonary infarction\n- Acidosis\n- Acute diastolic heart failure\n- Benign hypertensive renal disease with renal failure\n- Benign prostatic hyperplasia with outflow obstruction\n- Candidiasis of mouth\n- Dysphagia\n- Hyperkalemia\n- Left heart failure\n- Atherosclerosis of aorta\n- Delay when starting to pass urine\n- Disorder due to type 2 diabetes mellitus\n- Hyperosmolality and or hypernatremia\n- Metabolic encephalopathy\n- Peripheral vascular disease\n- Septic shock\n- Late effect of medical and surgical care complication\n- Trauma and postoperative pulmonary insufficiency\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2014-02-22, presumably until 2014-03-11\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2014-03-10, presumably until 2015-11-28, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- famotidine 20 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-02-23\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2014-02-25, presumably until 2014-02-25\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-02-23, presumably until 2014-02-27\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2014-03-05, presumably until 2014-03-05\n- 24 HR nicotine 0.583 MG/HR Transdermal System, through Transdermal route, started on 2014-03-03, presumably until 2014-03-03\n- haloperidol 5 MG/ML Injectable Solution, started on 2014-03-03, presumably until 2014-03-04\n- ganciclovir 500 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- voriconazole 200 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-03-05\n- meropenem 500 MG Injection, through Intravenous route, started on 2014-02-25, presumably until 2014-03-07\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2014-02-25, presumably until 2014-03-09\n- cetirizine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2014-02-24, presumably until 2014-02-24\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2014-02-22, presumably until 2014-02-22\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-22\n- 100 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2014-02-25, presumably until 2014-03-09\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-02-24, presumably until 2014-03-07\n- sodium chloride 100 MG/ML Inhalation Solution, through Inhalation, started on 2014-02-22, presumably until 2014-02-22\n- nitroglycerin 0.02 MG/MG Topical Ointment, through Transdermal route, started on 2014-02-21, presumably until 2014-02-21\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-11\n- sulfamethoxazole 40 MG/ML / trimethoprim 8 MG/ML Oral Suspension, through Oral route, started on 2014-02-23, presumably until 2014-02-25\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2014-03-05, presumably until 2014-03-10\n- oxymetazoline hydrochloride 0.5 MG/ML Nasal Spray, through Nasal route, started on 2014-02-24, presumably until 2014-02-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2014-02-22, presumably until 2014-02-22\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2014-02-21, presumably until 2014-02-24\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2014-02-24, presumably until 2014-03-10\n- oseltamivir 75 MG Oral Capsule, through Oral route, started on 2014-02-22, presumably until 2014-02-23\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-03-03, presumably until 2014-05-09, with intended 0 refill(s). Instructions: inject 8 Units subcutaneous (under the skin) 2 times a day with meals.\n- cyclosporine, modified 100 MG/ML Oral Solution, through Oral route, started on 2014-02-25, presumably until 2014-03-10\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-02-23, presumably until 2014-03-02\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2014-02-28, presumably until 2014-03-11\n- lansoprazole 30 MG Disintegrating Oral Tablet, through Oral route, started on 2014-03-08, presumably until 2014-03-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2014-02-21, presumably until 2014-03-06\n- 24 HR metoprolol succinate 50 MG Extended Release Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-03-24, with intended 0 refill(s). Instructions: take 3 Tabs by mouth daily.\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-03-09\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, started on 2014-03-05, presumably until 2014-03-09\n- 25 ML sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2014-03-09, presumably until 2014-03-09\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-02-21, presumably until 2014-03-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2014-03-12, presumably until 2014-03-24, with intended 0 refill(s). Instructions: take 5 Tabs by mouth daily. Please taper dose down 5mg every two days (25mg->25mg->20mg->20mg->15mg->15mg->10mg->10mg->5mg ->5mg->off)\n- cisatracurium 2 MG/ML Injectable Solution, through Intravenous route, started on 2014-02-24, presumably until 2014-02-24\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-02-21, presumably until 2015-01-30, with intended 0 refill(s). Instructions: inject 4 Units subcutaneous (under the skin) 3 times a day before meals.\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-02-26, presumably until 2014-03-09\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2014-03-05, presumably until 2014-03-05\n- cefepime 2000 MG Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-24\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2014-02-22, presumably until 2014-02-22\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-03-02, presumably until 2014-03-08\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2014-02-23, presumably until 2014-02-23\n- levofloxacin 500 MG Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-03-15, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q48H.\n- sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet, through Oral route, started on 2014-03-10, presumably until 2014-03-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2014-02-25, presumably until 2014-02-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-02-23, presumably until 2014-03-10\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2014-02-22, presumably until 2014-02-22\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-22\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2014-03-08, presumably until 2014-03-10\n- oseltamivir 6 MG/ML Oral Suspension, through Oral route, started on 2014-02-24, presumably until 2014-03-06\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2014-02-23, presumably until 2014-02-23\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2014-03-02, presumably until 2014-03-02\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-27\n- cefepime 1000 MG Injection, through Intravenous route, started on 2014-02-24, presumably until 2014-02-25\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2014-02-22, presumably until 2014-02-24\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2014-02-22, presumably until 2014-03-11\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-02-21\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2014-02-24, presumably until 2014-02-24\n- midazolam 1 MG/ML Injectable Solution, started on 2014-02-24, presumably until 2014-03-02\n- sitagliptin 100 MG Oral Tablet, through Oral route, presumably until 2014-03-11. Instructions: take 100 mg by mouth.\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2014-02-26, presumably until 2014-03-04\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2014-02-28, presumably until 2014-02-28\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2014-03-08, presumably until 2014-03-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-18 07:37:00, ended at 2014-03-18 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Pleural effusion\n- Post-inflammatory pulmonary fibrosis\n- Infective pneumonia\n- Trauma and postoperative pulmonary insufficiency\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-24 07:55:33, ended at 2014-03-24 10:08:41\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Transplanted kidney present\n- Immune defect\n\n### Drug\n- metoprolol tartrate 50 MG Oral Tablet, through Oral route, presumably until 2015-11-28. Instructions: take 75 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-26 00:00:00, ended at 2014-04-26 00:00:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-02 13:12:00, ended at 2014-05-02 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-02 13:13:27, ended at 2014-05-02 15:08:25\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- sitagliptin 50 MG Oral Tablet, through Oral route, started on 2014-04-20, presumably until 2016-08-29. Instructions: take 100 mg by mouth Every Day \n- glipizide 10 MG Oral Tablet, through Oral route, started on 2014-04-20, presumably until 2016-02-29. Instructions: take 10 mg by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-09 11:26:59, ended at 2014-05-09 12:54:35\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Retention of urine\n- Essential hypertension\n- Hearing loss\n- Hyperlipidemia\n- Urinary symptoms\n- Peripheral vascular disease\n- Primary diagnosis: Transplanted kidney present\n- Benign prostatic hyperplasia with outflow obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-05-09 12:59:00, ended at 2014-05-09 23:59:00\nThe patient in this visit was 72 years old, unknown race, Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 111 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.69 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 196 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Erythrocyte sedimentation rate: 44 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 307 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 58 (milliliter per minute per square meter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 92.1 (femtoliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 28 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.68 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 6.3 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 318 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted kidney present\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 148.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "ea67a0d465cbb7db889f35594970faf64fdbb6cac68b3c0425cda45406fa1f97", "prompt_hash": "0971086eb4bedf820ce90334531b6439fe18cbbbccbaa7ccae776e18c2a3bbc0", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115971386, "visit_occurrence_id": 87597293, "visit_start_datetime": "2016-05-27 00:00:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 175.0, "current_label": 0, "next_value": 163.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-27 00:00:00, ended at 2014-05-27 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.62 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 118 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.9 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-06 00:00:00, ended at 2014-06-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2014-06-06, presumably until 2015-08-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth  daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-06 09:46:05, ended at 2014-06-06 12:22:48\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- General examination of patient\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Chronic kidney disease\n- Hyperlipidemia\n- Essential hypertension\n- Nodular prostate without urinary obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-20 09:24:09, ended at 2014-08-20 12:15:16\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Injury of free lower limb\n- Primary diagnosis: Soft tissue injury\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-06 00:00:00, ended at 2014-12-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 111 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- MCV [Entitic volume] by Automated count: 88 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.1 (ratio unit)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-11 00:00:00, ended at 2014-12-11 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2014-12-11, presumably until 2014-12-12, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-21 00:00:00, ended at 2015-05-21 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.06 (milligram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.45 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 128 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-20 00:00:00, ended at 2015-06-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary erectile dysfunction\n\n### Drug\n- sildenafil 25 MG Oral Tablet, through Oral route, started on 2015-06-20, presumably until 2016-06-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2015-08-29, presumably until 2016-11-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth   daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone acetate 25 MG Rectal Suppository, started on 2015-09-28, presumably until 2017-10-07, with intended 0 refill(s). Instructions: INSERT 1 SUPPOSITORY (25MG) BY RECTAL ROUTE 2TIMES EVERY DAY FOR 2 WEEKS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.42 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-27 00:00:00, ended at 2016-05-27 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio unit)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 12, "cumulated_approximate_token_count": 5092}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-27 00:00:00, ended at 2014-05-27 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.62 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 118 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.9 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 135 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-06 00:00:00, ended at 2014-06-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2014-06-06, presumably until 2015-08-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth  daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-06 09:46:05, ended at 2014-06-06 12:22:48\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- General examination of patient\n- Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report\n\n### Condition\n- Chronic kidney disease\n- Hyperlipidemia\n- Essential hypertension\n- Nodular prostate without urinary obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-20 09:24:09, ended at 2014-08-20 12:15:16\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Injury of free lower limb\n- Primary diagnosis: Soft tissue injury\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-06 00:00:00, ended at 2014-12-06 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 111 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 178 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 41 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 2.3 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- MCV [Entitic volume] by Automated count: 88 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.1 (ratio unit)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-11 00:00:00, ended at 2014-12-11 00:00:00\nThe patient in this visit was 79 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 3\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid va..., through Intramuscular route, started on 2014-12-11, presumably until 2014-12-12, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-05-21 00:00:00, ended at 2015-05-21 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 47 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.06 (milligram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.45 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 128 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.58 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 174 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 198 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-06-20 00:00:00, ended at 2015-06-20 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Secondary erectile dysfunction\n\n### Drug\n- sildenafil 25 MG Oral Tablet, through Oral route, started on 2015-06-20, presumably until 2016-06-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-29 00:00:00, ended at 2015-08-29 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lisinopril 10 MG Oral Tablet, started on 2015-08-29, presumably until 2016-11-29, with intended 4 refill(s). Instructions: Take 1 tablet by mouth   daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-26 00:00:00, ended at 2015-09-26 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrocortisone acetate 25 MG Rectal Suppository, started on 2015-09-28, presumably until 2017-10-07, with intended 0 refill(s). Instructions: INSERT 1 SUPPOSITORY (25MG) BY RECTAL ROUTE 2TIMES EVERY DAY FOR 2 WEEKS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-11-14 00:00:00, ended at 2015-11-14 00:00:00\nThe patient in this visit was 80 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 44 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 180 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9 (percent)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 3-10 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.42 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Triglyceride [Moles/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: None seen (per high power field)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-27 00:00:00, ended at 2016-05-27 00:00:00\nThe patient in this visit was 81 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 187 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.5 (ratio unit)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 175 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.9 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 175.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "ffa7b4030f5bfd90d52cff328cbeb7e0d0af436dbbb6e64100e65244eebc5359", "prompt_hash": "7ed7685ffb1f2fbd7ef2b9d09b39378c37c28bff2b1c7321851d99d6a950a389", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115972706, "visit_occurrence_id": 37411720, "visit_start_datetime": "2009-11-21 10:45:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 138.0, "current_label": 0, "next_value": 143.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Hospital, started at 2008-01-24 10:08:00, ended at 2008-02-01 13:40:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.6 (second)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-27 07:10:00, ended at 2008-02-27 23:59:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cellulitis and abscess of finger\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-22 00:00:00, ended at 2008-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 19.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- MCV [Entitic volume] by Automated count: 81.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Prothrombin time (PT): 30.6 (second)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.1 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-24 00:00:00, ended at 2008-05-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Prothrombin time (PT): 30.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-05-30 08:07:00, ended at 2008-05-30 16:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-traumatic tendon rupture\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take 30 mg by mouth. TID\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2008-05-30, presumably until 2008-05-30\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2009-05-22. Instructions: take by mouth as needed \n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2008-05-30, presumably until 2008-06-17, with quantity of 12.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-06-17. Instructions: take by mouth. TID\n- warfarin sodium 1 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth. \n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth daily. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-05-30, presumably until 2008-05-30, with quantity of 55.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-06-19 13:04:00, ended at 2008-06-19 19:47:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cataract\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take 30 mg by mouth 2 times a day. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take 2 Caps by mouth 2 times a day. \n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take by mouth daily. \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-09-01. Instructions: take 25 mg by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 300 mg by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth daily. \n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-26 00:00:00, ended at 2008-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 33.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.45 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-25 00:00:00, ended at 2008-07-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 346 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Prothrombin time (PT): 32.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-08 00:00:00, ended at 2008-08-08 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-20 00:00:00, ended at 2008-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 324 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-04 00:00:00, ended at 2008-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-09 00:00:00, ended at 2008-09-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Prothrombin time (PT): 29.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-09-11 10:38:00, ended at 2008-09-11 18:15:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-09-01. Instructions: take by mouth daily. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth 2 times a day. 09/10/2008\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-23 00:00:00, ended at 2008-09-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-09 00:00:00, ended at 2008-10-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 341 (microgram per deciliter)\n- Prothrombin time (PT): 25.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 9 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-24 00:00:00, ended at 2008-10-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 73.8 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 349 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-05 00:00:00, ended at 2008-11-05 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Prothrombin time (PT): 31.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 47 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.39 (thousand per microliter)\n- Prothrombin time (PT): 31.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-03 00:00:00, ended at 2008-12-03 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-09 00:00:00, ended at 2008-12-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-09 15:14:00, ended at 2008-12-11 17:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 28.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 3.6\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2009-02-20, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2009-02-27. Instructions: take 325 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-09\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2008-12-11. Instructions: take 500 mg by mouth 2 times a day. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-11\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-07-03. Instructions: 0.4 mg by Sublingual route as needed \n- ascorbic acid 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 500 mg by mouth 2 times a day. \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-12-10, presumably until 2008-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-24 00:00:00, ended at 2008-12-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 18.7 (second)\n- Tacrolimus [Mass/volume] in Blood: 20.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte sedimentation rate: 0 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-27 00:00:00, ended at 2008-12-27 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-06 00:00:00, ended at 2009-01-06 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Prothrombin time (PT): 27.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-23 00:00:00, ended at 2009-01-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 24.1 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.59 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-20 00:00:00, ended at 2009-02-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 60 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.86 (thousand per microliter)\n- Prothrombin time (PT): 29.4 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-02-21 15:20:00, ended at 2009-02-22 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peritonsillar abscess\n\n### Drug\n- clindamycin 150 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-02-21\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-03-01, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution, through Oral route, started on 2009-02-21, presumably until 2009-03-07, with intended 0 refill(s). Instructions: take 25 mL by mouth every 6 hours as needed for Pain. max 4 grams tylenol per day \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-02-21, presumably until 2009-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-02-27 09:12:00, ended at 2009-02-27 17:05:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.5 (second)\n- Prothrombin time (PT): 25.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2009-02-27, presumably until 2009-02-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-04 00:00:00, ended at 2009-03-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-03-04 14:48:00, ended at 2009-03-04 17:51:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 51.1 (second)\n- Prothrombin time (PT): 30.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-03-04, presumably until 2009-08-28, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-24 00:00:00, ended at 2009-03-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Prothrombin time (PT): 29.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-04-07 00:00:00, ended at 2009-04-07 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-15 11:24:00, ended at 2009-04-15 13:52:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2009-06-03. Instructions: take by mouth. \n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-04-15, presumably until 2009-04-15\n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-15, presumably until 2009-04-15\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- midazolam 1 MG/ML Injectable Solution, started on 2009-04-15, presumably until 2009-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-18 00:00:00, ended at 2009-04-18 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of function of stomach\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2009-04-18, presumably until 2012-05-31, with quantity of 90.0, with intended 4 refill(s). Instructions: take 300 mg by mouth daily with dinner. Take T PO every day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-22 00:00:00, ended at 2009-04-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Prothrombin time (PT): 18.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-01 00:00:00, ended at 2009-05-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-22 00:00:00, ended at 2009-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Prothrombin time (PT): 22.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-28 00:00:00, ended at 2009-05-28 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-05-28, presumably until 2009-10-24, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-29 00:00:00, ended at 2009-05-29 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-05-29, presumably until 2009-09-23, with quantity of 4.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-24 00:00:00, ended at 2009-06-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.04 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-26 00:00:00, ended at 2009-06-26 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-06-26, presumably until 2009-08-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-03 00:00:00, ended at 2009-07-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-24 00:00:00, ended at 2009-07-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Prothrombin time (PT): 28.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-25 00:00:00, ended at 2009-08-25 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 28.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-01 00:00:00, ended at 2009-09-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-03 00:00:00, ended at 2009-09-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-09-16, presumably until 2010-09-23, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-23 00:00:00, ended at 2009-09-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2010-02-23, with quantity of 4.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 12:14:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Prothrombin time (PT): 33.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- MCV [Entitic volume] by Automated count: 83.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Blood chemistry abnormal\n- Hyperlipidemia\n- Closed fracture of distal end of radius\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-30 13:55:43, ended at 2009-09-30 15:19:38\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-01 13:48:16, ended at 2009-10-01 15:06:06\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Disorder of eye due to diabetes mellitus\n- Vitreous hemorrhage\n- Vitreous opacities\n- Epiretinal membrane\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-09 14:34:29, ended at 2009-10-09 15:16:10\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-14 00:00:00, ended at 2009-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-15 13:20:00, ended at 2009-10-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)\n\n### Condition\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 10:24:00, ended at 2009-10-23 11:45:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-23 10:25:09, ended at 2009-10-23 13:40:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2009-10-24. Instructions: take by mouth as needed pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 11:46:00, ended at 2009-10-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte sedimentation rate: 3 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.6 (picogram)\n- Prothrombin time (PT): 26.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hypersensitivity angiitis\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-12-16, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-03-03, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-30 10:27:40, ended at 2009-10-30 14:31:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-30 10:32:00, ended at 2009-10-30 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-03 00:00:00, ended at 2009-11-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-18 09:47:20, ended at 2009-11-18 10:26:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 10:45:00, ended at 2009-11-21 12:33:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCV [Entitic volume] by Automated count: 80.0 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 68, "cumulated_approximate_token_count": 30034}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Hospital, started at 2008-01-24 10:08:00, ended at 2008-02-01 13:40:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 28.6 (second)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 83.3 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.74 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.93 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Prothrombin time (PT): 15.1 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 207 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2008-02-27 07:10:00, ended at 2008-02-27 23:59:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cellulitis and abscess of finger\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-14 00:00:00, ended at 2008-03-14 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 18 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 255 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-03-22 00:00:00, ended at 2008-03-22 00:00:00\nThe patient in this visit was 52 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.83 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 161 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCV [Entitic volume] by Automated count: 82.9 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 9.1 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 19.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-04-24 00:00:00, ended at 2008-04-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.3 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.76 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n- MCV [Entitic volume] by Automated count: 81.2 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Prothrombin time (PT): 30.6 (second)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-10 00:00:00, ended at 2008-05-10 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Homocysteine [Moles/volume] in Serum or Plasma: 10.1 (micromole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-05-24 00:00:00, ended at 2008-05-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.50 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Prothrombin time (PT): 30.0 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 3.0 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 6.5 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-05-30 08:07:00, ended at 2008-05-30 16:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-traumatic tendon rupture\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take 30 mg by mouth. TID\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2008-05-30, presumably until 2008-05-30\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- docusate sodium 100 MG Oral Capsule, through Oral route, presumably until 2009-05-22. Instructions: take by mouth as needed \n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2008-05-30, presumably until 2008-06-17, with quantity of 12.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-06-17. Instructions: take by mouth. TID\n- warfarin sodium 1 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth. \n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2011-03-29. Instructions: take by mouth daily. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-05-30, presumably until 2008-05-30, with quantity of 55.0, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-06-19 13:04:00, ended at 2008-06-19 19:47:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cataract\n\n### Drug\n- isosorbide dinitrate 30 MG Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take 30 mg by mouth 2 times a day. \n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take 2 Caps by mouth 2 times a day. \n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-06-26. Instructions: take by mouth daily. \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2009-09-01. Instructions: take 25 mg by mouth 2 times a day. \n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2008-09-11. Instructions: take by mouth daily. \n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 300 mg by mouth 2 times a day. \n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2008-09-11. Instructions: take by mouth 2 times a day. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth daily. \n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-06-19, presumably until 2008-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-06-26 00:00:00, ended at 2008-06-26 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 26.0 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 33.2 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 348 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.45 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.81 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-07-25 00:00:00, ended at 2008-07-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.10 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 78.2 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.65 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 346 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 56 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.76 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Prothrombin time (PT): 32.6 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.3 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 89 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.2 (picogram)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-08 00:00:00, ended at 2008-08-08 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 26.5 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-08-20 00:00:00, ended at 2008-08-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.5 (percent)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 324 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.0 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 76 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 64 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.8 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 11 (millimeter per hour)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Prothrombin time (PT): 31.7 (second)\n- Urate [Mass/volume] in Serum or Plasma: 4.6 (milligram per deciliter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 3.2 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-04 00:00:00, ended at 2008-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.9 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-09 00:00:00, ended at 2008-09-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 307 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.4 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Prothrombin time (PT): 29.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2008-09-11 10:38:00, ended at 2008-09-11 18:15:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gatifloxacin 3 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tropicamide 10 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2010-09-01. Instructions: take by mouth daily. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth 2 times a day. 09/10/2008\n- phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n- tetracaine hydrochloride 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2008-09-11, presumably until 2008-09-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-09-23 00:00:00, ended at 2008-09-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- MCV [Entitic volume] by Automated count: 77.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 316 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Prothrombin time (PT): 24.3 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.14 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-09 00:00:00, ended at 2008-10-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 341 (microgram per deciliter)\n- Prothrombin time (PT): 25.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.3 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 9 (microgram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-10-24 00:00:00, ended at 2008-10-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCV [Entitic volume] by Automated count: 73.8 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 4.5 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 349 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.0 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.83 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-05 00:00:00, ended at 2008-11-05 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Prothrombin time (PT): 31.6 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 80.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.1 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 266 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.63 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.85 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 47 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.7 (ratio)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 59 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.39 (thousand per microliter)\n- Prothrombin time (PT): 31.2 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-11-25 00:00:00, ended at 2008-11-25 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- MCH [Entitic mass] by Automated count: 26.6 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 29.6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.49 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.6 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-03 00:00:00, ended at 2008-12-03 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.0 (ratio)\n- Prothrombin time (PT): 22.4 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-09 00:00:00, ended at 2008-12-09 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.3 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 12.1 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 71 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.73 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.3 (picogram)\n- MCV [Entitic volume] by Automated count: 86.5 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.23 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 10.07 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2008-12-09 15:14:00, ended at 2008-12-11 17:25:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- MCV [Entitic volume] by Automated count: 87.1 (femtoliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.55 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Prothrombin time (PT): 28.2 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.70 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 27.5 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.54 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Body height: 5' 3.6\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 88.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 46.7 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Urinary tract infectious disease\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2009-02-20, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- ascorbic acid 250 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2009-02-27. Instructions: take 325 mg by mouth 2 times a day. \n- furosemide 20 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- isosorbide dinitrate 10 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-09\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- Osmotic 24 HR nifedipine 30 MG Extended Release Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, presumably until 2008-12-11. Instructions: take 500 mg by mouth 2 times a day. \n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2008-12-10, presumably until 2008-12-11\n- metoclopramide 5 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- warfarin sodium 4 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2008-12-11, presumably until 2008-12-11\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2008-12-09, presumably until 2008-12-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2008-12-09, presumably until 2008-12-10\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2008-12-09, presumably until 2008-12-11\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-07-03. Instructions: 0.4 mg by Sublingual route as needed \n- ascorbic acid 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take 500 mg by mouth 2 times a day. \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2008-12-10, presumably until 2008-12-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-12-10, presumably until 2008-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-24 00:00:00, ended at 2008-12-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.9 (percent)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Prothrombin time (PT): 18.7 (second)\n- Tacrolimus [Mass/volume] in Blood: 20.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 87.0 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Erythrocyte sedimentation rate: 0 (millimeter per hour)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.27 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 141 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2008-12-27 00:00:00, ended at 2008-12-27 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Tacrolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-06 00:00:00, ended at 2009-01-06 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Prothrombin time (PT): 27.4 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 38.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-01-23 00:00:00, ended at 2009-01-23 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 5.5 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.4 (percent)\n- Prothrombin time (PT): 24.1 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.59 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.2 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- MCV [Entitic volume] by Automated count: 89.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-02-20 00:00:00, ended at 2009-02-20 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 60 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 68 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 77.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 0.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.86 (thousand per microliter)\n- Prothrombin time (PT): 29.4 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Tacrolimus [Mass/volume] in Blood: 4.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 222 (thousand per microliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-02-21 15:20:00, ended at 2009-02-22 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peritonsillar abscess\n\n### Drug\n- clindamycin 150 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-02-21\n- clindamycin 300 MG Oral Capsule, through Oral route, started on 2009-02-21, presumably until 2009-03-01, with quantity of 28.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day. \n- acetaminophen 24 MG/ML / codeine phosphate 2.4 MG/ML Oral Solution, through Oral route, started on 2009-02-21, presumably until 2009-03-07, with intended 0 refill(s). Instructions: take 25 mL by mouth every 6 hours as needed for Pain. max 4 grams tylenol per day \n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2009-02-21, presumably until 2009-02-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-02-27 09:12:00, ended at 2009-02-27 17:05:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- aPTT in Platelet poor plasma by Coagulation assay: 36.5 (second)\n- Prothrombin time (PT): 25.9 (second)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML meperidine hydrochloride 25 MG/ML Cartridge, started on 2009-02-27, presumably until 2009-02-27\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2009-02-27, presumably until 2009-02-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-04 00:00:00, ended at 2009-03-04 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.2 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-03-04 14:48:00, ended at 2009-03-04 17:51:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- aPTT in Platelet poor plasma by Coagulation assay: 51.1 (second)\n- Prothrombin time (PT): 30.1 (second)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2009-03-04, presumably until 2009-08-28, with quantity of 60.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-03-24 00:00:00, ended at 2009-03-24 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.3 (percent)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.0 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.03 (thousand per microliter)\n- Prothrombin time (PT): 29.9 (second)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.65 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.9 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 2.9 (ratio)\n- MCH [Entitic mass] by Automated count: 29.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.7 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.38 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 4.1 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-04-07 00:00:00, ended at 2009-04-07 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Breast lump\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-04-15 11:24:00, ended at 2009-04-15 13:52:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, presumably until 2009-06-03. Instructions: take by mouth. \n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2009-04-15, presumably until 2009-04-15\n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2009-12-23. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-04-15, presumably until 2009-04-15\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, presumably until 2009-05-22. Instructions: take by mouth. \n- midazolam 1 MG/ML Injectable Solution, started on 2009-04-15, presumably until 2009-04-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-04-18 00:00:00, ended at 2009-04-18 00:00:00\nThe patient in this visit was 53 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of function of stomach\n\n### Drug\n- ranitidine 300 MG Oral Tablet, through Oral route, started on 2009-04-18, presumably until 2012-05-31, with quantity of 90.0, with intended 4 refill(s). Instructions: take 300 mg by mouth daily with dinner. Take T PO every day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-04-22 00:00:00, ended at 2009-04-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.45 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.1 (picogram)\n- MCV [Entitic volume] by Automated count: 91.0 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 240 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 14.5 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Prothrombin time (PT): 18.2 (second)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 78 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-01 00:00:00, ended at 2009-05-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Prothrombin time (PT): 19.2 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.7 (ratio)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-05-22 00:00:00, ended at 2009-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.5 (percent)\n- Prothrombin time (PT): 22.9 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 89.0 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.1 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 258 (thousand per microliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.77 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.09 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-28 00:00:00, ended at 2009-05-28 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-05-28, presumably until 2009-10-24, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-05-29 00:00:00, ended at 2009-05-29 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-05-29, presumably until 2009-09-23, with quantity of 4.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-24 00:00:00, ended at 2009-06-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Tacrolimus [Mass/volume] in Blood: 8.8 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.04 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.13 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: 2.4 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Prothrombin time (PT): 25.6 (second)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.2 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-06-26 00:00:00, ended at 2009-06-26 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2009-06-26, presumably until 2009-08-28, with quantity of 90.0, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-07-03 00:00:00, ended at 2009-07-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-07-24 00:00:00, ended at 2009-07-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.21 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.8 (percent)\n- MCV [Entitic volume] by Automated count: 84.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Prothrombin time (PT): 28.0 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.8 (picogram)\n- Cholesterol [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.2 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-08-25 00:00:00, ended at 2009-08-25 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.7 (ratio)\n- Neutrophils [#/volume] in Blood by Automated count: 3.63 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 283 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.1 (femtoliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.4 (percent)\n- Urate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Prothrombin time (PT): 28.4 (second)\n- Tacrolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.59 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.95 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-01 00:00:00, ended at 2009-09-01 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-03 00:00:00, ended at 2009-09-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- General examination of patient\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-16 00:00:00, ended at 2009-09-16 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted kidney present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2009-09-16, presumably until 2010-09-23, with quantity of 180.0, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-09-23 00:00:00, ended at 2009-09-23 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of bone and articular cartilage\n\n### Drug\n- alendronic acid 70 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2010-02-23, with quantity of 4.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth every 7 days. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 12:14:00, ended at 2009-09-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 267 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 140 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Prothrombin time (PT): 33.5 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.41 (million per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 3.4 (ratio)\n- MCV [Entitic volume] by Automated count: 83.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 7.4 (nanogram per milliliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted kidney present\n- Disorder of phosphorus metabolism\n- Blood chemistry abnormal\n- Hyperlipidemia\n- Closed fracture of distal end of radius\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-09-30 13:55:43, ended at 2009-09-30 15:19:38\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-01 13:48:16, ended at 2009-10-01 15:06:06\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 13 (millimeter mercury column)\n\n### Procedure\n- Scanning computerized ophthalmic diagnostic imaging, posterior segment, (eg, scanning laser) with interpretation and report, unilateral\n\n### Condition\n- Disorder of eye due to diabetes mellitus\n- Vitreous hemorrhage\n- Vitreous opacities\n- Epiretinal membrane\n- Vitreous degeneration\n- Disorder of eye due to type 1 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-09 14:34:29, ended at 2009-10-09 15:16:10\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Systemic lupus erythematosus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-14 00:00:00, ended at 2009-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-15 13:20:00, ended at 2009-10-15 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s)\n\n### Condition\n- Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 10:24:00, ended at 2009-10-23 11:45:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Atherosclerosis of arteries of the extremities\n- Intermittent claudication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-23 10:25:09, ended at 2009-10-23 13:40:03\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Intermittent claudication\n- Primary diagnosis: Atherosclerosis of arteries of the extremities\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, presumably until 2009-10-24. Instructions: take by mouth as needed pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-23 11:46:00, ended at 2009-10-23 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 84 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Erythrocyte sedimentation rate: 3 (millimeter per hour)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.66 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.8 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 305 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.4 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.5 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.84 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urate [Mass/volume] in Serum or Plasma: 3.4 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.6 (picogram)\n- Prothrombin time (PT): 26.4 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Hypersensitivity angiitis\n- Hyperlipidemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-12-16, with quantity of 30.0, with intended 2 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed pain \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2009-10-24 00:00:00, ended at 2009-10-24 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2009-10-24, presumably until 2010-03-03, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-30 10:27:40, ended at 2009-10-30 14:31:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Aseptic necrosis of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-30 10:32:00, ended at 2009-10-30 23:59:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, wrist; complete, minimum of 3 views\n\n### Condition\n- Wrist joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-11-03 00:00:00, ended at 2009-11-03 00:00:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hypersensitivity angiitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-11-18 09:47:20, ended at 2009-11-18 10:26:37\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- Routine gynecologic examination\n\n### Condition\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 10:45:00, ended at 2009-11-21 12:33:00\nThe patient in this visit was 54 years old, White, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Phosphate [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 6.3 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 2.6 (ratio)\n- Platelets [#/volume] in Blood by Automated count: 280 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.2 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCV [Entitic volume] by Automated count: 80.0 (femtoliter)\n- Urate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.6 (percent)\n- Prothrombin time (PT): 27.7 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.64 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Transplanted kidney present\n- Blood chemistry abnormal\n- Disorder of phosphorus metabolism\n- Postmenopausal bleeding\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 138.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "0a3b0bccd5bbd1d9ae40759545804a5a5c9b825f006bfb7d8c737923426d4302", "prompt_hash": "0e12a103bdaa7367b67ee54bf64c61bfca7cefcc8a53985b3bc98a1bad6bf24c", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 5, "doc": {"person_id": 115973298, "visit_occurrence_id": 178411357, "visit_start_datetime": "2021-05-08 00:00:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 173.0, "current_label": 0, "next_value": 158.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-05 00:00:00, ended at 2019-11-05 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.8 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-12 14:34:26, ended at 2019-11-12 15:40:52\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gastroesophageal reflux disease without esophagitis\n- Obesity\n- Diaphragmatic hernia\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-07-28, presumably until 2019-12-24, with intended 0 refill(s). Instructions: take 32 mg by mouth every bedtime\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2019-03-02, presumably until 2020-01-21, with intended 0 refill(s). Instructions: take 60 mg by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2019-04-30, presumably until 2020-01-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n- ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-12-16, presumably until 2019-11-12, with intended 0 refill(s). Instructions: 1 Spray by Nasal route\n- betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Cream, through Topical route, started on 2014-02-08, presumably until 2019-11-27, with intended 0 refill(s). Instructions: by Topical route\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2020-03-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-19 00:00:00, ended at 2019-11-19 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-27 15:09:41, ended at 2019-11-27 15:39:01\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-03 07:17:00, ended at 2019-12-03 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-02-15, with intended 3 refill(s). Instructions: take 32 mg by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-21 00:00:00, ended at 2020-01-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-16, with intended 3 refill(s). Instructions: take 1.5 Tabs (60 mg total) by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-15 00:00:00, ended at 2020-02-15 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, through Oral route, started on 2020-02-15, presumably until 2021-02-14, with intended 4 refill(s). Instructions: take 32 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-22 00:00:00, ended at 2020-02-22 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 21 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-01 14:44:24, ended at 2020-03-01 15:37:16\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Pure hypercholesterolemia\n- Primary diagnosis: Impaired fasting glycemia\n- Essential hypertension\n\n### Drug\n- 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection, through Intramuscular route, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- amoxicillin 500 MG Oral Tablet, started on 2020-02-29, presumably until 2020-07-14, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-01 13:40:00, ended at 2020-06-01 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Chronic kidney disease stage 2\n- Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-13 00:00:00, ended at 2020-07-13 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 89 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.2 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 13:51:07, ended at 2020-07-14 14:40:06\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Hyperkalemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Obesity\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-07-14, presumably until 2020-12-26, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Folate [Mass/volume] in Serum or Plasma: 6.6 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 537 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Chronic kidney disease due to hypertension\n- Chronic kidney disease stage 2\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 10:17:37, ended at 2020-07-29 11:00:09\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-07-29, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-12 09:59:41, ended at 2020-08-12 10:20:55\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Hyperglycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Benign prostatic hyperplasia\n- Finding of frequency of urination\n- Chronic kidney disease stage 2\n- Primary diagnosis: Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Malaise\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-08 00:00:00, ended at 2020-11-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.20 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Hyperglycemia\n- Chronic kidney disease stage 2\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 13:14:23, ended at 2020-11-14 13:49:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Body height: 6' 1\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Primary diagnosis: Chronic kidney disease stage 2\n- Disorder of hematopoietic structure\n- Obesity\n- Hyperglycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-26 00:00:00, ended at 2020-12-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, started on 2020-12-26, presumably until 2021-12-18, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2021-01-16, presumably until 2021-02-20, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS     (=60MG) AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2021-01-26, presumably until 2022-01-27, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-10 00:00:00, ended at 2021-02-10 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-14 13:08:00, ended at 2021-02-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-14 13:08:28, ended at 2021-02-14 15:01:06\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-20 11:16:43, ended at 2021-02-20 11:58:18\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Disorder of hematopoietic structure\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n- Chronic pain\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-20, presumably until 2021-02-25, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-02-20, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-25 00:00:00, ended at 2021-02-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-25, presumably until 2021-12-05, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-27 00:00:00, ended at 2021-02-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, started on 2021-02-28, presumably until 2022-02-27, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-08 00:00:00, ended at 2021-05-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 102 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.26 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 30, "cumulated_approximate_token_count": 8326}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-05 00:00:00, ended at 2019-11-05 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.8 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-12 14:34:26, ended at 2019-11-12 15:40:52\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1.2\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Gastroesophageal reflux disease without esophagitis\n- Obesity\n- Diaphragmatic hernia\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-07-28, presumably until 2019-12-24, with intended 0 refill(s). Instructions: take 32 mg by mouth every bedtime\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2019-03-02, presumably until 2020-01-21, with intended 0 refill(s). Instructions: take 60 mg by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2019-04-30, presumably until 2020-01-21, with intended 0 refill(s). Instructions: TAKE 1 TABLET EVERY DAY\n- ipratropium bromide 0.021 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2018-12-16, presumably until 2019-11-12, with intended 0 refill(s). Instructions: 1 Spray by Nasal route\n- betamethasone 0.5 MG/ML / clotrimazole 10 MG/ML Topical Cream, through Topical route, started on 2014-02-08, presumably until 2019-11-27, with intended 0 refill(s). Instructions: by Topical route\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2020-03-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-19 00:00:00, ended at 2019-11-19 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.93 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 178 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired glucose tolerance\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-11-27 15:09:41, ended at 2019-11-27 15:39:01\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-03 07:17:00, ended at 2019-12-03 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal aorta, real time with image documentation, screening study for abdominal aortic aneurysm (AAA)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 16 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-02-15, with intended 3 refill(s). Instructions: take 32 mg by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-21 00:00:00, ended at 2020-01-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-16, with intended 3 refill(s). Instructions: take 1.5 Tabs (60 mg total) by mouth every bedtime\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2020-01-21, presumably until 2021-01-26, with intended 3 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-15 00:00:00, ended at 2020-02-15 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, through Oral route, started on 2020-02-15, presumably until 2021-02-14, with intended 4 refill(s). Instructions: take 32 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-22 00:00:00, ended at 2020-02-22 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 21 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 151 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-03-01 14:44:24, ended at 2020-03-01 15:37:16\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Pure hypercholesterolemia\n- Primary diagnosis: Impaired fasting glycemia\n- Essential hypertension\n\n### Drug\n- 0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML Injection, through Intramuscular route, started on 2020-03-01, presumably until 2020-03-01, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time for 1 dose\n- amoxicillin 500 MG Oral Tablet, started on 2020-02-29, presumably until 2020-07-14, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-11 00:00:00, ended at 2020-04-11 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-06-01 13:40:00, ended at 2020-06-01 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Chronic kidney disease stage 2\n- Chronic kidney disease due to hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-13 00:00:00, ended at 2020-07-13 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 89 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.53 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0-2 (per high power field)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.4 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (international unit per liter)\n- Epithelial cells [#/area] in Urine sediment by Microscopy high power field: 0-10 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.2 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.99 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0-5 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urobilinogen [Mass/volume] in Urine by Test strip: 0.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-14 13:51:07, ended at 2020-07-14 14:40:06\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Hyperkalemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Obesity\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, through Oral route, started on 2020-07-14, presumably until 2020-12-26, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-21 00:00:00, ended at 2020-07-21 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Folate [Mass/volume] in Serum or Plasma: 6.6 (nanogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 537 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.00 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of hematopoietic structure\n- Chronic kidney disease due to hypertension\n- Chronic kidney disease stage 2\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-29 10:17:37, ended at 2020-07-29 11:00:09\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2020-07-29, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (25 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-12 09:59:41, ended at 2020-08-12 10:20:55\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Pure hypercholesterolemia\n- Primary diagnosis: Chronic kidney disease stage 2\n- Hyperglycemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Benign prostatic hyperplasia\n- Finding of frequency of urination\n- Chronic kidney disease stage 2\n- Primary diagnosis: Pure hypercholesterolemia\n- Impaired fasting glycemia\n- Malaise\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-08 00:00:00, ended at 2020-11-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.20 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 45 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 15.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.37 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 181 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 102 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease due to hypertension\n- Hyperglycemia\n- Chronic kidney disease stage 2\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-11-14 13:14:23, ended at 2020-11-14 13:49:50\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.07 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Body height: 6' 1\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23 (percent)\n- Platelets [#/volume] in Blood by Automated count: 232 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 88 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Primary diagnosis: Chronic kidney disease stage 2\n- Disorder of hematopoietic structure\n- Obesity\n- Hyperglycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-12-26 00:00:00, ended at 2020-12-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydrochlorothiazide 25 MG Oral Tablet, started on 2020-12-26, presumably until 2021-12-18, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-16 00:00:00, ended at 2021-01-16 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2021-01-16, presumably until 2021-02-20, with intended 3 refill(s). Instructions: TAKE 1 AND 1/2 TABLETS     (=60MG) AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-26 00:00:00, ended at 2021-01-26 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2021-01-26, presumably until 2022-01-27, with intended 3 refill(s). Instructions: TAKE 1 TABLET DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-10 00:00:00, ended at 2021-02-10 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-02-14 13:08:00, ended at 2021-02-14 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-14 13:08:28, ended at 2021-02-14 15:01:06\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Pain of left knee region\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-02-20 11:16:43, ended at 2021-02-20 11:58:18\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' .992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pain of left knee region\n- Obesity\n- Primary diagnosis: Chronic kidney disease stage 2\n- Primary diagnosis: Chronic kidney disease due to hypertension\n- Disorder of hematopoietic structure\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n- Chronic pain\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-20, presumably until 2021-02-25, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2021-02-20, presumably until 2021-05-23, with intended 1 refill(s). Instructions: take 1 Tab (40 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-02-25 00:00:00, ended at 2021-02-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- diclofenac sodium 0.01 MG/MG Topical Gel, started on 2021-02-25, presumably until 2021-12-05, with intended 2 refill(s). Instructions: Apply to left knee painful area 4 times daily prn for pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-02-27 00:00:00, ended at 2021-02-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- candesartan cilexetil 32 MG Oral Tablet, started on 2021-02-28, presumably until 2022-02-27, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH ONE TIME DAILY \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-08 00:00:00, ended at 2021-05-08 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 102 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.26 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 101 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 49 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.9 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Impaired fasting glycemia\n- Pure hypercholesterolemia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 173.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "b0f295db7e144e22985d2138cca3f0732df8a7269a8bf0b4204cc69ecc60a269", "prompt_hash": "b5448fd23beaa296d7621e4061b1ace8c3ece8ffbca86476517cb824891409f5", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115967142, "visit_occurrence_id": 59299748, "visit_start_datetime": "2014-02-19 10:29:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 132.0, "current_label": 0, "next_value": 122.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-01-08 13:06:00, ended at 2009-01-09 17:06:00\nThe patient in this visit was 54 years old, Native Hawaiian or Other Pacific Islander, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 203 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 135 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 13.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.2 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.05 (million per microliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.7 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Essential hypertension\n\n### Drug\n- aspirin 81 MG Oral Tablet, through Oral route, presumably until 2018-04-20. Instructions: take 1 Tab by mouth every bedtime.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-01-09. Instructions: take 20 mg by mouth.\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-01-08. Instructions: take 40 mg by mouth daily. \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-01-08, presumably until 2009-01-08\n- ibuprofen 600 MG Oral Tablet, through Oral route, presumably until 2014-02-19. Instructions: take 600 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-02-19 10:29:00, ended at 2014-02-21 20:34:00\nThe patient in this visit was 59 years old, Native Hawaiian or Other Pacific Islander, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Prothrombin time (PT): 14.4 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.2 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 6.3 (ratio)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Base excess in Blood by calculation: 13.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.68 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 4.7 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.03 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 173 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Body height: 5' 7.2\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 36 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n\n### Procedure\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Hospital discharge day management; more than 30 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Arterial puncture, withdrawal of blood for diagnosis\n- Noninvasive ventilation\n- Radiologic examination, chest; single view, frontal\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Hyperlipidemia\n- Abnormal findings on diagnostic imaging of skull and head\n- Cardiomegaly\n- Coronary arteriosclerosis\n- Hypoxemia\n- Morbid obesity\n- Edema\n- Erythema of skin\n- Primary diagnosis: Inflammatory disorder\n- Swelling of limb\n- Coronary atherosclerosis\n- Obesity\n- Old myocardial infarction\n- Extreme obesity with alveolar hypoventilation\n- Type 2 diabetes mellitus without complication\n- Aortocoronary bypass graft present\n- Cellulitis and abscess of lower leg\n- Chronic cor pulmonale\n- Ulcer of lower extremity\n- Congestive heart failure\n- Disorder of kidney and/or ureter\n- Chest pain\n- Dyspnea\n- Essential hypertension\n- Lung field abnormal\n- Obstructive sleep apnea syndrome\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2014-08-05. Instructions: take 1 Tab by mouth every morning.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-02-19, presumably until 2014-02-19\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-08-05. Instructions: take 20 mg by mouth as needed.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2018-04-20. Instructions: take 500 mg by mouth daily in the evening \n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-02-21\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-02-19, presumably until 2014-02-19\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, presumably until 2014-08-05. Instructions: take 12.5 mg by mouth daily.\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2014-02-20, presumably until 2014-03-27, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours.\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2014-02-19, presumably until 2014-02-20\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2014-10-30. Instructions: take 40 mg by mouth every bedtime.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-02-19, presumably until 2014-02-21\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2014-02-19, presumably until 2014-02-19\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2014-02-19, presumably until 2014-02-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-02-19, presumably until 2014-02-20\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2014-08-05. Instructions: place 0.4 mg under the tongue and let dissolve as needed for Chest pain. (Nitrostat only, do not substitute)\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-02-20, presumably until 2014-02-21\n\n", "cumulated_visit_num": 2, "cumulated_approximate_token_count": 3419}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-01-08 13:06:00, ended at 2009-01-09 17:06:00\nThe patient in this visit was 54 years old, Native Hawaiian or Other Pacific Islander, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 203 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.90 (thousand per microliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 135 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Prothrombin time (PT): 13.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.2 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.05 (million per microliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.7 (ratio)\n- Hemoglobin [Mass/volume] in Blood: 15.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 236 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.1 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chest pain\n- Essential hypertension\n\n### Drug\n- aspirin 81 MG Oral Tablet, through Oral route, presumably until 2018-04-20. Instructions: take 1 Tab by mouth every bedtime.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-01-09. Instructions: take 20 mg by mouth.\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2009-01-08, presumably until 2009-01-08. Instructions: take 40 mg by mouth daily. \n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-01-08, presumably until 2009-01-08\n- ibuprofen 600 MG Oral Tablet, through Oral route, presumably until 2014-02-19. Instructions: take 600 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-02-19 10:29:00, ended at 2014-02-21 20:34:00\nThe patient in this visit was 59 years old, Native Hawaiian or Other Pacific Islander, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Prothrombin time (PT): 14.4 (second)\n- Triglyceride [Moles/volume] in Serum or Plasma: 60 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 132 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.2 (percent)\n- MCH [Entitic mass] by Automated count: 30.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.2 (nanogram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 31.7 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 6.3 (ratio)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Base excess in Blood by calculation: 13.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.6 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.68 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 4.7 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.03 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 173 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 228 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.9 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Body height: 5' 7.2\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 36 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.1 (gram per deciliter)\n\n### Procedure\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Collection of venous blood by venipuncture\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Hospital discharge day management; more than 30 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Arterial puncture, withdrawal of blood for diagnosis\n- Noninvasive ventilation\n- Radiologic examination, chest; single view, frontal\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Hyperlipidemia\n- Abnormal findings on diagnostic imaging of skull and head\n- Cardiomegaly\n- Coronary arteriosclerosis\n- Hypoxemia\n- Morbid obesity\n- Edema\n- Erythema of skin\n- Primary diagnosis: Inflammatory disorder\n- Swelling of limb\n- Coronary atherosclerosis\n- Obesity\n- Old myocardial infarction\n- Extreme obesity with alveolar hypoventilation\n- Type 2 diabetes mellitus without complication\n- Aortocoronary bypass graft present\n- Cellulitis and abscess of lower leg\n- Chronic cor pulmonale\n- Ulcer of lower extremity\n- Congestive heart failure\n- Disorder of kidney and/or ureter\n- Chest pain\n- Dyspnea\n- Essential hypertension\n- Lung field abnormal\n- Obstructive sleep apnea syndrome\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2014-08-05. Instructions: take 1 Tab by mouth every morning.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2014-02-19, presumably until 2014-02-19\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-08-05. Instructions: take 20 mg by mouth as needed.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, presumably until 2018-04-20. Instructions: take 500 mg by mouth daily in the evening \n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-02-21, presumably until 2014-02-21\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-02-19, presumably until 2014-02-19\n- hydrochlorothiazide 12.5 MG Oral Tablet, through Oral route, presumably until 2014-08-05. Instructions: take 12.5 mg by mouth daily.\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2014-02-20, presumably until 2014-03-27, with intended 0 refill(s). Instructions: take 1 Cap by mouth every 6 hours.\n- pravastatin sodium 20 MG Oral Tablet, through Oral route, started on 2014-02-19, presumably until 2014-02-20\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2014-10-30. Instructions: take 40 mg by mouth every bedtime.\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-02-19, presumably until 2014-02-21\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2014-02-19, presumably until 2014-02-19\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2014-02-19, presumably until 2014-02-19\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2014-02-19, presumably until 2014-02-20\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2014-08-05. Instructions: place 0.4 mg under the tongue and let dissolve as needed for Chest pain. (Nitrostat only, do not substitute)\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-02-20, presumably until 2014-02-21\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 132.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "64508765ce15da9a6f08d4add1df1397be66b3b450bd11256e47f73daa9c3c84", "prompt_hash": "d0bc57d3e5f7b23f14fef93b299cdc093547639c864cbf47be8fe3a2b79cc762", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115967390, "visit_occurrence_id": 165937712, "visit_start_datetime": "2020-10-19 06:12:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 169.0, "current_label": 0, "next_value": 190.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-14 00:00:00, ended at 2013-08-14 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 35 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-02 07:51:00, ended at 2013-09-02 11:39:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-02 09:05:39, ended at 2013-09-02 11:27:09\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2013-10-02. Instructions: take 30 mg by mouth every morning.\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2013-09-02, presumably until 2014-04-25, with intended 6 refill(s). Instructions: take 3 Tabs by mouth Every Day. Two am and one pm\n- ticagrelor 90 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 90 mg by mouth 2 times a day.\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 325 mg by mouth daily.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2013-09-02, presumably until 2013-09-25, with intended 6 refill(s). Instructions: take 25 mg by mouth daily.\n- losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 100 mg by mouth daily.\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2013-11-05. Instructions: inject 30 Units subcutaneous (under the skin) Evening.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2013-09-02, presumably until 2013-10-02, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-02 11:40:00, ended at 2013-09-02 11:40:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.4 (nanogram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 13.2 (second)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.6 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 266 (milligram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 113 (nanogram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 182 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.88 (milli-international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 313 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-02 11:41:00, ended at 2013-09-02 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-03 00:00:00, ended at 2013-09-03 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-03 00:00:00, ended at 2013-09-03 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-03 00:00:00, ended at 2013-09-03 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n- Coronary atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:30:00, ended at 2013-09-05 13:30:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic ischemic heart disease\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:30:00, ended at 2013-09-05 13:30:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Chronic ischemic heart disease\n- Coronary atherosclerosis\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:31:00, ended at 2013-09-05 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Coronary atherosclerosis\n- Chronic ischemic heart disease\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-11 06:56:00, ended at 2013-09-11 06:56:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Lung field abnormal\n- Old myocardial infarction\n- Chronic ischemic heart disease\n- Coronary arteriosclerosis\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-11 06:57:00, ended at 2013-09-11 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Chronic ischemic heart disease\n- Lung field abnormal\n- Coronary arteriosclerosis\n- Heart disease\n- Old myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-18 00:00:00, ended at 2013-09-18 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-02 08:00:00, ended at 2013-10-02 10:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiopulmonary exercise testing, including measurements of minute ventilation, CO2 production, O2 uptake, and electrocardiographic recordings\n\n### Condition\n- Dyspnea\n- Congestive heart failure\n- Combined systolic and diastolic dysfunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-02 09:15:59, ended at 2013-10-02 10:38:57\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-10-02, presumably until 2013-11-08, with intended 9 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2013-10-02, presumably until 2013-11-08, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-02 11:00:00, ended at 2013-10-02 14:51:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing; simple (eg, 6-minute walk test, prolonged exercise test for bronchospasm with pre- and post-spirometry and oximetry)\n\n### Condition\n- Congestive heart failure\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-02 11:16:02, ended at 2013-10-02 14:45:58\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n- Primary diagnosis: Diabetic - poor control\n- Primary diagnosis: Diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-10-02, presumably until 2014-05-19, with intended 6 refill(s). Instructions: inject 15-20 Units subcutaneous (under the skin) 2 times a day before meals. Before breakfast take 15 units, before dinner take 20 units.\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-10-02, presumably until 2013-10-31, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-02 14:52:00, ended at 2013-10-02 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Cardiopulmonary exercise testing, including measurements of minute ventilation, CO2 production, O2 uptake, and electrocardiographic recordings\n- Bioimpedance-derived physiologic cardiovascular analysis\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-08 00:00:00, ended at 2013-10-08 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-09 00:00:00, ended at 2013-10-09 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-09 12:00:00, ended at 2013-10-09 13:16:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-09 12:05:57, ended at 2013-10-09 12:53:16\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Congestive heart failure\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-09 13:17:00, ended at 2013-10-09 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-31 00:00:00, ended at 2013-10-31 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of nervous system due to diabetes mellitus\n- Primary diagnosis: Polyneuropathy due to diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-10-31, presumably until 2013-11-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-01 00:00:00, ended at 2013-11-01 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Primary diagnosis: Primary cardiomyopathy\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-05 06:01:00, ended at 2013-11-05 17:24:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.6 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 4.3 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n\n### Procedure\n- Catheterization of right heart\n- Coronary arteriography using two catheters\n- Collection of venous blood by venipuncture\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Coronary arteriosclerosis\n- Diabetic - poor control\n- Old myocardial infarction\n- Angina pectoris\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Diabetes mellitus without complication\n\n### Drug\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-11-05, presumably until 2013-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-08 09:17:24, ended at 2013-11-08 10:30:56\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2014-01-10, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day with meals.\n- 24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2014-04-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-22 00:00:00, ended at 2013-11-22 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for transvenous insertion or replacement of pacing cardioverter-defibrillator\n\n### Condition\n- Primary cardiomyopathy\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2013-11-22, presumably until 2013-11-22\n- cefazolin 1000 MG Injection, started on 2013-11-22, presumably until 2013-11-22\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-22, presumably until 2013-11-22\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2013-11-22, presumably until 2013-11-22\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-22, presumably until 2013-11-22\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-22, presumably until 2013-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-22 06:14:00, ended at 2013-11-23 11:24:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 4.3 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Prothrombin time (PT): 14.0 (second)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.3 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Body height: 5' 5\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Implantation or replacement of automatic cardioverter/defibrillator, total system [AICD]\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion or replacement of permanent implantable defibrillator system, with transvenous lead(s), single or dual chamber\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Coronary arteriosclerosis\n- Imaging of thorax abnormal\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Old myocardial infarction\n- Chronic ischemic heart disease\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-23\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-22\n- ticagrelor 90 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-23\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-22\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2013-11-22, presumably until 2013-11-22\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2013-11-23, presumably until 2013-12-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-11-22, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-22, presumably until 2013-11-22\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-11-22, presumably until 2013-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-09 11:17:31, ended at 2013-12-09 11:47:10\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-10 00:00:00, ended at 2014-01-10 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-28 00:00:00, ended at 2014-01-28 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-30 10:21:05, ended at 2014-01-30 11:21:24\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Diabetic - poor control\n- Primary diagnosis: Pulmonary tuberculosis\n- Diabetes mellitus without complication\n\n### Drug\n- vitamin B6 50 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 8 refill(s). Instructions: take 1 Tab by mouth daily.\n- isoniazid 300 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 8 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-30 11:27:00, ended at 2014-01-30 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 42 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- MCH [Entitic mass] by Automated count: 26.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 80.1 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.75 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 240 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-25 00:00:00, ended at 2014-02-25 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Primary diagnosis: Diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-26 11:23:48, ended at 2014-02-26 11:47:02\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-26 11:48:00, ended at 2014-02-26 11:49:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-26 11:50:00, ended at 2014-02-26 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-04 10:35:43, ended at 2014-03-04 11:12:18\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Congestive heart failure\n- Primary diagnosis: Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-06 00:00:00, ended at 2014-03-06 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-06 00:00:00, ended at 2014-03-06 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of female breast\n- Primary diagnosis: Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-13 00:00:00, ended at 2014-03-13 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-13 09:22:00, ended at 2014-03-13 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Heart failure\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-21 00:00:00, ended at 2014-03-21 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 30 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-21 12:22:00, ended at 2014-03-21 13:24:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-21 13:25:00, ended at 2014-03-21 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Primary malignant neoplasm of female breast\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-21 13:25:00, ended at 2014-03-21 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-25 12:37:51, ended at 2014-03-25 13:49:16\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic systolic heart failure\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-04 00:00:00, ended at 2014-04-04 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-04 09:56:20, ended at 2014-04-04 11:38:39\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n- Diabetic - poor control\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-04-04, presumably until 2014-05-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-25 00:00:00, ended at 2014-04-25 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-04-25, presumably until 2014-05-19, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-25 12:28:00, ended at 2014-04-25 14:22:05\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-04-25, presumably until 2014-04-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Two am and one pm\n- 24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet, started on 2014-04-25, presumably until 2014-05-19, with intended 6 refill(s). Instructions: Pt sent home with hand written prescription for 240 mg tablet pill - to take one tablet in evening or two of 120 each pm together\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-25 14:27:00, ended at 2014-04-25 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.24 (milli-international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 219 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 96 (nanogram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 260 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.2 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.4 (nanogram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Primary cardiomyopathy\n- Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-14 00:00:00, ended at 2014-05-14 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy due to diabetes mellitus\n- Primary diagnosis: Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-05-14, presumably until 2014-07-18, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-05-17 19:59:00, ended at 2014-05-23 16:30:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 26 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 235 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 5\" (inch (US))\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 7.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 388 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.59 (milli-international unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 11 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 468 (nanogram per milliliter)\n- Lactate [Moles/volume] in Blood: 1.6 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Prothrombin time (PT): 16.2 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 13.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- Left ventricular Ejection fraction: 28.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 207 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- MCV [Entitic volume] by Automated count: 81.3 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 64 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.0 (second)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Hospital discharge day management; 30 minutes or less\n- Catheterization of right heart\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Procedure on single vessel\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Central venous catheter placement with guidance\n- Physical therapy evaluation\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Coronary arteriography using two catheters\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Revision of automatic implantable cardioverter/defibrillator\n- Percutaneous transluminal coronary angioplasty\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Radiologic examination, chest; single view, frontal\n- Insertion of drug-eluting coronary artery stent\n- Insertion of one vascular stent\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch\n\n### Condition\n- Diabetic - poor control\n- Fever\n- Helicobacter-associated disease\n- Essential hypertension\n- Hyperosmolality and or hypernatremia\n- Hypo-osmolality and or hyponatremia\n- Iron deficiency anemia\n- Long QT syndrome\n- Chest pain\n- Eye / vision finding\n- Atrial fibrillation\n- Primary diagnosis: Congestive heart failure\n- Diabetes mellitus without complication\n- Infective pneumonia\n- Leukocytosis\n- Coronary arteriosclerosis\n- Disorder of esophagus\n- Cardiomegaly\n- Chronic ischemic heart disease\n- Disorder of function of stomach\n- Disorder of lung\n- Hypovolemia\n- Lung field abnormal\n- Nonspecific tuberculin test reaction\n- Preinfarction syndrome\n- Primary diagnosis: Acute on chronic systolic heart failure\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Old myocardial infarction\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2014-05-23, presumably until 2014-05-23, with intended 0 refill(s). Instructions: take 2 Caps by mouth Q12H.\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 40 mg by mouth every morning.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2014-05-21, presumably until 2014-05-21\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-05-17, presumably until 2014-05-22\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-05-23, presumably until 2014-11-11, with intended 11 refill(s). Instructions: inject 10-20 Units subcutaneous (under the skin) 3 times a day. 10 units every morning, 15 units in afternoon, 20 units every evening\n- tetracycline hydrochloride 500 MG Oral Capsule, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-18\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- bismuth subsalicylate 35 MG/ML Oral Suspension, through Oral route, started on 2014-05-23, presumably until 2014-06-13, with intended 0 refill(s). Instructions: take 15 mL by mouth 4 times a day.\n- metronidazole 250 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-18\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2014-05-21, presumably until 2014-05-21\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-05-22, presumably until 2014-05-23\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-05-19, presumably until 2014-05-19\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2014-05-17, presumably until 2014-05-17\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-21, presumably until 2014-05-22\n- vitamin B6 50 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-23\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-05-18, presumably until 2014-05-23\n- isoniazid 300 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-23\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-05-18, presumably until 2014-05-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-05-18, presumably until 2014-05-19\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-05-19, presumably until 2014-05-22\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-20, presumably until 2014-05-21\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-05-18, presumably until 2014-05-23\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-05-20, presumably until 2014-05-23\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-05-17, presumably until 2014-05-18\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-20, presumably until 2014-05-21\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2014-05-19, presumably until 2014-05-19\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-05-20, presumably until 2014-09-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-17, presumably until 2014-05-22\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2014-05-22, presumably until 2014-05-22\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2014-05-18, presumably until 2014-05-21\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2014-05-19, presumably until 2014-05-19\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-05-20, presumably until 2014-06-13, with intended 0 refill(s). Instructions: instill 1 Drop to right eye 4 times a day.\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-05-18, presumably until 2014-05-18\n- 24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 120 mg by mouth Every Day.\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-22\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2014-05-18, presumably until 2014-05-18\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-19, presumably until 2015-05-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-06-22, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-05-18, presumably until 2014-05-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2014-05-22, presumably until 2014-05-22\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2014-05-20, presumably until 2014-05-22\n- clarithromycin 500 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2014-05-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q12H.\n- tetracycline hydrochloride 250 MG Oral Capsule, through Oral route, started on 2014-05-23, presumably until 2014-05-23, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2014-09-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-27 00:00:00, ended at 2014-05-27 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n- Helicobacter-associated disease\n- Acute on chronic combined systolic and diastolic heart failure\n- Diabetes mellitus without complication\n- Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-13 11:45:00, ended at 2014-06-13 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 249 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 11.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n- Polyneuropathy due to diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-07-18, presumably until 2014-11-23, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. appt needed for additional refills\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-01 10:15:49, ended at 2014-09-01 11:57:22\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Revision of automatic implantable cardioverter/defibrillator\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2015-09-01, with intended 3 refill(s). Instructions: take 1 tablet by mouth every bedtime.\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2015-06-10, with intended 3 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-01 12:05:00, ended at 2014-09-01 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 281 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 13.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiomyopathy associated with another disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2014-11-11, presumably until 2016-03-10, with intended 2 refill(s). Instructions: Inject SQ 3 times per day 10 minutes before each meal, Before breakfast: take 10 units, Before Lunch: 15 units, Before dinner: take 20 units\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-23 00:00:00, ended at 2014-11-23 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2014-11-23, presumably until 2014-12-15, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-24 00:00:00, ended at 2014-11-24 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2014-11-24, presumably until 2014-11-24, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-12-15, presumably until 2015-04-20, with intended 1 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-20 00:00:00, ended at 2015-04-20 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2015-04-21, presumably until 2015-09-15, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-09 00:00:00, ended at 2015-06-09 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, started on 2015-06-12, presumably until 2018-07-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY NIGHT AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-10 09:43:13, ended at 2015-06-10 14:27:42\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n- Revision of automatic implantable cardioverter/defibrillator\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n- Flatulence, eructation and gas pain\n- Primary diagnosis: Chronic combined systolic and diastolic heart failure\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2015-06-10, with intended 0 refill(s). Instructions: take 40 mg by mouth Evening\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 325 mg by mouth Evening\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2015-06-10, presumably until 2016-06-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 80 MG Oral Tablet, through Oral route, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 80 mg by mouth Evening\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2015-06-10, presumably until 2016-03-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-10, presumably until 2015-06-12, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2012-08-19, presumably until 2016-10-28, with intended 0 refill(s). Instructions: place 0.4 mg under the tongue and let dissolve\n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2015-06-22, with intended 0 refill(s). Instructions: take by mouth Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-18 11:16:53, ended at 2015-06-18 12:18:27\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, through Subcutaneous route, started on 2015-06-18, presumably until 2016-03-25, with intended 6 refill(s). Instructions: inject 1.2 mg subcutaneous (under the skin) daily with lunch\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-18 12:30:00, ended at 2015-06-18 23:59:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 15.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 438 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-22 00:00:00, ended at 2015-06-22 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2015-06-22, presumably until 2016-07-12, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2015-09-04, presumably until 2016-09-11, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-15 00:00:00, ended at 2015-09-15 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n- Peripheral nerve disease\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2015-09-24, presumably until 2016-05-23, with intended 5 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-28 00:00:00, ended at 2016-01-28 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- famotidine 20 MG Oral Tablet, started on 2016-01-29, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n- 12 HR ranolazine 500 MG Extended Release Oral Tablet, started on 2016-01-29, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 12 HOURS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-02 00:00:00, ended at 2016-02-02 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-16 10:27:52, ended at 2016-02-16 12:43:21\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Type 2 diabetes mellitus\n- Primary diagnosis: Chronic combined systolic and diastolic heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-16 12:49:00, ended at 2016-02-16 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 284 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 6.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 237 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 12.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 3480 (milligram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 181 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 114.00 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: >3000 (milligram per gram)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.12 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 281 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-23 00:00:00, ended at 2016-02-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 0.65 ML exenatide 3.08 MG/ML Pen Injector, started on 2016-02-23, presumably until 2016-06-15, with intended 11 refill(s). Instructions: Inject contents of syringe SQ once a week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-10 00:00:00, ended at 2016-03-10 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2016-03-11, presumably until 2017-03-11, with intended 11 refill(s). Instructions: INJECT SUBCUTANEOUSLY 15 UNITS BEFORE BREAKFAST AND 30 UNITS BEFORE DINNER. INJECT 10 MINUTES BEFORE EACH MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-25 00:00:00, ended at 2016-03-25 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n- Congestive heart failure\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-25 09:38:00, ended at 2016-03-25 13:08:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 28.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Hyperglycemia due to type 2 diabetes mellitus\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-25 11:54:13, ended at 2016-03-25 13:05:42\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, through Subcutaneous route, started on 2016-03-28, presumably until 2017-08-23, with intended 11 refill(s). Instructions: inject 0.6 mg subcutaneous (under the skin) Every Day Failed Bydureon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-25 13:09:00, ended at 2016-03-25 13:09:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-25 13:10:00, ended at 2016-03-25 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anabasine [Mass/volume] in Urine: <2.0 (nanogram per milliliter)\n- Prealbumin [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Nornicotine [Mass/volume] in Urine: <2.0 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.48 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Cotinine [Mass/volume] in Urine: <5.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 205 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1619 (picogram per milliliter)\n- Nicotine [Mass/volume] in Urine: <2.0 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-23 00:00:00, ended at 2016-05-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neuralgia\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2016-05-23, presumably until 2016-07-26, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 08:21:00, ended at 2016-05-31 10:37:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-31 09:04:07, ended at 2016-05-31 16:25:59\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 10:38:00, ended at 2016-05-31 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-15 00:00:00, ended at 2016-06-15 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-15 09:39:45, ended at 2016-06-15 14:39:47\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2016-06-15, presumably until 2016-06-15, with intended 11 refill(s). Instructions: INJECT SUBCUTANEOUSLY 15 UNITS BEFORE BREAKFAST AND 30 UNITS BEFORE DINNER. INJECT 10 MINUTES BEFORE EACH MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-15 10:21:51, ended at 2016-06-15 12:10:36\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Primary diagnosis: Heart failure\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-15 12:33:00, ended at 2016-06-15 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Chronic ischemic heart disease\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-16 00:00:00, ended at 2016-06-16 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2016-06-17, presumably until 2016-07-06, with intended 4 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-06 00:00:00, ended at 2016-07-06 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2016-07-06, presumably until 2017-07-23, with intended 4 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-12 00:00:00, ended at 2016-07-12 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2016-07-13, presumably until 2016-08-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-26 00:00:00, ended at 2016-07-26 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Neuralgia\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2016-07-27, presumably until 2016-08-23, with intended 11 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-11 00:00:00, ended at 2016-08-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2016-08-11, presumably until 2017-08-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-23 00:00:00, ended at 2016-08-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Disorder of endocrine system\n- Polyneuropathy associated with another disorder\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2016-08-24, presumably until 2017-09-26, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-23 00:00:00, ended at 2016-08-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of endocrine system\n- Polyneuropathy associated with another disorder\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2016-08-23, presumably until 2016-08-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-11 00:00:00, ended at 2016-09-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2016-09-13, presumably until 2017-06-13, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-28 09:45:50, ended at 2016-10-28 11:48:28\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Chronic ischemic heart disease\n- Diabetes mellitus\n- Heart failure\n- Complication due to diabetes mellitus\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2016-10-28, presumably until 2018-07-19, with intended 6 refill(s). Instructions: place 1 Tab under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-28 12:00:00, ended at 2016-10-28 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1027 (picogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- MCV [Entitic volume] by Automated count: 81.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Diabetes mellitus\n- Complication due to diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-14 09:19:16, ended at 2016-11-14 10:03:25\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Chronic ischemic heart disease\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-14 10:12:00, ended at 2016-11-14 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 853 (picogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-14 10:35:21, ended at 2016-11-14 13:17:37\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n\n### Drug\n- empagliflozin 10 MG Oral Tablet, through Oral route, started on 2016-11-14, presumably until 2017-06-11, with intended 6 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-19 00:00:00, ended at 2016-12-19 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Polyneuropathy associated with another disorder\n- Disorder of endocrine system\n- Type 2 diabetes mellitus\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2016-12-20, presumably until 2016-12-20, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-20 00:00:00, ended at 2017-02-20 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Urine: 55.60 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 731 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.41 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- MCV [Entitic volume] by Automated count: 81.7 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 32 (milligram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 58 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 8.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-20 11:16:07, ended at 2017-02-20 13:53:56\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Primary diagnosis: Heart failure\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-02-16, presumably until 2017-02-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-20 13:55:00, ended at 2017-02-20 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Heart failure\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-10 10:12:00, ended at 2017-03-10 12:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Heart failure\n- Complication due to diabetes mellitus\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-10 11:21:26, ended at 2017-03-10 13:19:48\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-10 13:00:00, ended at 2017-03-10 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.28 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.0 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1332 (picogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 193 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Heart failure\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-11 00:00:00, ended at 2017-03-11 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2017-03-14, presumably until 2017-08-23, with intended 11 refill(s). Instructions: Humalog 75/25 insulin mix  Before breakfast: take 15  Before lunch: 25 unit     Before dinner: take 30 units      \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-28 13:12:00, ended at 2017-03-28 17:44:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n- Glucose [Mass/volume] in Blood: 95 (milligram per deciliter)\n- Left ventricular Ejection fraction: 28.0 (percent)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 14.3 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.4 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 42 (percent)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Collection of blood specimen from a completely implantable venous access device\n- Insertion of Monitoring Device into Right Ventricle, Percutaneous Approach\n- Measurement of Cardiac Sampling and Pressure, Right Heart, Percutaneous Approach\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Monitoring of Cardiac Output, Percutaneous Approach\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Generalized ischemic myocardial dysfunction\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Heart failure\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Hypertensive heart failure\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-28 00:00:00, ended at 2017-04-28 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-19 09:20:25, ended at 2017-05-19 10:27:05\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-04-14, presumably until 2017-11-10, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- methotrexate 2.5 MG Oral Tablet, through Oral route, started on 2017-04-14, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 15 mg by mouth every 7 days \n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-04-18, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-11 00:00:00, ended at 2017-06-11 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- empagliflozin 10 MG Oral Tablet, started on 2017-06-13, presumably until 2018-07-19, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-13 00:00:00, ended at 2017-06-13 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2017-06-13, presumably until 2017-09-18, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-16 00:00:00, ended at 2017-06-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2017-06-18, presumably until 2017-08-23, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-26 09:50:15, ended at 2017-06-26 10:30:17\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 10:39:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.61 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 275 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, started on 2017-07-13, presumably until 2018-05-31, with intended 11 refill(s). Instructions: INJECT 1.2 MG SUBCUTANEOUS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary diabetes mellitus\n- Severe hyperglycemia due to diabetes mellitus\n- Complication due to diabetes mellitus\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-23 00:00:00, ended at 2017-07-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2017-07-23, presumably until 2017-10-04, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-10 00:00:00, ended at 2017-08-10 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2017-08-10, presumably until 2018-06-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-23 00:00:00, ended at 2017-08-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-23 00:00:00, ended at 2017-08-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus\n\n### Drug\n- carvedilol 25 MG Oral Tablet, started on 2017-08-23, presumably until 2018-07-19, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-23 09:57:58, ended at 2017-08-23 12:23:51\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2017-08-23, presumably until 2018-07-19, with intended 11 refill(s). Instructions: Humalog 75/25 insulin mix Before breakfast: take 18 Before lunch: 26 units  Before dinner: take 26 units\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-23 11:13:50, ended at 2017-08-23 13:17:06\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2017-08-23, presumably until 2017-08-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-08 00:00:00, ended at 2017-09-08 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-12 00:00:00, ended at 2017-09-12 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-18 00:00:00, ended at 2017-09-18 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sacubitril 24 MG / valsartan 26 MG Oral Tablet, through Oral route, started on 2017-09-18, presumably until 2018-06-01, with intended 0 refill(s). Instructions: take 24-26 mg by mouth 2 times a day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-23 00:00:00, ended at 2017-09-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Neuralgia\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2017-09-26, presumably until 2018-05-04, with intended 6 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 13:06:00, ended at 2017-10-04 13:06:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 13:07:00, ended at 2017-10-04 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.61 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 500 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.49 (micro-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 83.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.56 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic combined systolic and diastolic heart failure\n- Heart failure\n- Chronic ischemic heart disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Congestive heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-10-23 00:00:00, ended at 2017-10-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-10-23, presumably until 2017-10-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take 80mg in the morning, 40mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-10 10:13:57, ended at 2017-11-10 11:24:08\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2017-12-13, presumably until 2017-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-16 00:00:00, ended at 2018-01-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2018-01-17, presumably until 2018-01-17, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-17 08:03:00, ended at 2018-01-17 09:18:03\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-17 09:21:00, ended at 2018-01-17 09:21:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.2 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.74 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.53 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Secondary diabetes mellitus\n- Complication due to diabetes mellitus\n- Severe hyperglycemia due to diabetes mellitus\n- Kidney disease\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-17 09:22:00, ended at 2018-01-17 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Heart failure\n- Secondary diabetes mellitus\n- Severe hyperglycemia due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-07 00:00:00, ended at 2018-02-07 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2018-02-08, presumably until 2018-02-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-14 11:26:56, ended at 2018-03-14 13:55:49\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 30 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 1.88 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 206 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n\n### Procedure\n- Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead transvenous imp\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Primary diagnosis: Heart failure\n\n### Drug\n- digoxin 0.125 MG Oral Tablet, through Oral route, started on 2018-03-14, presumably until 2018-06-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-14 14:02:00, ended at 2018-03-14 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 567 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.9 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-03-22 00:00:00, ended at 2018-03-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.58 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-28 13:52:00, ended at 2018-03-28 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.52 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Heart failure\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-06 00:00:00, ended at 2018-04-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.56 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-13 00:00:00, ended at 2018-04-13 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-20 00:00:00, ended at 2018-04-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 23 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.67 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-27 00:00:00, ended at 2018-04-27 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 22 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-04 00:00:00, ended at 2018-05-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 18 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.58 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-04 00:00:00, ended at 2018-05-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neuralgia\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2018-05-08, presumably until 2018-07-19, with intended 6 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-11 00:00:00, ended at 2018-05-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.55 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 15 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-23 00:00:00, ended at 2018-05-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- spironolactone 25 MG Oral Tablet, started on 2018-05-23, presumably until 2018-07-19, with intended 6 refill(s). Instructions: TAKE 1/2 TABLET BY MOUTH DAILY\n- furosemide 80 MG Oral Tablet, started on 2018-05-23, presumably until 2018-06-01, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH IN THE MORNING AND IN THE AFTERNOON\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-23 09:48:00, ended at 2018-05-23 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.52 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.78 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 19 (calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 373 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-31 00:00:00, ended at 2018-05-31 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, started on 2018-06-05, presumably until 2018-07-19, with intended 11 refill(s). Instructions: INJECT 1.2 MG SUBCUTANEOUS EVERY DAY  90 day supply if insurance allows\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-01 00:00:00, ended at 2018-06-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Chronic combined systolic and diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-01 00:00:00, ended at 2018-06-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Primary diagnosis: Heart failure\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-06-01, presumably until 2018-07-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- digoxin 0.125 MG Oral Tablet, through Oral route, started on 2018-06-01, presumably until 2018-07-19, with intended 11 refill(s). Instructions: take 0.5 Tabs by mouth daily\n- furosemide 80 MG Oral Tablet, started on 2018-06-01, presumably until 2018-07-19, with intended 6 refill(s). Instructions: Take 80 mg (one tablet) in the morning and 40 mg (half of a tablet) in the afternoon.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-06-06 00:00:00, ended at 2018-06-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for heart transplant or heart/lung transplant\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Heart failure\n- Atrial fibrillation\n- Cardiomyopathy\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- 2 ML magnesium sulfate 500 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2018-06-06, presumably until 2018-06-07\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-06-06, presumably until 2018-06-06\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- ketamine 100 MG/ML Injectable Solution, started on 2018-06-06, presumably until 2018-06-06\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-06, presumably until 2018-06-06\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-06-06 15:50:00, ended at 2018-07-19 16:03:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Blood by calculation: 7 (millimole per liter)\n- C peptide [Mass/volume] in Serum or Plasma: 0.2 (nanogram per milliliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 45.5 (millimeter mercury column)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: >15.0 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.7 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Eosinophils [#/volume] in Blood by Manual count: 0.27 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Prothrombin time (PT): 26.1 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.70 (micro-international unit per milliliter)\n- Ammonia [Mass/volume] in Plasma: 42 (micromole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.44 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatinine renal clearance in 24 hour Urine and Serum or Plasma: 21 (milliliter per minute)\n- Left ventricular Ejection fraction: 57.7 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 8 (milli-international unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 88 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: >150 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 30.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Mixed venous blood: 0.64 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Hydroxyitraconazole [Mass/volume] in Serum or Plasma: <0.1 (microgram per milliliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.00 (thousand per microliter)\n- Myoglobin [Mass/volume] in Urine: 143 (microgram per liter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 8.53 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.31 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 395 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.30 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 310 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: >3500 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Body weight Stated: 92.0 (kilogram)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 284 (unit per liter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Itraconazole [Mass/volume] in Serum or Plasma: <0.1 (microgram per milliliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 804 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 2.71 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 97 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n- Aldolase [Enzymatic activity/volume] in Serum or Plasma: 13.5 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.60 (milligram per deciliter)\n- Body height Stated: 165 (centimeter)\n- Calcium.ionized [Moles/volume] in Blood: 1.08 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.6 (millimeter mercury column)\n- Ferritin [Mass/volume] in Serum or Plasma: 250.1 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 150 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 68.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 51 - 100 (per high power field)\n- Iron [Mass/volume] in Serum or Plasma: 28 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 93.5 (millimeter mercury column)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 15.5 (microgram per milliliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Evaluation of oral and pharyngeal swallowing function\n- Measurement of Cardiac Sampling and Pressure, Right Heart, Percutaneous Approach\n- Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Hemodialysis procedure with single evaluation by a physician or other qualified health care professional\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Controlled ventilation procedure and therapy, initiation and management\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies) requiring repeated evaluations by a physician or other qualified health care professional, with or without substantial re\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Transplantation of Heart, Allogeneic, Open Approach\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Radiologic examination, chest; single view\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Collection of venous blood by venipuncture\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Performance of Cardiac Output, Continuous\n- Endomyocardial biopsy\n- Insertion of Infusion Device into Right Atrium, Percutaneous Approach\n- Computed tomography, thorax, diagnostic; without contrast material\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Removal of Cardiac Lead from Heart, Open Approach\n- Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Performance of Urinary Filtration, Intermittent, Less than 6 Hours Per Day\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Insertion of Tunneled Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach\n- Computed tomography, head or brain; without contrast material\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Performance of Urinary Filtration, Continuous, Greater than 18 hours Per Day\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n- Insertion of Monitoring Device into Right Pulmonary Artery, Percutaneous Approach\n\n### Condition\n- Acute on chronic hypercapnic respiratory failure\n- Aortocoronary bypass graft present\n- Disorders of both mitral and tricuspid valves\n- Infection due to Escherichia coli\n- Iron deficiency anemia\n- Long QT syndrome\n- Pain at rest of left lower limb co-occurrent and due to atherosclerosis\n- Pleural effusion\n- Pulmonary hypertension\n- Aberrant premature complexes\n- Acute posthemorrhagic anemia\n- Atrial fibrillation\n- Conduction disorder of the heart\n- Diabetes mellitus without complication\n- Disorder of cardiovascular system\n- Disorder of transplanted heart\n- Hepatic failure\n- Hyperkalemia\n- Intermittent claudication of bilateral lower limbs co-occurrent and due to atherosclerosis\n- Supraventricular tachycardia\n- Ventricular tachycardia\n- Acute hypoxemic respiratory failure\n- Anemia in chronic kidney disease\n- Atherosclerosis of artery of lower limb\n- Cardiogenic shock\n- Cardiomegaly\n- Cardiomyopathy\n- Chronic total occlusion of coronary artery\n- Coronary artery graft present\n- Hypo-osmolality and or hyponatremia\n- Hypoglycemia due to type 2 diabetes mellitus\n- Rheumatic disease of heart valve\n- Skin sensation disturbance\n- Transplanted heart present\n- Abnormal findings on diagnostic imaging of lung\n- Acquired absence of organ\n- Congestive heart failure\n- Critical illness myopathy\n- Delirium\n- Diastolic heart failure\n- Edema, generalized\n- Electrocardiogram abnormal\n- Generalized ischemic myocardial dysfunction\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Late effect of complications of procedure\n- Late effect of medical and surgical care complication\n- Localized edema\n- Muscle pain\n- Muscle weakness\n- Old myocardial infarction\n- Right bundle branch block\n- Sepsis\n- Septic shock\n- Ventricular premature complex\n- Acidosis\n- Acute renal failure syndrome\n- Acute tubular necrosis\n- Altered mental status\n- Bacterial infection due to Pseudomonas\n- Cardiac transplant failure\n- Chronic ischemic heart disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Metabolic encephalopathy\n- Moderate protein-calorie malnutrition (weight for age 60-74 percent of standard)\n- Acute on chronic combined systolic and diastolic heart failure\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Blood coagulation disorder\n- Chronic kidney disease stage 3\n- Complication of anesthesia\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Heart failure\n- Hyperglycemia\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperosmolality and or hypernatremia\n- Hypertensive heart and chronic kidney disease\n- Leukocytosis\n- Low blood pressure\n- Persistent pain following procedure\n- Acute on chronic hypoxemic respiratory failure\n- Acute pulmonary edema\n- Atelectasis\n- Cardiac arrhythmia\n- Chronic passive congestion of liver\n- Disorder of digestive system\n- Disorder of immune function\n- Disorientated\n- Postoperative shock\n- Rest pain\n- Vocal cord paralysis\n- Atrial flutter\n- Bradycardia\n- Complication due to diabetes mellitus\n- End-stage renal disease\n- Finding of urine output\n- Hyperosmolarity\n- Left bundle branch block\n- Obesity\n- Pneumonia due to Pseudomonas\n- Pneumothorax\n- Rheumatoid arthritis\n- Shock\n- Chronic pulmonary edema\n- Disorder of plasma protein metabolism\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n\n### Drug\n- glycerin, started on 2018-06-11, presumably until 2018-06-11\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2018-07-02, presumably until 2018-12-17, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2018-06-28, presumably until 2018-07-12, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2018-06-11, presumably until 2018-06-23\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-15\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2018-06-08, presumably until 2018-06-11\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-06-09, presumably until 2018-06-11\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-15\n- 250 ML dopamine hydrochloride 3.2 MG/ML Injection, through Intravenous route, started on 2018-06-15, presumably until 2018-06-15\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-03, presumably until 2018-07-19, with intended 5 refill(s). Instructions: inject 33 Units subcutaneous (under the skin) 2 times a day\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2018-06-18, presumably until 2018-07-02\n- sodium citrate, through Intravenous route, started on 2018-06-09, presumably until 2018-06-25\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2018-06-07, presumably until 2018-06-15\n- haloperidol 5 MG/ML Injectable Solution, started on 2018-06-11, presumably until 2018-06-12\n- chlorothiazide 50 MG/ML Oral Suspension, through Oral route, started on 2018-06-08, presumably until 2018-06-17\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-07-04, presumably until 2019-07-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-19\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-06-17, presumably until 2018-06-23\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2018-06-11, presumably until 2018-06-11\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-06-15\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-03, presumably until 2018-07-09, with intended 5 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) 3 times a day before meals Additionally, inject 0-12 units subcutaneously 4 times a day before meals and at bedtime per sliding scale.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-28\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-06-26, presumably until 2018-06-28\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-08-24, with intended 2 refill(s). Instructions: take 2 Tabs by mouth daily Or as directed per prednisone taper card.\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2018-06-28, presumably until 2018-06-30\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-07-19\n- amphotericin B 50 MG Injection, started on 2018-06-07, presumably until 2018-06-07\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2018-06-11, presumably until 2018-06-11\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2018-06-09, presumably until 2018-06-15\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2018-06-29, presumably until 2018-08-16, with intended 0 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every Tuesday, Thursday and Saturday\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-06-29\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-07-09, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-15, presumably until 2018-06-15\n- cefazolin 1000 MG Injection, started on 2018-06-07, presumably until 2018-06-07\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2018-06-12, presumably until 2018-06-15\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-07-02\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-06-23, presumably until 2018-06-23\n- 5 ML iron sucrose 20 MG/ML Injection, through Intravenous route, started on 2018-06-29, presumably until 2018-08-16, with intended 0 refill(s). Instructions: 5 mL by Intravenous route every Tuesday, Thursday and Saturday For 9 doses.\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-06-07\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2018-06-10, presumably until 2018-06-16\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2018-06-08, presumably until 2018-07-02\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-08-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-06-07, presumably until 2018-07-19\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2018-06-08, presumably until 2019-05-31, with intended 11 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lansoprazole 30 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-07-02\n- 10 ML furosemide 10 MG/ML Injection, started on 2018-06-07, presumably until 2018-06-30\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2018-06-21, presumably until 2018-07-05\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-06-21, presumably until 2018-08-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-06-12, presumably until 2018-07-19\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, through Subcutaneous route, started on 2018-06-20, presumably until 2018-08-02, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 8 hours\n- citric acid, through Intravenous route, started on 2018-06-09, presumably until 2018-06-25\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2018-06-08, presumably until 2018-06-21\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2018-06-16, presumably until 2018-06-28\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-06-08, presumably until 2018-08-29, with intended 0 refill(s). Instructions: inject 23 Units subcutaneous (under the skin) 3 times a day with meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2018-06-07, presumably until 2018-06-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-06-19, presumably until 2018-06-21\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-06-13\n- hydroxyzine hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2018-06-12, presumably until 2018-06-12\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-07, presumably until 2018-06-15\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-17, presumably until 2018-06-23\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2018-06-09, presumably until 2018-06-26\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-06-07\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-07-03, presumably until 2018-07-30, with intended 11 refill(s). Instructions: take 1 Cap by mouth daily\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-06-21, presumably until 2018-06-25\n- sennosides, USP 35.2 MG/ML Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-06-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- venlafaxine 25 MG Oral Tablet, through Oral route, started on 2018-06-19, presumably until 2018-08-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth DAILY\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-06-07\n- albuterol 2 MG Oral Tablet, through Oral route, started on 2018-06-15, presumably until 2018-07-19, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 3 times a day\n- albuterol 0.4 MG/ML Oral Solution, through Oral route, started on 2018-06-21, presumably until 2018-07-02\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2018-06-08, presumably until 2018-08-29, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2018-07-05, presumably until 2018-07-05\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2018-07-02, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, started on 2018-07-19, presumably until 2018-08-16, with intended 0 refill(s). Instructions: On 07/19/2018, inject 15 units subcutaneously (under the skin) in the evening once. Then on 07/20/2018, inject 15 units SQ in the morning once. Then starting on 07/21/2018, inject 30 units SQ once daily in the morning thereafter.\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2018-06-21, presumably until 2018-09-10, with intended 2 refill(s). Instructions: Take 20 mL (200 mg) by mouth every morning and 10 mL (100 mg) every evening on an empty stomach.\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2018-06-28, presumably until 2019-07-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-07-05, presumably until 2018-09-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily Apply patch to upper back  for up to 12 hours in any 24 hour period.\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2018-06-09, presumably until 2018-06-12\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- midodrine hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-07-17\n- 10 ML atropine sulfate 0.1 MG/ML Prefilled Syringe, started on 2018-06-21, presumably until 2018-06-21\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-13\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-08, presumably until 2018-06-08\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2018-06-10, presumably until 2018-06-11\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-07-19\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2018-06-11, presumably until 2018-06-11\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2018-07-02, presumably until 2018-10-03, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2018-06-15, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- acyclovir 40 MG/ML Oral Suspension, through Oral route, started on 2018-06-08, presumably until 2018-07-02\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-11-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2018-07-03, presumably until 2018-08-16, with intended 0 refill(s). Instructions: take 4 Tabs by mouth as needed for Low blood sugar\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-09, presumably until 2018-06-09\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-08\n- methylprednisolone 125 MG Injection, started on 2018-06-07, presumably until 2018-06-07\n- melatonin 3 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-18, presumably until 2018-07-18\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2018-07-03, presumably until 2018-07-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-08 00:00:00, ended at 2018-06-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-11 00:00:00, ended at 2018-06-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-14 00:00:00, ended at 2018-06-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2018-06-14, presumably until 2018-06-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-19 00:00:00, ended at 2018-06-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-19, presumably until 2018-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-26 00:00:00, ended at 2018-06-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-26, presumably until 2018-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-28 00:00:00, ended at 2018-06-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-28, presumably until 2018-06-28\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-28, presumably until 2018-06-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-03 00:00:00, ended at 2018-07-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-03, presumably until 2018-07-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-06 00:00:00, ended at 2018-07-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-10 00:00:00, ended at 2018-07-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-10, presumably until 2018-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-18 00:00:00, ended at 2018-07-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-18, presumably until 2018-07-18\n- 2 ML verapamil hydrochloride 2.5 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- iodixanol, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-07-18, presumably until 2018-07-18\n- 250 ML nitroglycerin 0.1 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- midazolam 1 MG/ML Injectable Solution, started on 2018-07-18, presumably until 2018-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-07-27 00:00:00, ended at 2018-07-27 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2018-08-14, with intended 0 refill(s). Instructions: take 1 mg by mouth 2 times a day Total dose of 1mg AM, 1mg PM\n- amlodipine 2.5 MG Oral Tablet, through Oral route, presumably until 2018-08-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-07-30, presumably until 2018-08-14, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 0.5mg AM, 1mg PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-01 00:00:00, ended at 2018-08-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-08-02, presumably until 2018-08-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2018-08-02, presumably until 2018-08-02, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-02 10:49:54, ended at 2018-08-02 12:42:30\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-02 12:51:00, ended at 2018-08-02 13:22:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.48 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Itraconazole [Mass/volume] in Serum or Plasma: 1.0 (microgram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.3 (percent)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hydroxyitraconazole [Mass/volume] in Serum or Plasma: 1.4 (microgram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 10.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 218 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 100 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 264 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.75 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.6 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 153 (milligram per deciliter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-02 13:23:00, ended at 2018-08-02 14:57:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Endomyocardial biopsy\n- Measurement of Cardiac Sampling and Pressure, Right Heart, Percutaneous Approach\n\n### Condition\n- Transplanted heart present\n- Obesity\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Essential hypertension\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-13 09:08:00, ended at 2018-08-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.53 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.19 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.6 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-14 00:00:00, ended at 2018-08-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2018-08-14, presumably until 2018-08-17, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 1mg AM, 1mg PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-16 00:00:00, ended at 2018-08-16 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-08-16, presumably until 2018-08-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-16 12:53:00, ended at 2018-08-16 14:48:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n- Chronic kidney disease\n- Acute deep venous thrombosis of internal jugular vein\n- Disorder of transplanted heart\n- Essential hypertension\n- Embolism from thrombosis of vein of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-17 00:00:00, ended at 2018-08-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal level of blood mineral\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-08-17, presumably until 2018-09-10, with intended 3 refill(s). Instructions: Total dose of 0.5mg AM, 1mg PM\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-08-17, presumably until 2018-09-10, with intended 3 refill(s). Instructions: Total dose: 0.5mg in the am, 1mg in the pm.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2018-08-17, presumably until 2018-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-17 09:51:00, ended at 2018-08-17 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 15.9 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.83 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-20 00:00:00, ended at 2018-08-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2018-08-20, presumably until 2018-11-27, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-20 00:00:00, ended at 2018-08-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-20 13:50:00, ended at 2018-08-20 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Disorder of transplanted heart\n- Embolism from thrombosis of vein of lower extremity\n- Acute deep venous thrombosis of internal jugular vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-23 00:00:00, ended at 2018-08-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2018-08-23, presumably until 2018-08-29, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-08-23, presumably until 2018-08-24, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-23 08:00:00, ended at 2018-08-23 10:42:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n- Essential hypertension\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-23 09:14:30, ended at 2018-08-23 10:36:05\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Edema\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-23 10:43:00, ended at 2018-08-23 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.78 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.80 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-24 00:00:00, ended at 2018-08-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2018-08-24, presumably until 2018-09-17, with intended 2 refill(s). Instructions: take 1.5 Tabs by mouth daily\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-08-24, presumably until 2018-08-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-24 12:02:00, ended at 2018-08-24 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Gangrenous disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-24 12:03:48, ended at 2018-08-24 13:17:41\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Gangrenous disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-27 08:35:00, ended at 2018-08-27 10:39:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 73 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2018-08-27, presumably until 2018-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-28 00:00:00, ended at 2018-08-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-08-28 17:48:00, ended at 2018-09-10 13:53:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.82 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 9149 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.5 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.59 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Left ventricular Ejection fraction: 60.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.027 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Body height: 5' 5\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Hospital discharge day management; 30 minutes or less\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Radiologic examination, chest; 2 views\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Abdominal distension, gaseous\n- Disorder of transplanted heart\n- Dyspnea\n- Leukocytosis\n- Essential hypertension\n- Gangrene due to type 2 diabetes mellitus\n- Hypoglycemia due to type 2 diabetes mellitus\n- Peripheral angiopathy due to diabetes mellitus\n- Anemia in chronic kidney disease\n- Coag./bleeding tests abnormal\n- Congestive heart failure\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Late effect of complications of procedure\n- Tricuspid incompetence, non-rheumatic\n- Chest pain\n- Disorder of digestive system\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Long QT syndrome\n- Thrombus due to any device, implant AND/OR graft\n- Type 2 diabetes mellitus\n- Alkalosis\n- Disorder of eye due to type 2 diabetes mellitus\n- Gangrenous disorder\n- Heart failure\n- Acute on chronic diastolic heart failure\n- Diastolic heart failure\n- Transplanted heart present\n- Acute deep venous thrombosis of internal jugular vein\n- Cardiac transplant failure\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Constipation\n- Primary diagnosis: Hypervolemia\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Obesity\n- Valvular endocarditis\n- Acquired absence of organ\n- Acute renal failure syndrome\n- Allergic disposition\n- Pleural effusion\n- Chronic kidney disease stage 4\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-09-10\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- 250 ML dobutamine 1 MG/ML Injection, through Intravenous route, started on 2018-09-04, presumably until 2018-09-09\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-09, presumably until 2019-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- clonidine hydrochloride 0.3 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2018-09-04, presumably until 2018-09-04\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-11-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-06\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- prednisone 2.5 MG Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2018-09-10\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2019-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-09\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-08-28\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-09-10\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-09-10\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2018-09-03, presumably until 2018-09-09\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-08-29, presumably until 2018-09-10\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-09-01, presumably until 2018-09-04\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2018-09-02, presumably until 2018-09-05\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2018-09-10\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-08-29, presumably until 2018-09-10\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-09-02, presumably until 2018-09-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-09-02, presumably until 2018-09-02\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2018-09-04\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-08-29, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 5 Caps by mouth 2 times a day\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-08-29, presumably until 2018-09-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2019-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every other day\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2018-08-28, presumably until 2018-09-03\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-08-29, presumably until 2018-09-09\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 5 Tabs by mouth 2 times a day\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-28, presumably until 2018-09-02\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-30 00:00:00, ended at 2018-08-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-08-30, presumably until 2018-08-30\n- midazolam 1 MG/ML Injectable Solution, started on 2018-08-30, presumably until 2018-08-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-05 00:00:00, ended at 2018-09-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-10 00:00:00, ended at 2018-09-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2018-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2018-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 3 Tabs by mouth 2 times a day\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2019-01-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-09-10, presumably until 2018-09-18, with intended 0 refill(s). Instructions: take 5 Caps by mouth 2 times a day\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2018-09-27, with intended 0 refill(s). Instructions: take 5 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-11 00:00:00, ended at 2018-09-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-11 00:00:00, ended at 2018-09-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Complication due to diabetes mellitus\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-09-11, presumably until 2019-11-27, with intended 11 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) 2 times a day 22 units AM, 22 units PM\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-09-11, presumably until 2019-11-21, with intended 11 refill(s). Instructions: inject 17 Units subcutaneous (under the skin) 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-11 13:10:09, ended at 2018-09-11 13:10:51\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-12 00:00:00, ended at 2018-09-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-13 09:23:00, ended at 2018-09-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.26 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.09 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 378 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-13 09:42:41, ended at 2018-09-13 11:15:45\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2018-09-13, presumably until 2018-09-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-13, presumably until 2019-09-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-09-14, presumably until 2018-09-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-17 00:00:00, ended at 2018-09-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-09-17, presumably until 2019-01-20, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-18 00:00:00, ended at 2018-09-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-09-18, presumably until 2018-10-10, with intended 0 refill(s). Instructions: take 5 Caps by mouth 2 times a day Take 5 capsules in AM and 6 capsules in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-18 08:57:00, ended at 2018-09-18 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 337 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.69 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.75 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-21 08:44:00, ended at 2018-09-21 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 8.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.95 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.12 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-24 00:00:00, ended at 2018-09-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood chemistry abnormal\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 09:28:00, ended at 2018-09-27 09:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 7.3 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.03 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Everolimus [Mass/volume] in Blood: 2.5 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 10:00:00, ended at 2018-09-27 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 69.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of immune function\n- Hypomagnesemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-28 00:00:00, ended at 2018-09-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-10-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- everolimus 0.5 MG Oral Tablet, started on 2018-09-28, presumably until 2018-10-03, with intended 3 refill(s). Instructions: Take 1mg twice daily. Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-11-27, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-28 09:47:00, ended at 2018-09-28 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-10-01, presumably until 2018-10-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day 2nd prescription, please dispense!\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-01 09:40:00, ended at 2018-10-01 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Everolimus [Mass/volume] in Blood: 3.5 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 133 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.17 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.23 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-03 00:00:00, ended at 2018-10-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-10-03, presumably until 2018-11-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily 2nd prescription, please dispense!\n- everolimus 0.5 MG Oral Tablet, started on 2018-10-03, presumably until 2018-11-28, with intended 3 refill(s). Instructions: Take 1mg in the AM, 1.5mg in the PM. Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2018-10-03, presumably until 2018-10-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1000 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 10.5 (microgram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 230 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 18 (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7920 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.9 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 810 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 370 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-10-10, presumably until 2018-10-11, with intended 11 refill(s). Instructions: take 5 Caps by mouth 2 times a day Take 5 capsules in AM and 6 capsules in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-11 00:00:00, ended at 2018-10-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-10-11, presumably until 2018-12-07, with intended 11 refill(s). Instructions: Take 2.5mg in Am and 3 mg in PM\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-10-11, presumably until 2018-12-07, with intended 11 refill(s). Instructions: Take 0.5 mg in AM and as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-19 00:00:00, ended at 2018-10-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-22 00:00:00, ended at 2018-10-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-22 00:00:00, ended at 2018-10-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-10-22, presumably until 2018-10-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 7 days\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-10-22, presumably until 2018-11-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-22 07:58:00, ended at 2018-10-22 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 12.2 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 218 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Everolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 399 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.64 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 133 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Systolic heart failure\n- Transplanted heart present\n- Congestive heart failure\n- Gangrenous disorder\n- Hypomagnesemia\n- Blood chemistry abnormal\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-22 10:35:07, ended at 2018-10-22 11:46:40\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gangrenous disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-23 00:00:00, ended at 2018-10-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-23 00:00:00, ended at 2018-10-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-26 00:00:00, ended at 2018-10-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-29 00:00:00, ended at 2018-10-29 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal angioplasty\n- Angiography, extremity, unilateral, radiological supervision and interpretation\n- Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed\n- Amputation, toe; interphalangeal joint\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for diagnostic arteriography/venography\n\n### Condition\n- Atherosclerosis of artery of lower limb\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic occlusion of artery of extremity\n- Type 2 diabetes mellitus\n- Foot ulcer due to type 2 diabetes mellitus\n- Gangrene of left lower limb due to atherosclerosis\n- Peripheral angiopathy due to diabetes mellitus\n- Gangrene due to type 2 diabetes mellitus\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-11-02, presumably until 2018-11-02\n- cefazolin 1000 MG Injection, started on 2018-11-02, presumably until 2018-11-02\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-11-02, presumably until 2018-11-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n- ketamine 100 MG/ML Injectable Solution, started on 2018-11-02, presumably until 2018-11-02\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2018-11-02, presumably until 2018-11-02\n- midazolam 1 MG/ML Injectable Solution, started on 2018-11-02, presumably until 2018-11-02\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML mepivacaine hydrochloride 15 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-02 09:33:00, ended at 2018-11-03 14:20:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 124 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.7 (ratio)\n- Hematocrit [Volume Fraction] of Blood: 29 (percent)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Selective catheter placement, arterial system; initial third order or more selective abdominal, pelvic, or lower extremity artery branch, within a vascular family\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Amputation, toe; metatarsophalangeal joint\n- Detachment at Right 1st Toe, Complete, Open Approach\n- Collection of venous blood by venipuncture\n- Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed\n- Dilation of Right Anterior Tibial Artery, Percutaneous Approach\n- Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal angioplasty\n- Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach\n- Angiography, extremity, unilateral, radiological supervision and interpretation\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Fluoroscopy of Right Lower Extremity Arteries\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Chronic kidney disease\n- Chronic kidney disease stage 3\n- Foot ulcer due to type 2 diabetes mellitus\n- Gangrenous disorder\n- Peripheral angiopathy due to diabetes mellitus\n- Gangrene of left lower limb due to atherosclerosis\n- Primary diagnosis: Peripheral vascular disease\n- Type 2 diabetes mellitus\n- Chronic occlusion of artery of extremity\n- Gangrene due to type 2 diabetes mellitus\n- Acute renal failure syndrome\n- Atherosclerosis of artery of lower limb\n- Dissection of artery of lower limb\n- Transplanted heart present\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease due to hypertension\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours for 5 days\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- sodium iodide, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-11-02, presumably until 2018-11-02\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- povidone-iodine, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- potassium iodide, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-11-02, presumably until 2018-11-02\n- iodine, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2019-04-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-05 00:00:00, ended at 2018-11-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-09 00:00:00, ended at 2018-11-09 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 7065 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- MCV [Entitic volume] by Automated count: 79.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 16 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 36 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.68 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 837 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 395 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 10.3 (microgram per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 252 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 140 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 810 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per liter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.4 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-16 00:00:00, ended at 2018-11-16 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Drug-induced constipation\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-11-16, presumably until 2018-11-26, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-11-16, presumably until 2018-11-26, with intended 5 refill(s). Instructions: take 17 g by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-16 00:00:00, ended at 2018-11-16 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-19 00:00:00, ended at 2018-11-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-23 00:00:00, ended at 2018-11-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-23 00:00:00, ended at 2018-11-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-23 00:00:00, ended at 2018-11-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-26 09:57:00, ended at 2018-11-26 10:28:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 70.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted heart\n- Hyperlipidemia\n- Pure hypercholesterolemia\n- Essential hypertension\n- Hypomagnesemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-26 10:29:00, ended at 2018-11-26 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 235 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.13 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- MCV [Entitic volume] by Automated count: 79.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 364 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- MCH [Entitic mass] by Automated count: 24.3 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 110 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Everolimus [Mass/volume] in Blood: 1.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Hypomagnesemia\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-26 11:10:25, ended at 2018-11-26 12:19:19\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Essential hypertension\n- Hyperlipidemia\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-11-27 00:00:00, ended at 2018-11-27 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Absence of toe\n- Primary diagnosis: Acquired absence of organ\n- Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-11-27, presumably until 2019-07-05, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day 2nd prescription, please dispense!\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, started on 2018-11-27, presumably until 2019-02-14, with intended 11 refill(s). Instructions: Take 40mEq in the AM, 20mEq in the PM.\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-11-27, presumably until 2019-11-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2019-07-05, with intended 11 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-11-28 00:00:00, ended at 2018-11-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, started on 2018-11-28, presumably until 2018-12-07, with intended 3 refill(s). Instructions: Take 1.5mg BID; Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-30 00:00:00, ended at 2018-11-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-03 00:00:00, ended at 2018-12-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-03 10:32:00, ended at 2018-12-03 10:49:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Everolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.23 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 373 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.7 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 11.8 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-03 10:50:00, ended at 2018-12-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Peripheral vascular disease\n- Disorder of transplanted heart\n- Transplanted heart present\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-03 10:50:06, ended at 2018-12-03 12:27:12\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2018-12-03, presumably until 2019-02-14, with intended 0 refill(s). Instructions: by Topical route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-05 00:00:00, ended at 2018-12-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-12-05, presumably until 2018-12-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-12-07, presumably until 2019-01-20, with intended 11 refill(s). Instructions: Take 2mg in Am and 2 mg in PM\n- everolimus 0.5 MG Oral Tablet, started on 2018-12-07, presumably until 2019-01-20, with intended 3 refill(s). Instructions: Take 1mg BID; Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-10 00:00:00, ended at 2018-12-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.3 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 783 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 6.2 (microgram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 249 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 9 (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 6 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3602 (cells per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1114 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 52 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 370 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-14 00:00:00, ended at 2018-12-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-12-14, presumably until 2019-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-14 00:00:00, ended at 2018-12-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4744 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 9 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- MCV [Entitic volume] by Automated count: 76.9 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.0 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 3.9 (microgram per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Everolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 998 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 355 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.71 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- MCHC [Mass/volume] by Automated count: 30.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 650 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 268 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-19 00:00:00, ended at 2018-12-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-21 00:00:00, ended at 2018-12-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-24 00:00:00, ended at 2018-12-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-25 00:00:00, ended at 2018-12-25 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-28 00:00:00, ended at 2018-12-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-04 00:00:00, ended at 2019-01-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-07 00:00:00, ended at 2019-01-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- MCH [Entitic mass] by Automated count: 22.6 (picogram)\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 13.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 328 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- MCHC [Mass/volume] by Automated count: 29.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 865 (cells per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 1.2 (microgram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 59 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.70 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 370 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 714 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 16 (calculated)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per liter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6392 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-01-12 23:47:00, ended at 2019-01-20 14:28:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 34.10 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 3.731 (nanogram per milliliter)\n- Albumin [Mass/volume] in Urine: 203 (milligram per liter)\n- Body height: 5' 5\" (inch (US))\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: >70000 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Prothrombin time (PT): 14.3 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 95.8 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.67 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 595 (milligram per gram)\n- Sodium/Creatinine [Molar ratio] in Urine: <20 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 21 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 375 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 23.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Salicylates [Presence] in Urine: <0.3 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -8.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Everolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 76.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.93 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.88 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 18.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Left ventricular Ejection fraction: 41.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Radiologic examination, chest; single view\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Hospital discharge day management; 30 minutes or less\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Endomyocardial biopsy\n\n### Condition\n- Cardiac transplant failure\n- Chronic kidney disease stage 3\n- Open wound of foot\n- Renal disorder due to type 2 diabetes mellitus\n- Sepsis\n- Acute on chronic combined systolic and diastolic heart failure\n- Acute tubular necrosis\n- Anemia in chronic kidney disease\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Obesity\n- Peripheral vascular disease\n- Severe protein-calorie malnutrition (Gomez: less than 60 percent of standard weight)\n- Tachycardia\n- Transplanted heart present\n- Acidosis\n- Acute non-ST segment elevation myocardial infarction\n- Acute renal failure syndrome\n- Cardiogenic shock\n- Coronary thrombosis not resulting in myocardial infarction\n- Chronic pulmonary edema\n- Hyperkalemia\n- Localized edema\n- Pulmonary hypertension\n- Viral pneumonia\n- Atherosclerosis of coronary artery without angina pectoris\n- Blood coagulation disorder\n- Cardiomegaly\n- Chronic kidney disease stage 4\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Acquired absence of organ\n- Acute ischemic heart disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Disorder of immune function\n- Heart disease\n- Old myocardial infarction\n- Atrial fibrillation\n- Cardiac transplant rejection\n- Primary diagnosis: Chronic ischemic heart disease\n- Disorder of transplanted heart\n- Hypokalemia\n- Late effect of complications of procedure\n- Septic shock\n- Absence of toe\n- Acute on chronic hypoxemic respiratory failure\n- Congestive heart failure\n- Hypo-osmolality and or hyponatremia\n- Pneumonia and influenza\n- Takotsubo cardiomyopathy\n- Type 2 diabetes mellitus\n- Upper respiratory tract infection due to Influenza\n- Backache\n- Dehydration\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-01-20\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2019-01-15, presumably until 2019-01-19\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2019-01-14, presumably until 2019-01-15\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2019-01-15, presumably until 2019-03-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 30 days\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Cartridge, started on 2019-01-17, presumably until 2019-01-18\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-01-17, presumably until 2019-01-17\n- methylprednisolone 40 MG Injection, started on 2019-01-13, presumably until 2019-01-15\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2019-01-13, presumably until 2019-01-14\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-01-13, presumably until 2019-01-15\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-14\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-01-20\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-20\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2019-01-14, presumably until 2019-01-20\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2019-01-13, presumably until 2019-01-19\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2019-01-13, presumably until 2019-01-13\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2019-01-15, presumably until 2019-01-16\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-02-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-01-13, presumably until 2019-01-13\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-01-18, presumably until 2020-01-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-01-14, presumably until 2019-01-15\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-01-18, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-01-13, presumably until 2019-01-19\n- everolimus 0.75 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day Cytotoxic. Take with or without food. Swallow whole. do not break, chew or crush tablets.\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2019-01-13, presumably until 2019-01-13\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- oseltamivir 6 MG/ML Oral Suspension, through Oral route, started on 2019-01-13, presumably until 2019-01-16\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-20\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2019-01-13, presumably until 2019-01-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-20\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2019-01-16, presumably until 2019-01-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2019-01-13, presumably until 2019-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-01-13 00:00:00, ended at 2019-01-13 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-01-13, presumably until 2019-01-13\n- iodixanol, through Intravenous route, started on 2019-01-13, presumably until 2019-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-14 00:00:00, ended at 2019-01-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-21 00:00:00, ended at 2019-01-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-23 00:00:00, ended at 2019-01-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-01-23, presumably until 2019-02-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Cytotoxic. Take with or without food. Swallow whole. do not break, chew or crush tablets.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-25 00:00:00, ended at 2019-01-25 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-01 00:00:00, ended at 2019-02-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-19, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-01 00:00:00, ended at 2019-02-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-08 00:00:00, ended at 2019-02-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-13 00:00:00, ended at 2019-02-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 08:38:00, ended at 2019-02-14 10:14:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 312 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.42 (milligram per deciliter)\n- Everolimus [Mass/volume] in Blood: 2.6 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 79.2 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 29.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 1.7 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Essential hypertension\n- Disorder of transplanted heart\n- Transplanted heart present\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-14 09:01:55, ended at 2019-02-14 10:07:14\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-02-14 10:15:00, ended at 2019-02-14 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 68.0 (percent)\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-02-15, presumably until 2019-10-04, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 1mg Am, 1.5mg PM\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-02-15, presumably until 2019-10-04, with intended 1 refill(s). Instructions: take 1 Cap by mouth PM Total dose of 1mg AM, 1.5mg PM; Z94.1, Fax: 999-999-9999\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-18 00:00:00, ended at 2019-02-18 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-19 00:00:00, ended at 2019-02-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-02-19, presumably until 2019-05-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take 0.5 mg in AM and 1 mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-19 00:00:00, ended at 2019-02-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 2.5 MG Oral Tablet, through Oral route, started on 2019-02-19, presumably until 2019-04-03, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-22 00:00:00, ended at 2019-02-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-25 00:00:00, ended at 2019-02-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-01 00:00:00, ended at 2019-03-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-04 00:00:00, ended at 2019-03-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- MCV [Entitic volume] by Automated count: 76.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 842 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4802 (cells per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 3.4 (microgram per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 24 (calculated)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 987 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.0 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.05 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 69 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per liter)\n- MCH [Entitic mass] by Automated count: 23.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2019-03-06, presumably until 2019-07-05, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-08 00:00:00, ended at 2019-03-08 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-18 00:00:00, ended at 2019-03-18 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-22 00:00:00, ended at 2019-03-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-29 00:00:00, ended at 2019-03-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-01 00:00:00, ended at 2019-04-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- prednisone 2.5 MG Oral Tablet, through Oral route, started on 2019-04-03, presumably until 2019-10-03, with intended 6 refill(s). Instructions: take 1 Tab (2.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-04 00:00:00, ended at 2019-04-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-05 00:00:00, ended at 2019-04-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-12 00:00:00, ended at 2019-04-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-19 00:00:00, ended at 2019-04-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-22 00:00:00, ended at 2019-04-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 09:45:00, ended at 2019-04-29 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 29.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.89 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Everolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-01 00:00:00, ended at 2019-05-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2019-05-01, presumably until 2019-07-09, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-03 00:00:00, ended at 2019-05-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.2 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 951 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 3.0 (microgram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 161 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4904 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 22 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.45 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 643 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 299 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-10 00:00:00, ended at 2019-05-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-17 00:00:00, ended at 2019-05-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-20 00:00:00, ended at 2019-05-20 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-24 00:00:00, ended at 2019-05-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-31 00:00:00, ended at 2019-05-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-31 09:30:00, ended at 2019-05-31 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Gangrenous disorder\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-31 09:30:15, ended at 2019-05-31 11:29:56\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gangrenous disorder\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-03 00:00:00, ended at 2019-06-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-14 00:00:00, ended at 2019-06-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-17 00:00:00, ended at 2019-06-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-21 00:00:00, ended at 2019-06-21 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-24 00:00:00, ended at 2019-06-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-28 00:00:00, ended at 2019-06-28 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-01 00:00:00, ended at 2019-07-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-03 00:00:00, ended at 2019-07-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fatigue\n- Pure hypercholesterolemia\n- Type 1 diabetes mellitus without complication\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-03 00:00:00, ended at 2019-07-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-03 00:00:00, ended at 2019-07-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-04 00:00:00, ended at 2019-07-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Iron deficiency anemia\n\n### Drug\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, presumably until 2019-07-12, with intended 11 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-04 07:37:00, ended at 2019-07-04 09:47:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.10 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Everolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 242 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.89 (milligram per milligram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.2 (picogram)\n- MCV [Entitic volume] by Automated count: 78.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.16 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.1 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 171 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 49.0 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 194 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 55.28 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Pure hypercholesterolemia\n- Fatigue\n- Disorder of transplanted heart\n- Transplanted heart present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-04 08:10:26, ended at 2019-07-04 09:43:16\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Acute ST segment elevation myocardial infarction\n- Disorder of transplanted heart\n- Transplanted heart present\n- Conduction disorder of the heart\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-04 09:48:00, ended at 2019-07-04 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 67.2 (percent)\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Cardiomegaly\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Type 1 diabetes mellitus without complication\n- Iron deficiency anemia\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-05 00:00:00, ended at 2019-07-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-05 00:00:00, ended at 2019-07-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2019-07-05, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily 2nd prescription, please dispense!\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2019-07-05, presumably until 2020-07-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-08 00:00:00, ended at 2019-07-08 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-09 00:00:00, ended at 2019-07-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-07-09, presumably until 2019-10-22, with intended 11 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth 2 times a day Take 1 mg in AM and 1.5mg in PM.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-09 00:00:00, ended at 2019-07-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2019-07-09, presumably until 2019-12-23, with intended 11 refill(s). Instructions: take 2 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2019-07-12, presumably until 2020-08-21, with intended 11 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-15 00:00:00, ended at 2019-07-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-19 00:00:00, ended at 2019-07-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-22 00:00:00, ended at 2019-07-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-07-31 00:00:00, ended at 2019-07-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-07-31, presumably until 2019-07-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-31 00:00:00, ended at 2019-07-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-31 11:18:00, ended at 2019-07-31 12:26:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.24 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Everolimus [Mass/volume] in Blood: 5.6 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- MCV [Entitic volume] by Automated count: 79.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.88 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n\n### Procedure\n- Endomyocardial biopsy\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Cardiac transplant rejection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-01 00:00:00, ended at 2019-08-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-08-01, presumably until 2020-09-04, with intended 11 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-02 00:00:00, ended at 2019-08-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-09 00:00:00, ended at 2019-08-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-12 00:00:00, ended at 2019-08-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-16 00:00:00, ended at 2019-08-16 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-19 00:00:00, ended at 2019-08-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-30 00:00:00, ended at 2019-08-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-06 00:00:00, ended at 2019-09-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-11 00:00:00, ended at 2019-09-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-13 00:00:00, ended at 2019-09-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-13 00:00:00, ended at 2019-09-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-16 00:00:00, ended at 2019-09-16 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-02 00:00:00, ended at 2019-10-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-03 00:00:00, ended at 2019-10-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2019-10-03, presumably until 2020-10-16, with intended 11 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-03 00:00:00, ended at 2019-10-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-03 09:51:00, ended at 2019-10-03 10:28:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63.7 (percent)\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-03 10:29:00, ended at 2019-10-03 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.46 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.82 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 1.0 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 81.3 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- MCH [Entitic mass] by Automated count: 25.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-03 11:26:41, ended at 2019-10-03 12:14:25\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, presumably until 2020-10-20, with intended 11 refill(s). Instructions: take 0.1-0.2 mg by mouth as directed Take 0.1mg QAM and 0.2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2019-11-26, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-10-15 00:00:00, ended at 2019-10-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-10-15, presumably until 2019-10-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-15 09:46:00, ended at 2019-10-15 12:19:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 79.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.65 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCH [Entitic mass] by Automated count: 25.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.33 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Acquired absence of organ\n- Absence of toe\n- Chronic kidney disease due to hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease\n- Disorder of transplanted heart\n- Hyperlipidemia\n- Type 2 diabetes mellitus\n- Transplanted heart present\n- Cardiac transplant rejection\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-16 00:00:00, ended at 2019-10-16 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Everolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-19 00:00:00, ended at 2019-10-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-22 00:00:00, ended at 2019-10-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-10-22, presumably until 2020-04-24, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2022-06-10, with intended 11 refill(s). Instructions: INJECT 17 UNITS SUB-CUTANEOUSLY( UNDER THE SKIN) THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-22 00:00:00, ended at 2019-11-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 100 MG Oral Tablet, through Oral route, started on 2019-11-22, presumably until 2021-06-04, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-22 00:00:00, ended at 2019-11-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2019-11-22, with intended 11 refill(s). Instructions: INJECT 17 UNITS UNDER THE SKIN(UNDER THE SKIN) THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-26 00:00:00, ended at 2019-11-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2019-12-23, with intended 2 refill(s). Instructions: take 1 Tab (30 mg total) by mouth as directed\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2019-11-26, presumably until 2020-09-10, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-27 00:00:00, ended at 2019-11-27 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Complication due to diabetes mellitus\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, started on 2019-11-27, presumably until 2021-02-02, with intended 6 refill(s). Instructions: Inject subcutaneously 22 units AM, 22 units PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-07 00:00:00, ended at 2019-12-07 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-20 00:00:00, ended at 2019-12-20 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-23 09:55:00, ended at 2019-12-23 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.99 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.69 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.67 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- MCV [Entitic volume] by Automated count: 83.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Hyperlipidemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-23 10:19:13, ended at 2019-12-23 11:39:05\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n- Everolimus [Mass/volume] in Blood: 1.4 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2020-12-10, with intended 3 refill(s). Instructions: take 1 Tab (30 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 3.0 (milligram per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 827 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3631 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 233 (cells per microliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 12.3 (micromole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 13.5 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- MCH [Entitic mass] by Automated count: 25.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 42 (cells per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 77 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 567 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 27 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.5 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.7 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.1 (ratio)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 221.8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Hypomagnesemia\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-10-06, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-30 00:00:00, ended at 2019-12-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-03 00:00:00, ended at 2020-01-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-06 00:00:00, ended at 2020-01-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 08:12:00, ended at 2020-01-10 09:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Disorder of soft tissue\n- Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-10 08:12:54, ended at 2020-01-10 14:56:11\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Disorder of soft tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 10:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Localized edema\n- Disorder of soft tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-13 00:00:00, ended at 2020-01-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-20 00:00:00, ended at 2020-01-20 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-24 00:00:00, ended at 2020-01-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-31 00:00:00, ended at 2020-01-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-03 00:00:00, ended at 2020-02-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-07 00:00:00, ended at 2020-02-07 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-17 00:00:00, ended at 2020-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-21 00:00:00, ended at 2020-02-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-24 00:00:00, ended at 2020-02-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-06 00:00:00, ended at 2020-03-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-13 00:00:00, ended at 2020-03-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-20 00:00:00, ended at 2020-03-20 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-23 00:00:00, ended at 2020-03-23 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-27 00:00:00, ended at 2020-03-27 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-30 00:00:00, ended at 2020-03-30 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-30 00:00:00, ended at 2020-03-30 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperosmolarity\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-06 00:00:00, ended at 2020-04-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-10 00:00:00, ended at 2020-04-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-13 00:00:00, ended at 2020-04-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3202 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 25.1 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.1 (percent)\n- MCV [Entitic volume] by Automated count: 79.2 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.69 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 259 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 751 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1139 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 13.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 14:40:50, ended at 2020-04-15 15:07:23\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperosmolarity\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-04-15, presumably until 2020-11-03, with intended 11 refill(s). Instructions: inject 0.75 mg subcutaneous (under the skin) once a week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-17 00:00:00, ended at 2020-04-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Everolimus [Mass/volume] in Blood: 1.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.3 (picogram)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3819 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 202 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 610 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 19 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.75 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 28 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 941 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2020-04-24, presumably until 2020-07-16, with intended 11 refill(s). Instructions: take 3 Tabs (1.5 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-27 00:00:00, ended at 2020-04-27 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-04 00:00:00, ended at 2020-05-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-06 00:00:00, ended at 2020-05-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-06 00:00:00, ended at 2020-05-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-06 00:00:00, ended at 2020-05-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-08 00:00:00, ended at 2020-05-08 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-11 00:00:00, ended at 2020-05-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-15 00:00:00, ended at 2020-05-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-18 00:00:00, ended at 2020-05-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-22 00:00:00, ended at 2020-05-22 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-29 00:00:00, ended at 2020-05-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-01 00:00:00, ended at 2020-06-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-05 00:00:00, ended at 2020-06-05 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-12 00:00:00, ended at 2020-06-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-15 00:00:00, ended at 2020-06-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-16 00:00:00, ended at 2020-07-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2020-07-16, presumably until 2021-04-27, with intended 11 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth 2 times a day Total dose of 1.5mg twice daily\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2020-07-16, presumably until 2020-07-29, with intended 11 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-23 10:45:04, ended at 2020-07-23 11:09:56\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 183 (milligram per deciliter calculated)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent hemoglobin)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Complication due to diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Postprocedural asymptomatic ovarian failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-24 00:00:00, ended at 2020-07-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1056 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 622 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 16 (calculated)\n- Neutrophils [#/volume] in Blood by Automated count: 3625 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per liter)\n- MCH [Entitic mass] by Automated count: 26.2 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- MCV [Entitic volume] by Automated count: 80.4 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 160 (cells per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.3 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Everolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2020-07-30, presumably until 2022-06-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2020-07-29, presumably until 2021-04-29, with intended 11 refill(s). Instructions: take 1-2 Tabs (1-2 mg total) by mouth 2 times a day Take 1.5 mg in AM and 2 mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-13 00:00:00, ended at 2020-08-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.44 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 181 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 69 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 902 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 79.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3136 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 613 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 25 (calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Everolimus [Mass/volume] in Blood: 3.2 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 26.2 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.5 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-21 00:00:00, ended at 2020-08-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-02-02, with intended 3 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-09-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-03 00:00:00, ended at 2020-09-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, started on 2020-09-04, presumably until 2021-05-03, with intended 11 refill(s). Instructions: TAKE 1 CAPSULE(250 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-09 00:00:00, ended at 2020-09-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-10 00:00:00, ended at 2020-09-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2020-09-10, presumably until 2021-02-26, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-11 12:09:00, ended at 2020-09-11 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-02 00:00:00, ended at 2020-10-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-06 00:00:00, ended at 2020-10-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2020-10-06, presumably until 2021-02-26, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-07 00:00:00, ended at 2020-10-07 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-12 00:00:00, ended at 2020-10-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-12 00:00:00, ended at 2020-10-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, started on 2020-10-16, presumably until 2020-10-16, with intended 11 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-16 00:00:00, ended at 2020-10-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood glucose abnormal\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-16 00:00:00, ended at 2020-10-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2020-10-16, presumably until 2021-11-18, with intended 11 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-19 00:00:00, ended at 2020-10-19 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-19 06:12:00, ended at 2020-10-19 06:50:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.16 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 26.48 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 78.0 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Everolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.49 (micro-international unit per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 2.95 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 511, "cumulated_approximate_token_count": 118388}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-08-14 00:00:00, ended at 2013-08-14 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Electrocardiogram abnormal\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-02 00:00:00, ended at 2013-09-02 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 35 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-02 07:51:00, ended at 2013-09-02 11:39:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-02 09:05:39, ended at 2013-09-02 11:27:09\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2013-10-02. Instructions: take 30 mg by mouth every morning.\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2013-09-02, presumably until 2014-04-25, with intended 6 refill(s). Instructions: take 3 Tabs by mouth Every Day. Two am and one pm\n- ticagrelor 90 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 90 mg by mouth 2 times a day.\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 325 mg by mouth daily.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2013-09-02, presumably until 2013-09-25, with intended 6 refill(s). Instructions: take 25 mg by mouth daily.\n- losartan potassium 100 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 100 mg by mouth daily.\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, presumably until 2013-11-05. Instructions: inject 30 Units subcutaneous (under the skin) Evening.\n- carvedilol 12.5 MG Oral Tablet, through Oral route, started on 2013-09-02, presumably until 2013-10-02, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-02 11:40:00, ended at 2013-09-02 11:40:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.31 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.4 (nanogram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.75 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Prothrombin time (PT): 13.2 (second)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 5.6 (ratio)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 266 (milligram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 113 (nanogram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 276 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.7 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 248 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 182 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.7 (picogram)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.88 (milli-international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 313 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-02 11:41:00, ended at 2013-09-02 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-03 00:00:00, ended at 2013-09-03 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-03 00:00:00, ended at 2013-09-03 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-03 00:00:00, ended at 2013-09-03 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n- Coronary atherosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:30:00, ended at 2013-09-05 13:30:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Chronic ischemic heart disease\n- Coronary arteriosclerosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:30:00, ended at 2013-09-05 13:30:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extracranial arteries; complete bilateral study\n\n### Condition\n- Chronic ischemic heart disease\n- Coronary atherosclerosis\n- Disorder of carotid artery\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-05 13:31:00, ended at 2013-09-05 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Coronary atherosclerosis\n- Chronic ischemic heart disease\n- Intermittent claudication\n- Atherosclerosis of arteries of the extremities\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-11 06:56:00, ended at 2013-09-11 06:56:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Lung field abnormal\n- Old myocardial infarction\n- Chronic ischemic heart disease\n- Coronary arteriosclerosis\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-11 06:57:00, ended at 2013-09-11 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n- Cardiac magnetic resonance imaging for morphology and function without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Chronic ischemic heart disease\n- Lung field abnormal\n- Coronary arteriosclerosis\n- Heart disease\n- Old myocardial infarction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-18 00:00:00, ended at 2013-09-18 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-02 08:00:00, ended at 2013-10-02 10:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Cardiopulmonary exercise testing, including measurements of minute ventilation, CO2 production, O2 uptake, and electrocardiographic recordings\n\n### Condition\n- Dyspnea\n- Congestive heart failure\n- Combined systolic and diastolic dysfunction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-02 09:15:59, ended at 2013-10-02 10:38:57\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-10-02, presumably until 2013-11-08, with intended 9 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2013-10-02, presumably until 2013-11-08, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-02 11:00:00, ended at 2013-10-02 14:51:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pulmonary stress testing; simple (eg, 6-minute walk test, prolonged exercise test for bronchospasm with pre- and post-spirometry and oximetry)\n\n### Condition\n- Congestive heart failure\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-02 11:16:02, ended at 2013-10-02 14:45:58\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n- Primary diagnosis: Diabetic - poor control\n- Primary diagnosis: Diabetes mellitus without complication\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, through Subcutaneous route, started on 2013-10-02, presumably until 2014-05-19, with intended 6 refill(s). Instructions: inject 15-20 Units subcutaneous (under the skin) 2 times a day before meals. Before breakfast take 15 units, before dinner take 20 units.\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-10-02, presumably until 2013-10-31, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-02 14:52:00, ended at 2013-10-02 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Cardiopulmonary exercise testing, including measurements of minute ventilation, CO2 production, O2 uptake, and electrocardiographic recordings\n- Bioimpedance-derived physiologic cardiovascular analysis\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-08 00:00:00, ended at 2013-10-08 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-10-09 00:00:00, ended at 2013-10-09 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-09 12:00:00, ended at 2013-10-09 13:16:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-09 12:05:57, ended at 2013-10-09 12:53:16\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Congestive heart failure\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-10-09 13:17:00, ended at 2013-10-09 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-31 00:00:00, ended at 2013-10-31 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of nervous system due to diabetes mellitus\n- Primary diagnosis: Polyneuropathy due to diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-10-31, presumably until 2013-11-08, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-01 00:00:00, ended at 2013-11-01 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Primary diagnosis: Primary cardiomyopathy\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-05 06:01:00, ended at 2013-11-05 17:24:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.6 (percent)\n- Sodium [Moles/volume] in Blood: 141 (millimole per liter)\n- Potassium [Moles/volume] in Blood: 4.3 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 33 (percent)\n\n### Procedure\n- Catheterization of right heart\n- Coronary arteriography using two catheters\n- Collection of venous blood by venipuncture\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Coronary arteriosclerosis\n- Diabetic - poor control\n- Old myocardial infarction\n- Angina pectoris\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Diabetes mellitus without complication\n\n### Drug\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2013-11-05, presumably until 2013-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-08 09:17:24, ended at 2013-11-08 10:30:56\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2014-01-10, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day with meals.\n- 24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2014-04-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-22 00:00:00, ended at 2013-11-22 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for transvenous insertion or replacement of pacing cardioverter-defibrillator\n\n### Condition\n- Primary cardiomyopathy\n\n### Drug\n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2013-11-22, presumably until 2013-11-22\n- cefazolin 1000 MG Injection, started on 2013-11-22, presumably until 2013-11-22\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-11-22, presumably until 2013-11-22\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2013-11-22, presumably until 2013-11-22\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-11-22, presumably until 2013-11-22\n- midazolam 1 MG/ML Injectable Solution, started on 2013-11-22, presumably until 2013-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-11-22 06:14:00, ended at 2013-11-23 11:24:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 194 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Potassium [Moles/volume] in Blood: 4.3 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 36 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Prothrombin time (PT): 14.0 (second)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 29.3 (second)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- MCH [Entitic mass] by Automated count: 27.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Body height: 5' 5\" (inch (US))\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Implantation or replacement of automatic cardioverter/defibrillator, total system [AICD]\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion or replacement of permanent implantable defibrillator system, with transvenous lead(s), single or dual chamber\n- Collection of venous blood by venipuncture\n\n### Condition\n- Essential hypertension\n- Coronary arteriosclerosis\n- Imaging of thorax abnormal\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Old myocardial infarction\n- Chronic ischemic heart disease\n\n### Drug\n- losartan potassium 50 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- ketorolac tromethamine 10 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-23\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-22\n- ticagrelor 90 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-23\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-11-22, presumably until 2013-11-22\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2013-11-22, presumably until 2013-11-22\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2013-11-23, presumably until 2013-12-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 3 times a day.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-11-22, presumably until 2013-11-23\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-11-22, presumably until 2013-11-22\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2013-11-23, presumably until 2013-11-23\n- insulin glargine 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-11-22, presumably until 2013-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-09 11:17:31, ended at 2013-12-09 11:47:10\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-10 00:00:00, ended at 2014-01-10 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-01-28 00:00:00, ended at 2014-01-28 00:00:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-30 10:21:05, ended at 2014-01-30 11:21:24\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Diabetic - poor control\n- Primary diagnosis: Pulmonary tuberculosis\n- Diabetes mellitus without complication\n\n### Drug\n- vitamin B6 50 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 8 refill(s). Instructions: take 1 Tab by mouth daily.\n- isoniazid 300 MG Oral Tablet, through Oral route, started on 2014-01-30, presumably until 2015-01-30, with intended 8 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-30 11:27:00, ended at 2014-01-30 23:59:00\nThe patient in this visit was 50 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 47 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.74 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 42 (milliliter per minute per square meter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.3 (percent)\n- MCH [Entitic mass] by Automated count: 26.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.35 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 80.1 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.55 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.75 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 240 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-25 00:00:00, ended at 2014-02-25 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Primary diagnosis: Diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-26 11:23:48, ended at 2014-02-26 11:47:02\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-26 11:48:00, ended at 2014-02-26 11:49:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-02-26 11:50:00, ended at 2014-02-26 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-04 10:35:43, ended at 2014-03-04 11:12:18\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Diabetic - poor control\n- Congestive heart failure\n- Primary diagnosis: Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-06 00:00:00, ended at 2014-03-06 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-06 00:00:00, ended at 2014-03-06 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of female breast\n- Primary diagnosis: Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-13 00:00:00, ended at 2014-03-13 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-13 09:22:00, ended at 2014-03-13 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Heart failure\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-21 00:00:00, ended at 2014-03-21 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 30 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-21 12:22:00, ended at 2014-03-21 13:24:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-21 13:25:00, ended at 2014-03-21 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n- Computed tomography, abdomen and pelvis; without contrast material\n\n### Condition\n- Primary malignant neoplasm of female breast\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-21 13:25:00, ended at 2014-03-21 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-25 12:37:51, ended at 2014-03-25 13:49:16\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic systolic heart failure\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-04-04 00:00:00, ended at 2014-04-04 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-04 09:56:20, ended at 2014-04-04 11:38:39\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diabetes mellitus without complication\n- Type 2 diabetes mellitus without complication\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n- Diabetic - poor control\n\n### Drug\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-04-04, presumably until 2014-05-23, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-04-25 00:00:00, ended at 2014-04-25 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-04-25, presumably until 2014-05-19, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-25 12:28:00, ended at 2014-04-25 14:22:05\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Congestive heart failure\n\n### Drug\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2014-04-25, presumably until 2014-04-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. Two am and one pm\n- 24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet, started on 2014-04-25, presumably until 2014-05-19, with intended 6 refill(s). Instructions: Pt sent home with hand written prescription for 240 mg tablet pill - to take one tablet in evening or two of 120 each pm together\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-04-25 14:27:00, ended at 2014-04-25 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.24 (milli-international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 219 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 96 (nanogram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 260 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.2 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.4 (nanogram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 50 (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus without complication\n- Congestive heart failure\n- Primary cardiomyopathy\n- Pulmonary tuberculosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-05-14 00:00:00, ended at 2014-05-14 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Polyneuropathy due to diabetes mellitus\n- Primary diagnosis: Disorder of nervous system due to diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-05-14, presumably until 2014-07-18, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2014-05-17 19:59:00, ended at 2014-05-23 16:30:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Iron [Mass/volume] in Serum or Plasma: 26 (microgram per deciliter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 235 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 1.2 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 19 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 5\" (inch (US))\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 26.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Manual count: 10 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 7.9 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 388 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.59 (milli-international unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.6 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 11 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.5 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 468 (nanogram per milliliter)\n- Lactate [Moles/volume] in Blood: 1.6 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.45 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Prothrombin time (PT): 16.2 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 13.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.0 (gram per deciliter)\n- Left ventricular Ejection fraction: 28.7 (percent)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 207 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 24.5 (percent)\n- MCV [Entitic volume] by Automated count: 81.3 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <15 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 64 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 39.0 (second)\n\n### Procedure\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Hospital discharge day management; 30 minutes or less\n- Catheterization of right heart\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Procedure on single vessel\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Central venous catheter placement with guidance\n- Physical therapy evaluation\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Coronary arteriography using two catheters\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Revision of automatic implantable cardioverter/defibrillator\n- Percutaneous transluminal coronary angioplasty\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Radiologic examination, esophagus, including scout chest radiograph(s) and delayed image(s), when performed; single-contrast (eg, barium) study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Radiologic examination, chest; single view, frontal\n- Insertion of drug-eluting coronary artery stent\n- Insertion of one vascular stent\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch\n\n### Condition\n- Diabetic - poor control\n- Fever\n- Helicobacter-associated disease\n- Essential hypertension\n- Hyperosmolality and or hypernatremia\n- Hypo-osmolality and or hyponatremia\n- Iron deficiency anemia\n- Long QT syndrome\n- Chest pain\n- Eye / vision finding\n- Atrial fibrillation\n- Primary diagnosis: Congestive heart failure\n- Diabetes mellitus without complication\n- Infective pneumonia\n- Leukocytosis\n- Coronary arteriosclerosis\n- Disorder of esophagus\n- Cardiomegaly\n- Chronic ischemic heart disease\n- Disorder of function of stomach\n- Disorder of lung\n- Hypovolemia\n- Lung field abnormal\n- Nonspecific tuberculin test reaction\n- Preinfarction syndrome\n- Primary diagnosis: Acute on chronic systolic heart failure\n- Acute renal failure syndrome\n- Electrocardiogram abnormal\n- Old myocardial infarction\n\n### Drug\n- amoxicillin 500 MG Oral Capsule, through Oral route, started on 2014-05-23, presumably until 2014-05-23, with intended 0 refill(s). Instructions: take 2 Caps by mouth Q12H.\n- furosemide 20 MG Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 40 mg by mouth every morning.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2014-05-21, presumably until 2014-05-21\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2014-05-17, presumably until 2014-05-22\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, through Subcutaneous route, started on 2014-05-23, presumably until 2014-11-11, with intended 11 refill(s). Instructions: inject 10-20 Units subcutaneous (under the skin) 3 times a day. 10 units every morning, 15 units in afternoon, 20 units every evening\n- tetracycline hydrochloride 500 MG Oral Capsule, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-18\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- bismuth subsalicylate 35 MG/ML Oral Suspension, through Oral route, started on 2014-05-23, presumably until 2014-06-13, with intended 0 refill(s). Instructions: take 15 mL by mouth 4 times a day.\n- metronidazole 250 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day.\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-18\n- polyethylene glycol 3350 236000 MG / potassium chloride 2970 MG / sodium bicarbonate 6740 MG / sodium chloride 5860 MG / sodium sulfate 22740 MG Powder for Oral Solution, through Oral route, started on 2014-05-21, presumably until 2014-05-21\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-05-22, presumably until 2014-05-23\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2014-05-19, presumably until 2014-05-19\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2014-05-17, presumably until 2014-05-17\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2014-05-21, presumably until 2014-05-22\n- vitamin B6 50 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-23\n- insulin detemir 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-05-18, presumably until 2014-05-23\n- isoniazid 300 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-23\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2014-05-18, presumably until 2014-05-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2014-05-18, presumably until 2014-05-19\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2014-05-19, presumably until 2014-05-22\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2014-05-20, presumably until 2014-05-21\n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-05-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2014-05-18, presumably until 2014-05-23\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2014-05-20, presumably until 2014-05-23\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2014-05-17, presumably until 2014-05-18\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2014-05-20, presumably until 2014-05-21\n- hydromorphone hydrochloride 2 MG Oral Tablet, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2014-05-19, presumably until 2014-05-19\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2014-05-20, presumably until 2014-09-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2014-05-17, presumably until 2014-05-22\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2014-05-22, presumably until 2014-05-22\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2014-05-22, presumably until 2014-05-22\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2014-05-18, presumably until 2014-05-21\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2014-05-19, presumably until 2014-05-19\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2014-05-18, presumably until 2014-05-18\n- ketorolac tromethamine 5 MG/ML Ophthalmic Solution, through Intraocular route, started on 2014-05-20, presumably until 2014-06-13, with intended 0 refill(s). Instructions: instill 1 Drop to right eye 4 times a day.\n- 72 HR scopolamine 0.0139 MG/HR Transdermal System, through Transdermal route, started on 2014-05-18, presumably until 2014-05-18\n- 24 HR isosorbide mononitrate 120 MG Extended Release Oral Tablet, through Oral route, presumably until 2014-05-23. Instructions: take 120 mg by mouth Every Day.\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2014-05-18, presumably until 2014-05-22\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2014-05-18, presumably until 2014-05-18\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2014-05-19, presumably until 2015-05-23, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast.\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2015-06-22, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, through Intravenous route, started on 2014-05-18, presumably until 2014-05-19\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2014-05-22, presumably until 2014-05-22\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2014-05-20, presumably until 2014-05-22\n- clarithromycin 500 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2014-05-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth Q12H.\n- tetracycline hydrochloride 250 MG Oral Capsule, through Oral route, started on 2014-05-23, presumably until 2014-05-23, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day.\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-05-23, presumably until 2014-09-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-05-27 00:00:00, ended at 2014-05-27 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic ischemic heart disease\n- Helicobacter-associated disease\n- Acute on chronic combined systolic and diastolic heart failure\n- Diabetes mellitus without complication\n- Diabetic - poor control\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-06-13 11:45:00, ended at 2014-06-13 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 249 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 11.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Congestive heart failure\n- Type 2 diabetes mellitus without complication\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-07-18 00:00:00, ended at 2014-07-18 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of nervous system due to diabetes mellitus\n- Polyneuropathy due to diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-07-18, presumably until 2014-11-23, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. appt needed for additional refills\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-01 10:15:49, ended at 2014-09-01 11:57:22\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Revision of automatic implantable cardioverter/defibrillator\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Primary diagnosis: Cardiomyopathy associated with another disorder\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2015-09-01, with intended 3 refill(s). Instructions: take 1 tablet by mouth every bedtime.\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2014-09-01, presumably until 2015-06-10, with intended 3 refill(s). Instructions: take 1 tablet by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-01 12:05:00, ended at 2014-09-01 23:59:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 56 (milliliter per minute per square meter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 281 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 13.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cardiomyopathy associated with another disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-06 00:00:00, ended at 2014-11-06 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2014-11-11, presumably until 2016-03-10, with intended 2 refill(s). Instructions: Inject SQ 3 times per day 10 minutes before each meal, Before breakfast: take 10 units, Before Lunch: 15 units, Before dinner: take 20 units\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-23 00:00:00, ended at 2014-11-23 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2014-11-23, presumably until 2014-12-15, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-11-24 00:00:00, ended at 2014-11-24 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2014-11-24, presumably until 2014-11-24, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-12-15 00:00:00, ended at 2014-12-15 00:00:00\nThe patient in this visit was 51 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2014-12-15, presumably until 2015-04-20, with intended 1 refill(s). Instructions: take 1 Cap by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-04-20 00:00:00, ended at 2015-04-20 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2015-04-21, presumably until 2015-09-15, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-09 00:00:00, ended at 2015-06-09 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, started on 2015-06-12, presumably until 2018-07-19, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY NIGHT AT BEDTIME\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-10 09:43:13, ended at 2015-06-10 14:27:42\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n- Revision of automatic implantable cardioverter/defibrillator\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Congestive heart failure\n- Flatulence, eructation and gas pain\n- Primary diagnosis: Chronic combined systolic and diastolic heart failure\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2015-06-10, with intended 0 refill(s). Instructions: take 40 mg by mouth Evening\n- aspirin 325 MG Oral Tablet, through Oral route, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 325 mg by mouth Evening\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2015-06-10, presumably until 2016-06-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n- atorvastatin 80 MG Oral Tablet, through Oral route, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 80 mg by mouth Evening\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2015-06-10, presumably until 2016-03-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- 24 HR isosorbide mononitrate 60 MG Extended Release Oral Tablet, through Oral route, started on 2015-06-10, presumably until 2015-06-12, with intended 6 refill(s). Instructions: take 1 Tab by mouth every morning\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2012-08-19, presumably until 2016-10-28, with intended 0 refill(s). Instructions: place 0.4 mg under the tongue and let dissolve\n- clopidogrel 75 MG Oral Tablet, through Oral route, presumably until 2015-06-22, with intended 0 refill(s). Instructions: take by mouth Evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-06-18 11:16:53, ended at 2015-06-18 12:18:27\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus without complication\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, through Subcutaneous route, started on 2015-06-18, presumably until 2016-03-25, with intended 6 refill(s). Instructions: inject 1.2 mg subcutaneous (under the skin) daily with lunch\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2015-06-18 12:30:00, ended at 2015-06-18 23:59:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 15.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 130 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 438 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 92 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-06-22 00:00:00, ended at 2015-06-22 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2015-06-22, presumably until 2016-07-12, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-02 00:00:00, ended at 2015-09-02 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2015-09-04, presumably until 2016-09-11, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-15 00:00:00, ended at 2015-09-15 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Diabetes mellitus without complication\n- Primary diagnosis: Diabetic - poor control\n- Peripheral nerve disease\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2015-09-24, presumably until 2016-05-23, with intended 5 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-01-28 00:00:00, ended at 2016-01-28 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- famotidine 20 MG Oral Tablet, started on 2016-01-29, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n- 12 HR ranolazine 500 MG Extended Release Oral Tablet, started on 2016-01-29, presumably until 2016-01-29, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 12 HOURS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-02 00:00:00, ended at 2016-02-02 00:00:00\nThe patient in this visit was 52 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-16 10:27:52, ended at 2016-02-16 12:43:21\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congestive heart failure\n- Type 2 diabetes mellitus\n- Primary diagnosis: Chronic combined systolic and diastolic heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-02-16 12:49:00, ended at 2016-02-16 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 284 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 6.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 237 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 12.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Albumin [Mass/volume] in Urine: 3480 (milligram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 181 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 114.00 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 133 (millimole per liter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: >3000 (milligram per gram)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 3.9 (ratio)\n- Glucose [Mass/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.12 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 281 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-02-23 00:00:00, ended at 2016-02-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 0.65 ML exenatide 3.08 MG/ML Pen Injector, started on 2016-02-23, presumably until 2016-06-15, with intended 11 refill(s). Instructions: Inject contents of syringe SQ once a week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-03-10 00:00:00, ended at 2016-03-10 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2016-03-11, presumably until 2017-03-11, with intended 11 refill(s). Instructions: INJECT SUBCUTANEOUSLY 15 UNITS BEFORE BREAKFAST AND 30 UNITS BEFORE DINNER. INJECT 10 MINUTES BEFORE EACH MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-03-11 00:00:00, ended at 2016-03-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-25 00:00:00, ended at 2016-03-25 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n- Congestive heart failure\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-25 09:38:00, ended at 2016-03-25 13:08:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 28.1 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Hyperglycemia due to type 2 diabetes mellitus\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-25 11:54:13, ended at 2016-03-25 13:05:42\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, through Subcutaneous route, started on 2016-03-28, presumably until 2017-08-23, with intended 11 refill(s). Instructions: inject 0.6 mg subcutaneous (under the skin) Every Day Failed Bydureon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-25 13:09:00, ended at 2016-03-25 13:09:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-03-25 13:10:00, ended at 2016-03-25 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Anabasine [Mass/volume] in Urine: <2.0 (nanogram per milliliter)\n- Prealbumin [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Nornicotine [Mass/volume] in Urine: <2.0 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.48 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Cotinine [Mass/volume] in Urine: <5.0 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 205 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.6 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1619 (picogram per milliliter)\n- Nicotine [Mass/volume] in Urine: <2.0 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-23 00:00:00, ended at 2016-05-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neuralgia\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2016-05-23, presumably until 2016-07-26, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 08:21:00, ended at 2016-05-31 10:37:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-31 09:04:07, ended at 2016-05-31 16:25:59\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-05-31 10:38:00, ended at 2016-05-31 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-06-15 00:00:00, ended at 2016-06-15 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-15 09:39:45, ended at 2016-06-15 14:39:47\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2016-06-15, presumably until 2016-06-15, with intended 11 refill(s). Instructions: INJECT SUBCUTANEOUSLY 15 UNITS BEFORE BREAKFAST AND 30 UNITS BEFORE DINNER. INJECT 10 MINUTES BEFORE EACH MEAL\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-15 10:21:51, ended at 2016-06-15 12:10:36\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Primary diagnosis: Heart failure\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-06-15 12:33:00, ended at 2016-06-15 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 63 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.1 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Chronic ischemic heart disease\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-06-16 00:00:00, ended at 2016-06-16 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2016-06-17, presumably until 2016-07-06, with intended 4 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-06 00:00:00, ended at 2016-07-06 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2016-07-06, presumably until 2017-07-23, with intended 4 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-12 00:00:00, ended at 2016-07-12 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2016-07-13, presumably until 2016-08-11, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-07-26 00:00:00, ended at 2016-07-26 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Neuralgia\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2016-07-27, presumably until 2016-08-23, with intended 11 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-11 00:00:00, ended at 2016-08-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2016-08-11, presumably until 2017-08-10, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-08-23 00:00:00, ended at 2016-08-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Disorder of endocrine system\n- Polyneuropathy associated with another disorder\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2016-08-24, presumably until 2017-09-26, with intended 3 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-23 00:00:00, ended at 2016-08-23 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of endocrine system\n- Polyneuropathy associated with another disorder\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2016-08-23, presumably until 2016-08-23, with intended 3 refill(s). Instructions: take 1 Cap by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-09-11 00:00:00, ended at 2016-09-11 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2016-09-13, presumably until 2017-06-13, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-28 09:45:50, ended at 2016-10-28 11:48:28\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Chronic ischemic heart disease\n- Diabetes mellitus\n- Heart failure\n- Complication due to diabetes mellitus\n\n### Drug\n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, started on 2016-10-28, presumably until 2018-07-19, with intended 6 refill(s). Instructions: place 1 Tab under the tongue and let dissolve as needed for Chest pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-28 12:00:00, ended at 2016-10-28 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.4 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1027 (picogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.57 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 249 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.7 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- MCV [Entitic volume] by Automated count: 81.5 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.39 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 85 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.9 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.86 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic ischemic heart disease\n- Diabetes mellitus\n- Complication due to diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-14 09:19:16, ended at 2016-11-14 10:03:25\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Chronic ischemic heart disease\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-11-14 10:12:00, ended at 2016-11-14 23:59:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.43 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 853 (picogram per milliliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 121 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-14 10:35:21, ended at 2016-11-14 13:17:37\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Chronic kidney disease due to type 2 diabetes mellitus\n\n### Drug\n- empagliflozin 10 MG Oral Tablet, through Oral route, started on 2016-11-14, presumably until 2017-06-11, with intended 6 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-19 00:00:00, ended at 2016-12-19 00:00:00\nThe patient in this visit was 53 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Polyneuropathy associated with another disorder\n- Disorder of endocrine system\n- Type 2 diabetes mellitus\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2016-12-20, presumably until 2016-12-20, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-20 00:00:00, ended at 2017-02-20 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Creatinine [Mass/volume] in Urine: 55.60 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 731 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.41 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.6 (percent)\n- MCV [Entitic volume] by Automated count: 81.7 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 252 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Albumin [Mass/volume] in Urine: 32 (milligram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 58 (milligram per gram)\n- Neutrophils [#/volume] in Blood by Automated count: 8.20 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 80 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-20 11:16:07, ended at 2017-02-20 13:53:56\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Primary diagnosis: Heart failure\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n\n### Drug\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-02-16, presumably until 2017-02-23, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-20 13:55:00, ended at 2017-02-20 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Heart failure\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-10 10:12:00, ended at 2017-03-10 12:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Heart failure\n- Complication due to diabetes mellitus\n- Disorder of kidney and/or ureter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-03-10 11:21:26, ended at 2017-03-10 13:19:48\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-10 13:00:00, ended at 2017-03-10 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.28 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 157 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 8.0 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 1332 (picogram per milliliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 5.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 193 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Heart failure\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-03-11 00:00:00, ended at 2017-03-11 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2017-03-14, presumably until 2017-08-23, with intended 11 refill(s). Instructions: Humalog 75/25 insulin mix  Before breakfast: take 15  Before lunch: 25 unit     Before dinner: take 30 units      \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-03-28 13:12:00, ended at 2017-03-28 17:44:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n- Glucose [Mass/volume] in Blood: 95 (milligram per deciliter)\n- Left ventricular Ejection fraction: 28.0 (percent)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 14.3 (gram per deciliter)\n- Potassium [Moles/volume] in Blood: 3.4 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood: 42 (percent)\n- INR in Blood by Coagulation assay: 1.0 (ratio)\n\n### Procedure\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Collection of blood specimen from a completely implantable venous access device\n- Insertion of Monitoring Device into Right Ventricle, Percutaneous Approach\n- Measurement of Cardiac Sampling and Pressure, Right Heart, Percutaneous Approach\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Monitoring of Cardiac Output, Percutaneous Approach\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Generalized ischemic myocardial dysfunction\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Heart failure\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Hypertensive heart failure\n- Cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-28 00:00:00, ended at 2017-04-28 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-19 09:20:25, ended at 2017-05-19 10:27:05\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-04-14, presumably until 2017-11-10, with intended 0 refill(s). Instructions: take 10 mg by mouth daily\n- methotrexate 2.5 MG Oral Tablet, through Oral route, started on 2017-04-14, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 15 mg by mouth every 7 days \n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-04-18, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-11 00:00:00, ended at 2017-06-11 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- empagliflozin 10 MG Oral Tablet, started on 2017-06-13, presumably until 2018-07-19, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-13 00:00:00, ended at 2017-06-13 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- losartan potassium 25 MG Oral Tablet, started on 2017-06-13, presumably until 2017-09-18, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-06-16 00:00:00, ended at 2017-06-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-18 00:00:00, ended at 2017-06-18 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2017-06-18, presumably until 2017-08-23, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-26 09:50:15, ended at 2017-06-26 10:30:17\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Primary diagnosis: Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-26 10:39:00, ended at 2017-06-26 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.8 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 143 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.61 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 275 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-12 00:00:00, ended at 2017-07-12 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, started on 2017-07-13, presumably until 2018-05-31, with intended 11 refill(s). Instructions: INJECT 1.2 MG SUBCUTANEOUS EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-07-17 00:00:00, ended at 2017-07-17 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Secondary diabetes mellitus\n- Severe hyperglycemia due to diabetes mellitus\n- Complication due to diabetes mellitus\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-23 00:00:00, ended at 2017-07-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, started on 2017-07-23, presumably until 2017-10-04, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-10 00:00:00, ended at 2017-08-10 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2017-08-10, presumably until 2018-06-01, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-23 00:00:00, ended at 2017-08-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-23 00:00:00, ended at 2017-08-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus\n\n### Drug\n- carvedilol 25 MG Oral Tablet, started on 2017-08-23, presumably until 2018-07-19, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-23 09:57:58, ended at 2017-08-23 12:23:51\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.567\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 25 UNT/ML / insulin lispro protamine, human 75 UNT/ML Pen Injector, started on 2017-08-23, presumably until 2018-07-19, with intended 11 refill(s). Instructions: Humalog 75/25 insulin mix Before breakfast: take 18 Before lunch: 26 units  Before dinner: take 26 units\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-23 11:13:50, ended at 2017-08-23 13:17:06\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4.5\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2017-08-23, presumably until 2017-08-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-08 00:00:00, ended at 2017-09-08 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-12 00:00:00, ended at 2017-09-12 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-18 00:00:00, ended at 2017-09-18 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sacubitril 24 MG / valsartan 26 MG Oral Tablet, through Oral route, started on 2017-09-18, presumably until 2018-06-01, with intended 0 refill(s). Instructions: take 24-26 mg by mouth 2 times a day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-23 00:00:00, ended at 2017-09-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n- Neuralgia\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2017-09-26, presumably until 2018-05-04, with intended 6 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 13:06:00, ended at 2017-10-04 13:06:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-04 13:07:00, ended at 2017-10-04 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 243 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.5 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.61 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 168 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.80 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.20 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 500 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Globulin [Mass/volume] in Serum: 5.0 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.49 (micro-international unit per milliliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 83.0 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.56 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic combined systolic and diastolic heart failure\n- Heart failure\n- Chronic ischemic heart disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Congestive heart failure\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-10-23 00:00:00, ended at 2017-10-23 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2017-10-23, presumably until 2017-10-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take 80mg in the morning, 40mg in the evening\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-10 10:13:57, ended at 2017-11-10 11:24:08\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2017-12-13, presumably until 2017-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-16 00:00:00, ended at 2018-01-16 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2018-01-17, presumably until 2018-01-17, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-01-17 08:03:00, ended at 2018-01-17 09:18:03\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, review and report by a physician or other qualified health care \n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-17 09:21:00, ended at 2018-01-17 09:21:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 9.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 5.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 85.2 (femtoliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 159 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 257 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.74 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.53 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.4 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.12 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Secondary diabetes mellitus\n- Complication due to diabetes mellitus\n- Severe hyperglycemia due to diabetes mellitus\n- Kidney disease\n- Type 2 diabetes mellitus\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-01-17 09:22:00, ended at 2018-01-17 23:59:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Heart failure\n- Secondary diabetes mellitus\n- Severe hyperglycemia due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-02-07 00:00:00, ended at 2018-02-07 00:00:00\nThe patient in this visit was 54 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, started on 2018-02-08, presumably until 2018-02-08, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-03-14 11:26:56, ended at 2018-03-14 13:55:49\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 30 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Body height: 5' 4\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 1.88 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 206 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n\n### Procedure\n- Interrogation device evaluation (in person) with analysis, review and report by a physician or other qualified health care professional, includes connection, recording and disconnection per patient encounter; single, dual, or multiple lead transvenous imp\n\n### Condition\n- Type 2 diabetes mellitus\n- Chronic ischemic heart disease\n- Complication due to diabetes mellitus\n- Primary diagnosis: Heart failure\n\n### Drug\n- digoxin 0.125 MG Oral Tablet, through Oral route, started on 2018-03-14, presumably until 2018-06-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-14 14:02:00, ended at 2018-03-14 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 567 (picogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.9 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n- Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-03-22 00:00:00, ended at 2018-03-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 185 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.58 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-03-28 13:52:00, ended at 2018-03-28 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.52 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Type 2 diabetes mellitus\n- Heart failure\n- Complication due to diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-06 00:00:00, ended at 2018-04-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.56 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-13 00:00:00, ended at 2018-04-13 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-20 00:00:00, ended at 2018-04-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 23 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.67 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-27 00:00:00, ended at 2018-04-27 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.53 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 22 (calculated)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-04 00:00:00, ended at 2018-05-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 18 (calculated)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.58 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-04 00:00:00, ended at 2018-05-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neuralgia\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- duloxetine 20 MG Delayed Release Oral Capsule, started on 2018-05-08, presumably until 2018-07-19, with intended 6 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-11 00:00:00, ended at 2018-05-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.55 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 15 (calculated)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-23 00:00:00, ended at 2018-05-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- spironolactone 25 MG Oral Tablet, started on 2018-05-23, presumably until 2018-07-19, with intended 6 refill(s). Instructions: TAKE 1/2 TABLET BY MOUTH DAILY\n- furosemide 80 MG Oral Tablet, started on 2018-05-23, presumably until 2018-06-01, with intended 6 refill(s). Instructions: TAKE 1 TABLET BY MOUTH IN THE MORNING AND IN THE AFTERNOON\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-23 09:48:00, ended at 2018-05-23 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 188 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.52 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.78 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 19 (calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 97 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 373 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic ischemic heart disease\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-31 00:00:00, ended at 2018-05-31 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML liraglutide 6 MG/ML Pen Injector, started on 2018-06-05, presumably until 2018-07-19, with intended 11 refill(s). Instructions: INJECT 1.2 MG SUBCUTANEOUS EVERY DAY  90 day supply if insurance allows\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-01 00:00:00, ended at 2018-06-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congestive heart failure\n- Chronic ischemic heart disease\n- Chronic combined systolic and diastolic heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-01 00:00:00, ended at 2018-06-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n- Primary diagnosis: Heart failure\n\n### Drug\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-06-01, presumably until 2018-07-19, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- digoxin 0.125 MG Oral Tablet, through Oral route, started on 2018-06-01, presumably until 2018-07-19, with intended 11 refill(s). Instructions: take 0.5 Tabs by mouth daily\n- furosemide 80 MG Oral Tablet, started on 2018-06-01, presumably until 2018-07-19, with intended 6 refill(s). Instructions: Take 80 mg (one tablet) in the morning and 40 mg (half of a tablet) in the afternoon.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-06-06 00:00:00, ended at 2018-06-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for heart transplant or heart/lung transplant\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n\n### Condition\n- Heart failure\n- Atrial fibrillation\n- Cardiomyopathy\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- 2 ML magnesium sulfate 500 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 10 ML furosemide 10 MG/ML Injection, started on 2018-06-06, presumably until 2018-06-07\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-06-06, presumably until 2018-06-06\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- ketamine 100 MG/ML Injectable Solution, started on 2018-06-06, presumably until 2018-06-06\n- 10 ML tranexamic acid 100 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-06, presumably until 2018-06-06\n- 1 ML sufentanil 0.05 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2018-06-06 15:50:00, ended at 2018-07-19 16:03:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Base excess in Blood by calculation: 7 (millimole per liter)\n- C peptide [Mass/volume] in Serum or Plasma: 0.2 (nanogram per milliliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 45.5 (millimeter mercury column)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 24.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.5 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: >15.0 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.7 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 142 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n- Eosinophils [#/volume] in Blood by Manual count: 0.27 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.82 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 259 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 5 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.20 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.5 (picogram)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.5 (milligram per deciliter)\n- Prothrombin time (PT): 26.1 (second)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.70 (micro-international unit per milliliter)\n- Ammonia [Mass/volume] in Plasma: 42 (micromole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.44 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Creatinine renal clearance in 24 hour Urine and Serum or Plasma: 21 (milliliter per minute)\n- Left ventricular Ejection fraction: 57.7 (percent)\n- Leukocytes [#/volume] in Body fluid by Manual count: 8 (milli-international unit per milliliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 88 (percent)\n- Platelets [#/volume] in Blood by Automated count: 97 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.6 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: <2.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: >150 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 30.4 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Mixed venous blood: 0.64 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Hydroxyitraconazole [Mass/volume] in Serum or Plasma: <0.1 (microgram per milliliter)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 2.00 (thousand per microliter)\n- Myoglobin [Mass/volume] in Urine: 143 (microgram per liter)\n- Procalcitonin [Mass/volume] in Serum or Plasma: 8.53 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.31 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 28 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 395 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.30 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.3 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 4.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Blood: 4.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 310 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: >3500 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Arterial blood by calculation: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Body weight Stated: 92.0 (kilogram)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 284 (unit per liter)\n- Glucose [Mass/volume] in Blood: >500 (milligram per deciliter)\n- Itraconazole [Mass/volume] in Serum or Plasma: <0.1 (microgram per milliliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 804 (unit per liter)\n- Monocytes [#/volume] in Blood by Manual count: 2.71 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 97 (millimeter mercury column)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Tacrolimus [Mass/volume] in Blood: 9.9 (nanogram per milliliter)\n- Aldolase [Enzymatic activity/volume] in Serum or Plasma: 13.5 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 1.60 (milligram per deciliter)\n- Body height Stated: 165 (centimeter)\n- Calcium.ionized [Moles/volume] in Blood: 1.08 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 45.6 (millimeter mercury column)\n- Ferritin [Mass/volume] in Serum or Plasma: 250.1 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 5.2 (gram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.90 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 150 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 68.8 (second)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 51 - 100 (per high power field)\n- Iron [Mass/volume] in Serum or Plasma: 28 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 93.5 (millimeter mercury column)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 15.5 (microgram per milliliter)\n- Lidocaine [Mass/volume] in Serum or Plasma: <0.5 (microgram per milliliter)\n\n### Procedure\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Evaluation of oral and pharyngeal swallowing function\n- Measurement of Cardiac Sampling and Pressure, Right Heart, Percutaneous Approach\n- Introduction of Other Therapeutic Substance into Respiratory Tract, Via Natural or Artificial Opening Endoscopic\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Hemodialysis procedure with single evaluation by a physician or other qualified health care professional\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Controlled ventilation procedure and therapy, initiation and management\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Respiratory Ventilation, Greater than 96 Consecutive Hours\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies) requiring repeated evaluations by a physician or other qualified health care professional, with or without substantial re\n- Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psych\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Transplantation of Heart, Allogeneic, Open Approach\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Radiologic examination, chest; single view\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Collection of venous blood by venipuncture\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Performance of Cardiac Output, Continuous\n- Endomyocardial biopsy\n- Insertion of Infusion Device into Right Atrium, Percutaneous Approach\n- Computed tomography, thorax, diagnostic; without contrast material\n- Flexible endoscopic evaluation of swallowing by cine or video recording\n- Removal of Cardiac Lead from Heart, Open Approach\n- Insertion of Infusion Device into Right Internal Jugular Vein, Percutaneous Approach\n- Continuous positive airway pressure ventilation (CPAP), initiation and management\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Performance of Urinary Filtration, Intermittent, Less than 6 Hours Per Day\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of Infusion Device into Superior Vena Cava, Percutaneous Approach\n- Insertion of Tunneled Vascular Access Device into Chest Subcutaneous Tissue and Fascia, Percutaneous Approach\n- Computed tomography, head or brain; without contrast material\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Performance of Urinary Filtration, Continuous, Greater than 18 hours Per Day\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study\n- Insertion of Monitoring Device into Right Pulmonary Artery, Percutaneous Approach\n\n### Condition\n- Acute on chronic hypercapnic respiratory failure\n- Aortocoronary bypass graft present\n- Disorders of both mitral and tricuspid valves\n- Infection due to Escherichia coli\n- Iron deficiency anemia\n- Long QT syndrome\n- Pain at rest of left lower limb co-occurrent and due to atherosclerosis\n- Pleural effusion\n- Pulmonary hypertension\n- Aberrant premature complexes\n- Acute posthemorrhagic anemia\n- Atrial fibrillation\n- Conduction disorder of the heart\n- Diabetes mellitus without complication\n- Disorder of cardiovascular system\n- Disorder of transplanted heart\n- Hepatic failure\n- Hyperkalemia\n- Intermittent claudication of bilateral lower limbs co-occurrent and due to atherosclerosis\n- Supraventricular tachycardia\n- Ventricular tachycardia\n- Acute hypoxemic respiratory failure\n- Anemia in chronic kidney disease\n- Atherosclerosis of artery of lower limb\n- Cardiogenic shock\n- Cardiomegaly\n- Cardiomyopathy\n- Chronic total occlusion of coronary artery\n- Coronary artery graft present\n- Hypo-osmolality and or hyponatremia\n- Hypoglycemia due to type 2 diabetes mellitus\n- Rheumatic disease of heart valve\n- Skin sensation disturbance\n- Transplanted heart present\n- Abnormal findings on diagnostic imaging of lung\n- Acquired absence of organ\n- Congestive heart failure\n- Critical illness myopathy\n- Delirium\n- Diastolic heart failure\n- Edema, generalized\n- Electrocardiogram abnormal\n- Generalized ischemic myocardial dysfunction\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Late effect of complications of procedure\n- Late effect of medical and surgical care complication\n- Localized edema\n- Muscle pain\n- Muscle weakness\n- Old myocardial infarction\n- Right bundle branch block\n- Sepsis\n- Septic shock\n- Ventricular premature complex\n- Acidosis\n- Acute renal failure syndrome\n- Acute tubular necrosis\n- Altered mental status\n- Bacterial infection due to Pseudomonas\n- Cardiac transplant failure\n- Chronic ischemic heart disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Metabolic encephalopathy\n- Moderate protein-calorie malnutrition (weight for age 60-74 percent of standard)\n- Acute on chronic combined systolic and diastolic heart failure\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Blood coagulation disorder\n- Chronic kidney disease stage 3\n- Complication of anesthesia\n- Gastroesophageal reflux disease without esophagitis\n- Primary diagnosis: Heart failure\n- Hyperglycemia\n- Hyperglycemia due to type 2 diabetes mellitus\n- Hyperosmolality and or hypernatremia\n- Hypertensive heart and chronic kidney disease\n- Leukocytosis\n- Low blood pressure\n- Persistent pain following procedure\n- Acute on chronic hypoxemic respiratory failure\n- Acute pulmonary edema\n- Atelectasis\n- Cardiac arrhythmia\n- Chronic passive congestion of liver\n- Disorder of digestive system\n- Disorder of immune function\n- Disorientated\n- Postoperative shock\n- Rest pain\n- Vocal cord paralysis\n- Atrial flutter\n- Bradycardia\n- Complication due to diabetes mellitus\n- End-stage renal disease\n- Finding of urine output\n- Hyperosmolarity\n- Left bundle branch block\n- Obesity\n- Pneumonia due to Pseudomonas\n- Pneumothorax\n- Rheumatoid arthritis\n- Shock\n- Chronic pulmonary edema\n- Disorder of plasma protein metabolism\n- Type 2 diabetes mellitus\n- Urinary tract infectious disease\n\n### Drug\n- glycerin, started on 2018-06-11, presumably until 2018-06-11\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2018-07-02, presumably until 2018-12-17, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2018-06-28, presumably until 2018-07-12, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2018-06-11, presumably until 2018-06-23\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-15\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2018-06-08, presumably until 2018-06-11\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2018-06-09, presumably until 2018-06-11\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-15\n- 250 ML dopamine hydrochloride 3.2 MG/ML Injection, through Intravenous route, started on 2018-06-15, presumably until 2018-06-15\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-03, presumably until 2018-07-19, with intended 5 refill(s). Instructions: inject 33 Units subcutaneous (under the skin) 2 times a day\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2018-06-18, presumably until 2018-07-02\n- sodium citrate, through Intravenous route, started on 2018-06-09, presumably until 2018-06-25\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2018-06-07, presumably until 2018-06-15\n- haloperidol 5 MG/ML Injectable Solution, started on 2018-06-11, presumably until 2018-06-12\n- chlorothiazide 50 MG/ML Oral Suspension, through Oral route, started on 2018-06-08, presumably until 2018-06-17\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-07-04, presumably until 2019-07-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-19\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2018-06-17, presumably until 2018-06-23\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2018-06-11, presumably until 2018-06-11\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-06-15\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-07-03, presumably until 2018-07-09, with intended 5 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) 3 times a day before meals Additionally, inject 0-12 units subcutaneously 4 times a day before meals and at bedtime per sliding scale.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-28\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-06-26, presumably until 2018-06-28\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-08-24, with intended 2 refill(s). Instructions: take 2 Tabs by mouth daily Or as directed per prednisone taper card.\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2018-06-28, presumably until 2018-06-30\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2018-07-19, presumably until 2018-07-19\n- amphotericin B 50 MG Injection, started on 2018-06-07, presumably until 2018-06-07\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2018-06-11, presumably until 2018-06-11\n- mineral oil 0.15 MG/MG / petrolatum 0.83 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2018-06-09, presumably until 2018-06-15\n- 1 ML epoetin alfa 10000 UNT/ML Injection, through Subcutaneous route, started on 2018-06-29, presumably until 2018-08-16, with intended 0 refill(s). Instructions: inject 1 mL subcutaneous (under the skin) every Tuesday, Thursday and Saturday\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-06-29\n- midodrine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-07-09, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-15, presumably until 2018-06-15\n- cefazolin 1000 MG Injection, started on 2018-06-07, presumably until 2018-06-07\n- duloxetine 20 MG Delayed Release Oral Capsule, through Oral route, started on 2018-06-12, presumably until 2018-06-15\n- prednisone 1 MG/ML Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-07-02\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-06-23, presumably until 2018-06-23\n- 5 ML iron sucrose 20 MG/ML Injection, through Intravenous route, started on 2018-06-29, presumably until 2018-08-16, with intended 0 refill(s). Instructions: 5 mL by Intravenous route every Tuesday, Thursday and Saturday For 9 doses.\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-06-07\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2018-06-10, presumably until 2018-06-16\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2018-06-08, presumably until 2018-07-02\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-08-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime\n- 10 ML calcium chloride 100 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-06-07, presumably until 2018-07-19\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2018-06-08, presumably until 2019-05-31, with intended 11 refill(s). Instructions: 5 mL by Swish & Swallow route 3 times a day\n- lansoprazole 30 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-07-02\n- 10 ML furosemide 10 MG/ML Injection, started on 2018-06-07, presumably until 2018-06-30\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2018-06-21, presumably until 2018-07-05\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-06-21, presumably until 2018-08-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-06-12, presumably until 2018-07-19\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, through Subcutaneous route, started on 2018-06-20, presumably until 2018-08-02, with intended 0 refill(s). Instructions: inject 0.5 mL subcutaneous (under the skin) every 8 hours\n- citric acid, through Intravenous route, started on 2018-06-09, presumably until 2018-06-25\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2018-06-08, presumably until 2018-06-21\n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2018-06-16, presumably until 2018-06-28\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-06-08, presumably until 2018-08-29, with intended 0 refill(s). Instructions: inject 23 Units subcutaneous (under the skin) 3 times a day with meals\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2018-06-07, presumably until 2018-06-24\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2018-06-19, presumably until 2018-06-21\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-06-13\n- hydroxyzine hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2018-06-12, presumably until 2018-06-12\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-07, presumably until 2018-06-15\n- 50 ML glucose 500 MG/ML Prefilled Syringe, through Intravenous route, started on 2018-06-17, presumably until 2018-06-23\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2018-06-06, presumably until 2018-06-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2018-06-09, presumably until 2018-06-26\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-06-07\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-07-03, presumably until 2018-07-30, with intended 11 refill(s). Instructions: take 1 Cap by mouth daily\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-06-21, presumably until 2018-06-25\n- sennosides, USP 35.2 MG/ML Oral Solution, through Oral route, started on 2018-06-08, presumably until 2018-06-13\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- venlafaxine 25 MG Oral Tablet, through Oral route, started on 2018-06-19, presumably until 2018-08-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth DAILY\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-06-07\n- albuterol 2 MG Oral Tablet, through Oral route, started on 2018-06-15, presumably until 2018-07-19, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 3 times a day\n- albuterol 0.4 MG/ML Oral Solution, through Oral route, started on 2018-06-21, presumably until 2018-07-02\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2018-06-08, presumably until 2018-08-29, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n- 1 ML epoetin alfa 40000 UNT/ML Injection, started on 2018-07-05, presumably until 2018-07-05\n- gabapentin 100 MG Oral Capsule, through Oral route, started on 2018-07-02, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- insulin glargine 100 UNT/ML Injectable Solution, started on 2018-07-19, presumably until 2018-08-16, with intended 0 refill(s). Instructions: On 07/19/2018, inject 15 units subcutaneously (under the skin) in the evening once. Then on 07/20/2018, inject 15 units SQ in the morning once. Then starting on 07/21/2018, inject 30 units SQ once daily in the morning thereafter.\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2018-06-21, presumably until 2018-09-10, with intended 2 refill(s). Instructions: Take 20 mL (200 mg) by mouth every morning and 10 mL (100 mg) every evening on an empty stomach.\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2018-06-28, presumably until 2019-07-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2018-07-05, presumably until 2018-09-27, with intended 0 refill(s). Instructions: apply 1 Patch to skin daily Apply patch to upper back  for up to 12 hours in any 24 hour period.\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2018-06-09, presumably until 2018-06-12\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-07\n- midodrine hydrochloride 2.5 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-07-17\n- 10 ML atropine sulfate 0.1 MG/ML Prefilled Syringe, started on 2018-06-21, presumably until 2018-06-21\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-13\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2018-06-08, presumably until 2018-06-08\n- albuterol 5 MG/ML Inhalation Solution, through Inhalation, started on 2018-06-10, presumably until 2018-06-11\n- prednisone 20 MG Oral Tablet, through Oral route, started on 2018-07-03, presumably until 2018-07-19\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2018-06-11, presumably until 2018-06-11\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2018-07-02, presumably until 2018-10-03, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2018-06-15, presumably until 2018-07-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- acyclovir 40 MG/ML Oral Suspension, through Oral route, started on 2018-06-08, presumably until 2018-07-02\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2018-06-29, presumably until 2018-11-03, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- glucose 4000 MG Chewable Tablet, through Oral route, started on 2018-07-03, presumably until 2018-08-16, with intended 0 refill(s). Instructions: take 4 Tabs by mouth as needed for Low blood sugar\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-09, presumably until 2018-06-09\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2018-06-07, presumably until 2018-06-08\n- methylprednisolone 125 MG Injection, started on 2018-06-07, presumably until 2018-06-07\n- melatonin 3 MG Disintegrating Oral Tablet, through Oral route, started on 2018-06-18, presumably until 2018-07-18\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2018-07-03, presumably until 2018-07-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-08 00:00:00, ended at 2018-06-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Chronic ischemic heart disease\n- Congestive heart failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-11 00:00:00, ended at 2018-06-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic combined systolic and diastolic heart failure\n- Congestive heart failure\n- Chronic ischemic heart disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-14 00:00:00, ended at 2018-06-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Chronic ischemic heart disease\n- Type 2 diabetes mellitus\n\n### Drug\n- carvedilol 12.5 MG Oral Tablet, started on 2018-06-14, presumably until 2018-06-14, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-19 00:00:00, ended at 2018-06-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-19, presumably until 2018-06-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-26 00:00:00, ended at 2018-06-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-26, presumably until 2018-06-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-06-28 00:00:00, ended at 2018-06-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-06-28, presumably until 2018-06-28\n- midazolam 1 MG/ML Injectable Solution, started on 2018-06-28, presumably until 2018-06-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-03 00:00:00, ended at 2018-07-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-03, presumably until 2018-07-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-06 00:00:00, ended at 2018-07-06 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-10 00:00:00, ended at 2018-07-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-10, presumably until 2018-07-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-07-18 00:00:00, ended at 2018-07-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-07-18, presumably until 2018-07-18\n- 2 ML verapamil hydrochloride 2.5 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- iodixanol, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-07-18, presumably until 2018-07-18\n- 250 ML nitroglycerin 0.1 MG/ML Injection, through Intravenous route, started on 2018-07-18, presumably until 2018-07-18\n- midazolam 1 MG/ML Injectable Solution, started on 2018-07-18, presumably until 2018-07-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-07-27 00:00:00, ended at 2018-07-27 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, presumably until 2018-08-14, with intended 0 refill(s). Instructions: take 1 mg by mouth 2 times a day Total dose of 1mg AM, 1mg PM\n- amlodipine 2.5 MG Oral Tablet, through Oral route, presumably until 2018-08-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-07-30, presumably until 2018-08-14, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 0.5mg AM, 1mg PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-01 00:00:00, ended at 2018-08-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Primary diagnosis: Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-08-02, presumably until 2018-08-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- clopidogrel 75 MG Oral Tablet, started on 2018-08-02, presumably until 2018-08-02, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-02 10:49:54, ended at 2018-08-02 12:42:30\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-02 12:51:00, ended at 2018-08-02 13:22:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.2 (ratio)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.56 (thousand per microliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.48 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Itraconazole [Mass/volume] in Serum or Plasma: 1.0 (microgram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 22.3 (percent)\n- MCHC [Mass/volume] by Automated count: 30.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hydroxyitraconazole [Mass/volume] in Serum or Plasma: 1.4 (microgram per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.7 (percent)\n- Tacrolimus [Mass/volume] in Blood: 10.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 218 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 100 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 264 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.75 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 132 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 100.6 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 96 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.6 (picogram)\n- Triglyceride [Moles/volume] in Serum or Plasma: 153 (milligram per deciliter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-02 13:23:00, ended at 2018-08-02 14:57:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed\n- Endomyocardial biopsy\n- Measurement of Cardiac Sampling and Pressure, Right Heart, Percutaneous Approach\n\n### Condition\n- Transplanted heart present\n- Obesity\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Essential hypertension\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-13 09:08:00, ended at 2018-08-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 134 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.44 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.53 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.19 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.18 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.6 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-14 00:00:00, ended at 2018-08-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2018-08-14, presumably until 2018-08-17, with intended 3 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 1mg AM, 1mg PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-15 00:00:00, ended at 2018-08-15 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-16 00:00:00, ended at 2018-08-16 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-08-16, presumably until 2018-08-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-16 12:53:00, ended at 2018-08-16 14:48:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Transplanted heart present\n- Chronic kidney disease\n- Acute deep venous thrombosis of internal jugular vein\n- Disorder of transplanted heart\n- Essential hypertension\n- Embolism from thrombosis of vein of lower extremity\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-17 00:00:00, ended at 2018-08-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal level of blood mineral\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-08-17, presumably until 2018-09-10, with intended 3 refill(s). Instructions: Total dose of 0.5mg AM, 1mg PM\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-08-17, presumably until 2018-09-10, with intended 3 refill(s). Instructions: Total dose: 0.5mg in the am, 1mg in the pm.\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2018-08-17, presumably until 2018-09-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-17 09:51:00, ended at 2018-08-17 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.34 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.3 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Tacrolimus [Mass/volume] in Blood: 15.9 (nanogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.83 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.7 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.68 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 87.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-20 00:00:00, ended at 2018-08-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2018-08-20, presumably until 2018-11-27, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-20 00:00:00, ended at 2018-08-20 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-20 13:50:00, ended at 2018-08-20 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Disorder of transplanted heart\n- Embolism from thrombosis of vein of lower extremity\n- Acute deep venous thrombosis of internal jugular vein\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-23 00:00:00, ended at 2018-08-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2018-08-23, presumably until 2018-08-29, with intended 11 refill(s). Instructions: take 2 Tabs by mouth 2 times a day\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-08-23, presumably until 2018-08-24, with intended 11 refill(s). Instructions: take 2 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-23 08:00:00, ended at 2018-08-23 10:42:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 60.4 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n- Essential hypertension\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-23 09:14:30, ended at 2018-08-23 10:36:05\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Edema\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-23 10:43:00, ended at 2018-08-23 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 7.7 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.40 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 196 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 67 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.78 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 148 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.9 (picogram)\n- MCV [Entitic volume] by Automated count: 94.4 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.80 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-08-24 00:00:00, ended at 2018-08-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2018-08-24, presumably until 2018-09-17, with intended 2 refill(s). Instructions: take 1.5 Tabs by mouth daily\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-08-24, presumably until 2018-08-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-24 12:02:00, ended at 2018-08-24 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Gangrenous disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-08-24 12:03:48, ended at 2018-08-24 13:17:41\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Gangrenous disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-08-27 08:35:00, ended at 2018-08-27 10:39:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 73 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.1 (ratio)\n\n### Procedure\n- Collection of blood specimen from a completely implantable venous access device\n- Removal of tunneled central venous catheter, without subcutaneous port or pump\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- lidocaine 25 MG/ML / prilocaine 25 MG/ML Topical Cream, through Topical route, started on 2018-08-27, presumably until 2018-08-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-28 00:00:00, ended at 2018-08-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2018-08-28 17:48:00, ended at 2018-09-10 13:53:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 145 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.82 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: 9149 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 284 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 9.5 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.78 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.08 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 66 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.59 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 72 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.28 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Left ventricular Ejection fraction: 60.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.027 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Base excess in Blood by calculation: 1 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.9 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Body height: 5' 5\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n\n### Procedure\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Hospital discharge day management; 30 minutes or less\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A detailed or comprehensive history; A detailed or comprehensive examination; and Medical decision making that is straightforward or of \n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Radiologic examination, chest; 2 views\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Abdominal distension, gaseous\n- Disorder of transplanted heart\n- Dyspnea\n- Leukocytosis\n- Essential hypertension\n- Gangrene due to type 2 diabetes mellitus\n- Hypoglycemia due to type 2 diabetes mellitus\n- Peripheral angiopathy due to diabetes mellitus\n- Anemia in chronic kidney disease\n- Coag./bleeding tests abnormal\n- Congestive heart failure\n- Disorder of nervous system due to type 2 diabetes mellitus\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Late effect of complications of procedure\n- Tricuspid incompetence, non-rheumatic\n- Chest pain\n- Disorder of digestive system\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Long QT syndrome\n- Thrombus due to any device, implant AND/OR graft\n- Type 2 diabetes mellitus\n- Alkalosis\n- Disorder of eye due to type 2 diabetes mellitus\n- Gangrenous disorder\n- Heart failure\n- Acute on chronic diastolic heart failure\n- Diastolic heart failure\n- Transplanted heart present\n- Acute deep venous thrombosis of internal jugular vein\n- Cardiac transplant failure\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Constipation\n- Primary diagnosis: Hypervolemia\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Obesity\n- Valvular endocarditis\n- Acquired absence of organ\n- Acute renal failure syndrome\n- Allergic disposition\n- Pleural effusion\n- Chronic kidney disease stage 4\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-09-10\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2018-09-06, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- 250 ML dobutamine 1 MG/ML Injection, through Intravenous route, started on 2018-09-04, presumably until 2018-09-09\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-09, presumably until 2019-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- clonidine hydrochloride 0.3 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2018-09-04, presumably until 2018-09-04\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-09-07, presumably until 2018-11-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-06\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- prednisone 2.5 MG Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2018-09-10\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2019-09-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-09\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-08-28\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-09-10\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2018-09-10\n- hydralazine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-08-29\n- magnesium hydroxide 80 MG/ML Oral Suspension, through Oral route, started on 2018-09-03, presumably until 2018-09-09\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2018-08-29, presumably until 2018-09-10\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-09-01, presumably until 2018-09-04\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2018-09-02, presumably until 2018-09-05\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2018-09-10\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2018-08-29, presumably until 2018-09-10\n- 100 ML magnesium sulfate 10 MG/ML Injection, through Intravenous route, started on 2018-09-02, presumably until 2018-09-02\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-09-02, presumably until 2018-09-02\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-08-30, presumably until 2018-09-04\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-08-29, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 5 Caps by mouth 2 times a day\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2018-08-29, presumably until 2018-09-03\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2019-07-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every other day\n- itraconazole 10 MG/ML Oral Solution, through Oral route, started on 2018-08-28, presumably until 2018-09-03\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2018-08-29, presumably until 2018-09-09\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2018-08-31, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 5 Tabs by mouth 2 times a day\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2018-08-28, presumably until 2018-09-02\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2018-08-28, presumably until 2018-09-10\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2018-08-29, presumably until 2018-09-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-08-30 00:00:00, ended at 2018-08-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2018-08-30, presumably until 2018-08-30\n- midazolam 1 MG/ML Injectable Solution, started on 2018-08-30, presumably until 2018-08-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-05 00:00:00, ended at 2018-09-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-10 00:00:00, ended at 2018-09-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2018-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2018-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2019-09-10, with intended 0 refill(s). Instructions: take 3 Tabs by mouth 2 times a day\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2019-01-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth daily\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-09-10, presumably until 2018-09-18, with intended 0 refill(s). Instructions: take 5 Caps by mouth 2 times a day\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2018-09-10, presumably until 2018-09-27, with intended 0 refill(s). Instructions: take 5 Tabs by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-11 00:00:00, ended at 2018-09-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-09-11 00:00:00, ended at 2018-09-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Complication due to diabetes mellitus\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-09-11, presumably until 2019-11-27, with intended 11 refill(s). Instructions: inject 22 Units subcutaneous (under the skin) 2 times a day 22 units AM, 22 units PM\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, through Subcutaneous route, started on 2018-09-11, presumably until 2019-11-21, with intended 11 refill(s). Instructions: inject 17 Units subcutaneous (under the skin) 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-11 13:10:09, ended at 2018-09-11 13:10:51\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-12 00:00:00, ended at 2018-09-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-13 09:23:00, ended at 2018-09-13 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.01 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.29 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 11.26 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.09 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 7.8 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- MCH [Entitic mass] by Automated count: 29.1 (picogram)\n- MCV [Entitic volume] by Automated count: 90.6 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.26 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 378 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-13 09:42:41, ended at 2018-09-13 11:15:45\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2018-09-13, presumably until 2018-09-18, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-09-13, presumably until 2019-09-13, with intended 11 refill(s). Instructions: take 1 Tab by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-14 00:00:00, ended at 2018-09-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-09-14, presumably until 2018-09-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-17 00:00:00, ended at 2018-09-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-09-17, presumably until 2019-01-20, with intended 3 refill(s). Instructions: take 1.5 Tabs by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-18 00:00:00, ended at 2018-09-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-09-18, presumably until 2018-10-10, with intended 0 refill(s). Instructions: take 5 Caps by mouth 2 times a day Take 5 capsules in AM and 6 capsules in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-18 08:57:00, ended at 2018-09-18 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.00 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.58 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 337 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 4.9 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 173 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 11.69 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 134 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.75 MG Oral Tablet, through Oral route, started on 2018-09-21, presumably until 2018-09-28, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-21 00:00:00, ended at 2018-09-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-21 08:44:00, ended at 2018-09-21 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood: 8.6 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 174 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.02 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 84.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.95 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 313 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.12 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 93 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-24 00:00:00, ended at 2018-09-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood chemistry abnormal\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 09:28:00, ended at 2018-09-27 09:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.84 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 28.7 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 7.3 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- MCHC [Mass/volume] by Automated count: 31.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.1 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.03 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Everolimus [Mass/volume] in Blood: 2.5 (nanogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 9.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 271 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-27 10:00:00, ended at 2018-09-27 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 69.6 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Disorder of immune function\n- Hypomagnesemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-09-28 00:00:00, ended at 2018-09-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-10-01, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- everolimus 0.5 MG Oral Tablet, started on 2018-09-28, presumably until 2018-10-03, with intended 3 refill(s). Instructions: Take 1mg twice daily. Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-09-28, presumably until 2018-11-27, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-09-28 09:47:00, ended at 2018-09-28 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-10-01, presumably until 2018-10-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day 2nd prescription, please dispense!\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-01 09:40:00, ended at 2018-10-01 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Everolimus [Mass/volume] in Blood: 3.5 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 231 (thousand per microliter)\n- Anion gap in Serum or Plasma: 13 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.1 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.70 (million per microliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 8.3 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 28.9 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.81 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 133 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.17 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.23 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-10-03 00:00:00, ended at 2018-10-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-10-03, presumably until 2018-11-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily 2nd prescription, please dispense!\n- everolimus 0.5 MG Oral Tablet, started on 2018-10-03, presumably until 2018-11-28, with intended 3 refill(s). Instructions: Take 1mg in the AM, 1.5mg in the PM. Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2018-10-03, presumably until 2018-10-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1000 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 85.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 10.5 (microgram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 230 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 18 (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7920 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 11.9 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.60 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 810 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 42 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.0 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 370 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-10 00:00:00, ended at 2018-10-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2018-10-10, presumably until 2018-10-11, with intended 11 refill(s). Instructions: take 5 Caps by mouth 2 times a day Take 5 capsules in AM and 6 capsules in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-11 00:00:00, ended at 2018-10-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-10-11, presumably until 2018-12-07, with intended 11 refill(s). Instructions: Take 2.5mg in Am and 3 mg in PM\n- tacrolimus 0.5 MG Oral Capsule, started on 2018-10-11, presumably until 2018-12-07, with intended 11 refill(s). Instructions: Take 0.5 mg in AM and as directed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-12 00:00:00, ended at 2018-10-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-19 00:00:00, ended at 2018-10-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-22 00:00:00, ended at 2018-10-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-22 00:00:00, ended at 2018-10-22 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2018-10-22, presumably until 2018-10-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 4 times a day for 7 days\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-10-22, presumably until 2018-11-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-10-22 07:58:00, ended at 2018-10-22 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83.9 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 128 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 7.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.23 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 12.2 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 218 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Everolimus [Mass/volume] in Blood: 6.2 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 12.56 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 399 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 31 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 214 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.64 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 133 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.1 (ratio)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.59 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.3 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Systolic heart failure\n- Transplanted heart present\n- Congestive heart failure\n- Gangrenous disorder\n- Hypomagnesemia\n- Blood chemistry abnormal\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-22 10:35:07, ended at 2018-10-22 11:46:40\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gangrenous disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-23 00:00:00, ended at 2018-10-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- C reactive protein [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-23 00:00:00, ended at 2018-10-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-26 00:00:00, ended at 2018-10-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-29 00:00:00, ended at 2018-10-29 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal angioplasty\n- Angiography, extremity, unilateral, radiological supervision and interpretation\n- Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed\n- Amputation, toe; interphalangeal joint\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for diagnostic arteriography/venography\n\n### Condition\n- Atherosclerosis of artery of lower limb\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic occlusion of artery of extremity\n- Type 2 diabetes mellitus\n- Foot ulcer due to type 2 diabetes mellitus\n- Gangrene of left lower limb due to atherosclerosis\n- Peripheral angiopathy due to diabetes mellitus\n- Gangrene due to type 2 diabetes mellitus\n\n### Drug\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2018-11-02, presumably until 2018-11-02\n- cefazolin 1000 MG Injection, started on 2018-11-02, presumably until 2018-11-02\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2018-11-02, presumably until 2018-11-02\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n- ketamine 100 MG/ML Injectable Solution, started on 2018-11-02, presumably until 2018-11-02\n- 2 ML dexmedetomidine 0.1 MG/ML Injection, through Intravenous route, started on 2018-11-02, presumably until 2018-11-02\n- midazolam 1 MG/ML Injectable Solution, started on 2018-11-02, presumably until 2018-11-02\n- 2 ML alfentanil 0.5 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-02 00:00:00, ended at 2018-11-02 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Persistent pain following procedure\n\n### Drug\n- 30 ML mepivacaine hydrochloride 15 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-02 09:33:00, ended at 2018-11-03 14:20:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Blood: 124 (milligram per deciliter)\n- INR in Blood by Coagulation assay: 1.7 (ratio)\n- Hematocrit [Volume Fraction] of Blood: 29 (percent)\n- Potassium [Moles/volume] in Blood: 3.5 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 9.9 (gram per deciliter)\n- Sodium [Moles/volume] in Blood: 140 (millimole per liter)\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Selective catheter placement, arterial system; initial third order or more selective abdominal, pelvic, or lower extremity artery branch, within a vascular family\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Amputation, toe; metatarsophalangeal joint\n- Detachment at Right 1st Toe, Complete, Open Approach\n- Collection of venous blood by venipuncture\n- Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(s), unilateral; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed\n- Dilation of Right Anterior Tibial Artery, Percutaneous Approach\n- Revascularization, endovascular, open or percutaneous, tibial, peroneal artery, unilateral, initial vessel; with transluminal angioplasty\n- Dilation of Right Femoral Artery with Drug-eluting Intraluminal Device, using Drug-Coated Balloon, Percutaneous Approach\n- Angiography, extremity, unilateral, radiological supervision and interpretation\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Fluoroscopy of Right Lower Extremity Arteries\n- Intravenous infusion, hydration; initial, 31 minutes to 1 hour\n\n### Condition\n- Chronic kidney disease\n- Chronic kidney disease stage 3\n- Foot ulcer due to type 2 diabetes mellitus\n- Gangrenous disorder\n- Peripheral angiopathy due to diabetes mellitus\n- Gangrene of left lower limb due to atherosclerosis\n- Primary diagnosis: Peripheral vascular disease\n- Type 2 diabetes mellitus\n- Chronic occlusion of artery of extremity\n- Gangrene due to type 2 diabetes mellitus\n- Acute renal failure syndrome\n- Atherosclerosis of artery of lower limb\n- Dissection of artery of lower limb\n- Transplanted heart present\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease due to hypertension\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours for 5 days\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- sodium iodide, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- apixaban 2.5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-11-02, presumably until 2018-11-02\n- hydralazine hydrochloride 10 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- povidone-iodine, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- potassium iodide, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2018-11-02, presumably until 2018-11-02\n- iodine, through Topical route, started on 2018-08-12, presumably until 2019-02-14, with intended 0 refill(s). Instructions: 1 Spray by Topical route 2 times a day\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2018-11-03\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2018-11-03, presumably until 2019-04-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2018-11-02, presumably until 2018-11-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-05 00:00:00, ended at 2018-11-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-09 00:00:00, ended at 2018-11-09 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- MCH [Entitic mass] by Automated count: 24.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 7065 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 28.4 (percent)\n- MCV [Entitic volume] by Automated count: 79.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 78.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 16 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 36 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.8 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.68 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 837 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 395 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 10.3 (microgram per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 252 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 130 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Hemoglobin [Mass/volume] in Blood: 8.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 140 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 810 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 30 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per liter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.4 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-16 00:00:00, ended at 2018-11-16 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Drug-induced constipation\n\n### Drug\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2018-11-16, presumably until 2018-11-26, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2018-11-16, presumably until 2018-11-26, with intended 5 refill(s). Instructions: take 17 g by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-16 00:00:00, ended at 2018-11-16 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-19 00:00:00, ended at 2018-11-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-23 00:00:00, ended at 2018-11-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-23 00:00:00, ended at 2018-11-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-23 00:00:00, ended at 2018-11-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-26 09:57:00, ended at 2018-11-26 10:28:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 70.3 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Chronic kidney disease\n- Disorder of transplanted heart\n- Hyperlipidemia\n- Pure hypercholesterolemia\n- Essential hypertension\n- Hypomagnesemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-11-26 10:29:00, ended at 2018-11-26 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 9.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.8 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 75.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.8 (ratio)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 235 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.13 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 115 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.02 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- MCV [Entitic volume] by Automated count: 79.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 364 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- MCH [Entitic mass] by Automated count: 24.3 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 4.3 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 110 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 133 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Everolimus [Mass/volume] in Blood: 1.7 (nanogram per milliliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 179 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.67 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Hypomagnesemia\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-11-26 11:10:25, ended at 2018-11-26 12:19:19\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted heart present\n- Essential hypertension\n- Hyperlipidemia\n- Chronic kidney disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-11-27 00:00:00, ended at 2018-11-27 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Absence of toe\n- Primary diagnosis: Acquired absence of organ\n- Disorder of transplanted heart\n- Hyperlipidemia\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2018-11-27, presumably until 2019-07-05, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day 2nd prescription, please dispense!\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, started on 2018-11-27, presumably until 2019-02-14, with intended 11 refill(s). Instructions: Take 40mEq in the AM, 20mEq in the PM.\n- hydralazine hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-11-27, presumably until 2019-11-22, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- pravastatin sodium 40 MG Oral Tablet, through Oral route, presumably until 2019-07-05, with intended 11 refill(s). Instructions: take 1 Tab by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-11-28 00:00:00, ended at 2018-11-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, started on 2018-11-28, presumably until 2018-12-07, with intended 3 refill(s). Instructions: Take 1.5mg BID; Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-30 00:00:00, ended at 2018-11-30 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-03 00:00:00, ended at 2018-12-03 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-03 10:32:00, ended at 2018-12-03 10:49:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 78.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 120 (unit per liter)\n- Everolimus [Mass/volume] in Blood: 7.9 (nanogram per milliliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.23 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 373 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.7 (picogram)\n- Tacrolimus [Mass/volume] in Blood: 11.8 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 21 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.73 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.73 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 125 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.1 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.9 (percent)\n- Globulin [Mass/volume] in Serum: 4.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-12-03 10:50:00, ended at 2018-12-03 23:59:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n\n### Condition\n- Peripheral vascular disease\n- Disorder of transplanted heart\n- Transplanted heart present\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-12-03 10:50:06, ended at 2018-12-03 12:27:12\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- collagenase 0.25 UNT/MG Topical Ointment, through Topical route, started on 2018-12-03, presumably until 2019-02-14, with intended 0 refill(s). Instructions: by Topical route daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-05 00:00:00, ended at 2018-12-05 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-12-05, presumably until 2018-12-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2018-12-07 00:00:00, ended at 2018-12-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, started on 2018-12-07, presumably until 2019-01-20, with intended 11 refill(s). Instructions: Take 2mg in Am and 2 mg in PM\n- everolimus 0.5 MG Oral Tablet, started on 2018-12-07, presumably until 2019-01-20, with intended 3 refill(s). Instructions: Take 1mg BID; Cytotoxic. Take with  food. Swallow whole. do not break, chew or crush tablets.  Z94.1  DOT: 06/06/2018\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-10 00:00:00, ended at 2018-12-10 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter calculated)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.3 (femtoliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 783 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 6.2 (microgram per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 249 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.63 (million per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.5 (percent)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 9 (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 6 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 27.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 8.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.16 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- MCH [Entitic mass] by Automated count: 24.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3602 (cells per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 119 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.5 (percent)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1114 (cells per microliter)\n- Basophils [#/volume] in Blood by Automated count: 52 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 370 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-14 00:00:00, ended at 2018-12-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2018-12-14, presumably until 2019-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-14 00:00:00, ended at 2018-12-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 163 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4744 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 9 (calculated)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.1 (picogram)\n- MCV [Entitic volume] by Automated count: 76.9 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.0 (femtoliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 3.9 (microgram per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Everolimus [Mass/volume] in Blood: 4.0 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 998 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 355 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.71 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- MCHC [Mass/volume] by Automated count: 30.1 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 650 (cells per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 268 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter calculated)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.8 (percent)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 112 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-19 00:00:00, ended at 2018-12-19 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-21 00:00:00, ended at 2018-12-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-24 00:00:00, ended at 2018-12-24 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-25 00:00:00, ended at 2018-12-25 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-28 00:00:00, ended at 2018-12-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-04 00:00:00, ended at 2019-01-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-07 00:00:00, ended at 2019-01-07 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.4 (percent)\n- MCH [Entitic mass] by Automated count: 22.6 (picogram)\n- MCV [Entitic volume] by Automated count: 77.1 (femtoliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 13.0 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 328 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- MCHC [Mass/volume] by Automated count: 29.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 76.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 865 (cells per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 1.2 (microgram per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 59 (cells per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.70 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 370 (cells per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 714 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 16 (calculated)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.1 (calculated)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per liter)\n- Platelets [#/volume] in Blood by Automated count: 319 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6392 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-11 00:00:00, ended at 2019-01-11 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2019-01-12 23:47:00, ended at 2019-01-20 14:28:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 34.10 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Tacrolimus [Mass/volume] in Blood: 8.4 (nanogram per milliliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 3.731 (nanogram per milliliter)\n- Albumin [Mass/volume] in Urine: 203 (milligram per liter)\n- Body height: 5' 5\" (inch (US))\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.13 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma: >70000 (picogram per milliliter)\n- Platelets [#/volume] in Blood by Automated count: 273 (thousand per microliter)\n- Prothrombin time (PT): 14.3 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 95.8 (second)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.67 (million per microliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 10.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Microalbumin/Creatinine [Mass Ratio] in Urine: 595 (milligram per gram)\n- Sodium/Creatinine [Molar ratio] in Urine: <20 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Anion gap in Serum or Plasma: 21 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 375 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 23.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.9 (percent)\n- Salicylates [Presence] in Urine: <0.3 (milligram per deciliter)\n- Base excess in Arterial blood by calculation: -8.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.20 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.9 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 60 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Everolimus [Mass/volume] in Blood: 9.3 (nanogram per milliliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCV [Entitic volume] by Automated count: 76.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.93 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 3.88 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.0 (percent)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.75 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Bicarbonate [Moles/volume] in Specimen: 18.6 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Left ventricular Ejection fraction: 41.4 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Ultrasound, retroperitoneal (eg, renal, aorta, nodes), real time with image documentation; complete\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Critical care, evaluation and management of the critically ill or critically injured patient; each additional 30 minutes (List separately in addition to code for primary service)\n- Radiologic examination, chest; single view\n- Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right heart catheterization\n- Hospital discharge day management; 30 minutes or less\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Fluoroscopy of Multiple Coronary Arteries using Low Osmolar Contrast\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Medical decision making that is straightforward or o\n- Endomyocardial biopsy\n\n### Condition\n- Cardiac transplant failure\n- Chronic kidney disease stage 3\n- Open wound of foot\n- Renal disorder due to type 2 diabetes mellitus\n- Sepsis\n- Acute on chronic combined systolic and diastolic heart failure\n- Acute tubular necrosis\n- Anemia in chronic kidney disease\n- Electrocardiogram abnormal\n- Hyperglycemia due to type 2 diabetes mellitus\n- Obesity\n- Peripheral vascular disease\n- Severe protein-calorie malnutrition (Gomez: less than 60 percent of standard weight)\n- Tachycardia\n- Transplanted heart present\n- Acidosis\n- Acute non-ST segment elevation myocardial infarction\n- Acute renal failure syndrome\n- Cardiogenic shock\n- Coronary thrombosis not resulting in myocardial infarction\n- Chronic pulmonary edema\n- Hyperkalemia\n- Localized edema\n- Pulmonary hypertension\n- Viral pneumonia\n- Atherosclerosis of coronary artery without angina pectoris\n- Blood coagulation disorder\n- Cardiomegaly\n- Chronic kidney disease stage 4\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Acquired absence of organ\n- Acute ischemic heart disease\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Disorder of immune function\n- Heart disease\n- Old myocardial infarction\n- Atrial fibrillation\n- Cardiac transplant rejection\n- Primary diagnosis: Chronic ischemic heart disease\n- Disorder of transplanted heart\n- Hypokalemia\n- Late effect of complications of procedure\n- Septic shock\n- Absence of toe\n- Acute on chronic hypoxemic respiratory failure\n- Congestive heart failure\n- Hypo-osmolality and or hyponatremia\n- Pneumonia and influenza\n- Takotsubo cardiomyopathy\n- Type 2 diabetes mellitus\n- Upper respiratory tract infection due to Influenza\n- Backache\n- Dehydration\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-01-20\n- sodium bicarbonate 650 MG Oral Tablet, through Oral route, started on 2019-01-15, presumably until 2019-01-19\n- chlorothiazide 500 MG Oral Tablet, through Oral route, started on 2019-01-14, presumably until 2019-01-15\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2019-01-15, presumably until 2019-03-06, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 30 days\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Cartridge, started on 2019-01-17, presumably until 2019-01-18\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2019-01-17, presumably until 2019-01-17\n- methylprednisolone 40 MG Injection, started on 2019-01-13, presumably until 2019-01-15\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-20\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2019-01-13, presumably until 2019-01-14\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-01-13, presumably until 2019-01-15\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- prednisone 10 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-14\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-01-20\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-01-17, presumably until 2019-01-20\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2019-01-14, presumably until 2019-01-20\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2019-01-13, presumably until 2019-01-19\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2019-01-13, presumably until 2019-01-13\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2019-01-15, presumably until 2019-01-16\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-02-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2019-01-13, presumably until 2019-01-13\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2019-01-18, presumably until 2020-01-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2019-01-14, presumably until 2019-01-15\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-01-18, presumably until 2019-02-15, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2019-01-13, presumably until 2019-01-19\n- everolimus 0.75 MG Oral Tablet, through Oral route, started on 2019-01-20, presumably until 2019-02-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day Cytotoxic. Take with or without food. Swallow whole. do not break, chew or crush tablets.\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2019-01-13, presumably until 2019-01-13\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- oseltamivir 6 MG/ML Oral Suspension, through Oral route, started on 2019-01-13, presumably until 2019-01-16\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2019-01-13, presumably until 2019-01-13\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-20\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- bumetanide 0.25 MG/ML Injectable Solution, through Intravenous route, started on 2019-01-13, presumably until 2019-01-19\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-19\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2019-01-13, presumably until 2019-01-20\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2019-01-16, presumably until 2019-01-16\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2019-01-13, presumably until 2019-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-01-13 00:00:00, ended at 2019-01-13 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-01-13, presumably until 2019-01-13\n- iodixanol, through Intravenous route, started on 2019-01-13, presumably until 2019-01-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-14 00:00:00, ended at 2019-01-14 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-18 00:00:00, ended at 2019-01-18 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-21 00:00:00, ended at 2019-01-21 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-23 00:00:00, ended at 2019-01-23 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-01-23, presumably until 2019-02-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Cytotoxic. Take with or without food. Swallow whole. do not break, chew or crush tablets.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-25 00:00:00, ended at 2019-01-25 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-02-01 00:00:00, ended at 2019-02-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2019-02-01, presumably until 2019-02-19, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-01 00:00:00, ended at 2019-02-01 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-08 00:00:00, ended at 2019-02-08 00:00:00\nThe patient in this visit was 55 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-13 00:00:00, ended at 2019-02-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-02-14 08:38:00, ended at 2019-02-14 10:14:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.1 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 23.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 5.44 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 312 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.42 (milligram per deciliter)\n- Everolimus [Mass/volume] in Blood: 2.6 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 13.4 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 79.2 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.6 (percent)\n- Globulin [Mass/volume] in Serum: 4.1 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 29.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 72.9 (percent)\n- Tacrolimus [Mass/volume] in Blood: 1.7 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Essential hypertension\n- Disorder of transplanted heart\n- Transplanted heart present\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-02-14 09:01:55, ended at 2019-02-14 10:07:14\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-02-14 10:15:00, ended at 2019-02-14 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 68.0 (percent)\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-15 00:00:00, ended at 2019-02-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2019-02-15, presumably until 2019-10-04, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day Total dose of 1mg Am, 1.5mg PM\n- tacrolimus 0.5 MG Oral Capsule, through Oral route, started on 2019-02-15, presumably until 2019-10-04, with intended 1 refill(s). Instructions: take 1 Cap by mouth PM Total dose of 1mg AM, 1.5mg PM; Z94.1, Fax: 999-999-9999\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-18 00:00:00, ended at 2019-02-18 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-02-19 00:00:00, ended at 2019-02-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-02-19, presumably until 2019-05-01, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day Take 0.5 mg in AM and 1 mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-19 00:00:00, ended at 2019-02-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- prednisone 2.5 MG Oral Tablet, through Oral route, started on 2019-02-19, presumably until 2019-04-03, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-22 00:00:00, ended at 2019-02-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-25 00:00:00, ended at 2019-02-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-01 00:00:00, ended at 2019-03-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-04 00:00:00, ended at 2019-03-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- MCV [Entitic volume] by Automated count: 76.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 200 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.4 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 842 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4802 (cells per microliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 3.4 (microgram per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 24 (calculated)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter calculated)\n- Lymphocytes [#/volume] in Blood by Automated count: 987 (cells per microliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.0 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.05 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 69 (cells per microliter)\n- MCHC [Mass/volume] by Automated count: 31.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 82 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.86 (million per liter)\n- MCH [Entitic mass] by Automated count: 23.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 301 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-06 00:00:00, ended at 2019-03-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acyclovir 200 MG Oral Capsule, through Oral route, started on 2019-03-06, presumably until 2019-07-05, with intended 6 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-08 00:00:00, ended at 2019-03-08 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-11 00:00:00, ended at 2019-03-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-15 00:00:00, ended at 2019-03-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-18 00:00:00, ended at 2019-03-18 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-22 00:00:00, ended at 2019-03-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-29 00:00:00, ended at 2019-03-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-01 00:00:00, ended at 2019-04-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- prednisone 2.5 MG Oral Tablet, through Oral route, started on 2019-04-03, presumably until 2019-10-03, with intended 6 refill(s). Instructions: take 1 Tab (2.5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-03 00:00:00, ended at 2019-04-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-04 00:00:00, ended at 2019-04-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperglycemia due to type 2 diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-05 00:00:00, ended at 2019-04-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-08 00:00:00, ended at 2019-04-08 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-12 00:00:00, ended at 2019-04-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-15 00:00:00, ended at 2019-04-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-19 00:00:00, ended at 2019-04-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-22 00:00:00, ended at 2019-04-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-26 00:00:00, ended at 2019-04-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-04-29 00:00:00, ended at 2019-04-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-04-29 09:45:00, ended at 2019-04-29 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 29.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.89 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 330 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.2 (percent)\n- MCV [Entitic volume] by Automated count: 82.0 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.8 (percent)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.7 (percent)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.1 (thousand per microliter)\n- Tacrolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.4 (percent)\n- Everolimus [Mass/volume] in Blood: 1.8 (nanogram per milliliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.11 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 24.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.01 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n- Essential hypertension\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic kidney disease\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-30 00:00:00, ended at 2019-04-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-05-01 00:00:00, ended at 2019-05-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2019-05-01, presumably until 2019-07-09, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-03 00:00:00, ended at 2019-05-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-06 00:00:00, ended at 2019-05-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.5 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.2 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 951 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 77.4 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Tacrolimus [Mass/volume] in Blood by LC/MS/MS: 3.0 (microgram per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 161 (cells per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4904 (cells per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter calculated)\n- Potassium [Moles/volume] in Serum or Plasma: 5.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 22 (calculated)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 27 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.45 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 73.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 40 (cells per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 643 (cells per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 299 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-10 00:00:00, ended at 2019-05-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-13 00:00:00, ended at 2019-05-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-17 00:00:00, ended at 2019-05-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-20 00:00:00, ended at 2019-05-20 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-24 00:00:00, ended at 2019-05-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-27 00:00:00, ended at 2019-05-27 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-05-31 00:00:00, ended at 2019-05-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-05-31 09:30:00, ended at 2019-05-31 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Gangrenous disorder\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-31 09:30:15, ended at 2019-05-31 11:29:56\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gangrenous disorder\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-03 00:00:00, ended at 2019-06-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-07 00:00:00, ended at 2019-06-07 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-10 00:00:00, ended at 2019-06-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-14 00:00:00, ended at 2019-06-14 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-17 00:00:00, ended at 2019-06-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-21 00:00:00, ended at 2019-06-21 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-24 00:00:00, ended at 2019-06-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-06-28 00:00:00, ended at 2019-06-28 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-01 00:00:00, ended at 2019-07-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-03 00:00:00, ended at 2019-07-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fatigue\n- Pure hypercholesterolemia\n- Type 1 diabetes mellitus without complication\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-03 00:00:00, ended at 2019-07-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-03 00:00:00, ended at 2019-07-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-04 00:00:00, ended at 2019-07-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Iron saturation [Mass Fraction] in Serum or Plasma: 9 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Iron deficiency anemia\n\n### Drug\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, presumably until 2019-07-12, with intended 11 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-04 07:37:00, ended at 2019-07-04 09:47:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.0 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.10 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hemoglobin [Mass/volume] in Blood: 10.2 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 2.8 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 98 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.17 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Everolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 20.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 242 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 0.89 (milligram per milligram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 259 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- MCH [Entitic mass] by Automated count: 24.2 (picogram)\n- MCV [Entitic volume] by Automated count: 78.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.16 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 202 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 100 (unit per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 9.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 116 (unit per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.1 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 171 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.6 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 49.0 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 65 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 194 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 55.28 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n\n### Condition\n- Pure hypercholesterolemia\n- Fatigue\n- Disorder of transplanted heart\n- Transplanted heart present\n- Type 1 diabetes mellitus without complication\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-07-04 08:10:26, ended at 2019-07-04 09:43:16\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n\n### Condition\n- Acute ST segment elevation myocardial infarction\n- Disorder of transplanted heart\n- Transplanted heart present\n- Conduction disorder of the heart\n- Electrocardiogram abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-04 09:48:00, ended at 2019-07-04 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 67.2 (percent)\n\n### Procedure\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; supervision only, without interpretation and report\n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; tracing only, without interpretation and report\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation \n- Cardiovascular stress test using maximal or submaximal treadmill or bicycle exercise, continuous electrocardiographic monitoring, and/or pharmacological stress; interpretation and report only\n\n### Condition\n- Cardiomegaly\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Disorder of transplanted heart\n- Type 1 diabetes mellitus without complication\n- Iron deficiency anemia\n- Fatigue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-05 00:00:00, ended at 2019-07-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-05 00:00:00, ended at 2019-07-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- bumetanide 2 MG Oral Tablet, through Oral route, started on 2019-07-05, presumably until 2019-10-04, with intended 3 refill(s). Instructions: take 1 Tab (2 mg total) by mouth daily 2nd prescription, please dispense!\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2019-07-05, presumably until 2020-07-30, with intended 3 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-08 00:00:00, ended at 2019-07-08 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-09 00:00:00, ended at 2019-07-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-07-09, presumably until 2019-10-22, with intended 11 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth 2 times a day Take 1 mg in AM and 1.5mg in PM.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-09 00:00:00, ended at 2019-07-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2019-07-09, presumably until 2019-12-23, with intended 11 refill(s). Instructions: take 2 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n\n### Drug\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2019-07-12, presumably until 2020-08-21, with intended 11 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-12 00:00:00, ended at 2019-07-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-15 00:00:00, ended at 2019-07-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-19 00:00:00, ended at 2019-07-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-22 00:00:00, ended at 2019-07-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-26 00:00:00, ended at 2019-07-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-29 00:00:00, ended at 2019-07-29 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-07-31 00:00:00, ended at 2019-07-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Endomyocardial biopsy\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-07-31, presumably until 2019-07-31\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-07-31 00:00:00, ended at 2019-07-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-31 11:18:00, ended at 2019-07-31 12:26:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 253 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 4.4 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.2 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.84 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.24 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Everolimus [Mass/volume] in Blood: 5.6 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 24.6 (picogram)\n- MCV [Entitic volume] by Automated count: 79.9 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.88 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 213 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 104 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 39 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.48 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.8 (percent)\n\n### Procedure\n- Endomyocardial biopsy\n- Excision of Right Ventricle, Percutaneous Approach, Diagnostic\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n- Cardiac transplant rejection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-01 00:00:00, ended at 2019-08-01 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2019-08-01, presumably until 2020-09-04, with intended 11 refill(s). Instructions: take 1 Cap (250 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-02 00:00:00, ended at 2019-08-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-05 00:00:00, ended at 2019-08-05 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-09 00:00:00, ended at 2019-08-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-12 00:00:00, ended at 2019-08-12 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-16 00:00:00, ended at 2019-08-16 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-19 00:00:00, ended at 2019-08-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-23 00:00:00, ended at 2019-08-23 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-26 00:00:00, ended at 2019-08-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-08-30 00:00:00, ended at 2019-08-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-02 00:00:00, ended at 2019-09-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-06 00:00:00, ended at 2019-09-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-09 00:00:00, ended at 2019-09-09 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Disorder of fluid AND/OR electrolyte\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-11 00:00:00, ended at 2019-09-11 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-13 00:00:00, ended at 2019-09-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-13 00:00:00, ended at 2019-09-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-09-16 00:00:00, ended at 2019-09-16 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of fluid AND/OR electrolyte\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-02 00:00:00, ended at 2019-10-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-03 00:00:00, ended at 2019-10-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2019-10-03, presumably until 2020-10-16, with intended 11 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-03 00:00:00, ended at 2019-10-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-03 09:51:00, ended at 2019-10-03 10:28:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 63.7 (percent)\n\n### Procedure\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, follow-up or limited study\n\n### Condition\n- Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-03 10:29:00, ended at 2019-10-03 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.80 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.46 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.82 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- Tacrolimus [Mass/volume] in Blood: 1.0 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Anion gap in Serum or Plasma: 14 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 30.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.19 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 81.3 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.9 (percent)\n- MCH [Entitic mass] by Automated count: 25.0 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-10-03 11:26:41, ended at 2019-10-03 12:14:25\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- clonidine hydrochloride 0.1 MG Oral Tablet, through Oral route, presumably until 2020-10-20, with intended 11 refill(s). Instructions: take 0.1-0.2 mg by mouth as directed Take 0.1mg QAM and 0.2mg QPM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2019-10-04, presumably until 2019-11-26, with intended 3 refill(s). Instructions: take 1 Tab (1 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2019-10-15 00:00:00, ended at 2019-10-15 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2019-10-15, presumably until 2019-10-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-10-15 09:46:00, ended at 2019-10-15 12:19:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 85 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 158 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.49 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.4 (percent)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 79.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.65 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- MCH [Entitic mass] by Automated count: 25.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.5 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.33 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 264 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Endomyocardial biopsy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n\n### Condition\n- Acquired absence of organ\n- Absence of toe\n- Chronic kidney disease due to hypertension\n- Chronic kidney disease due to type 2 diabetes mellitus\n- Chronic kidney disease\n- Disorder of transplanted heart\n- Hyperlipidemia\n- Type 2 diabetes mellitus\n- Transplanted heart present\n- Cardiac transplant rejection\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-16 00:00:00, ended at 2019-10-16 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Everolimus [Mass/volume] in Blood: 9.4 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-10-19 00:00:00, ended at 2019-10-19 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-22 00:00:00, ended at 2019-10-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2019-10-22, presumably until 2020-04-24, with intended 11 refill(s). Instructions: take 1 mg by mouth 2 times a day \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-21 00:00:00, ended at 2019-11-21 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2022-06-10, with intended 11 refill(s). Instructions: INJECT 17 UNITS SUB-CUTANEOUSLY( UNDER THE SKIN) THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-22 00:00:00, ended at 2019-11-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- hydralazine hydrochloride 100 MG Oral Tablet, through Oral route, started on 2019-11-22, presumably until 2021-06-04, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-11-22 00:00:00, ended at 2019-11-22 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication due to diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n- 3 ML insulin lispro 100 UNT/ML Pen Injector, started on 2019-11-22, presumably until 2019-11-22, with intended 11 refill(s). Instructions: INJECT 17 UNITS UNDER THE SKIN(UNDER THE SKIN) THREE TIMES DAILY WITH MEALS\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-26 00:00:00, ended at 2019-11-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, presumably until 2019-12-23, with intended 2 refill(s). Instructions: take 1 Tab (30 mg total) by mouth as directed\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2019-11-26, presumably until 2020-09-10, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-11-27 00:00:00, ended at 2019-11-27 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Complication due to diabetes mellitus\n\n### Drug\n- 3 ML insulin isophane, human 100 UNT/ML Pen Injector, started on 2019-11-27, presumably until 2021-02-02, with intended 6 refill(s). Instructions: Inject subcutaneously 22 units AM, 22 units PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-04 00:00:00, ended at 2019-12-04 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-12-07 00:00:00, ended at 2019-12-07 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-10 00:00:00, ended at 2019-12-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Type 2 diabetes mellitus\n- Primary diagnosis: Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-20 00:00:00, ended at 2019-12-20 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-12-23 09:55:00, ended at 2019-12-23 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.99 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.8 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 17 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 25.3 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 3.69 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 30.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 209 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.67 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- MCV [Entitic volume] by Automated count: 83.5 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.1 (gram per deciliter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Pure hypercholesterolemia\n- Disorder of transplanted heart\n- Hyperlipidemia\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-23 10:19:13, ended at 2019-12-23 11:39:05\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n- Everolimus [Mass/volume] in Blood: 1.4 (nanogram per milliliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n- Pure hypercholesterolemia\n- Transplanted heart present\n\n### Drug\n- 24 HR isosorbide mononitrate 30 MG Extended Release Oral Tablet, through Oral route, started on 2019-12-23, presumably until 2020-12-10, with intended 3 refill(s). Instructions: take 1 Tab (30 mg total) by mouth every morning\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-24 00:00:00, ended at 2019-12-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.4 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 45 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method: 3.0 (milligram per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 827 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.2 (calculated)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3631 (cells per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 233 (cells per microliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 12.3 (micromole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.6 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 13.5 (femtoliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- MCH [Entitic mass] by Automated count: 25.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 42 (cells per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 77 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter calculated)\n- Monocytes [#/volume] in Blood by Automated count: 567 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 27 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 86 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 1.5 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 81.7 (femtoliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 159 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.1 (ratio)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 221.8 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperlipidemia\n- Hypomagnesemia\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2019-12-24, presumably until 2020-10-06, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-12-26 00:00:00, ended at 2019-12-26 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of transplanted heart\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-12-30 00:00:00, ended at 2019-12-30 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperosmolarity\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-03 00:00:00, ended at 2020-01-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-06 00:00:00, ended at 2020-01-06 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 08:12:00, ended at 2020-01-10 09:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n- Disorder of soft tissue\n- Localized edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-10 08:12:54, ended at 2020-01-10 14:56:11\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n- Disorder of soft tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 10:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Localized edema\n- Disorder of soft tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-13 00:00:00, ended at 2020-01-13 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-20 00:00:00, ended at 2020-01-20 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-24 00:00:00, ended at 2020-01-24 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-27 00:00:00, ended at 2020-01-27 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-31 00:00:00, ended at 2020-01-31 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-03 00:00:00, ended at 2020-02-03 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-07 00:00:00, ended at 2020-02-07 00:00:00\nThe patient in this visit was 56 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-10 00:00:00, ended at 2020-02-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-14 00:00:00, ended at 2020-02-14 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-17 00:00:00, ended at 2020-02-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-21 00:00:00, ended at 2020-02-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-24 00:00:00, ended at 2020-02-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-02-28 00:00:00, ended at 2020-02-28 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-02 00:00:00, ended at 2020-03-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-06 00:00:00, ended at 2020-03-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-09 00:00:00, ended at 2020-03-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-13 00:00:00, ended at 2020-03-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-16 00:00:00, ended at 2020-03-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-20 00:00:00, ended at 2020-03-20 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-23 00:00:00, ended at 2020-03-23 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-27 00:00:00, ended at 2020-03-27 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-30 00:00:00, ended at 2020-03-30 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-30 00:00:00, ended at 2020-03-30 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperosmolarity\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-03 00:00:00, ended at 2020-04-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-06 00:00:00, ended at 2020-04-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-10 00:00:00, ended at 2020-04-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-13 00:00:00, ended at 2020-04-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 214 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 44 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3202 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 26 (calculated)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 49 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per liter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 25.1 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.3 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.1 (percent)\n- MCV [Entitic volume] by Automated count: 79.2 (femtoliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.69 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 259 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.8 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 751 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1139 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 13.0 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-15 14:40:50, ended at 2020-04-15 15:07:23\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperosmolarity\n- Primary diagnosis: Type 2 diabetes mellitus\n\n### Drug\n- 0.5 ML dulaglutide 1.5 MG/ML Auto-Injector, through Subcutaneous route, started on 2020-04-15, presumably until 2020-11-03, with intended 11 refill(s). Instructions: inject 0.75 mg subcutaneous (under the skin) once a week\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-17 00:00:00, ended at 2020-04-17 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-20 00:00:00, ended at 2020-04-20 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-21 00:00:00, ended at 2020-04-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.6 (percent)\n- Everolimus [Mass/volume] in Blood: 1.9 (nanogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 10.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.3 (picogram)\n- MCV [Entitic volume] by Automated count: 79.8 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3819 (cells per microliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 239 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 202 (cells per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 34 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.15 (million per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 16.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 610 (cells per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 19 (calculated)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.75 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 28 (cells per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 941 (cells per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2020-04-24, presumably until 2020-07-16, with intended 11 refill(s). Instructions: take 3 Tabs (1.5 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-24 00:00:00, ended at 2020-04-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-27 00:00:00, ended at 2020-04-27 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-01 00:00:00, ended at 2020-05-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-04 00:00:00, ended at 2020-05-04 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-05-06 00:00:00, ended at 2020-05-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperglycemia due to type 2 diabetes mellitus\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-06 00:00:00, ended at 2020-05-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-05-06 00:00:00, ended at 2020-05-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus\n- Hyperglycemia due to type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-08 00:00:00, ended at 2020-05-08 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-11 00:00:00, ended at 2020-05-11 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-15 00:00:00, ended at 2020-05-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-18 00:00:00, ended at 2020-05-18 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-22 00:00:00, ended at 2020-05-22 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-25 00:00:00, ended at 2020-05-25 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-05-29 00:00:00, ended at 2020-05-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-01 00:00:00, ended at 2020-06-01 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-05 00:00:00, ended at 2020-06-05 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-08 00:00:00, ended at 2020-06-08 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-12 00:00:00, ended at 2020-06-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Hypomagnesemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-06-15 00:00:00, ended at 2020-06-15 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-16 00:00:00, ended at 2020-07-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 0.5 MG Oral Tablet, through Oral route, started on 2020-07-16, presumably until 2021-04-27, with intended 11 refill(s). Instructions: take 1 Tab (0.5 mg total) by mouth 2 times a day Total dose of 1.5mg twice daily\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2020-07-16, presumably until 2020-07-29, with intended 11 refill(s). Instructions: take 1 Tab (1 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-07-23 10:45:04, ended at 2020-07-23 11:09:56\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose mean value [Mass/volume] in Blood Estimated from glycated hemoglobin: 183 (milligram per deciliter calculated)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.3 (percent hemoglobin)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Complication due to diabetes mellitus\n- Primary diagnosis: Type 2 diabetes mellitus\n- Postprocedural asymptomatic ovarian failure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-24 00:00:00, ended at 2020-07-24 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 109 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1056 (cells per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 622 (cells per microliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 16 (calculated)\n- Neutrophils [#/volume] in Blood by Automated count: 3625 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per liter)\n- MCH [Entitic mass] by Automated count: 26.2 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.2 (percent)\n- MCV [Entitic volume] by Automated count: 80.4 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 39 (cells per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 160 (cells per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.34 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.3 (percent)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.3 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Everolimus [Mass/volume] in Blood: 2.7 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, started on 2020-07-30, presumably until 2022-06-09, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-07-29 00:00:00, ended at 2020-07-29 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- everolimus 1 MG Oral Tablet, through Oral route, started on 2020-07-29, presumably until 2021-04-29, with intended 11 refill(s). Instructions: take 1-2 Tabs (1-2 mg total) by mouth 2 times a day Take 1.5 mg in AM and 2 mg in PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-13 00:00:00, ended at 2020-08-13 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.44 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 181 (cells per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.8 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.12 (million per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 36 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 69 (cells per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 902 (cells per microliter)\n- MCV [Entitic volume] by Automated count: 79.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3136 (cells per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 613 (cells per microliter)\n- Platelets [#/volume] in Blood by Automated count: 205 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: 25 (calculated)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Everolimus [Mass/volume] in Blood: 3.2 (nanogram per milliliter)\n- MCH [Entitic mass] by Automated count: 26.2 (picogram)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 12.5 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-08-21 00:00:00, ended at 2020-08-21 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n- Pure hypercholesterolemia\n\n### Drug\n- rosuvastatin calcium 20 MG Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-02-02, with intended 3 refill(s). Instructions: take 1 Tab (20 mg total) by mouth daily\n- calcium carbonate 1250 MG / cholecalciferol 200 UNT Oral Tablet, through Oral route, started on 2020-08-21, presumably until 2021-09-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-09-03 00:00:00, ended at 2020-09-03 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, started on 2020-09-04, presumably until 2021-05-03, with intended 11 refill(s). Instructions: TAKE 1 CAPSULE(250 MG) BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-09 00:00:00, ended at 2020-09-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-10 00:00:00, ended at 2020-09-10 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- bumetanide 1 MG Oral Tablet, through Oral route, started on 2020-09-10, presumably until 2021-02-26, with intended 3 refill(s). Instructions: take 2 Tabs (2 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-09-11 12:09:00, ended at 2020-09-11 23:59:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of lower extremity arteries or arterial bypass grafts; unilateral or limited study\n- Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording \n\n### Condition\n- Peripheral vascular disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-25 00:00:00, ended at 2020-09-25 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-02 00:00:00, ended at 2020-10-02 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-05 00:00:00, ended at 2020-10-05 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-06 00:00:00, ended at 2020-10-06 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Primary diagnosis: Transplanted heart present\n\n### Drug\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2020-10-06, presumably until 2021-02-26, with intended 3 refill(s). Instructions: take 1 Tab (5 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-07 00:00:00, ended at 2020-10-07 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperosmolarity\n- Type 2 diabetes mellitus\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-09 00:00:00, ended at 2020-10-09 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-12 00:00:00, ended at 2020-10-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-10-12 00:00:00, ended at 2020-10-12 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, started on 2020-10-16, presumably until 2020-10-16, with intended 11 refill(s). Instructions: TAKE 2 TABLETS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-16 00:00:00, ended at 2020-10-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Blood glucose abnormal\n- Pure hypercholesterolemia\n- Transplanted heart present\n- Disorder of transplanted heart\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-16 00:00:00, ended at 2020-10-16 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- mycophenolate mofetil 500 MG Oral Tablet, through Oral route, started on 2020-10-16, presumably until 2021-11-18, with intended 11 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-19 00:00:00, ended at 2020-10-19 00:00:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-10-19 06:12:00, ended at 2020-10-19 06:50:00\nThe patient in this visit was 57 years old, unknown race, Hispanic or Latino, FEMALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 187 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 25.8 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.16 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Creatinine [Mass/volume] in Urine: 26.48 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.57 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol non HDL [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 15.0 (percent)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Protein [Mass/volume] in Urine collected for unspecified duration: 78.0 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.6 (percent)\n- Everolimus [Mass/volume] in Blood: 7.6 (nanogram per milliliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 7.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.7 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 220 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 236 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.49 (micro-international unit per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 169 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.8 (percent)\n- Anion gap in Serum or Plasma: 15 (millimole per liter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.2 (ratio)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Protein/Creatinine [Mass Ratio] in Urine: 2.95 (milligram per milligram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 30 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Pretreatment of serum for use in RBC antibody identification; incubation with inhibitors, each\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of transplanted heart\n- Transplanted heart present\n- Pure hypercholesterolemia\n- Blood glucose abnormal\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 169.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "30be3cd1b9f4d79a94c375ee0ac5bb3444d1da4d0e34544ad810a4d45f02d3a7", "prompt_hash": "678ad70ddbc0e711b7332e3eb028b0e05796812d00df6dd72d731ae1a68b8719", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 8, "doc": {"person_id": 115968228, "visit_occurrence_id": 148541641, "visit_start_datetime": "2019-11-09 00:00:00", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 146.0, "current_label": 0, "next_value": 128.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-11 00:00:00, ended at 2013-01-11 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-01-27 20:42:00, ended at 2013-02-05 17:30:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 178 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 109.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 18.0 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 7 (nanogram per milliliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 37.8 (picogram)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 69 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.9 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 11.7 (microgram per milliliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 200 (cells)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.09 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 410 (nanogram per milliliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 294 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 825 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.91 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 39 (percent)\n\n### Procedure\n- Phlebography of the portal venous system using contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract formation/dilatation, stent placement and all associated imag\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Intra-abdominal venous shunt\n- Computed tomography, abdomen; with contrast material(s)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Acquired absence of organ\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Esophageal varices associated with another disorder\n- Leukocytosis\n- Thrombocytopenic disorder\n- Viral hepatitis B without hepatic coma\n- Hypervolemia\n- Hypo-osmolality and or hyponatremia\n- Interstitial emphysema of lung\n- Coag./bleeding tests abnormal\n- Pleural effusion\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Non-infectious disorder of lymphatics\n- Swelling of limb\n- Deficiency anemias\n- Lung field abnormal\n- Pneumothorax\n- Splenomegaly\n- Viral hepatitis C\n- Ascites\n- Portal hypertension\n- Sequela of chronic liver disease\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-01-30, presumably until 2013-02-03\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2013-01-29, presumably until 2013-01-31\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-01\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-08. Instructions: take 40 mg by mouth daily.  \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2014-02-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-02-02, presumably until 2013-02-02\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-04\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2013-02-05\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-06-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-02-01, presumably until 2013-02-05\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-12. Instructions: take 40 mg by mouth daily.  \n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-05\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-01-30, presumably until 2013-01-31\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-02-01, presumably until 2013-02-01\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 3 Tabs by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-01-27, presumably until 2013-06-20. Instructions: take 0.4 mg by mouth Every Day.  \n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-08-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2013-01-29, presumably until 2013-01-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-01-27, presumably until 2013-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-02-03 00:00:00, ended at 2013-02-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); intrahepatic or portal circulation (eg, transvenous intrahepatic portosystemic shunt[s] [TIPS])\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Pneumothorax\n- Pleural effusion\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-02-03, presumably until 2013-02-03\n- 500 ML sodium chloride 30 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-02-03, presumably until 2013-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-03-31, presumably until 2013-07-08, with intended 11 refill(s). Instructions: take 15 mL by mouth 2 times a day. Titrate to achieve BM 3-4x/daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:17:00, ended at 2013-04-01 10:22:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:23:00, ended at 2013-04-01 23:59:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 19 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 185 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 115 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- Neutrophils [#/volume] in Blood by Manual count: 5.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 76 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 212 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 43 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 269 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 789 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Prothrombin time (PT): 17.5 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 110.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-06-20 17:47:00, ended at 2013-07-08 15:35:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 774 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 69 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 152 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 278 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Osmolality of Serum or Plasma: 261 (milliosmole per kilogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 15.5 (microgram per milliliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 134 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 397 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.66 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 64.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.3 (millimole per liter)\n- Prothrombin time (PT): N/A (second)\n- Thrombin time: 18.9 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.0 (second)\n- Body height: 5' 10\" (inch (US))\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 154 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 116 (percent)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 82 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 113.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.76 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 175.3 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.87 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Left ventricular Ejection fraction: 62 (percent)\n- MCH [Entitic mass] by Automated count: 39.2 (picogram)\n- Osmolality of Urine: 319 (milliosmole per kilogram)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Angioplasty of other non-coronary vessel(s)\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Thoracentesis\n- Revision of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract recannulization/dilatation, stent placement and all associated\n- Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Procedure on single vessel\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n\n### Condition\n- Allergic reaction caused by insect bite and/or insect sting\n- Esophageal varices\n- Anemia\n- Gastroesophageal reflux disease\n- Viral hepatitis C\n- Acquired absence of organ\n- Candidiasis of urogenital site\n- Cirrhosis - non-alcoholic\n- Depressive disorder\n- Hyperkalemia\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Primary bacterial peritonitis\n- Altered mental status\n- Hepatic coma due to viral hepatitis C\n- Lung field abnormal\n- Sequela of chronic liver disease\n- Ascites\n- Atelectasis\n- Cramp in limb\n- Pleural effusion\n- Portal hypertension\n- Cardiomegaly\n- Chronic lymphoid leukemia in remission\n- Chronic lymphoid leukemia, disease\n- Edema\n- Hyperosmolality and or hypernatremia\n- Incontinence of feces\n- Splenomegaly\n- Premature beats\n\n### Drug\n- nadolol 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-06-23\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-07-07\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-06-29, presumably until 2013-07-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-23\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-07-08, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-06-24, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-06-23, presumably until 2013-07-03\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-06-20\n- amphotericin B 50 MG Injection, started on 2013-07-04, presumably until 2013-07-08\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-07-08\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-07-03, presumably until 2013-07-03\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-09-01. Instructions: take 2,000 mg by mouth daily.\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-29, presumably until 2013-07-08\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-06-21, presumably until 2013-06-23\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2013-06-29, presumably until 2013-07-01\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-07-01\n- cholecalciferol 0.05 MG Oral Capsule, through Oral route, presumably until 2013-09-01. Instructions: take 1 Cap by mouth Every Day.\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2013-06-26, presumably until 2013-06-26\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-20\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-06-21, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 30 mL by mouth every 6 hours.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-06-28, presumably until 2013-06-30\n- phenazopyridine hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-07-06, presumably until 2013-07-08\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-09-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML Injection, through Intravenous route, started on 2013-07-03, presumably until 2013-07-04\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-06-23, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-02\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2013-07-02, presumably until 2013-07-08\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-22 00:00:00, ended at 2013-06-22 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic lymphoid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-12 09:28:00, ended at 2013-07-12 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-15 09:38:28, ended at 2013-07-15 09:46:40\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Cirrhosis - non-alcoholic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-08-07 10:15:00, ended at 2013-09-01 15:40:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 68 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 41.5 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: <5.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.44 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 529 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.5 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Body height: 5' 7.323\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 216 (microgram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.21 (milli-international unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 9.0 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 296 (unit per liter)\n- MCH [Entitic mass] by Automated count: 37.7 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prothrombin time (PT): 29.8 (second)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 57.1 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 89 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 52 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 24 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: >10.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.0 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Selective catheter placement, venous system; first order branch (eg, renal vein, jugular vein)\n- Packed blood cell transfusion\n- Transjugular biopsy of liver\n- Central venous catheter placement with guidance\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Thoracentesis\n- Controlled ventilation procedure and therapy, initiation and management\n- Transcatheter biopsy\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Transfusion of coagulation factors\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Occupational therapy re-evaluation\n- Splitting of blood or blood products, each unit\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Delayed allogeneic transplantation, cadaver donor\n- Collection of blood specimen from a completely implantable venous access device\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Platelet transfusion\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Physical therapy evaluation\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Other transplant of liver\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transfusion of other serum\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy re-evaluation\n- Insertion of pleural tube drain\n- Cholecystectomy\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Transcatheter biopsy, radiological supervision and interpretation\n- Other incision of other bile duct\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Infusion of immunosuppressive antibody therapy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n- Pooling of platelets or other blood products\n\n### Condition\n- Acute tubular necrosis\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Postprocedural state finding\n- Candidiasis\n- Delirium\n- Depressive disorder\n- Low blood pressure\n- Malaise\n- Primary diagnosis: Transplanted liver present\n- Acute pharyngitis\n- Hypercalcemia\n- Metabolic encephalopathy\n- Portal hypertension\n- Pulmonary congestion and hypostasis\n- Splenomegaly\n- Anemia in chronic kidney disease\n- Fever\n- Lung field abnormal\n- Supraventricular premature beats\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Cirrhosis - non-alcoholic\n- Coag./bleeding tests abnormal\n- Disorder of tongue\n- Esophageal varices\n- Hepatorenal syndrome\n- Viral hepatitis C\n- Acute respiratory failure\n- Cardiomegaly\n- Chronic hepatitis C\n- Hypervolemia\n- Primary bacterial peritonitis\n- Sequela of chronic liver disease\n- Urinary tract infectious disease\n- Allergic reaction caused by insect bite and/or insect sting\n- Anemia\n- Chronic kidney disease\n- Chronic viral hepatitis C with hepatic coma\n- Jaundice\n- Pneumothorax\n- Acquired absence of organ\n- Ascites\n- Dizziness and giddiness\n- Hypo-osmolality and or hyponatremia\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Hyperkalemia\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2013-08-13, presumably until 2013-08-16\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-09-05, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-08-19\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2013-08-23, presumably until 2014-03-24, with intended 11 refill(s). Instructions: take 4 Caps by mouth 2 times a day.\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-08-11, presumably until 2013-08-11\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2013-08-07, presumably until 2013-08-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-16\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2013-08-16, presumably until 2013-08-20\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2013-08-13, presumably until 2013-08-17\n- haloperidol 5 MG/ML Injectable Solution, started on 2013-08-20, presumably until 2013-08-31\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-09-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-08-09, presumably until 2013-08-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-11-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2013-08-10, presumably until 2013-08-10\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-08-11, presumably until 2013-08-17\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2013-08-18, presumably until 2013-08-22, with intended 11 refill(s). Instructions: Take up to 4 caps PO BID\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2013-08-13, presumably until 2013-08-14\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2013-08-10, presumably until 2013-08-11\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2013-08-15, presumably until 2013-08-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-08-17, presumably until 2013-12-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2013-08-30, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-08-31, presumably until 2013-09-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2013-08-25, presumably until 2013-08-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2013-08-26, presumably until 2013-12-19, with intended 2 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day.\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2013-08-25, presumably until 2013-08-25\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-08-09, presumably until 2013-08-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-08-10, presumably until 2013-08-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-27\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-12-19, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-08-13, presumably until 2013-08-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-08-17, presumably until 2013-09-01\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2013-08-20, presumably until 2013-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-08-08, presumably until 2013-08-08\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-08, presumably until 2013-08-08\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-08-09, presumably until 2013-08-11\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-30\n- risperidone 0.5 MG Oral Tablet, through Oral route, started on 2013-08-30, presumably until 2013-09-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-08-11\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2013-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2015-12-10, with intended 11 refill(s). Instructions: take 20 mg by mouth daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2013-08-14, presumably until 2013-08-17\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2013-08-29, presumably until 2013-09-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-08-17, presumably until 2013-08-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2013-08-13, presumably until 2013-08-28\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2013-08-23, presumably until 2013-09-01\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-12-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-08-19, presumably until 2013-08-29\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2013-08-16, presumably until 2013-08-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-09-01, presumably until 2013-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; liver transplant (recipient)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n\n### Condition\n- Acute hepatitis C\n- Cirrhosis - non-alcoholic\n- Hepatic encephalopathy\n- Portal hypertension\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-13, presumably until 2013-08-13\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- midazolam 1 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-13\n- methylprednisolone 125 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-04 09:21:00, ended at 2013-09-04 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 471 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 183 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n- Anemia\n- Disorder of hematopoietic structure\n- Transplanted liver present\n- Chronic lymphoid leukemia, disease\n- Viral hepatitis C\n- Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-08 09:08:29, ended at 2013-09-08 15:00:09\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Acute renal failure syndrome\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2013-09-12, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-19 00:00:00, ended at 2013-09-19 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, started on 2013-09-19, presumably until 2013-09-19, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-29 09:50:37, ended at 2013-09-29 11:13:13\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Viral hepatitis C\n- Transplanted liver present\n- Cerebral hemorrhage\n\n### Drug\n- levetiracetam 750 MG Oral Tablet, through Oral route, presumably until 2016-08-25. Instructions: take  by mouth 2 times a day.\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2014-03-24. Instructions: take 50 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-29 11:19:00, ended at 2013-09-29 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.99 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cerebral hemorrhage\n- Essential hypertension\n- Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-31 15:44:15, ended at 2013-10-31 16:42:44\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.717\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-01 13:21:16, ended at 2013-11-01 14:45:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral hemorrhage\n\n### Drug\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-12-19. Instructions: take 1,000 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2013-11-09, presumably until 2013-12-19, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-19 12:58:00, ended at 2013-12-19 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Headache\n- Essential hypertension\n- Altered sensation of skin\n- Transplanted liver present\n- Cerebral hemorrhage\n- Seizure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-19 14:14:37, ended at 2013-12-19 15:31:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2016-09-26. Instructions: take 0.1 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-17 00:00:00, ended at 2014-02-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Friction blister without infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-23 00:00:00, ended at 2014-03-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Viral hepatitis C\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 09:53:00, ended at 2014-03-24 11:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 6.77 (log copies per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL: [000000] (international unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.16 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of magnesium metabolism\n- Transplanted liver present\n- Disorder of oral soft tissues\n- Viral hepatitis C\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 12:00:00, ended at 2014-03-24 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-04 00:00:00, ended at 2014-06-04 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, started on 2014-06-04, presumably until 2014-06-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-08 00:00:00, ended at 2014-06-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2014-06-08, presumably until 2015-03-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-11 00:00:00, ended at 2014-08-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2014-08-11, presumably until 2014-08-11, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-03 00:00:00, ended at 2014-09-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sertraline 100 MG Oral Tablet, started on 2014-09-03, presumably until 2014-09-03, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of magnesium metabolism\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-09-27, presumably until 2015-12-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2014-09-27, presumably until 2014-09-27, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-27 00:00:00, ended at 2014-12-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2014-12-27, presumably until 2015-12-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-20 00:00:00, ended at 2015-03-20 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-03-20, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet, through Oral route, started on 2015-03-26, presumably until 2015-09-16, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-04 00:00:00, ended at 2015-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-04, presumably until 2015-09-13, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-13 00:00:00, ended at 2015-09-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2016-08-25, with intended 11 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-16 00:00:00, ended at 2015-09-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2015-10-17, presumably until 2015-10-17, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-25 00:00:00, ended at 2015-09-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-16 00:00:00, ended at 2015-10-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-10 00:00:00, ended at 2015-12-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hyperkalemia\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-04-27, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2016-12-25, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-19 00:00:00, ended at 2015-12-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-11 00:00:00, ended at 2016-06-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.39 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 58 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 26 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-09 00:00:00, ended at 2016-07-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 86 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.54 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- cycloSPORINE [Mass/volume] in Blood: 80 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-04 00:00:00, ended at 2016-08-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-20 00:00:00, ended at 2016-08-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 87 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-25 16:47:09, ended at 2016-08-25 17:35:51\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n- Disorder of immune function\n- Transplanted liver present\n- Chronic hepatitis C\n\n### Drug\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2016-08-08, presumably until 2016-08-25, with intended 1 refill(s). Instructions: take 100 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-12 00:00:00, ended at 2016-09-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.30 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 53 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-22 09:50:32, ended at 2016-09-22 10:43:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-26 08:29:04, ended at 2016-09-26 09:40:12\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Benign neoplasm of transverse colon\n- Polyp of colon\n- Primary diagnosis: Cirrhosis of liver\n- Nocturia\n- Plantar fascial fibromatosis\n- B-cell chronic lymphocytic leukemia\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2016-09-26, presumably until 2016-09-26, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-08 11:24:23, ended at 2016-10-08 12:27:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Basal cell carcinoma of face\n- Disorder of immune function\n- Disorder of skin and/or subcutaneous tissue\n- Senile hyperkeratosis\n- Neoplasm of uncertain behavior of skin\n- Trichilemmal cyst\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2016-11-04, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congenital anomaly of skin\n- Primary diagnosis: Basal cell carcinoma of skin\n\n### Drug\n- fluorouracil 50 MG/ML Topical Cream, through Topical route, started on 2016-10-13, presumably until 2016-11-12, with intended 1 refill(s). Instructions: by Topical route 2 times a day To right anterior thigh lesion, cover with bandaid, x 3-4 wks. Expect redness, crusting, poss. Itching\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 51 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-20 00:00:00, ended at 2016-10-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-22 08:59:00, ended at 2016-10-22 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.6 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Polyp of colon\n- Cirrhosis of liver\n- Benign neoplasm of transverse colon\n- Nocturia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-22 09:05:36, ended at 2016-10-22 09:47:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-24 07:18:14, ended at 2016-10-24 10:51:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less\n- Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (\n\n### Condition\n- Primary diagnosis: Basal cell carcinoma of face\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2016-10-24, presumably until 2016-10-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 5 days\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2016-10-24, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congenital anomaly of skin\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2016-11-05, presumably until 2016-11-12, with intended 0 refill(s). Instructions: Apply to affected area twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.31 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.3 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-25 00:00:00, ended at 2016-12-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Transplanted liver present\n- Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2016-12-25, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-05 16:48:59, ended at 2017-01-05 17:28:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open wound of lower leg\n- Hyperkalemia\n- Hypomagnesemia\n- Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth as needed\n- hydrocortisone 0.025 MG/MG Topical Ointment, started on 2017-01-05, presumably until 2017-01-19, with intended 0 refill(s). Instructions: Apply to open area on R leg as directed daily. Wash daily with soap/water\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 09:48:47, ended at 2017-01-19 10:29:14\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-21 00:00:00, ended at 2017-01-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 144 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 47 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Transplanted liver present\n- Hernia of anterior abdominal wall\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- cefazolin 1000 MG Injection, started on 2017-02-04, presumably until 2017-02-04\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-04 05:22:00, ended at 2017-02-05 16:37:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Body height: 5' 7.992\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- Supplement Abdominal Wall with Synthetic Substitute, Open Approach\n- Repair initial incisional or ventral hernia; reducible\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Implantation of mesh or other prosthesis for open incisional or ventral hernia repair or mesh for closure of debridement for necrotizing soft tissue infection (List separately in addition to code for the incisional or ventral hernia repair)\n\n### Condition\n- Primary diagnosis: Incisional hernia\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Major depression, single episode\n- Obesity\n- Viral hepatitis C\n- Cirrhosis of liver\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-02-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed (constipation)\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-02-04, presumably until 2017-02-05\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-02-04, presumably until 2017-02-05\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-12 11:22:17, ended at 2017-02-12 11:48:57\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-23 00:00:00, ended at 2017-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-25 00:00:00, ended at 2017-03-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.36 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 49 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 76 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-21 00:00:00, ended at 2017-04-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 82 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Transplanted liver present\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-06-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 42 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-23 11:53:35, ended at 2017-05-23 13:22:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-05-23 14:22:00, ended at 2017-06-05 11:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 438 (per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Protein [Mass/volume] in Cerebral spinal fluid: 107 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.35 (milligram per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence: <1:64 (titer)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Histoplasma capsulatum Ag [Mass/volume] in Urine: 0.05 (nanogram per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.4 (microgram per milliliter)\n- Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.57 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 8\" (inch (US))\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Prothrombin time (PT): 15.4 (second)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocyte sedimentation rate: 7 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n\n### Condition\n- Acquired absence of organ\n- Disorder of digestive system\n- Disorder of intestine\n- Electrocardiogram abnormal\n- Lymphocytosis\n- Complication of transplanted liver\n- Disorder of immune function\n- Esophageal varices without bleeding, associated with another disorder\n- Headache\n- Loss of appetite\n- Transplanted liver present\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Dizziness and giddiness\n- B-cell chronic lymphocytic leukemia\n- Bradycardia\n- Chronic kidney disease\n- Encephalitis due to Herpesviridae\n- Fever\n- Spontaneous cerebral hemorrhage\n- Anterograde amnesia\n- Chronic hepatitis C\n- General finding of observation of patient\n- Hypo-osmolality and or hyponatremia\n- Pain in right lower limb\n- Abdominal pain\n- Depressive disorder\n- Hypomagnesemia\n- Chronic kidney disease due to hypertension\n- Obesity\n- Pain in left lower limb\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Acute renal failure syndrome\n- Parastomal hernia\n- Splenomegaly\n- Visual disturbance\n- Kidney stone\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-06-02, presumably until 2017-07-01, with intended 1 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-05-26, presumably until 2017-06-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-05-30, presumably until 2017-06-17, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2019-06-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth daily as needed\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-07-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-05-23, presumably until 2017-05-27\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2017-05-24, presumably until 2017-05-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-06-01, presumably until 2017-06-01\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2017-06-01, presumably until 2017-06-04\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-06-01, presumably until 2017-06-04\n- gadobenate, through Intravenous route, started on 2017-05-28, presumably until 2017-06-02\n- cholecalciferol 0.01 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-02\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2017-05-28, presumably until 2017-05-29\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-05-23, presumably until 2017-06-01\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-05-30, presumably until 2017-09-22, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-06-04\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-05-29, presumably until 2017-05-29\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-05-25\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-12, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 3 times a day for 14 days\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-05-29, presumably until 2017-05-31\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2018-03-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2017-05-29\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-05-26, presumably until 2017-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-27 00:00:00, ended at 2017-05-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-28 09:23:00, ended at 2017-05-28 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Fever\n- Abnormal findings on diagnostic imaging of lung\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-12 16:03:02, ended at 2017-06-12 16:50:56\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-06-17, presumably until 2017-06-19, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2017-06-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-19 09:33:55, ended at 2017-06-19 10:12:44\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-19 10:13:00, ended at 2017-06-19 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.8 (percent)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.45 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 08:11:40, ended at 2017-06-24 10:57:32\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 250 mg by mouth\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2018-01-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 20 mg by mouth\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 12:41:35, ended at 2017-06-24 13:39:49\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 14:47:02, ended at 2017-06-24 15:29:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-24, presumably until 2017-07-29, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-28 00:00:00, ended at 2017-06-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-27, presumably until 2017-07-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-07-01, presumably until 2017-09-22, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-07, presumably until 2018-07-11, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-07 08:01:00, ended at 2017-07-07 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electroencephalogram (EEG); including recording awake and asleep\n\n### Condition\n- Spontaneous cerebral hemorrhage\n- Encephalitis due to Herpesviridae\n- Headache\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-29 14:23:37, ended at 2017-07-29 15:05:45\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n- Transplanted liver present\n- Spontaneous cerebral hemorrhage\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-29, presumably until 2018-07-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-20 00:00:00, ended at 2017-08-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-20 15:31:23, ended at 2017-08-20 16:43:44\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-20 15:53:00, ended at 2017-08-20 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.19 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Cirrhosis of liver\n- Basal cell carcinoma of face\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-24 00:00:00, ended at 2017-08-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.6 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: None Detected (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-27 00:00:00, ended at 2017-08-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cholecalciferol 0.01 MG Oral Tablet, started on 2017-08-28, presumably until 2018-08-28, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 144 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 95 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 53 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: <25 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-04 00:00:00, ended at 2017-09-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-08 00:00:00, ended at 2017-09-08 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, started on 2017-09-08, presumably until 2017-09-22, with intended 11 refill(s). Instructions: Take 3 Caps by mouth twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-18 00:00:00, ended at 2017-09-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-21 00:00:00, ended at 2017-09-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 13 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 46 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 96 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-21 00:00:00, ended at 2017-09-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2018-03-04, presumably until 2018-04-20, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-22 13:24:07, ended at 2017-09-22 13:55:59\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Spontaneous cerebral hemorrhage\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, presumably until 2018-05-25, with intended 0 refill(s). Instructions: take by mouth 3 tab AM, 3 tab PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2017-09-24, presumably until 2018-04-20, with intended 0 refill(s). Instructions: take 420 g by mouth as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-30 00:00:00, ended at 2017-09-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-09-30, presumably until 2017-10-06, with intended 4 refill(s). Instructions: take 1 Cap by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-02 00:00:00, ended at 2017-10-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-10-06 00:00:00, ended at 2017-10-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2017-10-06, presumably until 2017-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-06 08:09:00, ended at 2017-10-06 12:07:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- Obesity\n- B-cell chronic lymphocytic leukemia\n- Viral hepatitis C\n- Transplanted liver present\n- Cirrhosis of liver\n- Diverticulosis of large intestine without diverticulitis\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-16 00:00:00, ended at 2017-10-16 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-21 00:00:00, ended at 2017-10-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- cycloSPORINE [Mass/volume] in Blood: 53 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-23 00:00:00, ended at 2017-10-23 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-28 14:04:00, ended at 2017-10-28 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Transplanted liver present\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-30 00:00:00, ended at 2017-10-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-03 13:32:56, ended at 2017-11-03 14:28:18\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-05 11:32:00, ended at 2017-11-05 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Spontaneous cerebral hemorrhage\n- Encephalitis due to Herpesviridae\n\n### Drug\n- gadobenate, through Intravenous route, started on 2017-11-05, presumably until 2017-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-06 00:00:00, ended at 2017-11-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-13 00:00:00, ended at 2017-11-13 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-20 00:00:00, ended at 2017-11-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56 (percent)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 26 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-27 00:00:00, ended at 2017-11-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-04 00:00:00, ended at 2017-12-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-11 00:00:00, ended at 2017-12-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-18 00:00:00, ended at 2017-12-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-25 00:00:00, ended at 2017-12-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-01 00:00:00, ended at 2018-01-01 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-08 00:00:00, ended at 2018-01-08 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-14 00:00:00, ended at 2018-01-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.20 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 48 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-14 00:00:00, ended at 2018-01-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Hyperkalemia\n- Hypomagnesemia\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2018-01-14, presumably until 2019-04-06, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2018-01-14, presumably until 2019-04-06, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2018-01-14, presumably until 2019-04-11, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-15 00:00:00, ended at 2018-01-15 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-22 00:00:00, ended at 2018-01-22 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-29 00:00:00, ended at 2018-01-29 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-05 00:00:00, ended at 2018-02-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-12 00:00:00, ended at 2018-02-12 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-19 00:00:00, ended at 2018-02-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-26 00:00:00, ended at 2018-02-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-04 00:00:00, ended at 2018-03-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2018-03-04, presumably until 2019-04-11, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-04 00:00:00, ended at 2018-03-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal level of blood mineral\n- Transplanted liver present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2018-03-04, presumably until 2019-03-04, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-05 00:00:00, ended at 2018-03-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-12 00:00:00, ended at 2018-03-12 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-19 00:00:00, ended at 2018-03-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-22 00:00:00, ended at 2018-03-22 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 143 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 119 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- cycloSPORINE [Mass/volume] in Blood: 37 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (international unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-25 00:00:00, ended at 2018-03-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 92 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 88 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 45 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 48 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-26 00:00:00, ended at 2018-03-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-29 00:00:00, ended at 2018-03-29 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-02 00:00:00, ended at 2018-04-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-05 00:00:00, ended at 2018-04-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-12 00:00:00, ended at 2018-04-12 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-16 00:00:00, ended at 2018-04-16 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-19 00:00:00, ended at 2018-04-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-20 00:00:00, ended at 2018-04-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hand pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-20 10:26:13, ended at 2018-04-20 11:08:55\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fracture of metacarpal bone\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-06-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 15:49:07, ended at 2018-04-21 16:31:04\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Closed fracture of shaft of fifth metacarpal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-23 00:00:00, ended at 2018-04-23 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-26 00:00:00, ended at 2018-04-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-30 00:00:00, ended at 2018-04-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-03 00:00:00, ended at 2018-05-03 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-06 00:00:00, ended at 2018-05-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hand pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-07 00:00:00, ended at 2018-05-07 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-10 00:00:00, ended at 2018-05-10 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 28 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (international unit per liter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.21 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.7 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-14 00:00:00, ended at 2018-05-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-17 00:00:00, ended at 2018-05-17 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-17 08:44:00, ended at 2018-05-17 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hand; minimum of 3 views\n\n### Condition\n- Hand pain\n- Closed fracture of fifth metacarpal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-17 08:44:24, ended at 2018-05-17 09:32:56\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fracture of shaft of metacarpal bone\n- Primary diagnosis: Delayed union of fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-21 00:00:00, ended at 2018-05-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Disorder of immune function\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-21 00:00:00, ended at 2018-05-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-21 10:35:49, ended at 2018-05-21 11:31:38\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Essential hypertension\n- Open fracture of fifth metacarpal bone\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-24 00:00:00, ended at 2018-05-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-25 00:00:00, ended at 2018-05-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, started on 2018-05-25, presumably until 2019-04-11, with intended 4 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-31 00:00:00, ended at 2018-05-31 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-05 00:00:00, ended at 2018-06-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-09-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-07 00:00:00, ended at 2018-06-07 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.15 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 25 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-11 00:00:00, ended at 2018-06-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-14 00:00:00, ended at 2018-06-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-18 00:00:00, ended at 2018-06-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-21 00:00:00, ended at 2018-06-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-25 00:00:00, ended at 2018-06-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-28 00:00:00, ended at 2018-06-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-28 11:13:58, ended at 2018-06-28 13:11:34\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fracture of shaft of metacarpal bone\n- Dupuytren's disease of palm\n- Primary diagnosis: Delayed union of fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-28 11:35:00, ended at 2018-06-28 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hand; minimum of 3 views\n\n### Condition\n- Fracture of base of fifth metacarpal\n- Fracture of shaft of metacarpal bone\n- Delayed union of fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-02 00:00:00, ended at 2018-07-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-05 00:00:00, ended at 2018-07-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-09 00:00:00, ended at 2018-07-09 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-11 00:00:00, ended at 2018-07-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2018-07-12, presumably until 2019-09-14, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-12 00:00:00, ended at 2018-07-12 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.97 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.2 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 35 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 12 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 49 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-14 00:00:00, ended at 2018-07-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-07-14, presumably until 2019-06-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-14 00:00:00, ended at 2018-07-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-07-14, presumably until 2018-07-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-16 00:00:00, ended at 2018-07-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-19 00:00:00, ended at 2018-07-19 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-23 00:00:00, ended at 2018-07-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-30 00:00:00, ended at 2018-07-30 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-06 00:00:00, ended at 2018-08-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-09 00:00:00, ended at 2018-08-09 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-13 00:00:00, ended at 2018-08-13 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.16 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57 (percent)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 35 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 37 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.6 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-16 00:00:00, ended at 2018-08-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-20 00:00:00, ended at 2018-08-20 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-23 00:00:00, ended at 2018-08-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-27 00:00:00, ended at 2018-08-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-30 00:00:00, ended at 2018-08-30 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-02 13:56:52, ended at 2018-09-02 15:03:10\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nocturia\n- Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Depressive disorder\n- Obesity\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2018-09-02, presumably until 2019-09-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-03 00:00:00, ended at 2018-09-03 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-06 00:00:00, ended at 2018-09-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-06 16:24:46, ended at 2018-09-06 17:18:26\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver function tests abnormal\n- Disorder of immune function\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-10 00:00:00, ended at 2018-09-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-13 00:00:00, ended at 2018-09-13 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-17 00:00:00, ended at 2018-09-17 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-20 00:00:00, ended at 2018-09-20 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-24 00:00:00, ended at 2018-09-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-27 00:00:00, ended at 2018-09-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-04 00:00:00, ended at 2018-10-04 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-11 00:00:00, ended at 2018-10-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.23 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 40 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-20 09:52:12, ended at 2018-10-20 10:53:37\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions\n\n### Condition\n- Disorder of immune function\n- Melanocytic nevus\n- Primary diagnosis: Epidermoid cyst of skin\n- Inflamed seborrheic keratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-22 00:00:00, ended at 2018-10-22 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-29 00:00:00, ended at 2018-10-29 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-05 00:00:00, ended at 2018-11-05 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-08 00:00:00, ended at 2018-11-08 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-15 00:00:00, ended at 2018-11-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-16 00:00:00, ended at 2018-11-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cholecalciferol 0.01 MG Oral Tablet, started on 2018-11-16, presumably until 2019-11-16, with intended 11 refill(s). Instructions: Take 1 tablet orally everyday\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-19 00:00:00, ended at 2018-11-19 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-22 00:00:00, ended at 2018-11-22 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-29 00:00:00, ended at 2018-11-29 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-03 00:00:00, ended at 2018-12-03 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-06 00:00:00, ended at 2018-12-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-10 00:00:00, ended at 2018-12-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-13 00:00:00, ended at 2018-12-13 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-20 00:00:00, ended at 2018-12-20 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-24 00:00:00, ended at 2018-12-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-27 00:00:00, ended at 2018-12-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-03 00:00:00, ended at 2019-01-03 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-07 00:00:00, ended at 2019-01-07 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-14 00:00:00, ended at 2019-01-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-17 00:00:00, ended at 2019-01-17 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-21 00:00:00, ended at 2019-01-21 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-24 00:00:00, ended at 2019-01-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-31 00:00:00, ended at 2019-01-31 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-07 00:00:00, ended at 2019-02-07 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 159 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 336 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 55 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-18 00:00:00, ended at 2019-02-18 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-21 00:00:00, ended at 2019-02-21 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-25 00:00:00, ended at 2019-02-25 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-04 00:00:00, ended at 2019-03-04 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-07 00:00:00, ended at 2019-03-07 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-06 00:00:00, ended at 2019-04-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Hyperkalemia\n- Hypomagnesemia\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2019-04-06, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-06, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-11 00:00:00, ended at 2019-04-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Hypomagnesemia\n- Gastroesophageal reflux disease without esophagitis\n- Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, started on 2019-04-11, presumably until 2020-05-07, with intended 4 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2019-04-11, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2019-04-11, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 1 Tab (0.1 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-27 10:26:48, ended at 2019-04-27 10:49:29\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Melanocytic nevus\n- Primary diagnosis: Epidermoid cyst of skin\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-16 00:00:00, ended at 2019-06-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2019-06-16, presumably until 2020-06-11, with intended 3 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-05 11:57:38, ended at 2019-09-05 13:22:02\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- Disorder of immune function\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-14 00:00:00, ended at 2019-09-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Depressive disorder\n- Transplanted liver present\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-09-15, presumably until 2019-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n- atorvastatin 10 MG Oral Tablet, started on 2019-09-15, presumably until 2019-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:37:13, ended at 2019-09-28 12:02:41\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Disorder of immune function\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Melanocytic nevus\n- Squamous cell carcinoma of skin of face\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Squamous cell carcinoma of skin of face\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-09 00:00:00, ended at 2019-11-09 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n", "cumulated_visit_num": 278, "cumulated_approximate_token_count": 71093}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-11 00:00:00, ended at 2013-01-11 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-01-27 20:42:00, ended at 2013-02-05 17:30:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 5.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 2.8 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.0 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 178 (microgram per deciliter)\n- MCV [Entitic volume] by Automated count: 109.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 89 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.5 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 90 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 39.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.5 (millimole per liter)\n- Prothrombin time (PT): 18.0 (second)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 7 (nanogram per milliliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.48 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 37.8 (picogram)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 0.95 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.4 (percent)\n- Iron [Mass/volume] in Serum or Plasma: 69 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 46.9 (percent)\n- MCHC [Mass/volume] by Automated count: 35.4 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 11.7 (microgram per milliliter)\n- Cells counted [#] in Chorionic villus sample by Molecular genetics method: 200 (cells)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.09 (million per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 410 (nanogram per milliliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 37 (unit per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 294 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.91 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 77 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.6 (ratio)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 825 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 3.91 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 26 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 39 (percent)\n\n### Procedure\n- Phlebography of the portal venous system using contrast material\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Insertion of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract formation/dilatation, stent placement and all associated imag\n- Collection of venous blood by venipuncture\n- Radiologic examination, chest; single view, frontal\n- Intra-abdominal venous shunt\n- Computed tomography, abdomen; with contrast material(s)\n- Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study\n\n### Condition\n- Acquired absence of organ\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Esophageal varices associated with another disorder\n- Leukocytosis\n- Thrombocytopenic disorder\n- Viral hepatitis B without hepatic coma\n- Hypervolemia\n- Hypo-osmolality and or hyponatremia\n- Interstitial emphysema of lung\n- Coag./bleeding tests abnormal\n- Pleural effusion\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Non-infectious disorder of lymphatics\n- Swelling of limb\n- Deficiency anemias\n- Lung field abnormal\n- Pneumothorax\n- Splenomegaly\n- Viral hepatitis C\n- Ascites\n- Portal hypertension\n- Sequela of chronic liver disease\n\n### Drug\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-01-30, presumably until 2013-02-03\n- codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution, through Oral route, started on 2013-01-29, presumably until 2013-01-31\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-01\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-08. Instructions: take 40 mg by mouth daily.  \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2014-02-04, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-02-02, presumably until 2013-02-02\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-04\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2013-02-05\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-06-20, with intended 1 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-02-01, presumably until 2013-02-05\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-07-12. Instructions: take 40 mg by mouth daily.  \n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-05\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2013-01-30, presumably until 2013-01-31\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-02-01, presumably until 2013-02-01\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 30 mL by mouth 2 times a day.\n- spironolactone 25 MG Oral Tablet, through Oral route, started on 2013-02-02, presumably until 2014-02-04, with intended 3 refill(s). Instructions: take 3 Tabs by mouth daily.\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2013-01-27, presumably until 2013-06-20. Instructions: take 0.4 mg by mouth Every Day.  \n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-01-31, presumably until 2013-02-04\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-02-04, presumably until 2013-08-03, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2013-01-29, presumably until 2013-01-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-01-27, presumably until 2013-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-02-03 00:00:00, ended at 2013-02-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); intrahepatic or portal circulation (eg, transvenous intrahepatic portosystemic shunt[s] [TIPS])\n\n### Condition\n- Cirrhosis - non-alcoholic\n- Pneumothorax\n- Pleural effusion\n\n### Drug\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2013-02-03, presumably until 2013-02-03\n- 500 ML sodium chloride 30 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2013-02-03, presumably until 2013-02-03\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2013-02-03, presumably until 2013-02-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-03-31, presumably until 2013-07-08, with intended 11 refill(s). Instructions: take 15 mL by mouth 2 times a day. Titrate to achieve BM 3-4x/daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:17:00, ended at 2013-04-01 10:22:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-04-01 10:23:00, ended at 2013-04-01 23:59:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 3.7 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 186 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.6 (gram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 19 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 185 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 115 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.22 (million per microliter)\n- MCH [Entitic mass] by Automated count: 38.0 (picogram)\n- Neutrophils [#/volume] in Blood by Manual count: 5.6 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 76 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.1 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 212 (microgram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 43 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 269 (unit per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 789 (nanogram per milliliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.5 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n- Prothrombin time (PT): 17.5 (second)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 110.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 51 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 200 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 4.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-06-20 17:47:00, ended at 2013-07-08 15:35:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 774 (nanogram per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 69 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 6.8 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 152 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 278 (unit per liter)\n- Basophils [#/volume] in Blood by Manual count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.8 (percent)\n- Eosinophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.21 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Iron [Mass/volume] in Serum or Plasma: 155 (microgram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 56 (percent)\n- Osmolality of Serum or Plasma: 261 (milliosmole per kilogram)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 15.5 (microgram per milliliter)\n- Basophils/100 leukocytes in Blood by Manual count: 1 (percent)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 2.4 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 134 (microgram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 397 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.97 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 242 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.66 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 64.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 6.3 (millimole per liter)\n- Prothrombin time (PT): N/A (second)\n- Thrombin time: 18.9 (second)\n- aPTT in Platelet poor plasma by Coagulation assay: 41.0 (second)\n- Body height: 5' 10\" (inch (US))\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 154 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 116 (percent)\n- Lactate [Moles/volume] in Blood: 1.2 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 7.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 82 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 99 (unit per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: >1000 (picogram per milliliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 9.74 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 113.4 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.76 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.2 (gram per deciliter)\n- Reticulocytes [#/volume] in Blood by Automated count: 175.3 (thousand per microliter)\n- Reticulocytes/100 erythrocytes in Blood by Automated count: 7.87 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 2.8 (gram per deciliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 35 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.2 (percent)\n- Left ventricular Ejection fraction: 62 (percent)\n- MCH [Entitic mass] by Automated count: 39.2 (picogram)\n- Osmolality of Urine: 319 (milliosmole per kilogram)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Collection of venous blood by venipuncture\n- Angioplasty of other non-coronary vessel(s)\n- Physical therapy evaluation\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Thoracentesis\n- Revision of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein catheterization, portography with hemodynamic evaluation, intrahepatic tract recannulization/dilatation, stent placement and all associated\n- Thoracentesis, needle or catheter, aspiration of the pleural space; with imaging guidance\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); additional sequential infusion of a new drug/substance, up to 1 hour (List separately in addition to code for primary procedure)\n- Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour\n- Procedure on single vessel\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n\n### Condition\n- Allergic reaction caused by insect bite and/or insect sting\n- Esophageal varices\n- Anemia\n- Gastroesophageal reflux disease\n- Viral hepatitis C\n- Acquired absence of organ\n- Candidiasis of urogenital site\n- Cirrhosis - non-alcoholic\n- Depressive disorder\n- Hyperkalemia\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Hypo-osmolality and or hyponatremia\n- Primary diagnosis: Primary bacterial peritonitis\n- Altered mental status\n- Hepatic coma due to viral hepatitis C\n- Lung field abnormal\n- Sequela of chronic liver disease\n- Ascites\n- Atelectasis\n- Cramp in limb\n- Pleural effusion\n- Portal hypertension\n- Cardiomegaly\n- Chronic lymphoid leukemia in remission\n- Chronic lymphoid leukemia, disease\n- Edema\n- Hyperosmolality and or hypernatremia\n- Incontinence of feces\n- Splenomegaly\n- Premature beats\n\n### Drug\n- nadolol 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-06-23\n- vitamin K1 5 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-07-07\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-06-29, presumably until 2013-07-08\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-23\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- spironolactone 100 MG Oral Tablet, through Oral route, started on 2013-07-08, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- nadolol 40 MG Oral Tablet, through Oral route, started on 2013-06-24, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 0.5 Tabs by mouth daily.\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-08\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-06-23, presumably until 2013-07-03\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2013-06-20, presumably until 2013-06-20\n- amphotericin B 50 MG Injection, started on 2013-07-04, presumably until 2013-07-08\n- spironolactone 50 MG Oral Tablet, through Oral route, started on 2013-06-27, presumably until 2013-07-08\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2013-07-03, presumably until 2013-07-03\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-09-01. Instructions: take 2,000 mg by mouth daily.\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-29, presumably until 2013-07-08\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-06-21, presumably until 2013-06-23\n- chlorothiazide 500 MG Injection, through Intravenous route, started on 2013-06-29, presumably until 2013-07-01\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-07-01\n- cholecalciferol 0.05 MG Oral Capsule, through Oral route, presumably until 2013-09-01. Instructions: take 1 Cap by mouth Every Day.\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2013-06-26, presumably until 2013-06-26\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-06-20, presumably until 2013-06-20\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-06-21, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 30 mL by mouth every 6 hours.\n- sodium polystyrene sulfonate 250 MG/ML Oral Suspension, through Oral route, started on 2013-06-26, presumably until 2013-06-27\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-06-28, presumably until 2013-06-30\n- phenazopyridine hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-07-06, presumably until 2013-07-08\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-07-01, presumably until 2013-09-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML Injection, through Intravenous route, started on 2013-07-03, presumably until 2013-07-04\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-06-23, presumably until 2013-09-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-07-02\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2013-07-02, presumably until 2013-07-08\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2013-06-28, presumably until 2013-06-30\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-06-21, presumably until 2013-06-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-06-22 00:00:00, ended at 2013-06-22 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic lymphoid leukemia, disease\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-07-12 09:28:00, ended at 2013-07-12 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.323\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-15 09:38:28, ended at 2013-07-15 09:46:40\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Cirrhosis - non-alcoholic\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2013-08-07 10:15:00, ended at 2013-09-01 15:40:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 4.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 68 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 69 (milligram per deciliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 41.5 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 54.6 (second)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: <5.0 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Base excess in Blood by calculation: 8.0 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.44 (millimole per liter)\n- Ferritin [Mass/volume] in Serum or Plasma: 529 (nanogram per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 95 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.5 (gram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Body height: 5' 7.323\" (inch (US))\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 216 (microgram per deciliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.21 (milli-international unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 9.0 (thousand per microliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 23 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Bicarbonate [Moles/volume] in Specimen: 32.9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 6.8 (milligram per deciliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 5.2 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 296 (unit per liter)\n- MCH [Entitic mass] by Automated count: 37.7 (picogram)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 4 (percent)\n- Prothrombin time (PT): 29.8 (second)\n- Tacrolimus [Mass/volume] in Blood: 8.5 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 57.1 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.10 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 89 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Iron [Mass/volume] in Serum or Plasma: 52 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 24 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 39 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 6.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 36.0 (gram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: >10.0 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.0 (millimole per liter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Selective catheter placement, venous system; first order branch (eg, renal vein, jugular vein)\n- Packed blood cell transfusion\n- Transjugular biopsy of liver\n- Central venous catheter placement with guidance\n- Therapeutic procedure, 1 or more areas, each 15 minutes; neuromuscular reeducation of movement, balance, coordination, kinesthetic sense, posture, and/or proprioception for sitting and/or standing activities\n- Thoracentesis\n- Controlled ventilation procedure and therapy, initiation and management\n- Transcatheter biopsy\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Transfusion of coagulation factors\n- Dialysis procedure other than hemodialysis (eg, peritoneal dialysis, hemofiltration, or other continuous renal replacement therapies), with single evaluation by a physician or other qualified health care professional\n- Hemodialysis\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Occupational therapy re-evaluation\n- Splitting of blood or blood products, each unit\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Delayed allogeneic transplantation, cadaver donor\n- Collection of blood specimen from a completely implantable venous access device\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Continuous invasive mechanical ventilation for less than 96 consecutive hours\n- Platelet transfusion\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Physical therapy evaluation\n- Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes\n- Other transplant of liver\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transfusion of other serum\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Physical therapy re-evaluation\n- Insertion of pleural tube drain\n- Cholecystectomy\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Transcatheter biopsy, radiological supervision and interpretation\n- Other incision of other bile duct\n- Duplex scan of aorta, inferior vena cava, iliac vasculature, or bypass grafts; unilateral or limited study\n- Infusion of immunosuppressive antibody therapy\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Collection of venous blood by venipuncture\n- Pooling of platelets or other blood products\n\n### Condition\n- Acute tubular necrosis\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Postprocedural state finding\n- Candidiasis\n- Delirium\n- Depressive disorder\n- Low blood pressure\n- Malaise\n- Primary diagnosis: Transplanted liver present\n- Acute pharyngitis\n- Hypercalcemia\n- Metabolic encephalopathy\n- Portal hypertension\n- Pulmonary congestion and hypostasis\n- Splenomegaly\n- Anemia in chronic kidney disease\n- Fever\n- Lung field abnormal\n- Supraventricular premature beats\n- Thrombocytopenic disorder\n- Acute renal failure syndrome\n- Cirrhosis - non-alcoholic\n- Coag./bleeding tests abnormal\n- Disorder of tongue\n- Esophageal varices\n- Hepatorenal syndrome\n- Viral hepatitis C\n- Acute respiratory failure\n- Cardiomegaly\n- Chronic hepatitis C\n- Hypervolemia\n- Primary bacterial peritonitis\n- Sequela of chronic liver disease\n- Urinary tract infectious disease\n- Allergic reaction caused by insect bite and/or insect sting\n- Anemia\n- Chronic kidney disease\n- Chronic viral hepatitis C with hepatic coma\n- Jaundice\n- Pneumothorax\n- Acquired absence of organ\n- Ascites\n- Dizziness and giddiness\n- Hypo-osmolality and or hyponatremia\n- Hypovolemia\n- Chronic lymphoid leukemia, disease\n- Hyperkalemia\n- Pleural effusion\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2013-08-13, presumably until 2013-08-16\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-09-05, with intended 11 refill(s). Instructions: take 3 Caps by mouth 2 times a day.\n- fluconazole 200 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-08-19\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2013-08-23, presumably until 2014-03-24, with intended 11 refill(s). Instructions: take 4 Caps by mouth 2 times a day.\n- 1 ML octreotide 0.1 MG/ML Injection, started on 2013-08-11, presumably until 2013-08-11\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2013-08-07, presumably until 2013-08-12\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-16\n- piperacillin 2000 MG / tazobactam 250 MG Injection, through Intravenous route, started on 2013-08-16, presumably until 2013-08-20\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2013-08-13, presumably until 2013-08-17\n- haloperidol 5 MG/ML Injectable Solution, started on 2013-08-20, presumably until 2013-08-31\n- zinc sulfate 220 MG Oral Capsule, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-09-01\n- 50 ML albumin human, USP 250 MG/ML Injection, through Intravenous route, started on 2013-08-09, presumably until 2013-08-11\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-11-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed.\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2013-08-10, presumably until 2013-08-10\n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2013-08-11, presumably until 2013-08-17\n- tacrolimus 1 MG Oral Capsule, through Oral route, started on 2013-08-18, presumably until 2013-08-22, with intended 11 refill(s). Instructions: Take up to 4 caps PO BID\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- mineral oil 0.425 MG/MG / petrolatum 0.568 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2013-08-13, presumably until 2013-08-14\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2013-08-10, presumably until 2013-08-11\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2013-08-15, presumably until 2013-08-15\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2013-08-17, presumably until 2013-12-19, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- tacrolimus 5 MG Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2013-08-30, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- furosemide 40 MG Oral Tablet, through Oral route, started on 2013-08-31, presumably until 2013-09-05, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2013-08-25, presumably until 2013-08-31\n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2013-08-26, presumably until 2013-12-19, with intended 2 refill(s). Instructions: 5 mL by Swish & Swallow route 4 times a day.\n- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe, started on 2013-08-25, presumably until 2013-08-25\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2013-08-09, presumably until 2013-08-10\n- 10 ML furosemide 10 MG/ML Injection, started on 2013-08-10, presumably until 2013-08-27\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-27\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-08-16\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2013-08-21, presumably until 2013-12-19, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day.\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2013-08-13, presumably until 2013-08-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2013-08-17, presumably until 2013-09-01\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- lactulose 667 MG/ML Oral Solution, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- fluconazole 100 MG Oral Tablet, through Oral route, started on 2013-08-20, presumably until 2013-08-25\n- 2 ML ondansetron 2 MG/ML Injection, started on 2013-08-08, presumably until 2013-08-08\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-16\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-08, presumably until 2013-08-08\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2013-08-09, presumably until 2013-08-11\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2013-08-13, presumably until 2013-08-30\n- risperidone 0.5 MG Oral Tablet, through Oral route, started on 2013-08-30, presumably until 2013-09-12, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily in the evening.\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2013-08-08, presumably until 2013-08-11\n- furosemide 80 MG Oral Tablet, through Oral route, started on 2013-08-18, presumably until 2013-09-01\n- sulfamethoxazole 400 MG / trimethoprim 80 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2014-08-19, with intended 11 refill(s). Instructions: take 1 Tab by mouth every Monday, Wednesday and Friday.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-19, presumably until 2015-12-10, with intended 11 refill(s). Instructions: take 20 mg by mouth daily.\n- 200 ML fluconazole 2 MG/ML Injection, through Intravenous route, started on 2013-08-14, presumably until 2013-08-17\n- glucose 50 MG/ML Injection, through Intravenous route, started on 2013-08-08, presumably until 2013-08-12\n- rifaximin 550 MG Oral Tablet, through Oral route, started on 2013-08-07, presumably until 2013-08-11\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2013-08-29, presumably until 2013-09-29, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours.\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2013-08-17, presumably until 2013-08-17\n- 2 ML heparin sodium, porcine 1000 UNT/ML Injection, started on 2013-08-13, presumably until 2013-08-28\n- nystatin 100 UNT/MG Topical Powder, through Topical route, started on 2013-08-23, presumably until 2013-09-01\n- valganciclovir 450 MG Oral Tablet, through Oral route, started on 2013-08-19, presumably until 2013-12-19, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2013-08-19, presumably until 2013-08-29\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2013-08-16, presumably until 2013-08-19\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2013-09-01, presumably until 2013-09-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for intraperitoneal procedures in upper abdomen including laparoscopy; liver transplant (recipient)\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n\n### Condition\n- Acute hepatitis C\n- Cirrhosis - non-alcoholic\n- Hepatic encephalopathy\n- Portal hypertension\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- vecuronium bromide 1 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-13\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- piperacillin 4000 MG / tazobactam 500 MG Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- vasopressin (USP) 20 UNT/ML Injectable Solution, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2013-08-13, presumably until 2013-08-13\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- 500 ML glucose 100 MG/ML Injection, through Intravenous route, started on 2013-08-12, presumably until 2013-08-12\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-12\n- midazolam 1 MG/ML Injectable Solution, started on 2013-08-12, presumably until 2013-08-13\n- methylprednisolone 125 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2013-08-12 00:00:00, ended at 2013-08-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- cefazolin 1000 MG Injection, started on 2013-08-12, presumably until 2013-08-12\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2013-08-13, presumably until 2013-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-04 09:21:00, ended at 2013-09-04 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.1 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.97 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 6.2 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.31 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 471 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.26 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.42 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.3 (percent)\n- MCH [Entitic mass] by Automated count: 30.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 183 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.48 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39.4 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- MCV [Entitic volume] by Automated count: 92.3 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Acute renal failure syndrome\n- Anemia\n- Disorder of hematopoietic structure\n- Transplanted liver present\n- Chronic lymphoid leukemia, disease\n- Viral hepatitis C\n- Lymphocytosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-08 09:08:29, ended at 2013-09-08 15:00:09\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Acute renal failure syndrome\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2013-09-12, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-19 00:00:00, ended at 2013-09-19 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- docusate sodium 250 MG Oral Capsule, started on 2013-09-19, presumably until 2013-09-19, with intended 0 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-29 09:50:37, ended at 2013-09-29 11:13:13\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n- Chronic lymphoid leukemia, disease\n- Primary diagnosis: Viral hepatitis C\n- Transplanted liver present\n- Cerebral hemorrhage\n\n### Drug\n- levetiracetam 750 MG Oral Tablet, through Oral route, presumably until 2016-08-25. Instructions: take  by mouth 2 times a day.\n- losartan potassium 50 MG Oral Tablet, through Oral route, presumably until 2014-03-24. Instructions: take 50 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-09-29 11:19:00, ended at 2013-09-29 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 168 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.44 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 167 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.38 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): >60 (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.36 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.99 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.38 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Cerebral hemorrhage\n- Essential hypertension\n- Viral hepatitis C\n- Chronic lymphoid leukemia, disease\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-10-31 15:44:15, ended at 2013-10-31 16:42:44\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.717\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Viral hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-01 13:21:16, ended at 2013-11-01 14:45:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cerebral hemorrhage\n\n### Drug\n- ascorbic acid 1000 MG Oral Tablet, through Oral route, presumably until 2013-12-19. Instructions: take 1,000 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-11-09 00:00:00, ended at 2013-11-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2013-11-09, presumably until 2013-12-19, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2013-12-19 12:58:00, ended at 2013-12-19 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Headache\n- Essential hypertension\n- Altered sensation of skin\n- Transplanted liver present\n- Cerebral hemorrhage\n- Seizure\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-12-19 14:14:37, ended at 2013-12-19 15:31:21\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Viral hepatitis C\n- Primary diagnosis: Cirrhosis - non-alcoholic\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2016-09-26. Instructions: take 0.1 mg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-17 00:00:00, ended at 2014-02-17 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Friction blister without infection\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-03-23 00:00:00, ended at 2014-03-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of magnesium metabolism\n- Viral hepatitis C\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 09:53:00, ended at 2014-03-24 11:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.46 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Hepatitis C virus RNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection: 6.77 (log copies per milliliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 iU/mL: [000000] (international unit per milliliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 40 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.16 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): 49 (milliliter per minute per square meter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.2 (femtoliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of magnesium metabolism\n- Transplanted liver present\n- Disorder of oral soft tissues\n- Viral hepatitis C\n- Acute renal failure syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-03-24 12:00:00, ended at 2014-03-24 23:59:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-06-04 00:00:00, ended at 2014-06-04 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, started on 2014-06-04, presumably until 2014-06-04, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-06-08 00:00:00, ended at 2014-06-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2014-06-08, presumably until 2015-03-20, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-11 00:00:00, ended at 2014-08-11 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, started on 2014-08-11, presumably until 2014-08-11, with intended 11 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-03 00:00:00, ended at 2014-09-03 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- sertraline 100 MG Oral Tablet, started on 2014-09-03, presumably until 2014-09-03, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of magnesium metabolism\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2014-09-27, presumably until 2015-12-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-09-27 00:00:00, ended at 2014-09-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2014-09-27, presumably until 2014-09-27, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-12-27 00:00:00, ended at 2014-12-27 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of oral soft tissues\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2014-12-27, presumably until 2015-12-27, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-20 00:00:00, ended at 2015-03-20 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperkalemia\n- Transplanted liver present\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-03-20, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-03-26 00:00:00, ended at 2015-03-26 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet, through Oral route, started on 2015-03-26, presumably until 2015-09-16, with intended 5 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-04 00:00:00, ended at 2015-09-04 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-04, presumably until 2015-09-13, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-13 00:00:00, ended at 2015-09-13 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2015-09-25, with intended 11 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-09-13, presumably until 2016-08-25, with intended 11 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-09-16 00:00:00, ended at 2015-09-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, started on 2015-10-17, presumably until 2015-10-17, with intended 0 refill(s). Instructions: TAKE ONE TABLET BY MOUTH THREE TIMES DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-09-25 00:00:00, ended at 2015-09-25 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-09-25, presumably until 2015-10-16, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-09-25, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-16 00:00:00, ended at 2015-10-16 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Primary diagnosis: Transplanted liver present\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-10-16, presumably until 2015-12-10, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-12-10 00:00:00, ended at 2015-12-10 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hyperkalemia\n- Hypomagnesemia\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-12-10, presumably until 2017-04-27, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2015-12-10, presumably until 2016-12-25, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2015-12-19 00:00:00, ended at 2015-12-19 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic hepatitis C\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-02-12 00:00:00, ended at 2016-02-12 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-06-11 00:00:00, ended at 2016-06-11 00:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 99 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.25 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.39 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 160 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.4 (percent)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 58 (nanogram per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 35 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 26 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 142 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-07-09 00:00:00, ended at 2016-07-09 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.43 (million per microliter)\n- MCV [Entitic volume] by Automated count: 89 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 86 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.54 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.2 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59 (percent)\n- cycloSPORINE [Mass/volume] in Blood: 80 (nanogram per milliliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-04 00:00:00, ended at 2016-08-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-08-20 00:00:00, ended at 2016-08-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 87 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.8 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 93 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 165 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 38 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-08-25 16:47:09, ended at 2016-08-25 17:35:51\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cirrhosis of liver\n- Disorder of immune function\n- Transplanted liver present\n- Chronic hepatitis C\n\n### Drug\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2016-08-08, presumably until 2016-08-25, with intended 1 refill(s). Instructions: take 100 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-09-12 00:00:00, ended at 2016-09-12 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 34 (percent)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.1 (percent)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 81 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 176 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 110 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.35 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.0 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 10.0 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.30 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 53 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-22 09:50:32, ended at 2016-09-22 10:43:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Obesity\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-09-26 08:29:04, ended at 2016-09-26 09:40:12\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Benign neoplasm of transverse colon\n- Polyp of colon\n- Primary diagnosis: Cirrhosis of liver\n- Nocturia\n- Plantar fascial fibromatosis\n- B-cell chronic lymphocytic leukemia\n\n### Drug\n- 0.5 ML Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 UNT/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inacti..., through Intramuscular route, started on 2016-09-26, presumably until 2016-09-26, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-08 11:24:23, ended at 2016-10-08 12:27:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; each separate/additional lesion (List separately in addition to code for primary procedure)\n- Biopsy of skin, subcutaneous tissue and/or mucous membrane (including simple closure), unless otherwise listed; single lesion\n\n### Condition\n- Basal cell carcinoma of face\n- Disorder of immune function\n- Disorder of skin and/or subcutaneous tissue\n- Senile hyperkeratosis\n- Neoplasm of uncertain behavior of skin\n- Trichilemmal cyst\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Neoplastic disease of uncertain behavior\n\n### Drug\n- furosemide 40 MG Oral Tablet, through Oral route, presumably until 2016-11-04, with intended 0 refill(s). Instructions: take 40 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-13 00:00:00, ended at 2016-10-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Congenital anomaly of skin\n- Primary diagnosis: Basal cell carcinoma of skin\n\n### Drug\n- fluorouracil 50 MG/ML Topical Cream, through Topical route, started on 2016-10-13, presumably until 2016-11-12, with intended 1 refill(s). Instructions: by Topical route 2 times a day To right anterior thigh lesion, cover with bandaid, x 3-4 wks. Expect redness, crusting, poss. Itching\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-14 00:00:00, ended at 2016-10-14 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 162 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.27 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 73 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 51 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.13 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-10-20 00:00:00, ended at 2016-10-20 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2016-10-22 08:59:00, ended at 2016-10-22 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 3 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.37 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.7 (percent)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.34 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.9 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 0.6 (nanogram per milliliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 68 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.50 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Polyp of colon\n- Cirrhosis of liver\n- Benign neoplasm of transverse colon\n- Nocturia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-22 09:05:36, ended at 2016-10-22 09:47:10\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: B-cell chronic lymphocytic leukemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-10-24 07:18:14, ended at 2016-10-24 10:51:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or less\n- Mohs micrographic technique, including removal of all gross tumor, surgical excision of tissue specimens, mapping, color coding of specimens, microscopic examination of specimens by the surgeon, and histopathologic preparation including routine stain(s) (\n\n### Condition\n- Primary diagnosis: Basal cell carcinoma of face\n\n### Drug\n- cephalexin 500 MG Oral Capsule, through Oral route, started on 2016-10-24, presumably until 2016-10-29, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day for 5 days\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2016-10-24, presumably until 2017-01-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 to 6 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-05 00:00:00, ended at 2016-11-05 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Congenital anomaly of skin\n\n### Drug\n- hydrocortisone 25 MG/ML Topical Cream, started on 2016-11-05, presumably until 2016-11-12, with intended 0 refill(s). Instructions: Apply to affected area twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-11-13 00:00:00, ended at 2016-11-13 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 4.36 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.31 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 54 (international unit per liter)\n- MCV [Entitic volume] by Automated count: 92 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.3 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.9 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 104 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.3 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Platelets [#/volume] in Blood by Automated count: 175 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 80 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 9 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 168 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-25 00:00:00, ended at 2016-12-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hypomagnesemia\n- Transplanted liver present\n- Hyperkalemia\n\n### Drug\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2016-12-25, presumably until 2017-01-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-05 16:48:59, ended at 2017-01-05 17:28:58\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Open wound of lower leg\n- Hyperkalemia\n- Hypomagnesemia\n- Transplanted liver present\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: 2 caps twice daily take  by mouth.\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-12, with intended 1 refill(s). Instructions: take 1 Tab by mouth as needed\n- hydrocortisone 0.025 MG/MG Topical Ointment, started on 2017-01-05, presumably until 2017-01-19, with intended 0 refill(s). Instructions: Apply to open area on R leg as directed daily. Wash daily with soap/water\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Cap by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-06-05, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2017-05-23, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-01-05, presumably until 2018-01-14, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-01-19 09:48:47, ended at 2017-01-19 10:29:14\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- Incisional hernia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-01-21 00:00:00, ended at 2017-01-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.29 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 106 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.40 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection: HCV Not Detected (international unit per milliliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 144 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 47 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 20 ML bupivacaine liposome 13.3 MG/ML Injection, through Infiltration route, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-02-04 00:00:00, ended at 2017-02-04 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for hernia repairs in upper abdomen; lumbar and ventral (incisional) hernias and/or wound dehiscence\n\n### Condition\n- Transplanted liver present\n- Hernia of anterior abdominal wall\n\n### Drug\n- neostigmine methylsulfate 0.5 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- calcium chloride 0.0014 MEQ/ML / potassium chloride 0.004 MEQ/ML / sodium chloride 0.103 MEQ/ML / sodium lactate 0.028 MEQ/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- cefazolin 1000 MG Injection, started on 2017-02-04, presumably until 2017-02-04\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-02-04, presumably until 2017-02-04\n- midazolam 1 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2017-02-04, presumably until 2017-02-04\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-02-04, presumably until 2017-02-04\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-02-04 05:22:00, ended at 2017-02-05 16:37:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 52 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 94.2 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 123 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 75 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Body height: 5' 7.992\" (inch (US))\n- Hemoglobin [Mass/volume] in Blood: 12.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- Supplement Abdominal Wall with Synthetic Substitute, Open Approach\n- Repair initial incisional or ventral hernia; reducible\n- Level III - Surgical pathology, gross and microscopic examination Abortion, induced Abscess Aneurysm - arterial/ventricular Anus, tag Appendix, other than incidental Artery, atheromatous plaque Bartholin's gland cyst Bone fragment(s), other than pathologi\n- Collection of venous blood by venipuncture\n- Implantation of mesh or other prosthesis for open incisional or ventral hernia repair or mesh for closure of debridement for necrotizing soft tissue infection (List separately in addition to code for the incisional or ventral hernia repair)\n\n### Condition\n- Primary diagnosis: Incisional hernia\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Essential hypertension\n- Hernia of anterior abdominal wall\n- Major depression, single episode\n- Obesity\n- Viral hepatitis C\n- Cirrhosis of liver\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-02-05, presumably until 2017-02-05\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-04\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-02-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day as needed (constipation)\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-02-04, presumably until 2017-02-05\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-02-04, presumably until 2017-02-05\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-02-04, presumably until 2017-02-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-12 11:22:17, ended at 2017-02-12 11:48:57\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Hernia of anterior abdominal wall\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-02-23 00:00:00, ended at 2017-02-23 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-03-25 00:00:00, ended at 2017-03-25 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 37 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.24 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.4 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.36 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 94 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 49 (nanogram per milliliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 76 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 120 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-21 00:00:00, ended at 2017-04-21 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.33 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.7 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 145 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 15 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 47 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 144 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 82 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.26 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 10 (international unit per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 54 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 91 (femtoliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n- Transplanted liver present\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-06-24, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-22 00:00:00, ended at 2017-05-22 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.1 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: 42 (nanogram per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 95 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 145 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 141 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.5 (percent)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.1 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.66 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 26 (international unit per liter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 135 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 8 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 39 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.8 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-23 11:53:35, ended at 2017-05-23 13:22:24\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fever\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2017-05-23 14:22:00, ended at 2017-06-05 11:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Erythrocytes [#/volume] in Cerebral spinal fluid: 4 (per microliter)\n- Glucose [Mass/volume] in Blood: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Cerebral spinal fluid: 438 (per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.0 (percent)\n- Protein [Mass/volume] in Cerebral spinal fluid: 107 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Cystatin C [Mass/volume] in Serum or Plasma: 1.35 (milligram per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Chlamydia trachomatis IgG Ab [Titer] in Serum by Immunofluorescence: <1:64 (titer)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.5 (percent)\n- Chlamydophila psittaci IgG Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.4 (percent)\n- Histoplasma capsulatum Ag [Mass/volume] in Urine: 0.05 (nanogram per milliliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.53 (thousand per microliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 13.4 (microgram per milliliter)\n- Chlamydia trachomatis IgM Ab [Titer] in Serum by Immunofluorescence: <1:10 (titer)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.57 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.7 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.5 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Body height: 5' 8\" (inch (US))\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.59 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Prothrombin time (PT): 15.4 (second)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Erythrocyte sedimentation rate: 7 (millimeter per hour)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n\n### Procedure\n- Physical therapy evaluation: low complexity, requiring these components: A history with no personal factors and/or comorbidities that impact the plan of care; An examination of body system(s) using standardized tests and measures addressing 1-2 elements f\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coor\n- Hospital discharge day management; more than 30 minutes\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Drainage of Spinal Canal, Percutaneous Approach, Diagnostic\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An \n- Evaluation of speech sound production (eg, articulation, phonological process, apraxia, dysarthria); with evaluation of language comprehension and expression (eg, receptive and expressive language)\n- Collection of venous blood by venipuncture\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n\n### Condition\n- Acquired absence of organ\n- Disorder of digestive system\n- Disorder of intestine\n- Electrocardiogram abnormal\n- Lymphocytosis\n- Complication of transplanted liver\n- Disorder of immune function\n- Esophageal varices without bleeding, associated with another disorder\n- Headache\n- Loss of appetite\n- Transplanted liver present\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Dizziness and giddiness\n- B-cell chronic lymphocytic leukemia\n- Bradycardia\n- Chronic kidney disease\n- Encephalitis due to Herpesviridae\n- Fever\n- Spontaneous cerebral hemorrhage\n- Anterograde amnesia\n- Chronic hepatitis C\n- General finding of observation of patient\n- Hypo-osmolality and or hyponatremia\n- Pain in right lower limb\n- Abdominal pain\n- Depressive disorder\n- Hypomagnesemia\n- Chronic kidney disease due to hypertension\n- Obesity\n- Pain in left lower limb\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n- Acute renal failure syndrome\n- Parastomal hernia\n- Splenomegaly\n- Visual disturbance\n- Kidney stone\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-06-02, presumably until 2017-07-01, with intended 1 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, presumably until 2017-06-05, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-05-26, presumably until 2017-06-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-05-30, presumably until 2017-06-17, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-04\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2019-06-01, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth daily as needed\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-07-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2017-05-23, presumably until 2017-05-27\n- 0.5 ML Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumo..., through Intramuscular route, started on 2017-05-24, presumably until 2017-05-24\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2017-06-01, presumably until 2017-06-01\n- 1 ML hydralazine hydrochloride 20 MG/ML Injection, started on 2017-06-01, presumably until 2017-06-04\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-08-20, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime as needed\n- amlodipine 5 MG Oral Tablet, through Oral route, started on 2017-06-01, presumably until 2017-06-04\n- gadobenate, through Intravenous route, started on 2017-05-28, presumably until 2017-06-02\n- cholecalciferol 0.01 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-08-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-05-23, presumably until 2017-06-02\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2017-05-28, presumably until 2017-05-29\n- cyclosporine, modified 100 MG Oral Capsule, through Oral route, started on 2017-05-23, presumably until 2017-06-01\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-05-30, presumably until 2017-09-22, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-23\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-05-25\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-05-23, presumably until 2017-06-04\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-05-29, presumably until 2017-05-29\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-05-25\n- valacyclovir 1000 MG Oral Tablet, through Oral route, started on 2017-05-31, presumably until 2017-06-12, with intended 0 refill(s). Instructions: take 2 Tabs by mouth 3 times a day for 14 days\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-05-29, presumably until 2017-05-31\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2018-03-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-05-27, presumably until 2017-05-29\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2017-05-24, presumably until 2017-06-05\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-05-26, presumably until 2017-05-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-05-27 00:00:00, ended at 2017-05-27 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 62.4 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-05-28 09:23:00, ended at 2017-05-28 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Fever\n- Abnormal findings on diagnostic imaging of lung\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-12 16:03:02, ended at 2017-06-12 16:50:56\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-06-17 00:00:00, ended at 2017-06-17 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- 10 ML acyclovir 50 MG/ML Injection, through Intravenous route, started on 2017-06-17, presumably until 2017-06-19, with intended 0 refill(s). Instructions: 13.7 mL by Intravenous route every 8 hours\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-20, presumably until 2017-06-24, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-19 09:33:55, ended at 2017-06-19 10:12:44\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-06-19 10:13:00, ended at 2017-06-19 23:59:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 110 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.64 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.49 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 173 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.90 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 26.8 (percent)\n- MCV [Entitic volume] by Automated count: 96.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 51 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.45 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.1 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 08:11:40, ended at 2017-06-24 10:57:32\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Intraocular pressure of right eye: 18 (millimeter mercury column)\n- Intraocular pressure of left eye: 17 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- mycophenolate mofetil 250 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 250 mg by mouth\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 100 mg by mouth 2 times a day\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2018-01-14, with intended 0 refill(s). Instructions: take 1 Tab by mouth\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 20 mg by mouth\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-06-05, presumably until 2017-06-24, with intended 0 refill(s). Instructions: take 5 mg by mouth every 4 hours\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 12:41:35, ended at 2017-06-24 13:39:49\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-06-24 14:47:02, ended at 2017-06-24 15:29:50\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 7.992\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-06-24, presumably until 2017-07-29, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-06-28 00:00:00, ended at 2017-06-28 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-27, presumably until 2017-07-27, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-01 00:00:00, ended at 2017-07-01 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, started on 2017-07-01, presumably until 2017-09-22, with intended 11 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-06 00:00:00, ended at 2017-07-06 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2017-07-07, presumably until 2018-07-11, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-07-07 08:01:00, ended at 2017-07-07 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Electroencephalogram (EEG); including recording awake and asleep\n\n### Condition\n- Spontaneous cerebral hemorrhage\n- Encephalitis due to Herpesviridae\n- Headache\n- Visual disturbance\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-29 14:23:37, ended at 2017-07-29 15:05:45\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Visual disturbance\n- Transplanted liver present\n- Spontaneous cerebral hemorrhage\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-29, presumably until 2018-07-14, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-19 00:00:00, ended at 2017-08-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-20 00:00:00, ended at 2017-08-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-20 15:31:23, ended at 2017-08-20 16:43:44\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Basal cell carcinoma of face\n- Primary diagnosis: Cirrhosis of liver\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-20 15:53:00, ended at 2017-08-20 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.7 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.19 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.7 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.48 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.03 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.92 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.5 (percent)\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 69.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.71 (million per microliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Transplanted liver present\n- Cirrhosis of liver\n- Basal cell carcinoma of face\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-21 00:00:00, ended at 2017-08-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-24 00:00:00, ended at 2017-08-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 74 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.6 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood: None Detected (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 11 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.81 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.01 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.6 (percent)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Protein [Mass/volume] in Serum or Plasma: 5.9 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 46 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 139 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 1.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-08-27 00:00:00, ended at 2017-08-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cholecalciferol 0.01 MG Oral Tablet, started on 2017-08-28, presumably until 2018-08-28, with intended 11 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-08-28 00:00:00, ended at 2017-08-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 144 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 153 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 95 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- MCH [Entitic mass] by Automated count: 32.7 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.2 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 53 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 83 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.23 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: <25 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 77 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-04 00:00:00, ended at 2017-09-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-08 00:00:00, ended at 2017-09-08 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, started on 2017-09-08, presumably until 2017-09-22, with intended 11 refill(s). Instructions: Take 3 Caps by mouth twice daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-11 00:00:00, ended at 2017-09-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-18 00:00:00, ended at 2017-09-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-21 00:00:00, ended at 2017-09-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 55 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.8 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 13 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.4 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 46 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.8 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (international unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 88 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.14 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 64 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 62 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 96 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.4 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-21 00:00:00, ended at 2017-09-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2018-03-04, presumably until 2018-04-20, with intended 0 refill(s). Instructions: TAKE 1 CAPSULE BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-22 13:24:07, ended at 2017-09-22 13:55:59\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 8\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n- Spontaneous cerebral hemorrhage\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, through Oral route, presumably until 2018-05-25, with intended 0 refill(s). Instructions: take by mouth 3 tab AM, 3 tab PM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- polyethylene glycol 3350 420000 MG / potassium chloride 1480 MG / sodium bicarbonate 5720 MG / sodium chloride 11200 MG Powder for Oral Solution, through Oral route, started on 2017-09-24, presumably until 2018-04-20, with intended 0 refill(s). Instructions: take 420 g by mouth as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-25 00:00:00, ended at 2017-09-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-09-30 00:00:00, ended at 2017-09-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2017-09-30, presumably until 2017-10-06, with intended 4 refill(s). Instructions: take 1 Cap by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-02 00:00:00, ended at 2017-10-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-10-06 00:00:00, ended at 2017-10-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- midazolam 1 MG/ML Injectable Solution, started on 2017-10-06, presumably until 2017-10-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-06 08:09:00, ended at 2017-10-06 12:07:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the m\n- Colonoscopy, flexible; diagnostic, including collection of specimen(s) by brushing or washing, when performed (separate procedure)\n- Inspection of Lower Intestinal Tract, Via Natural or Artificial Opening Endoscopic\n\n### Condition\n- Obesity\n- B-cell chronic lymphocytic leukemia\n- Viral hepatitis C\n- Transplanted liver present\n- Cirrhosis of liver\n- Diverticulosis of large intestine without diverticulitis\n- Paralytic syndrome on one side of the body as late effect of cerebrovascular accident\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-09 00:00:00, ended at 2017-10-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-16 00:00:00, ended at 2017-10-16 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-21 00:00:00, ended at 2017-10-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 66 (international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (international unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 48 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 97 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- cycloSPORINE [Mass/volume] in Blood: 53 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 19 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 164 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.4 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.3 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 55 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.21 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-23 00:00:00, ended at 2017-10-23 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-10-28 14:04:00, ended at 2017-10-28 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Dual-energy X-ray absorptiometry (DXA), bone density study, 1 or more sites; axial skeleton (eg, hips, pelvis, spine)\n\n### Condition\n- Transplanted liver present\n- Disorder of bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-10-30 00:00:00, ended at 2017-10-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-11-03 13:32:56, ended at 2017-11-03 14:28:18\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Encephalitis due to Herpesviridae\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-11-05 11:32:00, ended at 2017-11-05 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Spontaneous cerebral hemorrhage\n- Encephalitis due to Herpesviridae\n\n### Drug\n- gadobenate, through Intravenous route, started on 2017-11-05, presumably until 2017-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-06 00:00:00, ended at 2017-11-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-13 00:00:00, ended at 2017-11-13 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-20 00:00:00, ended at 2017-11-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56 (percent)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 26 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 36 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.2 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 19 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 29 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 148 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-11-27 00:00:00, ended at 2017-11-27 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-04 00:00:00, ended at 2017-12-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-11 00:00:00, ended at 2017-12-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-18 00:00:00, ended at 2017-12-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-12-25 00:00:00, ended at 2017-12-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-01 00:00:00, ended at 2018-01-01 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-08 00:00:00, ended at 2018-01-08 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-14 00:00:00, ended at 2018-01-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 28 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.20 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.3 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 140 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 172 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.3 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 22 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.9 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 93 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood: 48 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-01-14 00:00:00, ended at 2018-01-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Hyperkalemia\n- Hypomagnesemia\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2018-01-14, presumably until 2019-04-06, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2018-01-14, presumably until 2019-04-06, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2018-01-14, presumably until 2019-04-11, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-15 00:00:00, ended at 2018-01-15 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-22 00:00:00, ended at 2018-01-22 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-01-29 00:00:00, ended at 2018-01-29 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-05 00:00:00, ended at 2018-02-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-12 00:00:00, ended at 2018-02-12 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-19 00:00:00, ended at 2018-02-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-02-26 00:00:00, ended at 2018-02-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-04 00:00:00, ended at 2018-03-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Primary diagnosis: Gastroesophageal reflux disease without esophagitis\n\n### Drug\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2018-03-04, presumably until 2019-04-11, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-03-04 00:00:00, ended at 2018-03-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal level of blood mineral\n- Transplanted liver present\n\n### Drug\n- magnesium amino acid chelate 133 MG Oral Tablet, through Oral route, started on 2018-03-04, presumably until 2019-03-04, with intended 4 refill(s). Instructions: take 1 Tab by mouth 3 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-05 00:00:00, ended at 2018-03-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-12 00:00:00, ended at 2018-03-12 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-19 00:00:00, ended at 2018-03-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-22 00:00:00, ended at 2018-03-22 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 143 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.6 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 18 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 119 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- cycloSPORINE [Mass/volume] in Blood: 37 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 98 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.1 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (international unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.95 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.7 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 50 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-25 00:00:00, ended at 2018-03-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.84 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.5 (percent)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 28 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 92 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.7 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 43 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 88 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 45 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 63 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 48 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Platelets [#/volume] in Blood by Automated count: 152 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 20 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol [Mass/volume] in Serum or Plasma: 148 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.18 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 17 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Globulin [Mass/volume] in Serum: 2.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-26 00:00:00, ended at 2018-03-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-03-29 00:00:00, ended at 2018-03-29 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-02 00:00:00, ended at 2018-04-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-05 00:00:00, ended at 2018-04-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-09 00:00:00, ended at 2018-04-09 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-12 00:00:00, ended at 2018-04-12 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-16 00:00:00, ended at 2018-04-16 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-19 00:00:00, ended at 2018-04-19 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-20 00:00:00, ended at 2018-04-20 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hand pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-20 10:26:13, ended at 2018-04-20 11:08:55\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fracture of metacarpal bone\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-04-20, presumably until 2018-06-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 15:49:07, ended at 2018-04-21 16:31:04\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Closed fracture of shaft of fifth metacarpal bone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-23 00:00:00, ended at 2018-04-23 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-26 00:00:00, ended at 2018-04-26 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-04-30 00:00:00, ended at 2018-04-30 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-03 00:00:00, ended at 2018-05-03 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-06 00:00:00, ended at 2018-05-06 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hand pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-07 00:00:00, ended at 2018-05-07 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-10 00:00:00, ended at 2018-05-10 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 154 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 28 (nanogram per milliliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 97 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 12 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (international unit per liter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.21 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.06 (million per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.7 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-14 00:00:00, ended at 2018-05-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-17 00:00:00, ended at 2018-05-17 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-05-17 08:44:00, ended at 2018-05-17 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hand; minimum of 3 views\n\n### Condition\n- Hand pain\n- Closed fracture of fifth metacarpal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-17 08:44:24, ended at 2018-05-17 09:32:56\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fracture of shaft of metacarpal bone\n- Primary diagnosis: Delayed union of fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-21 00:00:00, ended at 2018-05-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Disorder of immune function\n- Primary diagnosis: Osteoporosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-21 00:00:00, ended at 2018-05-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-21 10:35:49, ended at 2018-05-21 11:31:38\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Essential hypertension\n- Open fracture of fifth metacarpal bone\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-24 00:00:00, ended at 2018-05-24 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-05-25 00:00:00, ended at 2018-05-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, started on 2018-05-25, presumably until 2019-04-11, with intended 4 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-28 00:00:00, ended at 2018-05-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-05-31 00:00:00, ended at 2018-05-31 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-04 00:00:00, ended at 2018-06-04 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-05 00:00:00, ended at 2018-06-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2018-06-07, presumably until 2018-09-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-07 00:00:00, ended at 2018-06-07 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.1 (percent)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 99 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 69 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.15 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 23 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 25 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.21 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.4 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 153 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 33.5 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-11 00:00:00, ended at 2018-06-11 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-14 00:00:00, ended at 2018-06-14 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-18 00:00:00, ended at 2018-06-18 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-21 00:00:00, ended at 2018-06-21 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-25 00:00:00, ended at 2018-06-25 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-06-28 00:00:00, ended at 2018-06-28 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-06-28 11:13:58, ended at 2018-06-28 13:11:34\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Fracture of shaft of metacarpal bone\n- Dupuytren's disease of palm\n- Primary diagnosis: Delayed union of fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-06-28 11:35:00, ended at 2018-06-28 23:59:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, hand; minimum of 3 views\n\n### Condition\n- Fracture of base of fifth metacarpal\n- Fracture of shaft of metacarpal bone\n- Delayed union of fracture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-02 00:00:00, ended at 2018-07-02 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-05 00:00:00, ended at 2018-07-05 00:00:00\nThe patient in this visit was 55 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-09 00:00:00, ended at 2018-07-09 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-11 00:00:00, ended at 2018-07-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2018-07-12, presumably until 2019-09-14, with intended 12 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-12 00:00:00, ended at 2018-07-12 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.05 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.97 (million per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.2 (thousand per microliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 35 (nanogram per milliliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 58 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 0.9 (ratio)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 12 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Globulin [Mass/volume] in Serum: 1.7 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.3 (picogram)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 56 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.6 (gram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.0 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.4 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.9 (percent)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 49 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-14 00:00:00, ended at 2018-07-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-07-14, presumably until 2019-06-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-14 00:00:00, ended at 2018-07-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- amlodipine 10 MG Oral Tablet, through Oral route, started on 2018-07-14, presumably until 2018-07-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-16 00:00:00, ended at 2018-07-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-19 00:00:00, ended at 2018-07-19 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-23 00:00:00, ended at 2018-07-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-07-30 00:00:00, ended at 2018-07-30 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-02 00:00:00, ended at 2018-08-02 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-06 00:00:00, ended at 2018-08-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-09 00:00:00, ended at 2018-08-09 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-13 00:00:00, ended at 2018-08-13 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.16 (million per microliter)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.6 (percent)\n- Platelets [#/volume] in Blood by Automated count: 158 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 76 (international unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57 (percent)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 35 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.5 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 37 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.6 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.17 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-16 00:00:00, ended at 2018-08-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-20 00:00:00, ended at 2018-08-20 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-23 00:00:00, ended at 2018-08-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-27 00:00:00, ended at 2018-08-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-08-30 00:00:00, ended at 2018-08-30 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-02 13:56:52, ended at 2018-09-02 15:03:10\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Nocturia\n- Transplanted liver present\n- B-cell chronic lymphocytic leukemia\n- Depressive disorder\n- Obesity\n\n### Drug\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2018-09-02, presumably until 2019-09-14, with intended 12 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-03 00:00:00, ended at 2018-09-03 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-06 00:00:00, ended at 2018-09-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-06 16:24:46, ended at 2018-09-06 17:18:26\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9.016\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Liver function tests abnormal\n- Disorder of immune function\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-10 00:00:00, ended at 2018-09-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-13 00:00:00, ended at 2018-09-13 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-17 00:00:00, ended at 2018-09-17 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-20 00:00:00, ended at 2018-09-20 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-23 00:00:00, ended at 2018-09-23 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-24 00:00:00, ended at 2018-09-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-09-27 00:00:00, ended at 2018-09-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-01 00:00:00, ended at 2018-10-01 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-04 00:00:00, ended at 2018-10-04 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-08 00:00:00, ended at 2018-10-08 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-11 00:00:00, ended at 2018-10-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29 (percent)\n- MCH [Entitic mass] by Automated count: 33.1 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 155 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 67 (international unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.23 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Globulin [Mass/volume] in Serum: 2.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 108 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 99 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.29 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (international unit per liter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 40 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-15 00:00:00, ended at 2018-10-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-10-20 09:52:12, ended at 2018-10-20 10:53:37\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), of benign lesions other than skin tags or cutaneous vascular proliferative lesions; up to 14 lesions\n\n### Condition\n- Disorder of immune function\n- Melanocytic nevus\n- Primary diagnosis: Epidermoid cyst of skin\n- Inflamed seborrheic keratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-22 00:00:00, ended at 2018-10-22 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-25 00:00:00, ended at 2018-10-25 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-10-29 00:00:00, ended at 2018-10-29 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-01 00:00:00, ended at 2018-11-01 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-05 00:00:00, ended at 2018-11-05 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-08 00:00:00, ended at 2018-11-08 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-12 00:00:00, ended at 2018-11-12 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-15 00:00:00, ended at 2018-11-15 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-16 00:00:00, ended at 2018-11-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n\n### Drug\n- cholecalciferol 0.01 MG Oral Tablet, started on 2018-11-16, presumably until 2019-11-16, with intended 11 refill(s). Instructions: Take 1 tablet orally everyday\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-19 00:00:00, ended at 2018-11-19 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-22 00:00:00, ended at 2018-11-22 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-26 00:00:00, ended at 2018-11-26 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-11-29 00:00:00, ended at 2018-11-29 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-03 00:00:00, ended at 2018-12-03 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-06 00:00:00, ended at 2018-12-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-10 00:00:00, ended at 2018-12-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-13 00:00:00, ended at 2018-12-13 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-17 00:00:00, ended at 2018-12-17 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-20 00:00:00, ended at 2018-12-20 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-24 00:00:00, ended at 2018-12-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-27 00:00:00, ended at 2018-12-27 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2018-12-31 00:00:00, ended at 2018-12-31 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-03 00:00:00, ended at 2019-01-03 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-07 00:00:00, ended at 2019-01-07 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-10 00:00:00, ended at 2019-01-10 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-14 00:00:00, ended at 2019-01-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-17 00:00:00, ended at 2019-01-17 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-21 00:00:00, ended at 2019-01-21 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-24 00:00:00, ended at 2019-01-24 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-28 00:00:00, ended at 2019-01-28 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-01-31 00:00:00, ended at 2019-01-31 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-04 00:00:00, ended at 2019-02-04 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-07 00:00:00, ended at 2019-02-07 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-11 00:00:00, ended at 2019-02-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-14 00:00:00, ended at 2019-02-14 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.8 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 159 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.10 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.1 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.0 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 20 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 124 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 49 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (international unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 70 (international unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.07 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 32 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood by Immunoassay: 336 (nanogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 55 (milligram per deciliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-18 00:00:00, ended at 2019-02-18 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-21 00:00:00, ended at 2019-02-21 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-25 00:00:00, ended at 2019-02-25 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-02-28 00:00:00, ended at 2019-02-28 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-04 00:00:00, ended at 2019-03-04 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-03-07 00:00:00, ended at 2019-03-07 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-06 00:00:00, ended at 2019-04-06 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Transplanted liver present\n- Hyperkalemia\n- Hypomagnesemia\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- sertraline 100 MG Oral Tablet, through Oral route, started on 2019-04-06, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 1 Tab (100 mg total) by mouth daily\n- hydrochlorothiazide 12.5 MG / losartan potassium 50 MG Oral Tablet, through Oral route, started on 2019-04-06, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 1 Tab by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-11 00:00:00, ended at 2019-04-11 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperkalemia\n- Hypomagnesemia\n- Gastroesophageal reflux disease without esophagitis\n- Transplanted liver present\n\n### Drug\n- cyclosporine, modified 25 MG Oral Capsule, started on 2019-04-11, presumably until 2020-05-07, with intended 4 refill(s). Instructions: take 3 Caps by mouth 2 times a day\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2019-04-11, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 20 mg by mouth daily\n- fludrocortisone acetate 0.1 MG Oral Tablet, through Oral route, started on 2019-04-11, presumably until 2020-06-04, with intended 4 refill(s). Instructions: take 1 Tab (0.1 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-04-27 10:26:48, ended at 2019-04-27 10:49:29\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of immune function\n- Melanocytic nevus\n- Primary diagnosis: Epidermoid cyst of skin\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-16 00:00:00, ended at 2019-06-16 00:00:00\nThe patient in this visit was 56 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2019-06-16, presumably until 2020-06-11, with intended 3 refill(s). Instructions: take 1 Tab (500 mg total) by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-05 11:57:38, ended at 2019-09-05 13:22:02\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Transplanted liver present\n- Disorder of immune function\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-09-14 00:00:00, ended at 2019-09-14 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- B-cell chronic lymphocytic leukemia\n- Depressive disorder\n- Transplanted liver present\n\n### Drug\n- amlodipine 10 MG Oral Tablet, started on 2019-09-15, presumably until 2019-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n- atorvastatin 10 MG Oral Tablet, started on 2019-09-15, presumably until 2019-12-13, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-09-28 11:37:13, ended at 2019-09-28 12:02:41\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Disorder of immune function\n- Primary diagnosis: Neoplasm of uncertain behavior of skin\n- Melanocytic nevus\n- Squamous cell carcinoma of skin of face\n- Senile hyperkeratosis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-10-04 00:00:00, ended at 2019-10-04 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Squamous cell carcinoma of skin of face\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2019-11-09 00:00:00, ended at 2019-11-09 00:00:00\nThe patient in this visit was 57 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 122 (milligram per deciliter)\n- cycloSPORINE [Mass/volume] in Blood: 50 (nanogram per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Globulin [Mass/volume] in Serum: 1.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.7 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 149 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.02 (million per microliter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 31 (international unit per liter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 53 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (international unit per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 69 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.09 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 24 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 65 (international unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 146 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 24 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.4 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 146.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8311a86d233c38c915dd9e97b49fd2f64aa7a26bfffc4947cd86b9bb577b023a", "prompt_hash": "69c6f5873efce19730db7c53f03ad84ea8eacdc6078edc96a2e26e447c84d970", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115968738, "visit_occurrence_id": 60760446, "visit_start_datetime": "2014-04-09 10:28:35", "measurement_name": "totalcholesterol", "measurement_concept_name": "Cholesterol [Mass/volume] in Serum or Plasma", "current_value": 190.0, "current_label": 0, "next_value": 199.0, "next_label": 0, "threshold": "200", "normal_direction": "below", "unit": "mg/dL", "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-20 00:00:00, ended at 2012-11-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory disorder of digestive tract\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2012-11-20, presumably until 2013-06-21, with intended 6 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-25 10:35:50, ended at 2012-11-25 12:02:19\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 81.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 86.5 (microgram per milliliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 106.3 (milligram per gram of creatinine)\n- Body height: 5' 4\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 105 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Inflammatory disorder of digestive tract\n- Bipolar disorder\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-11-25, presumably until 2012-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-12-09 00:00:00, ended at 2012-12-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-09, presumably until 2012-12-26, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-19 00:00:00, ended at 2012-12-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neck pain\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-12-19, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-21 00:00:00, ended at 2012-12-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-12-21, presumably until 2013-06-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-26 00:00:00, ended at 2012-12-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-26, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-09 00:00:00, ended at 2013-01-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-01-09, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-03-31, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-12 00:00:00, ended at 2013-01-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n- Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-07-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-01-12. Instructions: take 1 Tab by mouth 2 times a day as needed.  \n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-01-13, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-20 00:00:00, ended at 2013-01-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2013-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-02-07 00:00:00, ended at 2013-02-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-07, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-02-07, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-20 00:00:00, ended at 2013-02-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-02-20, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 10:28:21, ended at 2013-02-24 11:53:30\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Bipolar disorder\n- Hyperlipidemia\n- Insomnia\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-24, presumably until 2013-03-20, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- quetiapine 50 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-04-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-02-24, presumably until 2013-09-13, with intended 3 refill(s). Instructions: take 1 Felman by mouth every bedtime as needed for Insomnia.\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-06-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-20 00:00:00, ended at 2013-03-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-03-20, presumably until 2013-04-04, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Hyperlipidemia\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-07, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-04-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-04 00:00:00, ended at 2013-04-04 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-04, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-05 00:00:00, ended at 2013-04-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-07 00:00:00, ended at 2013-04-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n- Bipolar disorder\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2014-03-16, with intended 3 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-28, with intended 6 refill(s). Instructions: take 3 Tabs by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-21 00:00:00, ended at 2013-04-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-05-05, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-06-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-25 00:00:00, ended at 2013-04-25 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 5 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-28 11:09:55, ended at 2013-04-28 12:48:57\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Disorder of lumbar spine\n- Disorder of muscle\n- Mucopurulent chronic bronchitis\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- 12 HR oxycodone hydrochloride 40 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. For chronic pain\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2013-04-28, presumably until 2014-07-02, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-03 00:00:00, ended at 2013-05-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-05, presumably until 2013-05-17, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2013-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Disorder of muscle\n\n### Drug\n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2013-05-05, presumably until 2013-06-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-14 00:00:00, ended at 2013-05-14 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-15, presumably until 2013-05-15, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-17 00:00:00, ended at 2013-05-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-17, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-18 00:00:00, ended at 2013-05-18 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Disorder of muscle\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-06-12, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2013-06-02, presumably until 2013-08-16, with intended 3 refill(s). Instructions: Use as directed as needed for allergic reaction\n- 12 HR oxycodone hydrochloride 30 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-02, presumably until 2013-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-07 00:00:00, ended at 2013-06-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-10-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-12 00:00:00, ended at 2013-06-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-12, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Essential hypertension\n- Hyperlipidemia\n- Inflammatory disorder of digestive tract\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-06-21, presumably until 2015-05-17, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-23, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-04-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-12-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- ranitidine 150 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-18, with intended 3 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-20, presumably until 2013-06-28, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-23 00:00:00, ended at 2013-06-23 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-06-23, presumably until 2013-07-05, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-26 00:00:00, ended at 2013-06-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-28 00:00:00, ended at 2013-06-28 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-28, presumably until 2013-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-05 00:00:00, ended at 2013-07-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-05, presumably until 2013-07-19, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-07-06 00:00:00, ended at 2013-07-06 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Recurrent major depression\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-07-24. Instructions: take 1 Tab by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-08-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-16 00:00:00, ended at 2013-07-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-07-16, presumably until 2013-07-16, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-17 11:30:09, ended at 2013-07-17 12:59:33\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Osteoarthritis of knee\n- Mucopurulent chronic bronchitis\n- Chronic pain syndrome\n- Disorder of muscle\n- Recurrent major depression\n- Essential hypertension\n\n### Drug\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2013-07-17, presumably until 2013-12-12, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day. For muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-19, presumably until 2013-08-18, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-21 00:00:00, ended at 2013-07-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-21, presumably until 2013-10-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-15 00:00:00, ended at 2013-08-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-08-15, presumably until 2014-05-06, with intended 4 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-16 12:58:26, ended at 2013-08-16 14:26:39\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.400 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Obstructive sleep apnea syndrome\n- Hyperlipidemia\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Backache\n- Bipolar disorder\n- Disorder of muscle\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Chronic sinusitis\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-16, presumably until 2013-08-18, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- azithromycin 250 MG Oral Tablet, started on 2013-08-16, presumably until 2013-09-20, with intended 0 refill(s). Instructions: Take 2 tabs today, then 1 tab daily for next 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-17 00:00:00, ended at 2013-08-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-08-18, presumably until 2013-10-11, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-30 08:49:35, ended at 2013-08-30 10:39:58\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Disorder of muscle\n- Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-09-13, presumably until 2014-03-27, with intended 4 refill(s). Instructions: take 1 Pohl by mouth every bedtime as needed for Insomnia.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-09-13, presumably until 2013-09-13, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-09-13, presumably until 2013-10-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-14 00:00:00, ended at 2013-09-14 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of muscle\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2013-09-14, presumably until 2014-10-03, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-20 12:43:54, ended at 2013-09-20 13:48:20\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Chronic pain syndrome\n- Essential hypertension\n- Disorder of lumbar spine\n- Disorder of muscle\n- Morbid obesity\n- Borderline personality disorder\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2013-09-20, presumably until 2013-10-30, with intended 0 refill(s). Instructions: Take 60 mg a day per Dr. Pritts\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-09 00:00:00, ended at 2013-10-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Primary diagnosis: Recurrent major depression\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-10-09, presumably until 2014-02-21, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-10-10, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-04-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-10-11, presumably until 2013-11-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- alprazolam 2 MG Oral Tablet, started on 2013-10-09, presumably until 2013-10-09, with intended 4 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-23 00:00:00, ended at 2013-10-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, started on 2013-10-23, presumably until 2013-12-15, with intended 0 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-30 00:00:00, ended at 2013-10-30 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2013-11-08, presumably until 2014-04-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2013-12-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-01 00:00:00, ended at 2013-11-01 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2013-11-01, presumably until 2013-11-01, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-20 09:06:04, ended at 2013-11-20 11:05:24\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Morbid obesity\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Backache\n- Chronic pain syndrome\n- Disorder of lumbar spine\n- Chronic pain\n\n### Drug\n- influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension, through Intramuscular route, started on 2013-11-20, presumably until 2013-11-21, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-12-11, presumably until 2014-03-28, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-12-11, presumably until 2014-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-12 00:00:00, ended at 2013-12-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Backache\n\n### Drug\n- baclofen 10 MG Oral Tablet, started on 2013-12-12, presumably until 2014-04-22, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 3 TIMES A DAY. FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-15 00:00:00, ended at 2013-12-15 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-12-15, presumably until 2015-04-10, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-01-08, presumably until 2014-02-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2014-01-08, presumably until 2015-03-26, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-01-08, presumably until 2014-04-09, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-09 08:49:38, ended at 2014-02-09 10:07:01\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis of knee\n- Primary diagnosis: Carpal tunnel syndrome\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of lumbar spine\n- Disorder of muscle\n- Major depression, single episode\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-02-09, presumably until 2014-03-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-02-21 00:00:00, ended at 2014-02-21 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-02-21, presumably until 2014-05-05, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-03-09 00:00:00, ended at 2014-03-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-03-09, presumably until 2014-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Capsule, started on 2014-03-16, presumably until 2014-06-08, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-27 00:00:00, ended at 2014-03-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n- Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2014-03-28, presumably until 2014-06-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- temazepam 30 MG Oral Capsule, started on 2014-03-27, presumably until 2014-08-20, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-04-05 00:00:00, ended at 2014-04-05 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:28:35, ended at 2014-04-09 11:39:27\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 10.5 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 36 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.24 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 4.480 (micro-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Backache\n- Carpal tunnel syndrome\n- Primary diagnosis: Major depression, single episode\n- Essential hypertension\n- Chronic pain syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-04-09, presumably until 2014-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n", "cumulated_visit_num": 67, "cumulated_approximate_token_count": 13894}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient's next Cholesterol [Mass/volume] in Serum or Plasma measurement will be normal or abnormal based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-20 00:00:00, ended at 2012-11-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Inflammatory disorder of digestive tract\n\n### Drug\n- ranitidine 150 MG Oral Tablet, started on 2012-11-20, presumably until 2013-06-21, with intended 6 refill(s). Instructions: TAKE 1 TABLET TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-25 10:35:50, ended at 2012-11-25 12:02:19\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Urine: 81.4 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 157 (milligram per deciliter)\n- Albumin [Mass/volume] in Urine: 86.5 (microgram per milliliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Albumin/Creatinine [Mass Ratio] in Urine: 106.3 (milligram per gram of creatinine)\n- Body height: 5' 4\" (inch (US))\n- Cholesterol [Mass/volume] in Serum or Plasma: 177 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 105 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Inflammatory disorder of digestive tract\n- Bipolar disorder\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-11-25, presumably until 2012-12-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2012-12-09 00:00:00, ended at 2012-12-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-09, presumably until 2012-12-26, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-19 00:00:00, ended at 2012-12-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Neck pain\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2012-12-19, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-21 00:00:00, ended at 2012-12-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of muscle\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2012-12-21, presumably until 2013-06-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-12-26 00:00:00, ended at 2012-12-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2012-12-26, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-09 00:00:00, ended at 2013-01-09 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-01-09, presumably until 2013-02-07, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-03-31, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-01-09, presumably until 2013-01-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-12 00:00:00, ended at 2013-01-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n- Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-07-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2013-01-12, presumably until 2013-01-12. Instructions: take 1 Tab by mouth 2 times a day as needed.  \n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-01-13, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-01-20 00:00:00, ended at 2013-01-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of muscle\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-01-20, presumably until 2013-02-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-02-07 00:00:00, ended at 2013-02-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-07, presumably until 2013-02-24, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-02-07, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-20 00:00:00, ended at 2013-02-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n- Disorder of muscle\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-02-20, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed (for breakthrough pain).\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 10:28:21, ended at 2013-02-24 11:53:30\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of lumbar spine\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Bipolar disorder\n- Hyperlipidemia\n- Insomnia\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-02-24, presumably until 2013-03-20, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- quetiapine 50 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-04-28, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-02-24, presumably until 2013-09-13, with intended 3 refill(s). Instructions: take 1 Felman by mouth every bedtime as needed for Insomnia.\n- alprazolam 2 MG Oral Tablet, through Oral route, started on 2013-02-24, presumably until 2013-06-20, with intended 3 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed for Anxiety.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-20 00:00:00, ended at 2013-03-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-03-20, presumably until 2013-04-04, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-03-31 00:00:00, ended at 2013-03-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Hyperlipidemia\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-07, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-04-25, with intended 6 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-03-31, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-04 00:00:00, ended at 2013-04-04 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-04, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-05 00:00:00, ended at 2013-04-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-04-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-04-07 00:00:00, ended at 2013-04-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n- Bipolar disorder\n- Primary diagnosis: Essential hypertension\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2014-03-16, with intended 3 refill(s). Instructions: take 2 Tabs by mouth Every Day.\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-28, with intended 6 refill(s). Instructions: take 3 Tabs by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-07, presumably until 2013-04-25, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-21 00:00:00, ended at 2013-04-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-04-21, presumably until 2013-05-05, with intended 3 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-06-07, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-04-25 00:00:00, ended at 2013-04-25 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Hyperlipidemia\n- Essential hypertension\n\n### Drug\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 5 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-04-25, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-28 11:09:55, ended at 2013-04-28 12:48:57\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Disorder of lumbar spine\n- Disorder of muscle\n- Mucopurulent chronic bronchitis\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- 12 HR oxycodone hydrochloride 40 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. For chronic pain\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-04-28, presumably until 2013-06-21, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- NDA020983 60 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2013-04-28, presumably until 2014-07-02, with intended 3 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-03 00:00:00, ended at 2013-05-03 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n- Cervical spondylosis without myelopathy\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-05, presumably until 2013-05-17, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-05-08, presumably until 2013-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-05 00:00:00, ended at 2013-05-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Disorder of muscle\n\n### Drug\n- 12 HR oxycodone hydrochloride 20 MG Extended Release Oral Tablet, through Oral route, started on 2013-05-05, presumably until 2013-06-02, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-14 00:00:00, ended at 2013-05-14 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-15, presumably until 2013-05-15, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-17 00:00:00, ended at 2013-05-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-17, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-18 00:00:00, ended at 2013-05-18 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Disorder of muscle\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-06-12, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2013-06-02, presumably until 2013-08-16, with intended 3 refill(s). Instructions: Use as directed as needed for allergic reaction\n- 12 HR oxycodone hydrochloride 30 MG Extended Release Oral Tablet, through Oral route, started on 2013-06-02, presumably until 2013-06-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-05-31 00:00:00, ended at 2013-05-31 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-05-31, presumably until 2013-05-31, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-07 00:00:00, ended at 2013-06-07 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Joint pain\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Recurrent major depression\n\n### Drug\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-06-21, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-06-07, presumably until 2013-10-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-12 00:00:00, ended at 2013-06-12 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-12, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Essential hypertension\n- Hyperlipidemia\n- Inflammatory disorder of digestive tract\n- Mucopurulent chronic bronchitis\n- Type 2 diabetes mellitus without complication\n- Primary diagnosis: Recurrent major depression\n- Allergic rhinitis\n\n### Drug\n- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2013-06-21, presumably until 2015-05-17, with intended 3 refill(s). Instructions: 2 Sprays by Nasal route Every Day.\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, through Oral route, started on 2013-06-23, presumably until 2013-06-23, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 to 6 hours as needed for Cough.\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-04-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- metformin hydrochloride 500 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-05-08, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n- quetiapine 100 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2013-12-11, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- ranitidine 150 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-18, with intended 3 refill(s). Instructions: take 150 mg by mouth 2 times a day.\n- lisinopril 20 MG Oral Tablet, through Oral route, started on 2013-06-21, presumably until 2014-07-03, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-20 00:00:00, ended at 2013-06-20 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Agoraphobia without history of panic disorder without limited symptom attacks\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-20, presumably until 2013-06-28, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-23 00:00:00, ended at 2013-06-23 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-06-23, presumably until 2013-07-05, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-06-26 00:00:00, ended at 2013-06-26 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-06-28 00:00:00, ended at 2013-06-28 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-06-28, presumably until 2013-08-15, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-05 00:00:00, ended at 2013-07-05 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-05, presumably until 2013-07-19, with intended 0 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-07-06 00:00:00, ended at 2013-07-06 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Recurrent major depression\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-07-24. Instructions: take 1 Tab by mouth 2 times a day.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-07-07, presumably until 2013-08-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-16 00:00:00, ended at 2013-07-16 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-07-16, presumably until 2013-07-16, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-07-17 11:30:09, ended at 2013-07-17 12:59:33\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Bipolar disorder\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Disorder of lumbar spine\n- Osteoarthritis of knee\n- Mucopurulent chronic bronchitis\n- Chronic pain syndrome\n- Disorder of muscle\n- Recurrent major depression\n- Essential hypertension\n\n### Drug\n- baclofen 10 MG Oral Tablet, through Oral route, started on 2013-07-17, presumably until 2013-12-12, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day. For muscle spasm\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-19 00:00:00, ended at 2013-07-19 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-07-19, presumably until 2013-08-18, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-07-21 00:00:00, ended at 2013-07-21 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Bipolar disorder\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-07-21, presumably until 2013-10-25, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-08-15 00:00:00, ended at 2013-08-15 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- alprazolam 2 MG Oral Tablet, started on 2013-08-15, presumably until 2014-05-06, with intended 4 refill(s). Instructions: TAKE 1 TABLET ORALLY 4 TIMES A DAY AS NEEDED FOR ANXIETY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-16 12:58:26, ended at 2013-08-16 14:26:39\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.74 (million per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.5 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.5 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.7 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 31 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.1 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 39 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 101 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 2.400 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 72 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 58 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 184 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 71 (international unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.96 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.2 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 107 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.8 (percent)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 155 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 52 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Obstructive sleep apnea syndrome\n- Hyperlipidemia\n- Primary diagnosis: Recurrent major depression\n- Cervical spondylosis without myelopathy\n- Backache\n- Bipolar disorder\n- Disorder of muscle\n- Type 2 diabetes mellitus without complication\n- Essential hypertension\n- Chronic sinusitis\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2013-08-16, presumably until 2013-08-18, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-08-16, presumably until 2013-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- azithromycin 250 MG Oral Tablet, started on 2013-08-16, presumably until 2013-09-20, with intended 0 refill(s). Instructions: Take 2 tabs today, then 1 tab daily for next 4 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-08-17 00:00:00, ended at 2013-08-17 00:00:00\nThe patient in this visit was 50 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-08-18, presumably until 2013-10-11, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-08-30 08:49:35, ended at 2013-08-30 10:39:58\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Borderline personality disorder\n- Primary diagnosis: Disorder of muscle\n- Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n\n### Drug\n- temazepam 30 MG Oral Capsule, through Oral route, started on 2013-09-13, presumably until 2014-03-27, with intended 4 refill(s). Instructions: take 1 Pohl by mouth every bedtime as needed for Insomnia.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-09-13, presumably until 2013-09-13, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-09-12 00:00:00, ended at 2013-09-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-09-13, presumably until 2013-10-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-09-14 00:00:00, ended at 2013-09-14 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of muscle\n\n### Drug\n- gabapentin 300 MG Oral Capsule, started on 2013-09-14, presumably until 2014-10-03, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH TWICE A DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-20 12:43:54, ended at 2013-09-20 13:48:20\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Chronic pain syndrome\n- Essential hypertension\n- Disorder of lumbar spine\n- Disorder of muscle\n- Morbid obesity\n- Borderline personality disorder\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, started on 2013-09-20, presumably until 2013-10-30, with intended 0 refill(s). Instructions: Take 60 mg a day per Dr. Pritts\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-09 00:00:00, ended at 2013-10-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Long-term drug therapy\n\n### Condition\n- Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n- Primary diagnosis: Recurrent major depression\n- Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2013-10-09, presumably until 2014-02-21, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n- bupropion hydrochloride 100 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-10-10, with intended 6 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n- simvastatin 40 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2013-10-09, with intended 3 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2013-10-09, presumably until 2014-04-23, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 3 to 4 hours as needed for Pain.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-10-11, presumably until 2013-11-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed for Pain.\n- alprazolam 2 MG Oral Tablet, started on 2013-10-09, presumably until 2013-10-09, with intended 4 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-23 00:00:00, ended at 2013-10-23 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, started on 2013-10-23, presumably until 2013-12-15, with intended 0 refill(s). Instructions: TAKE 3 TABLETS BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-10-30 00:00:00, ended at 2013-10-30 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2013-11-08, presumably until 2014-04-13, with intended 6 refill(s). Instructions: take 1 Cap by mouth daily.\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-11-08, presumably until 2013-12-11, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-11-01 00:00:00, ended at 2013-11-01 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, started on 2013-11-01, presumably until 2013-11-01, with intended 1 refill(s). Instructions: TAKE 1 TABLET BY MOUTH EVERY 3-4 HOURS AS NEEDED FOR PAIN\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-11-20 09:06:04, ended at 2013-11-20 11:05:24\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Major depression, single episode\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Morbid obesity\n- Essential hypertension\n- Type 2 diabetes mellitus without complication\n- Disorder of muscle\n- Backache\n- Chronic pain syndrome\n- Disorder of lumbar spine\n- Chronic pain\n\n### Drug\n- influenza A virus vaccine, A-Victoria-361-2011 (H3N2)-like virus 0.03 MG/ML / influenza A-California-7-2009-(H1N1)v-like virus vaccine 0.03 MG/ML / influenza B virus vaccine, B-Massachusetts-2-2012-like virus 0.03 MG/ML Injectable Suspension, through Intramuscular route, started on 2013-11-20, presumably until 2013-11-21, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle One Time.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2013-12-11, presumably until 2014-03-28, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-11 00:00:00, ended at 2013-12-11 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2013-12-11, presumably until 2014-01-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-12-12 00:00:00, ended at 2013-12-12 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chronic pain\n- Primary diagnosis: Backache\n\n### Drug\n- baclofen 10 MG Oral Tablet, started on 2013-12-12, presumably until 2014-04-22, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH 3 TIMES A DAY. FOR MUSCLE SPASM\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-12-15 00:00:00, ended at 2013-12-15 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- divalproex sodium 250 MG Delayed Release Oral Tablet, through Oral route, started on 2013-12-15, presumably until 2015-04-10, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cervical spondylosis without myelopathy\n- Chronic pain syndrome\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-01-08, presumably until 2014-02-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 to 8 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-08 00:00:00, ended at 2014-01-08 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- simvastatin 40 MG Oral Tablet, started on 2014-01-08, presumably until 2015-03-26, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- metformin hydrochloride 500 MG Oral Tablet, started on 2014-01-08, presumably until 2014-04-09, with intended 6 refill(s). Instructions: TAKE 1 TAB BY MOUTH 2 TIMES A DAY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-09 08:49:38, ended at 2014-02-09 10:07:01\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Osteoarthritis of knee\n- Primary diagnosis: Carpal tunnel syndrome\n- Chronic pain syndrome\n- Cervical spondylosis without myelopathy\n- Type 2 diabetes mellitus without complication\n- Disorder of lumbar spine\n- Disorder of muscle\n- Major depression, single episode\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-02-09, presumably until 2014-03-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-02-21 00:00:00, ended at 2014-02-21 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mucopurulent chronic bronchitis\n\n### Drug\n- codeine phosphate 2 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution, started on 2014-02-21, presumably until 2014-05-05, with intended 4 refill(s). Instructions: TAKE 5 ML BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED FOR COUGH\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-03-09 00:00:00, ended at 2014-03-09 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain syndrome\n- Primary diagnosis: Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-03-09, presumably until 2014-04-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-16 00:00:00, ended at 2014-03-16 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR venlafaxine 150 MG Extended Release Oral Capsule, started on 2014-03-16, presumably until 2014-06-08, with intended 3 refill(s). Instructions: TAKE 2 CAPSULES BY MOUTH EVERY DAY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-03-27 00:00:00, ended at 2014-03-27 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Insomnia\n- Major depression, single episode\n\n### Drug\n- quetiapine 50 MG Oral Tablet, started on 2014-03-28, presumably until 2014-06-27, with intended 3 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY BEDTIME.\n- temazepam 30 MG Oral Capsule, started on 2014-03-27, presumably until 2014-08-20, with intended 3 refill(s). Instructions: TAKE ONE CAPSULE BY MOUTH AT BEDTIME FOR INSOMNIA\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-04-05 00:00:00, ended at 2014-04-05 00:00:00\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-04-09 10:28:35, ended at 2014-04-09 11:39:27\nThe patient in this visit was 51 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Urine: 10.5 (microgram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 61 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.3 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 44 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.50 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.8 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 180 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 190 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 103 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 36 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (international unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 262 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.24 (milligram per deciliter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 6.3 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 3.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.3 (gram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 51 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 95 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Body height: 5' 4\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.8 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.5 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 4.480 (micro-international unit per milliliter)\n- Basophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Globulin [Mass/volume] in Serum: 2.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic pain\n- Backache\n- Carpal tunnel syndrome\n- Primary diagnosis: Major depression, single episode\n- Essential hypertension\n- Chronic pain syndrome\n- Hyperlipidemia\n- Type 2 diabetes mellitus without complication\n- Cervical spondylosis without myelopathy\n\n### Drug\n- acetaminophen 325 MG / oxycodone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2014-04-09, presumably until 2014-05-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\n\nYou are a medical AI assistant predicting patient Cholesterol [Mass/volume] in Serum or Plasma trends given the patient's recent and current EHR visit records provided above. The Cholesterol [Mass/volume] in Serum or Plasma value in the current visit is 190.0 mg/dL.\n\nINSTRUCTIONS:\n- Predict if the next available Cholesterol [Mass/volume] in Serum or Plasma measurement in the following visits will be abnormal\n- For Cholesterol [Mass/volume] in Serum or Plasma, normal values are 200 mg/dL or below, while abnormal values are above 200 mg/dL.\n- Do not provide any explanation, reasoning, or additional text\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "661f53750f5b6c51fd024d417391d34c0e5794889226c1331dd7b86c399646a2", "prompt_hash": "7db020fcaf0cf80e590645340f49071d51a82c8b7c7af64b35e0b894be9aad48", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
